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Summary 
Metabolomics, the qualitative and quantitative analysis of metabolites is a valuable approach 
for understanding the biochemical processes in the cells. Particularly important are the 
intracellular metabolites that supply the cell with energy, serve as building blocks and act as 
signaling molecules. The analytical tools applied for analysis of intracellular metabolites 
should be capable to cope with the large number of metabolites to be analyzed and the 
complex matrix in the samples. Therefore the combination of separation and detection 
techniques is commonly applied for analysis of intracellular metabolites with liquid 
chromatography mass spectrometry (LC-MS) as the most commonly used.  
The primary goal of this Ph.D. study was to develop an LC-MS method together with sample 
preparation for analysis of intracellular metabolites such as nucleotides, sugar phosphates, 
organic acids, coenzymes etc.. In the studies conducted during this Ph.D. the developed 
method was used to understand how the genetic manipulations in various organisms, 
influence the levels of their intracellular metabolites. The method development was divided 
into three steps: i) optimization of the MS detection, ii) establishment and optimization of the 
chromatographic separation and iii) optimization of the sample preparation. A substantial part 
of the thesis was focused on the development of the LC-MS method. For quantitative targeted 
analysis of a group of defined metabolites, triple quadrupole (QqQ) MS was used. The 
optimization of the MS detection aimed to determine multiple reaction monitoring (MRM) 
transitions of the analytes and to increase the sensitivity by testing different ion-source 
parameters and collision energies. This resulted in optimized detection of more than 50 
intracellular metabolites. During the optimization of the chromatographic separation, anion 
exchange (AEC), ion chromatography (IC) and ion-pair reversed phase (IP-RP) were tested 
with the ion-pair giving the best compromise between retention, separation and stability of 
the compounds during the chromatographic separation. By testing different types and 
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concentrations of ion-pair reagent and different concentrations of acetic acid as a counter ion, 
it was found that a solution of 10 mM tributylamine (TBA) and 10 mM acetic acid gave the 
best compromise between chromatographic retention and separation.  
Establishment of proper sample preparation (quenching and extraction) procedures for 
intracellular metabolites was necessary in order to obtain meaningful metabolomics data. The 
main idea was to find a sample preparation method that will give the best compromise 
between an acceptable energy charge ratio (ECR, usually between 0.80-0.95) low leakage 
during the quenching and high recovery of the metabolites after the extraction. Quenching 
and extraction procedures for bacteria, yeast, mammalian cells and filamentous fungi were 
tested. Cold MeOH as a quenching method combined with boiling EtOH or 
MeOH/chloroform as extraction method showed to work well for Saccharomyces cerevisiae 
(S. cerevisiae) resulting in an ECR of 0.80-0.95 and less than 10 % leakage. Quenching of 
bacteria and fungi showed to be challenging task due to the high susceptibility of these 
organisms to leakage during quenching. Quenching using formic acid, where the cells were 
not separated from the media, was shown to work well for Lactococcus lactis (L. lactis) but 
not for Streptomyces coelicolor (S. coelicolor) and Microbispora corallina (M. corallina). 
The reason for this was speculated to be due to the filamentous growth of these organisms.  
Other quenching procedures were tested for S. coelicolor and M. corallina with -40 °C 
MeOH/H2O (60/40, v/v) giving an acceptable ECR (in the range of 0.80-0.95). However 
leakage was observed for both organisms. For filamentous fungi, filtration in combination 
with cold methanol or 0 °C saline resulted in successful quenching. In the case of cold 
methanol quenching the concentration of AMP and ADP in the quenching supernatant was 
found to be 30 % of the total amount found in the biomass and the supernatant. Saline at 0 °C 
showed to be a good quenching solution for mammalian cells as well and was combined with 
an extraction procedure based on the addition of cold MeOH and ACN/H2O (50/50, v/v).   
v 
 
In another study conducted during this Ph.D. a novel approach for creating an authentic 
matrix that can be used for validation of analytical methods was established. This 
circumvents the problem with the absence of a matrix free of the analyte which is needed for 
preparation of the calibration curves for quantification of intracellular metabolites. The 
spiking matrix was produced by extracting biomass obtained from growing S. cerevisiae in a 
media that contained 
13
C labeled glucose/non-labeled glucose (50/50, w/w). The advantage of 
this matrix was that the pools of the compounds with only 
12
C or 
13
C carbons were very low 
or even not measurable and showed minimal or no interference to the spiked amount of non-
labeled standards and their stable isotope-labeled internal standards (SIL-IS).  
Finally the developed IP-RP LC-MS method was coupled to a quadrupole time of flight (Q-
TOF) MS for multitargeted analysis, detection and identification of as many known unknown 
metabolites as possible in different biological matrices. The feasibility of using the Q-TOF 
MS was evaluated by analysis of extracts from three different organisms: S. cerevisiae, M. 
corallina and S. coelicolor. The screening concept in this study was based on two 
approaches: i) aggressive dereplication of the full scan high resolution MS (HR-MS) data 
using search lists of known compounds and ii) high resolution tandem MS (MS/HRMS) data 
searched in Metabolite Link (METLIN) library.  
The data presented here show that the methods developed during this Ph.D. study were 
successfully applied for targeted and multitargeted analysis of different classes of 
intracellular metabolites such as nucleotides, sugar phosphates, coeznymes and organic acids. 
In addition sample preparation methods were established for different microorganisms 
capable of extracting broad range of metabolites. Finally these methods have shown to be 
valuable addition to the ‘’omics’’ tools used to reveal key information regarding the 
metabolism and the regulation in the biological systems.  
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Sammenfatning 
Metabolomics, den kvalitative og kvantitative analyse af metabolitter er en værdifuld metode 
til forståelsen af de biokemiske processer i cellerne. Særligt vigtige er de intracellulære 
metabolitter, der supplerer cellen med energi, bruges som byggeklodser og fungerer som 
signalmolekyler. De analytiske redskaber anvendt til måling af intracellulære metabolitter bør 
være i stand til at håndtere den store mængde af metabolitter, der skal analyseres og den 
komplekse matrix i prøverne. Derfor anvender man normalt kombinationen af separation og 
detektion, til analysen af intracellulære metabolitter med flydende kromatografi og masse 
spektrometri (LC-MS) som den mest almindeligt anvendte.      
Hovedformålet med dette Ph.D. studium var at udvikle en LC-MS metode sammen med 
prøve forberedelse til analyse af intracellulære metabolitter såsom nukleotider, sukker 
fosfater, organiske syre, co-enzymer etc.. I studierne udført under denne Ph.D., blev den 
udviklede metode brugt til at forstå hvordan den genetiske manipulering i forskellige 
organismer påvirker niveauet af deres intracellulære metabolitter. Metode udviklingen blev 
inddelt i tre trin: i) optimering af MS-detektionen, ii) etablering og optimering af den 
kromatografiske separation og iii) optimering af prøve forberedelse. En betydelig del af 
afhandlingen fokuserede på udviklingen af denne LC-MS metode. Triple quadrupole (QqQ) 
MS blev anvendt til kvantitativ målrettet analyse af en gruppe af definerede metabolitter. 
Optimeringen af MS detektionen stilede imod at bestemme multiple reaction monitoring 
(MRM) i.f.t. overgange af analytterne og mod at forøge følsomheden ved at teste forskellige 
ion-kilde parametre samt kollisions energier. Dette resulterede i optimeret detektion af af 
mere end 50 intracellulære metabolitter. Undervejs i optimeringen af kromatografisk 
adskillelse blev anion bytning (AEC), ion kromatografi (IC) og ion-par omvendt fase (IP-RP) 
testet med det ion-par der gav det bedste kompromis mellem retention, adskillelse og 
stabilitet af stofferne igennem den kromatografiske adskillelse. Ved testning af forskellige 
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typer og koncentrationer af ion-par reagent og forskellige koncentrationer af eddikesyre som 
en modbalance ion blev det vist at en opløsning af 10 mM tributylamine og 10 mM 
eddikesyre gav det bedste kompromis mellem kromatografisk retention og adskillelse. 
Etableringen af ordentlige prøve forberedelse (quenching og ekstraktion) procedure til 
intracellulære metabolitter var nødvendig for at kunne opnå betydningsfulde data. 
Hovedformålet var at finde en metode, der ville give det bedste kompromis mellem et 
acceptabelt energi ladnings forhold (ECR, normal mellem 0.80-0.95), lav lækage under 
quenchingen og høj gendannelse af metabolitterne efter ekstraktionen. Quenching og 
ekstraktions procedure for bakterier, gær, mammale celler og filamentiøse svampe blev 
analyseret. Quenchingen af bakterier og svampe viste sig at være en udfordrende opgave på 
grund af den høje modtagelighed af disse organismer overfor lækage under quenchingen. 
Quenching med myresyre, hvor cellerne ikke blev adskilt fra mediet, blev påvist at virke godt 
for Lactococcus lactis (L. lactis), men ikke for Streptomyces coelicolor (S. coelicolor) eller 
Microbispora corallina (M. corallina). Årsagen til dette blev antaget at være på grund af 
organismernes filamentiøse vækst. Andre quenching procedurer blev testet for S. coelicolor 
og M. corallina med -40 °C MeOH/H2O (60/40, v/v), resulterende i en acceptabel ECR (i 
området 0.80-0.90). Dog blev lækage observeret for begge organismer. For filamentiøse 
svampe blev filtrering i kombination med kold metanol brugt til quenching. Men 
koncentrationerne af AMP og ADP i quenching supernatanten var omkring 30 % af den totale 
mængde fundet i biomassen og supernatanten. Kold MeOH som en quenching metode i 
kombination med EtOH eller MeOH/kloroform som ekstraktions metode viste sig at fungere 
godt for Saccharomyces cerevisiae (S. cerevisiae). Saltvand ved 0 °C viste sig, som en god 
quenchings opløsning for mammale celler imens ekstraktions proceduren var baseret på 
tilsætning af kold MeOH og ACN/H2O (50/50, v/v). 
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I et andet studie udført under denne Ph.D. blev en ny tilgang etableret til dannelsen af en 
kunstig matrix som kan bruges til validering af analytiske metoder. Med dette omgås 
problemet med mangel af en matrix fri for analytterne, som er nødvendig til forberedelsen af 
kalibreringskurverne til kvantificering af intracellulære metabolitter. Spiking matricen blev 
produceret ved at ekstrahere biomasse opnået fra voksende S. cerevisiae i et medie, som 
indeholdt 
13
C mærket glukose/umærket glukose (50/50, w/w). Fordelen ved at bruge denne 
matrix var, at puljerne af stoffer med kun 
12
C eller 
13
C kulstoffer var meget lave eller næsten 
ikke målbare og viste minimal eller ingen interferens af den spikede mængde af umærkede 
standarder og deres stabile isotopiske mærkede interne standarder (SIL-IS). 
Til slut blev den udviklede IR-RP LC-MS metode koblet til en quadropol time of flight (Q-
TOF) MS til multimålrettet analyse, detektion og identifikation af så mange kendte ukendte 
metabolitter, som muligt i forskellige biologiske matricer. Gennemførligheden ved brugen af 
Q-TOF MS blev evalueret ved at analysere ekstrakter fra tre forskellige organismer: S. 
cerevisiae, M. corallina og S. coelicolor. Screenings konceptet i dette studie, var baseret på to 
tilgange: i) aggresiv dereplikation af fuldt scannet høj opløsning MS (HR-MS) data ved brug 
af søgningslister med kendte stoffer og ii) høj opløsning tandem MS (MS/HRMS) data 
gennemsøgt i Metabolite Link (METLIN) biblioteket. 
Den data, som er blevet præsenteret her viser at metoderne udviklet under dette Ph.D. 
studium blev succesfuldt anvendt til målrettet og multimålrettet analyse af forskellige klasser 
af intracellulære metabolitter såsom nukleotider, sukker fosfater, coenzymer og organiske 
syre. Endvidere blev prøve forberedelses metoder etableret til forskellige mikroorganismer 
der let kan ekstrahere et bredt udvalg af metabolitter med god gendannelse. Slutteligt blev 
disse metoder påvist at være en værdifuld tilføjelse til ”omics” værktøjerne brugt til at 
afslører nøgle informationer angående metabolismen og reguleringen i biologiske systemer.  
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1. Introduction to the work done during this thesis 
The primary aim of this thesis was establishment of LC-MS based analytical methods for 
qualitative and quantitative analysis of intracellular metabolites from various 
microorganisms. The establishment process covered all aspects from sample preparation to 
detection by complementary separation and mass spectrometry detection. The method was 
subsequently utilized in targeted approaches to quantify the changes in intracellular 
metabolite concentrations as a response of gene alteration or stress conditions. Furthermore, 
multitargeted approach was also conducted in order to identify as many intracellular 
metabolites as possible. The ability to measure the intracellular metabolites can help in 
understanding the various biological and biochemical processes in the living organisms. 
The thesis is divided into two sections: i) introduction and ii) results and discussion. The 
introduction section describes the importance and the relevant terms in the field of the 
intracellular metabolites analysis with a focus on the analytical and sample preparation 
challenges. Resent developments in mass spectrometry and separation techniques used in 
metabolomics studies are also covered. The results and discussion section covers the results 
from the analytical and sample preparation method development and the findings from 
application of the methods for measurement of intracellular metabolites in various 
microorganisms. 
The work in this thesis resulted in 6 peer reviewed and 1 non-peer reviewed papers. 
Paper 1 covered the development of the separation and detection method which is applied for 
the analysis of nucleotides in Lactococcus lactis. 
Paper 2 applied the developed method for analysis of c-diGMP, a signaling molecule 
responsible for the shifts between the motile and sessile life in Ruegeria mobilis. 
Paper 3 applied the method in the analysis of a targeted group of intracellular metabolites 
involved in the production of vanillin-β-glucoside in Saccharomyces cerevisiae.  
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Paper 4 applied the method for measurement of the central carbon metabolites to investigate 
the effects of the recombinant protein production on the metabolism. 
Paper 5 describes an approach for creating a blank matrix that can be used for spiking and 
validation of analytical methods for measurement of intracellular metabolites. 
Paper 6 covers the multitargeted analysis of the intracellular metabolites extracted from 
various organisms. 
Paper 7 (non-peer reviewed) covers the different steps and challenges in the analysis of 
intracellular metabolites. 
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1.1 Introduction to metabolomics 
Metabolomics covers the analytical approaches and data evaluation to obtain information 
about the metabolites in a biological system [1-5]. It can be considered as the comprehensive 
qualitative and quantitative analysis of all low molecular weight (<1000 Da) metabolites both 
intracellular and extracellular [1-5]. However due to the physicochemical and structural 
diversity of the metabolites which include small organic compounds such as organic acids, 
inorganic ionic species, monosaccharides, amino acids, nucleotides, sugar phosphates etc., 
this goal has not been reached yet. Despite the primary metabolites, which are important for 
the life of the cells, a wide range of secondary metabolites exist as well, resulting in 
approximately 1000 metabolites in S. cerevisiae [6,7] or up to 200.000 in plants [2,3,8]. The 
work in this thesis was focused on the measurement of the primary metabolites that occur 
inside the cell. Therefore the following section focuses on the importance of intracellular 
metabolites.  
1.1.1 Intracellular metabolites and their importance 
In industrial biotechnology, cell factories are used for production of a range of valuable 
products such as proteins (enzymes or biopharmaceuticals), antibiotics, food additives etc. [9-
13]. The production rate and the amounts of the produced products are usually connected with 
the primary metabolism inside the cells because the primary central carbon metabolism 
provides precursors, cofactors, energy in the form of adenosine 5’-triphosphate (ATP) and 
redox equivalents such as nicotinamide adenine dinucleotide phosphate, reduced (NADPH) 
for the synthesis of the industrially relevant products [9,12]. The central carbon metabolism is 
a network of reactions that convert the main carbon source into building blocks and energy. 
According to the classical textbooks, the central carbon metabolism includes the Embden-
Meyerhof-Parnas (EMP) pathway of glycolysis, the pentose phosphate pathway (PPP), and 
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the tricarboxylic acid cycle (TCA) (Figure 1), with individual variations depending on the 
ecological position in which the organism lives [14-16].  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 1. Central carbon metabolism  
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The relevant intracellular metabolites that are involved in the central carbon metabolism can 
be classified into:  
 carboxylic acids (e.g., pyruvate),  
 phosphorylated compounds including sugar phosphates (e.g. glucose 6-phosphate (G6P)),  
 phospho-carboxylic acids (e.g., phosphoenolpyruvate (PEP)) and  
 nucleotides such as ATP, nicotinamide adenine dinucleotide (NAD+) and nicotinamide 
adenine dinucleotide phosphate (NADP+) [17]. 
Besides being energy sources and building blocks for DNA and RNA, nucleotides can act as 
signaling molecules as well. Cyclic nucleotides such as cyclic di-3',5'-guanylate (c-diGMP), 
cyclic di-3',5'-adenylate (c-diAMP), adenosine 3',5'-cyclic phosphate (cAMP) and guanosine 
3',5'-cyclic phosphate (cGMP) have key roles in signaling processes in all domains of life [18-
21].  
Understanding of the primary cellular metabolism can be utilized to increase the production 
of precursors for the industrially relevant metabolites and for optimization of the 
biotechnological processes in general. The measurement of the intracellular metabolite pools 
together with the metabolic flux analysis can help in understanding how the genetic 
manipulations affect the metabolism of the cell, to identify bottlenecks in target pathways and 
to predict targets for metabolic engineering [22,23]. Combining the metabolomics data with 
those from the genomics, transcriptomics and proteomics analysis, helps in understanding the 
metabolism and the regulations in the cells [13].   
1.1.2 Challenges in measuring intracellular metabolites 
Three properties of the intracellular metabolites make their analysis challenging [24,25]:  
i) The rapid turn-over - due to the fast turn-over rate of the metabolic pools, the 
intracellular metabolite concentrations can be adjusted rapidly to new levels. Turnover 
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times of for example the central carbon metabolism are in the range of seconds whereas 
for amino acids it is in the range of minutes. Therefore, fast sampling and metabolism 
arrest is necessary for analysis of these metabolites [24-29]; 
ii) The varied abundance - the levels of the intracellular metabolites in the cell are 
determined by the function of the enzymes and therefore at a certain metabolic state, 
some of the metabolites can be present in very high amounts, whereas others will be 
present in trace amounts [1,24,25]; 
iii) The physicochemical diversity - the intracellular metabolites exhibit different 
physicochemical characteristics and can for example contain one or more phosphate or 
carboxylic groups or both (Figure 1). Furthermore distinguishing between some of the 
metabolites can also be difficult due to the similarities in their elemental composition and 
structures [1, 24,25,28,30].  
The following sections will cover the approaches and the steps in the analysis of intracellular 
metabolites. 
1.2 Designing a metabolomics experiment-targeted versus untargeted approach  
Metabolomics can be mainly divided into two approaches: targeted and untargeted. Which 
approach will be applied depends on the question that needs to be answered [30-32].  
A substantial part of this Ph.D. study was based on the targeted approach where a 
predetermined set of metabolites related to a specific metabolic pathway of interest were 
measured. This approach answers the questions concerning the level of a specific analyte in a 
sample and enables quantification of the metabolites of interest by employing authentic 
standards for creating calibration curves [32,33]. Consequently this approach is focused on the 
quantitative changes of the measured metabolites in the cell. The advantages of the targeted 
metabolomics with QqQ are the increased specificity and sensitivity where metabolites 
7 
 
present in very low amounts can be quantified [31-33]. However it fails in detecting 
previously uncharacterized compounds because only selected metabolites are measured. 
There is a wealth of literature where selected intracellular metabolites are targeted and 
measured in order to address metabolic responses caused by e.g. genetic engineering, 
modified growth conditions etc. [34-38]. For e.g. the responses of S. cerevisiae to the redox 
perturbations caused by overexpressing nicotinamide adenine dinucleotide, reduced (NADH) 
oxidase, NADH kinase and transhydrogenase has been investigated using the targeted 
approach, by measurement of ATP, adenosine 5'-diphosphate (ADP) and the redox cofactors 
[34]. Targeted metabolomics was also applied in the study conducted by Boer et al. [37] 
where intracellular metabolites were measured in S. cerevisiae to investigate the pathways 
linking the nutrient environment to growth rate. The measurements showed that some of the 
intracellular metabolites limiting growth include glutamine, ATP, pyruvate and uridine 5'-
triphosphate (UTP). Targeted LC-MS metabolomics was also applied for investigating the 
changes in the metabolite pools due to nutrient depletion in S. coelicolor. Decrease of the 
phosphorylated metabolite pools was observed in the phosphate and glutamine limited 
cultures, while decline in the amino acid and organic pools was observed in the glutamine 
limited cultures [38].    
Untargeted metabolomics is considered to be a hypothesis free or hypothesis generating 
approach [31,32]. This approach has the aim of measuring as many known and unknown 
metabolites as possible, to answer the question what is the metabolic profile of a biological 
sample [31,32]. High resolution instruments are traditionally applied for untargeted 
metabolomics [31]. Using these instruments, information on the accurate mass, isotopic 
pattern and isotope abundances of the compounds in the sample of interest can be obtained. 
This together with the specific retention time and the accurate mass of the fragments 
facilitates the identification of the unknowns. The untargeted approach offers the advantage 
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of less method development compared to targeted approach, but the data generated is more 
complex and therefore requires additional data analysis [39]. Hundreds of peaks can be 
detected in a sample thus the manual inspection of the peaks is very time consuming. 
However with the recent developments within bioinformatics tools, identification of the 
metabolic peaks has become a relatively automated process. The accurate mass of the 
metabolite detected by the MS is searched for in a metabolite database such as METLIN [40] 
(for electrospray ionization tandem mass spectrometry, https://metlin.scripps.edu/index.php) 
or national institute for standard and technology (NIST) database [41] (for electron impact 
ionization mass spectrometry, http://www.nist.gov/srd/nist1.htm). The database match is 
considered as a putative identification of the metabolites. Thus the result must be confirmed 
by comparing the fragmentation pattern of the compound that has been assigned to the peak, 
to the measured fragmentation pattern for the particular compound in the sample of interest 
[31,40]. Untargeted metabolomics has been used to study the changes in the intracellular 
metabolic profile of the human liver cell line HEPG2 as a response to the exposure to a 
selected toxicant [42].   
Despite of the approach chosen and the question that needs to be answered the analysis of the 
intracellular metabolites can be divided into three steps: i) sample preparation, ii) sample 
analysis and iii) data analysis and interpretation. During method development (which was the 
main part of this thesis) the work flow usually starts with optimization of the metabolite 
detection followed by establishment of the sample preparation method. Therefore techniques 
for analysis of the intracellular metabolites will be discussed first followed by the most 
commonly used sample preparation methods. 
1.3 Analytical platforms used in metabolomics 
Mass spectrometry in combination with a separation method is the key technology for 
analysis of intracellular metabolites. The recent significant progress in MS based 
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metabolomics gives the researchers opportunities to choose between different separation 
techniques such as capillary electrophoresis (CE), gas chromatography (GC) and liquid 
chromatography (LC) [1,4,43-45]. MS in combination with a sample preparation and 
separation technique has high sensitivity and wide linear dynamic range and is therefore often 
used for analysis of intracellular metabolites. 
Nuclear magnetic resonance (NMR) is another technology applied for metabolomics studies. 
The advantage of NMR is the minimal requirement for sample preparation, it is not 
destructive, it is useful in structural characterization of unknowns but it has low sensitivity [1, 
[46,47].    
1.3.1 Separation techniques 
The use of a separation technique is essential for metabolomics studies due to the large 
number of metabolites to be analyzed and the complexity of the biological samples. The 
choice of separation technique (GC, CE or LC) to be applied depends on the initial goal of 
the study and the metabolite class of interest. Table 1 lists some of the advantages and 
disadvantages of the most commonly used separation techniques in combination with MS. 
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Table 1. Advantages and disadvantages of the most commonly used mass spectrometry based analytical 
techniques in metabolomics [1,17,48-50]. 
 
GC is widely used in metabolomics studies due to the high separation efficiency and the easy 
interfacing with MS [1,50,51]. GC is primarily used for thermally stable and volatile 
metabolites. Chemical derivatization (e.g. silylation) is necessary for semi-volatile 
compounds, which is considered as a time consuming step that complicates the sample 
preparation and increases the variances in the analysis [48]. In addition, a considerable 
number of very polar metabolites cannot be analyzed due to the non-volatility. Simultaneous 
analysis of amino and organic acids using GC-MS was shown to be possible using 
Technique Advantages Disadvantages Metabolites analyzed 
GC-MS  Suitable for volatile and semi 
volatile analytes  
 Good and reproducible 
separation 
 Databases available due to the 
reproducibility of the  
fragmentation  
 Not suitable for non-volatile 
and thermally labile compounds 
 Requires derivatization which is 
time consuming 
 Derivatization can cause 
difficulties in the identification 
of unknowns 
Amino acids 
Carboxylic acids 
Purines and 
pyrimidines 
Sugar phosphates 
CE-MS  Good separation 
 Requires small sample volumes 
 No buffer gradient is applied 
thus no fluctuation in the 
electrospray ionization  
 Interfacing difficulties with MS 
 Incompatible buffers with MS 
 Poor sensitivity 
 Migration time shifts 
Organic acids 
Sugar phosphates 
Nucleotides 
Coenzymes 
LC-MS  Derivatization not necessary 
 Suitable for polar, semi polar 
and non-polar metabolites 
 Offers a wide range of 
stationary phases with different 
functionalities (RP, hydrophilic 
interaction chromatography, 
ion-exchange) 
 Allows analysis of thermally 
labile analytes 
 Electrospray ionization suffers 
from matrix effects 
 Restrictions on eluents (only 
volatile buffers and additives 
can be used) 
 Fragmentation not reproducible 
as in GC-MS  
 
Organic acids 
Sugar phosphates 
Nucleotides 
Coenzymes 
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chloroformate derivatization [50], while for sugar phosphates using silylation [51]. Sellick et 
al. [52] described a protocol for analysis of several intracellular metabolites using GC-MS, 
however it was not possible to analyze the thermally labile metabolites such as ATP, ADP, 
NAD+, nicotinamide adenine dinucleotide, reduced (NADH). 
CE provides efficient separation of charged metabolites and has the advantage of a small 
volume required for analysis. It is not often used in metabolomics analysis but it is becoming 
a promising technique as shown by several published CE-MS methods for analysis of 
intracellular metabolites [30,53,54]. 
Büsher et al. [44] made an extensive comparison of GC-MS, CE-MS and LC-MS for the 
analysis of 75 intracellular metabolites such as sugar phosphates, nucleotides, coenzymes, 
redox cofactors, amino and organic acids. The three separation techniques were compared in 
terms of metabolite coverage, matrix effects, separation of isomers, sensitivity, analysis time 
and reproducibility, with LC giving the best compromise between the tested parameters. 
The coupling of LC with MS was facilitated with the introduction of atmospheric pressure 
ionization techniques such as electrospray ionization (ESI) and atmospheric pressure 
chemical ionization (APCI). The coupling of LC with MS requires compatible eluents. Non-
volatile buffers and additives (phosphate, Na
+
, K
+
 etc.) should not be used as it can affect the 
evaporation thus reducing the signal intensity. Reversed phase chromatography uses solvents 
compatible with MS (volatile buffers e.g. ammonium acetate, organic solvents e.g. methanol, 
acetonitrile). The combination of RP and acidic mobile phases has been shown to work for a 
number of nitrogen containing compounds such as amino acids, purine and pyrimidine bases 
and monophosphorylated nucleotides, but not for di and triphosphorylated compounds [55]. 
The alternatives to RP for separation of intracellular metabolites are: hydrophilic interaction 
chromatography (HILIC), AEC, IC and IP-RP. Each of these separation modes has its own 
advantages and disadvantages and some of them are summarized in Table 2. 
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Table 2. Advantages and disadvantages of the most commonly applied LC modes for separation of intracellular 
metabolites [17,56-59] 
 Advantages Disadvantages 
HILIC  enhanced sensitivity with MS 
detection (compared to RP) 
 
 cannot distinguish between structural isomers 
 reproducibility issues 
 poor peak shape 
AEC  can retain anionic compounds  high content of salt in the eluent not 
compatible with ESI 
 difficulties in elution of well retained   
compounds with multiple charges   
IC  can retain anionic compounds 
 good reproducibility 
 some metabolites are not stable at the high pH 
required for elution 
 MS not compatible solvents-suppressor needed 
Ion pair   can retain anionic compound 
 can separate structural isomers 
 more reproducible and better peak 
shape than HILIC 
 MS compatible eluents 
 system contamination 
 long equilibration time 
 operation in only one MS mode (positive or 
negative) 
 
IP-RP was used during this Ph.D. study for separation of the intracellular metabolites of 
interest and is therefore discussed in more detail. IP-RP is an alternative to ion-exchange 
chromatography and is usually considered as a modification of RP chromatography for 
retention of ionized compounds. IP-RP has been shown to be more reproducible, to give 
better separation especially for structural isomers and better peak shape than HILIC [17,57].  
Hydrophobic stationary phases and solvents containing ion-pair reagents are used to separate 
the ionic compounds in IP-RP. For retention of negatively charged compounds, alkylamines 
are typically used. The non-volatile tetraalkylammonium salts that were used in the past as 
ion-pair reagents, have nowadays been replaced by more volatile reagents such as 
dibutylamine (DBA) and tributylamine (TBA) [17,57,60-63]. The alkyl chains of the ion-pair 
reagent interact with the hydrophobic functionalities from the stationary phase while the 
amino group interacts with the negatively charged analyte. One of the hypotheses for IP-RP 
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retention assumes that the formation of the ion-pairs happens in the solution, which then 
partitions between the mobile and the stationary phase (Figure 2A) [60]. 
 
 
 
 
 
 
 
Figure 2. Schematic representation of the two mechanisms of retention in ion-pair chromatography. 
 
The second proposed mechanism, that is most commonly accepted, assumes that the 
hydrophobic part of the ion pair reagent adsorbs on the hydrophobic stationary phase to form 
a dynamic ion-exchange surface. The analyte is then retained on this surface by ion-exchange 
mechanism and formation of ion-pairs between the ionic compounds and the ion pair reagents 
with opposite charge as shown in Figure 2B [60]. 
IP-RP has been widely applied for the analysis of intracellular metabolites. Luo et al. [17] 
reported simultaneous analysis of the central carbon metabolites from Escherichia coli (E. 
coli) using IP-RP-LC tandem mass spectrometry (MS/MS). This paper also covers some of 
the most important method development steps in IP-RP such as type and concentration of the 
ion-pair reagent, the pH of the mobile phase, as well as type and strength of the organic 
solvent. The analysis of nucleotides in yeast using ion-pairing for separation has also been 
previously reported by Seifar et al. [61], while Coulier et al. uses the IP-RP separation 
method for analysis of the same metabolites in bacteria [63].  
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Despite the advantages of IP-RP over the other separation techniques for intracellular 
metabolites, several issues need to be taken into account before choosing this type of 
chromatographic separation. This technique can retain and separate only charged molecules. 
The ion pair reagent can never be fully washed from the column and the LC system, thus one 
should dedicate a particular column and LC to ion-pair application. Furthermore, since the 
ion-pair reagent can cause ion suppression, the MS needs to be operated in an ionization 
mode opposite to the charge of the ion-pair reagent used in the mobile phase.    
1.3.2 Mass spectrometry detection  
Various types of mass spectrometers are nowadays used in metabolomics approaches. They 
generally differ in the ionization source and the mass analyzer. The commonly used ion 
sources are electron ionization (EI), APCI and ESI [45,47]. EI is used in connection with GC 
and is a so called ‘’hard’’ ionization since it causes fragmentation of the molecular ion. The 
fragmentations are characteristic and reproducible, which allows identification of the MS 
peaks by comparison to those in public and commercial databases (e.g NIST that contain 
generalized collection of chemicals or FiehnLib for metabolites) [41,64]. ESI (for polar 
molecules) and APCI (for less polar molecules) are considered as ‘’soft’’ ionization 
techniques due to the low energy to which the analytes are exposed during the ionization thus 
resulting in less fragmentation [45,65]. ESI works well with polar molecules and is thus well 
suited for the intracellular metabolites. In ESI the liquid sample is nebulized, evaporated by 
applying heat and nitrogen gas and ionized under atmospheric pressure in a strong electric 
field (Figure 3) [65].  
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Figure 3. Scheme of electrospray ionization.  
A well-known problem with ESI is the matrix effect (ion suppression or enchancement) 
caused by interfering compounds that elute at the same time as the metabolite of interest [66]. 
The matrix effects are usually corrected by using SIL-IS [61,66,67] which will be discussed in 
more detail in the method validation part.  
The mass analyzer provides separation of the ions according to their mass-to-charge ratio 
(m/z). The most important criteria for the mass analyzers are: sensitivity, mass resolution, 
accuracy, scan speed or acquisition rate and MS/MS capabilities [65]. The most commonly 
applied analyzers in metabolomics studies are the quadrupole and the time-of-flight (TOF). 
The quadrupole mass analyzers are robust, relatively cheap and easy to use. It can act as a 
filter and let only ions with a certain m/z pass or it can act as a scanning instrument where 
ions of different m/z are detected consecutively thereby a mass spectrum is obtained (full 
scan mode) [65]. The operation principle in TOF involves measuring the time required for an 
ion to travel down a flight tube to the detector. TOF provides high resolution and mass 
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accuracy which allows reliable assignment of the measured masses to the elemental 
composition of a compound [45,65].    
The mass analyzers can be combined to a tandem mass spectrometer (MS/MS), where two 
mass analyzers are combined with a collision cell in between. The tandem mass 
spectrometers used during this Ph.D. were the QqQ and the Q-TOF MS. Instrumentally the 
QqQ contains two quadrupoles mass analyzers arranged in series, with a collision cell in 
between which can be a quadrupole or a hexapole (Figure 4). QqQ offers high specificity, 
sensitivity and high dynamic range [68]. 
  
Figure 4. Schematic overview of a QqQ mass spectrometer. Figure modified from Agilent 6400 Series Triple 
Quadrupole LC/MS, Concepts Guide [69]. 
 
When compared to the QqQ, in the Q-TOF instrument the third quadrupole has been changed 
by TOF mass analyzer (Figure 5). Q-TOF can be operated as a TOF or as a tandem mass 
spectrometer where a precursor ion is isolated by a quadrupole mass analyzer, fragmented in 
the collision cell and the fragment spectrum is acquired in the TOF mass analyzer. A Q-TOF 
instrument combines the high mass resolution of a TOF instrument with the MS/MS 
capability facilitating the tentative identification of unknown compounds. 
Capillary Octopole Lences Quadrupole (Q1) Quadrupole (Q2)Collision cell Detector
Nebulizer
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Figure 5. Schematic overview of a QTOF-MS instrument. Figure modified from 6200Series TOF and 6500 
Series Q-TOF LC/MS System, Concepts Guide [70]. 
 
1.3.2.1 Multiple reactions monitoring versus full scan high resolution MS  
QqQ MS are traditionally applied in the targeted approach and are typically operated in 
MRM mode (Figure 6A) [43]. In development of an MRM method a precursor ion, product 
ion and collision energy are optimized for each analyte to give the best signal. Careful 
selection of the product ions is necessary especially for structural isomers as these 
compounds often produce very similar product ions. In an MRM mode the first quadrupole 
selects the precursor ion of interest, the second quadrupole fragments the precursor ion, while 
the third quadrupole isolates the proper product ion (Figure 6A).                                           
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Figure 6. Schematic overview of the different acquisition modes used during this Ph.D. showing the difference 
in the data obtained 
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This process is repeated for each metabolite in a cyclic manner and has the advantage to 
determine selected metabolites in a few minutes from a small amount of sample. One of the 
disadvantages of the MRM is that the number of metabolites that can be measured is limited. 
By introducing too many MRM transitions into the method, the scan time per MRM needs to 
be lowered. This will compromise the signal to noise (S/N) ratio and the number of data 
points across the peak (ideally 10-20) important for reliable quantification (Figure 7) [43].  
  
 
 
Figure 7. Overlaid chromatograms showing 11 data points (red color) and 3 data points (black color) across a 
chromatographic peak. 
 
The so called dynamic MRM (DMRM) acquisition mode of the Agilent QqQ (called 
Scheduled MRM
TM 
in the QqQ from AB Sciex) offers an increased number of metabolites 
monitored per run. In DMRM or Scheduled MRM
TM
 mode, the chromatographic run is 
divided into time segments where the MRM transitions of a specific compound are monitored 
only in the time segment where the particular compound elutes. The advantage of this 
operating mode is lower number of concurrent transitions, longer dwell times per particular 
MRM, better peak symmetry, increased sensitivity and better S/N.  
Another approach to increase the number of metabolites monitored is the full scan MS 
experiments, where all ions generated from the sample are measured (Figure 6B). However, 
full scan measurements on a low resolution and low scan speed instrument such as the QqQ 
instruments are not optimal, especially for low mass compounds, due to interference from 
contaminants with the same nominal mass [43]. Furthermore, the signal of the low abundant 
Time (min)
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compounds will be hidden by the high background noise compromising the quantification. 
Full scan measurements on a high resolution instrument such as Q-TOF MS (or Furrier 
Transform MS such as Orbitrap) overcome these issues due to the high mass accuracy and 
the mass based separation.  
Q-TOF offers both full scan HR-MS (Figure 6B) and MS/HRMS measurements (Figure 6C, 
D and E). The HRMS measurements are conducted when accurate mass MS data or 
determination of precursor ion masses for subsequent MS/MS are needed. The MS/MS data 
can be obtained by the targeted MS/MS, auto MS/MS or all ions MS/MS (MS
E
 in Waters Q-
TOF instruments). 
Targeted MS/MS involves manual selection of the precursor ion based on the MS data and is 
used when the precursor ion of interest is known (Figure 6C). Using targeted approach better 
selectivity can be achieved and by comparing the fragmentation pattern with those in a 
database, identification of the compound can be achieved [71,72]. 
Auto MS/MS approach is used for obtaining MS/MS data of complex samples where the 
operator does not know which precursor ions to choose. The auto MS/MS mode provides MS 
and MS/MS data from a single run, by combining MS scan cycles with MS/MS scans of 
selected precursor ions depending on their abundance in the MS scan (Figure 6D) [65]. The 
disadvantage of this mode is that not all metabolites detected will be fragmented and the 
more concentrated metabolites will be preferred for fragmentation than the less concentrated. 
However, exclusion or inclusion lists for selection of precursor ions can help in increasing the 
fraction of metabolites that can be fragmented thus providing useful MS/MS data.  
The advantage of all ions MS/MS approach is that all the ions despite of their intensity will 
be fragmented which eliminates the need of specifying the precursor ions (Figure 6E) [64]. 
The data are acquired at both low and high collision energy. The low value produces the 
precursor ions for the compounds and the high value generates the precursor and their 
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product ions. The fragmentation patters can be used to reveal structural information about the 
known and unknowns. However this approach was not very suitable for the analysis of 
intracellular metabolites since many of them produce similar fragments which complicate the 
identification of the metabolites. 
During this Ph.D. study MRM (Paper 1-5), HRMS or MS/HRMS (Paper 6) measurements 
were used. MRM was used for the quantitative measurement of the selected list of 
metabolites relevant for the particular study. The high resolution measurements were used for 
detection and putative identification of as many metabolites as possible in the biological 
extracts. 
1.4 Sample preparation 
Due to differences in cell structure the sample preparation is organism dependent and it is 
therefore difficult to establish a general sample preparation method for both prokaryotes and 
eukaryotes [25]. During this thesis I have worked with organisms from both domains thus an 
overview of the sample preparation techniques for both prokaryote and eukaryote will be 
given. The sample preparation for intracellular metabolites analysis consists of four steps: 
rapid sampling, quenching, extraction and sample concentration. The rapid sampling is 
usually achieved by in-house developed devices and not commercially available ones. The 
main characteristics of these devices are the sampling time and the reproducibility of the 
sampling [28,73]. 
1.4.1 Quenching 
After sampling, the metabolism of the cells needs to be inactivated (quenched) in order to get 
a representative sample of the physiological state of interest. The quenching is usually 
evaluated by the adenylate energy charge ratio (ECR) given by the formula 
(ATP + 0.5ADP) (ATP + ADP + AMP)⁄  [74,75]. For a growing cell the ECR is in the range 
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of 0.80-0.95 and indicates high amount of ATP relative to ADP and AMP, thus a 
physiologically healthy cell [75].  In general there are two quenching strategies [28]. The first 
strategy allows separation of the quenching supernatant from the biomass, whereas the 
second one does not allow that separation, thus the quenching and extraction are combined. 
In both cases the quenching is usually done by changes in the pH (below 2 or above 10) or 
temperature (-40°C or 80°C) [25]. During this study, quenching using cold MeOH /water, 
cold MeOH/glycerol, formic acid, cold buffered and non-buffered saline (0.9% (w/v) NaCl) 
were tested. 
In the literature there is no agreement on which quenching technique gives the best balance 
between the main problems that arise during the quenching such as physical or chemical 
alterations of the metabolites, metabolite leakage and contamination. Table 3 lists some of the 
quenching procedures found in the literature, together with their advantages and 
disadvantages.
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Table 3. Advantages, disadvantages and applications of commonly used quenching procedures. 
 
Quenching Organism Advantages Disadvantages References 
Acid/bases   Bacteria 
 Yeast 
 Combined quenching and extraction 
therefore no losses due to leakage 
 
 Media components can interfere with 
the analysis 
 Extracellular and intracellular 
metabolites are not separated 
[76-78] 
Cold MeOH  Bacteria 
 Yeast 
 Filamentous fungi 
 Reproducible and simple 
 Allows separation of the intracellular 
metabolites from the extracellular 
 Leakage especially when applied to 
bacteria 
[35-37,61,79-
83] 
Glycerol (combined 
with methanol or 
saline) 
 Bacteria 
 Yeast 
 Cryoprotectant-no harm to cells and 
membranes 
 Lower temperatures than -40 °C can be 
obtained when combined with MeOH 
 High boiling point, difficult to remove 
it from the quenching supernatant- 
leakage cannot be evaluated   
 Residues of glycerol result in viscous 
extracts difficult to inject in LC-MS  
 Requires washing step for removing the 
glycerol residues 
[84,85] 
Cold saline  Mammalian cells 
 
 The temperature applied (0 °C) are  mild 
 Combined with filtration suitable for 
amino acids analysis  
 It is not suitable for metabolites with 
fast turn over (e.g. phosphorylated)  
[24, 86] 
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One important requirement for the quenching approach is to avoid losses of the metabolites 
due to leakage or residual metabolic activity. The chemical alteration of the metabolites 
during the sample preparation is also an issue and it is not always taken into consideration 
during the method development. Ortmayr et al. [87] and Sporty et al. [88] showed that the 
sample preparation procedure is the major contributor to the overall measurement uncertainty 
of the redox cofactors. Therefore detailed study on the stability of the analytes during the 
sample preparation is necessary for better accuracy.  
Yeast has been considered to be more stable during the quenching when compared to the 
bacteria. The first attempt at separation of the quenching supernatant from the yeast cells was 
done by Sáez and Lagunas [89] by using fast filtration followed by washing the cells with -40 
°C MeOH/H2O (60/40, v/v). Later De Konin and Van Dam [90] improved this technique by 
sampling yeast directly into -40 °C MeOH/H2O (60/40, v/v) followed by centrifugation to 
separate the cells. Nowadays this quenching technique is one of the most frequently used 
methods for sub second arrest of the enzymatic activities in the cells. However it has been 
shown that yeast is also prone to leakage during the conventional cold MeOH/H2O quenching 
which can be reduced by using pure MeOH at -40 °C or lower [81]. Furthermore, decreasing 
the exposure time of the yeast cells to the cold MeOH/H2O quenching solution will decrease 
the loss of the intracellular metabolites as a result of leakage during the quenching. Several 
other alternatives to the cold methanol technique have also been suggested in the literature. 
Villas-Bôas et al. [84] showed that by using cold glycerol/saline solution for quenching of 
yeast and bacteria better metabolite recoveries can be obtained when compared to the 
MeOH/H2O. Link et al. [85] showed that the combination of glycerol and methanol is a better 
option due to the lower viscosity of the quenching solution as well as possibilities for sample 
handling at temperatures lower than -40 °C. The glycerol/MeOH combination showed 
reduced leakage especially for ATP in E. coli when compared to the MeOH/H2O quenching.  
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Today bacteria and filamentous fungi are known to be more susceptible to leakage when 
using the current quenching procedures than for example yeast and thus the quenching of 
bacteria is a challenging task [83,91]. If possible cell separation from the quenching solution 
is usually avoided for bacteria. Thus the measurement of the intracellular metabolites requires 
preparation of two different samples, one from the entire culture and one from the culture 
supernatant. The intracellular metabolites are then determined by subtraction of the levels of 
extracellular metabolites from the sum of intra and extracellular metabolites [82]. However 
this has been shown to suffer from large standard deviations. More recent example of a 
quenching method based on pH change, where the quenching and the extraction were 
combined, was reported by Jendersen et al. for L. lactis using cold 10 M formic acid [92]. 
The quenching showed to be suitable for analysis of nucleotide phosphates.  
Due to the low amount of the intracellular metabolites and high amount of the extracellular 
compounds e.g. media components, the separation of the cells from the quenching 
supernatant is a critical issue. In general the separation of the biomass from the quenching 
supernatant is achieved by either centrifugation or filtration [24]. In this respect, the time used 
for separation is the crucial parameter. During the centrifugation the cells are exposed to low 
temperatures and a cold shock phenomenon might induce leak of the metabolites in the 
quenching supernatant [91]. Fast filtration of the bacterial cells without quenching followed 
by wash using saline solution have been shown to be a reliable quenching method for 
analysis of amino acid pools [91]. However, the washing step that is used to remove the 
residues from the extracellular metabolites can also induce leakage and loss of the 
intracellular metabolites [93,94]. Some studies showed that filtration is not a fast enough 
quenching method for analysis of the metabolites with fast turn-over rate such as the 
phosphorylated metabolites [91]. Furthermore blockage of the filter, limits the amount of 
biomass that can be separated from the quenching supernatant [24]. Care must also be taken 
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regarding the pore size of the filters that might result in loss of the cells into the filtrate. In 
respect to the quenching of filamentous fungi, Jonge et al. [95] showed that cold MeOH/H2O 
used for arresting the yeast metabolism, can also be applied for quenching of Penicillium 
chrysogenum. In this study decreasing the MeOH percentage from 60% to 40% (v/v), 
consequently the temperature from -40 to -25°C, resulted in reduced leakage. 
Mammalian cells have been shown to be more fragile than bacteria and yeast due to the lack 
of a cell wall [24]. Thus, a rapid quenching method for animal cells should retain cell 
integrity and be compatible with the separation steps used to remove culture medium from 
the cells. The conventional cold MeOH/H2O method has been shown to damage the cell 
membrane of the mammalian cells resulting in leakage and loss of the intracellular 
metabolites in the quenching medium [24]. Dietmar et al. [24] tested several different 
quenching solutions for mammalian cells such as buffered and non-buffered -40 °C 
MeOH/H2O (60/40, v/v) and 0.9 % (w/v) NaCl (0 °C), with the latter showing the least 
damage of the cell membrane and lowest leakage of the intracellular metabolites into the 
quenching solution. Furthermore, the centrifugation has been shown to be more suitable for 
the cell separation from the quenching supernatant than the filtration. The reason for the 
reduced efficiency of the filtration when compared to centrifugation was speculated to be the 
three-way interaction among cells, filter, and the quenching solution. 
Other quenching procedures given in the literature use cold EtOH/H2O mixture or liquid 
nitrogen as quenching solutions [96,97].  
1.4.2 Extraction 
The step following the metabolism arrest is the extraction of the intracellular metabolites that 
aims to disrupt the cell structure and release the metabolites from the interior of the cell. The 
extraction method should extract the metabolites in their original state in a quantitative 
manner and should prevent any chemical or physical alterations. As for the quenching there is 
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no standardized extraction method and a range of different solutions and procedures have 
been described in the literature (for references see Table 4). Furthermore, due to the high 
chemical and physical diversity of the intracellular metabolites, each solution and condition 
for extraction may favor a limited range of metabolites and work best with a certain cell type. 
Combinations of different organic solvents, elevated temperature in combination with boiling 
solvent (H2O, EtOH or MeOH), acidic or basic solutions and freeze-thaw cycles are some of 
the extraction methods for intracellular metabolites (for references see Table 4). Table 4 
summarizes the advantages and disadvantages of the commonly used procedures their 
advantages and disadvantages. 
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Table 4. Advantages and disadvantages of the most commonly used extraction procedures as well as their applications
Extraction Organism Advantages Disadvantages References 
Boiling EtOH  Yeast 
 Bacteria 
 Filamentous fungi 
 Easy and fast procedure 
 High temperature increases efficiency and 
denaturation of enzymes 
 Ethanol is not toxic 
 Some metabolites are not stable at high 
temperatures 
[35-37,62,81] 
MeOH/chloroform  Yeast 
 Bacteria 
 
 Extraction of both polar and non-polar 
metabolites 
 Denaturation of proteins by chloroform 
 Extraction at low temperature - suitable for 
thermally labile compounds 
 Labor intensive 
 Chloroform is toxic 
[27,34] 
Acid/bases   Bacteria  Usually combines quenching and 
extraction therefore no losses due to 
leakage 
 
 Some metabolites are not stable under 
extreme pH 
 Neutralization step is required for e.g. 
perchloric acid  and can result in reduced 
recovery 
 Freeze/thaw necessary to increase the 
efficiency of the extraction 
[77,98-100] 
Cold pure methanol  Bacteria 
 
 Easily removable by evaporation 
 Extraction at low temperature  suitable for 
thermally labile compounds 
 Low recoveries  
 
[97] 
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Combination of different polar and non-polar organic solvents is frequently used for 
extraction of intracellular metabolites. The combination of buffered methanol-water mixture 
together with chloroform at low temperatures has been used for extraction of intracellular 
metabolites from yeast and bacteria [27,34,101]. The advantage of this extraction is that it 
allows extraction of two big groups of metabolites, polar and non-polar, under mild 
conditions at low temperature but it has been considered as tedious and time consuming. 
Although some studies report that this combination of solvents result in poor recovery of 
some of the metabolites [102], others find this method to be optimal and comparable with the 
other extraction methods [24,101]. Boiling ethanol is a very popular extraction method 
especially for yeast [35-37,61,81]. The high temperature increases the extraction efficiency of 
ethanol as well as the denaturation of the enzymes. Furthermore ethanol is less toxic than 
chloroform. However some studies have reported poor recoveries of the phosphorylated 
metabolites and tricarboxylic acids due to high temperatures applied during extraction [24,27]. 
On the contrary, Canelas et al. [101] reported that the metabolite recoveries were similar 
when boiling ethanol and MeOH/chloroform were used for extraction of the intracellular 
metabolites from yeast. Acids (perchloric and hydrochloric acid) or alkali solutions 
(potassium and sodium hydroxide) have also been used for extraction of the metabolites that 
are stable at extreme high or low pH. Losses of many primary metabolites have been 
demonstrated by using the extraction at extreme pH [27,99]. Furthermore the acid-base 
methods due to salt production during neutralization are problematic for mass spectrometry 
applications [27,99,101]. To increase the permeability of the cells, freeze-thawing is often 
included in the extraction processes and has also been combined with the approaches where 
the cells are not separated from the quenching supernatant prior to extraction [76,92]. 
Mechanical disruption of the cell with a bead beater was used by Sporty et al. [88] for 
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analysis of NAD+ and NADH from yeast in combination with ice cold nitrogen saturated 
ammonium acetate to reduce the oxidation of NADH to NAD+.  
However, it should be noted that it is practically impossible to avoid losses of the metabolites 
during the extraction. Furthermore the diversity of the analytes makes the simultaneous 
extraction and determination of all intracellular metabolites impossible. Therefore the 
extraction method applied should be a compromise between the reproducibility, metabolite 
recoveries and compatibility with the analytical method.  
1.4.3 Concentration of the extract 
The most commonly used approaches for sample concentration is freeze drying 
(lyophilization), vacuum and nitrogen evaporation. Freeze-drying is commonly used for 
aqueous samples and has the advantages that the solvent is evaporated without using heat 
which reduces the possibility of heat degradation of the metabolites. However the freeze-
drying can be time consuming and is not very suitable if organic solvents have been used 
during the extraction [25].   
An alternative to the freeze-drying is the vacuum or nitrogen evaporation. This type of 
evaporation is more suitable for organic solvents than aqueous samples. The evaporation of 
the aqueous samples can take a longer time and usually requires heating which is not suitable 
for thermally labile compounds. 
For sample purification solid phase extraction (SPE, DSPE) is commonly applied especially 
in the case of complex matrices such as biofluids, tissue samples and environmental samples 
(lake sediment) where the quantification can be hampered by matrix effects [103-105]. Anion 
exchange SPE has also been shown to work well for phosphate removal, which can interfere 
with the analysis of the intracellular metabolites causing ion suppression [105].  Charcoal has 
been used in dispersive solid extraction to separate the aromatic from the non-aromatic 
intracellular metabolites [78,92].  
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1.5 Analytical method validation and quantification 
The main objective of any analytical measurement is to obtain reliable and reproducible data 
avoiding false positive or negative results. The validation of the analytical methods provides 
information on the quality, reliability and reproducibility of the established analytical 
method. When using LC-MS, the general validation approach involves determination of: i) 
linearity, ii) precision and accuracy/recovery, iii) limit of detection, iv) matrix effects [106-
109]. 
Linearity. The linearity of the analytical method is investigated by creating calibration 
curves in at least three orders of magnitude. In general three approaches for creating the 
calibration curves were used during this Ph.D.: i) external calibration, ii) the standard 
addition approach and iii) calibration using internal standards (Figure 8) [110]. 
 
Figure 8. Schematic illustration of the calibrations using the A. external calibration; B. standard addition and C. 
calibration using internal standard 
 
In the extracellular calibration approach, the calibration curve is prepared in a surrogate 
matrix. The surrogate matrix can be a neat solution, growth media, extract from a mutant etc. 
that does not contain the compound or contains traces of it. In this approach a stock solution 
of the compound of interest is prepared in the surrogate matrix which is then diluted to 
prepare the calibrants.  
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Luo et al. [17] and Bennette et al. [57] used the standard addition method to quantify 
metabolites from the central carbon metabolism in E. coli and Synechococcus sp., 
respectively, where known increasing concentrations of analytes were added to individual 
aliquots of the sample of interest. The concentration of the analyte in the sample was 
determined from the intercept of the calibration curve (Figure 8B). However, the standard 
addition approach can be quite laborious, time consuming and require extensive amounts of 
samples, especially when multiple samples need to be quantified. Furthermore, for 
compounds that are present in high amounts in the sample such as ATP, saturation of the 
detector might occur at the high concentration end when using the standard addition method. 
The approach using internal standards usually involves addition of known amounts of SIL-IS 
to each of the calibration solutions and to the samples to be quantified.  The quantification is 
then based on the construction of a calibration curve by plotting the ratio of the peak area of 
the unlabeled and labeled analyte versus the concentration [61]. 
Precision and accuracy/recovery. The precision and accuracy/recovery can be assessed 
using spiked and unspiked samples that are processed through the sample preparation that are 
quantified against a calibration curve. The unspiked samples in this case are used to check for 
any presence of the analyte in the spiking matrix. Usually the precision and the accuracy/ 
recovery are determined on three different levels in triplicates and on three different days in 
order to check for inter- and intra-batch variability.    
Limit of detection (LOD). LOD is the smallest amount of analyte in the sample that can be 
detected. There are several approaches for determination of the LOD such as using the S/N 
ratio, from the standard deviation of the blank or from the calibration curve [111].   
Matrix effects. As previously mentioned when ESI is used for ionization, suppression or 
enchancement (matrix effects) of the analyte signal might be observed due to coeluting 
compounds present in the biological sample [66,76,112]. When using external calibration, due 
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to differences in the matrix the obtained MS signals will be different for the same compound 
in the calibrants and the samples. This can cause over or underestimation of the 
concentration. The suppression or enhancement of the signal is especially observed when 
quenched whole broth samples of leaky cells are analyzed and even more prominent when 
rich media is used for cultivations. Therefore the validation and quantification methods for 
intracellular metabolites are more complicated and less straightforward since it is difficult if 
not impossible to find a true biological matrix that will be free of the analytes of interest. 
The standard addition method corrects for possible matrix effects because it uses the 
authentic matrix to prepare the calibrants. The method using internal standards is also capable 
of correcting for matrix effects. Both the standard and its SIL-IS will be equally affected by 
the matrix effects resulting in unchanged peak ratio that is plotted against the concentration to 
create the calibration curve. 
The suppression/enhancement of the signal depends on the chemical structure of the molecule 
thus SIL-IS are used due to their structural and physico-chemical similarity with the analyte 
of interest. However, SIL-IS are not always available and they can be very expensive 
therefore structural analogues are sometimes used as internal standards [112]. Stokvis et al. 
[67] compared the use of structural analogues and SIL-IS for several anticancer agents using 
ESI-MS and MS/MS techniques. SIL-IS showed to be preferred over the structural analogue 
for accurate quantification. In some of the case studies, performance of the assay improved 
significantly after substitution of a well-functioning analogous internal standard with a SIL-
IS. Due to the unavailability of SIL-IS for many of the intracellular metabolites, Mashego et 
al. [113] proposed an alternative way of obtaining SIL by cultivating microorganisms on U-
13
C labeled substrates and subsequent extraction of the metabolites. The U-
13
C labeled 
extracts can serve as SIL-IS and can be added before the extraction to the unlabeled cell 
samples to correct for any possible losses during the sample preparation and for matrix 
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effects. However it should be noted that some of the labeled metabolites can be present in 
very small amounts in the cell extracts and this can create difficulties related to their 
detection and their use as SIL-IS.  
1.6 Data analysis 
The workflow used for analysis of the data depends on the question that needs to be answered 
and the type of the data acquired. The metabolomics studies usually aim for assessing or 
discovering important differences between groups of samples. The analytical technologies 
used in metabolomics such as LC-MS produce large amounts of data where statistical and 
computational methods are used to evaluate this data. This typically includes univariate 
(ANOVA, t-tests etc.) or multivariate statistical approaches (principle component analysis 
(PCA), clustering, partial least square regression (PLS) etc.) [44,114]. 
During this Ph.D. study, software by the instrument vendor (Agilent Technologies) was used 
for data processing e.g. Mass Hunter Qualitative and Quantitative analysis. For targeted 
analysis, qualitative analysis software was mainly used for reviewing chromatograms, peak 
finding, evaluation of baseline etc.. For the multitargeted approach this software was used for 
putative identification of the known unknowns extracted from different matrices. In this 
respect data were processed using the find by formula algorithm where the empirical formula 
was used to find matching masses in the data. Quantitative analysis program was used for 
creating calibration curves and quantification. For the multitargeted approach this program 
was used fast screening of compounds between different samples.  
Although statistical data analysis was not performed during this Ph.D., it is worth mentioning 
the application of the commonly used statistical tools for mass spectrometry data analysis. 
Clustering (shown as a heat map) is a statistical method that involves dividing observed 
datasets into several subclasses or clusters. This method was use by Hou et al. [34] to 
investigate the impact of decreased NADH levels to the concentration of the metabolites 
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involved in the central carbon metabolism when grown on glucose and ethanol. The statistical 
analysis showed that the growth conditions had a bigger impact on the metabolic profiles than 
the perturbations. Furthermore when grown on glucose the concentration of many glycolytic 
and TCA metabolites was increased compared to when grown on ethanol.   
Principle component analysis (PCA) is another statistical tool used to discover and visualize 
important differences between groups of samples. PCA together with clustering were used to 
investigate the effects of i) loss of cytosolic superoxide dismutase function and ii) chemical-
induced oxidative stress as well as iii) the metabolic profiles of different fly species of 
Drosophila melanogaster [56]. Clustered heat map was also used by Brauer et al. [115] to 
investigate the changes in the concentrations of the intracellular metabolites in S. cerevisiae 
and E. coli after glucose and nitrogen starvation.  
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2. Results and discussion 
2.1 Targeted metabolomics  
2.1.1 Optimization of liquid chromatography QqQ method 
The primary focus in developing the presented method was qualitative and quantitative 
analysis of various intracellular metabolites. Determination and optimization of the 
compound specific multiple reaction monitoring (MRM) transitions (Paper 1) was the first 
step in the establishment of the method. Most of the intracellular metabolites are 
phosphorylated or carboxylated, producing mainly [M-H]
-
 ions. Therefore the observed 
similarities in their fragmentation patterns were expected. Phosphorylated compounds 
generated [H2PO4]
-
 and [PO3]
- 
ions as the most intense fragments, while loss of CO2 was 
observed in the spectra of the carboxylated compounds. Thus, to avoid false positive results 
due to non-specific transitions, specific fragments (e.g. corresponding to purine or pyrimidine 
groups of the nucleotides) were used when possible. This was especially necessary when 
faced with analysis of compounds with the same elemental composition such as ATP and 
deoxyguanosine 5'-triphosphate (dGTP).  
Taking into consideration the anionic nature of the intracellular metabolites several 
possibilities were tested for their chromatographic separation. Mixed-mode chromatography 
(Acclaim® Trinity™ P1) combines multiple retention mechanisms such as cation exchange, 
anion exchange and reverse phase mechanism of retention. The possibility for separation of 
compounds with different functionalities made this type of chromatography very attractive 
and it was therefore tested for separation of the intracellular metabolites with sugar 
phosphates as model compounds. Retention on the column, was obtained (Figure 9), but both 
a salt and a pH gradient did not give a sufficient separation of these compounds.  
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Furthermore the high concentration of salt (50 mM ammonium formate) necessary to elute 
the sugar phosphates was not an ESI-MS friendly mobile phase (caused contamination of the 
ion-source resulting in suppression of the MS signal). This was an additional reason not to 
proceed with further optimizations of the mixed mode based chromatographic separation. 
Interfacing IC with a Bruker Q-TOF to investigate the applicability of this type of liquid 
chromatography for separation of the intracellular metabolites was a part of a master project 
in which I was involved as a supervisor [116]. Compounds ranging from nucleotides, sugar 
phosphates, organic acids and coenzymes were taken as model compounds. The main issues 
encountered when using IC for separation were related to the instability of some of the 
intracellular metabolites under the extreme high pH used in the eluent. Multiple unknown 
chromatographic peaks were detected in the chromatograms of the redox compounds. Flavin 
adenine dinucleotide (FAD) showed to be degraded to AMP under the high pH conditions, 
 
Figure 9. Chromatograms showing similarities in RT between the sugar phosphates F6P, G6P and R5P 
obtained using mixed mode LC-QqQ. Injection volume: 1μl; Concentration: 1μg/ml. Column: Acclaim Trinity 
P1. Eluent A: 50 mM ammonium formate pH 3.5; Eluent B: ACN. Gradient: 0-3 min 70-0 % B; 3-4 min 0 % 
B; 4-4.1 min 0-70 % B; 4.1-5 min 70 % B. F6P, fructose 6-phosphate; G6P, glucose 6-phosphate; R5P, ribose 
5-phosphate. 
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while hydrolysis of acetyl coenzyme A (Ac-CoA) resulted in only one peak in the 
chromatogram that corresponded to CoA. Dihydroxyacetone phosphate (DHAP) and 
glyceraldehyde 3-phosphate (G3P) showed to be unstable during the chromatography as well. 
Phosphate was the main peak detected in the DHAP standard, while two peaks were detected 
in the chromatogram of G3P, one corresponding to G3P and the other one to phosphate.  
Due to the lack of time no further experiments were carried out using the IC-Q-TOF MS 
technique. Despite the issues regarding the instability of some of the intracellular metabolites, 
IC showed a promising potential as a technique for analysis of intracellular metabolites. It 
gave good retention and separation of the various phosphorylated and carboxylated 
metabolites and showed to be suitable for analysis carboxydrates as well. In future it can be 
considered as a complementary technique to the IP-RP.  
2.1.1.1 Ion-pair chromatography 
Ion-pair chromatography has previously been proven to be a good separation technique for 
phosphorylated and carboxylated compounds [17,57,62,63,80] and was also used during this 
study. Paper 1 outlines the main part of the work related to the development of the ion-pair 
chromatographic method. Several parameters such as type of ion-pair reagent, concentration 
of ion-pair reagent and acetic acid, pH, organic solvent and column chemistry were 
previously shown to influence the retention of the anionic compounds when ion-pair 
chromatography was used [17]. Therefore during the development process these parameters 
had to be tested.   
Volatile alkylamines with diverse alkyl chain length such as triethylamine (TEA), DBA and 
TBA, were firstly tested in order to find the best compromise between the retention and 
separation of the metabolites of interest. Ten millimolar TEA gave slightly increased 
retention but not enough to be able to separate for example the sugar phosphates. Increasing 
the concentration of the TEA in the aqueous mobile phase (from 10 to 35 mM) and the 
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addition of the ion pair reagent into the organic mobile phase did not increase the RT of for 
example G6P. Neither the incorporation of an isocratic part at the beginning of the run nor 
the lowering of the percentage of organic solvent during the run improved the retention. The 
length of the alkyl chain was considered to be responsible for the poor retention of the 
metabolites, therefore two other ion-pair reagents with longer hydrophobic chains were 
tested: DBA and TBA. Bothe DBA and TBA resulted in improved retention. In the case of 
DBA the intensity of the nucleotides was decreased when compared to TBA. In addition 
better separation for AMP and deoxyguanosine 5'-monophosphate (dGMP) was obtained 
with TBA than with DBA when using the same gradient. Therefore TBA was chosen for 
further optimizations. The changes of the TBA concentration while keeping the ratio between 
the ion-pair reagent and the acetic acid unchanged, in order to keep the pH constant, gave 
interesting results on the retention of the different groups of compounds tested (Figure 10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
In the case of the early eluting compounds such as F6P and G6P, decrease of the retention 
was observed with the increase of the TBA concentration in the eluent. Guanosine 5’-
monophosphate (GMP) and dGMP showed only slight decrease in the retention by increasing 
the concentration of the ion-pair reagent, while guanosine 5’-triphosphate (GTP) showed 
slight increase. The late eluting compound acetyl-coenzyme A (Ac-CoA) showed increase in 
the retention by increasing the TBA concentration.  
 
 
   
 
   
 
 
 
Figure 10. Chromatograms showing the effect of increased concentration of TBA in the eluent on the retention 
of different intracellular metabolites, while keeping the ratio between TBA and acetic acid constant. Column: 
Luna 2.5 µl C18 (2)-HST (100 x 2 mm). Eluent B was 90 % MeOH containing the same concentration of TBA 
and acetic acid as eluent A, respectively. Gradient: 0-5 min 0 % B; 5-10 min 0-2 % B; 10-11 min 2-9 % B; 11-
16 min 9 % B; 16-18 min 9-25 % B; 18-19 min 25-50 % B; 19-23 min 50 % B; 23-24 min 50-0 % B; 24-29 
min 0 % B. GMP, guanosine 5'-monophosphate; GTP, guanosine 5'-triphosphate; Ac-CoA, acetyl coenzyme A. 
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As described in Paper 1 the concentration of the acetic acid, consequently the pH, had also 
an influence on the retention and separation of the intracellular metabolites. Due to the 
competitive effect of the acetate ion, by increasing the concentration of the acetic acid, 
decrease of the retention was observed. Furthermore, by changing the pH from 5.5 to 7.5 
changes in the intensity ratio between the monophosphates, diphosphates and triphosphates 
occurred. At lower pH the MS signal intensity of the monophosphates and diphosphates was 
higher than the triphosphates while an opposite trend was observed with higher pH. However 
taking into account the investigations made with changing the concentration of TBA and 
acetic acid, 10 mM TBA and 10 mM acetic acid was found to give a reasonable compromise 
between elution time, resolution and sensitivity. 
Isopropanol and MeOH were tested as organic solvents. Due to the stronger elution power of 
isopropanol, the separation of the compounds was affected and therefore MeOH was chosen 
for further optimizations. In addition, different reverse phase columns were also tested such 
as Phenomenex Luna C18(2)-HST, Onyx Monilithic C18, Agilent Zorbax extended C18 and 
Poroshell 120 Phenyl-Hexyl. The effect of the column chemistry was mostly on the peak 
shape and the spreading of the compounds with Poroshell 120 Phenyl-Hexyl column giving 
the best performance.  
It should be mentioned that, a newly installed column on the system was equilibrated 
overnight with the eluent containing the TBA. Furthermore, it was noted that when using the 
36 min. gradient (Paper 1) shifting of retention times occurred only when changing to new 
eluents. There was a shift in the RT for the compound eluting in the middle of the gradient 
e.g. monophosphorylated compounds. This was assumed to be due to the very slow gradient 
in the region where the monophosphorylated compounds were usually eluting.   
Furthermore, the effect of the TBA addition in the injection vial on the analysis of the 
nucleotides was tested as well. By injecting a mixture of the nucleotides with and without 
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TBA, at least 2x increase in the signal intensity was observed when injecting the samples 
with TBA (Figure 11).  
 
Figure 11. Chromatograms showing the effect of addition of TBA in the injection vial. Injection volume: 10 
µl; Concetration: 10 µg/ml. Column: LUNA 2.5µm C18(2)-HST. Eluent A:10 mM TBA and 10 mM acetic 
acid, eluent B: 90 % MeOH containing 10 mM TBA and 10 mM acetic acid. Gradient: 0-5 min 0 % B, 5-10 
min 0-2 % B, 10-11 min 2-9 % B, 11-16 min 9 % B, 16-18min 9-25 % B, 18-19 min 25-50 % B, 19-23 min 50 
% B, 23-24 min 50-0 % B, 24-34 min 0 % B. UDP-Glc, uridine 5'-diphosphate; dATP, deoxyadenosine 5'-
triphosphate. 
This has been explained by a displacement mechanism, where the common potassium and 
sodium adducts are displaced by alkylamine adducts which increases the signal of the singly 
charged molecular ions [M−H]− [17, 117]. 
In the case of the NADH and NADPH, it was noticed that when injecting pure standards of 
these two compounds, peak of NAD
+
 was detected in the NADH standard and NADP
+
 was 
detected in the NADPH standard. This indicated that oxidation was happening in the vial and 
was noted when injecting the standards both with and without TBA in the injection vial. As 
previously reported in the literature [87] ammonium acetate pH 8 has been shown to improve 
the stability of NADPH and reduce the oxidation. In order to investigate this, the standards of 
NADH and NADPH were prepared in 5 mM ammonium acetate pH 8, which indeed reduced 
the oxidation of these two compounds. However the addition of TBA in the injection vial was 
proven to increase the sensitivity of the nucleotides. Therefore 50 μg/ml solutions of NADPH 
and NADP
+
 was prepared by diluting the ammonium acetate stock solutions (pH 8) of these 
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two compounds into eluent A which contained TBA. It was noted that the addition of TBA 
did increase the sensitivity especially for NADPH, while the intensity of NADH was 
practically not affected. Furthermore, there was a minor increase of the NAD
+
 LC-MS peak 
in the NADH standard, while no peak of NADP
+
 was detected in the NADPH standard. 
However further investigations are necessary in order to check the long term stability of the 
NADH and NADPH solutions prepared in the ammonium acetate as well as the dilutions of 
these stocks into TBA.   
Within the intracellular metabolites, there are many compounds (sugar phosphates, 
ATP/dGTP, sugar nucleotides etc.) with the same elemental composition which has been a 
challenge during the method development. These compounds can often be indistinguishable 
by MS due to their identical elemental composition as well as similar fragmentation pattern. 
Therefore the gradient used during the analysis was crucial for the separation especially for 
the sugar phosphates. The 5 min isocratic run at the beginning of the 36 min gradient given in 
Paper 1 was necessary for achieving the separation of the sugar phosphates. By introducing 
even 5 % of the organic phase at the beginning of the gradient, the separation of the sugar 
phosphates was impaired. In addition, increasing the percentage of the organic phase up to 
100 % and keeping it for 1.5 min was necessary for a complete elution of the more retained 
compounds.  
In the case of the nucleotides, some of the isomers such as AMP/dGMP were 
chromatographically separated, while that was not the case for ATP/dGTP. Due to the fact 
that ATP and dGTP were chromatographically not separated, specific fragments that 
correspond to the guanine or adenine moiety were chosen in order to be able to quantify these 
compounds.  
The thirty six minutes gradient allowed a good separation of many of the isomers, but in 
general it was considered as time consuming and not very practical when long lists of 
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samples had to be analyzed. Therefore, compromise between the analysis time and the 
separation of the nucleotides was found by a 19.5 min gradient (Paper 5). However this 
gradient could not be used for separation of the sugar phosphates. The separation of the 
isomers was also considered as a parameter for the performance of the column. The impaired 
separation for example of the sugar phosphates was a sign that the column had to be changed. 
The retention of the compounds when using ion-pair chromatography depends on the number 
of charged groups present in the molecule that could interact with the ion-pair reagent. In the 
case of the phosphorylated and/or carboxylated compounds, correlation between the retention 
time (RT) and the number of the phosphate and/or carboxylic groups was observed. The 
order of elution for example of the phosphorylated nucleotides was monophosphates < 
diphosphates < triphosphates. The same was observed for the carboxylated compounds. 
Understanding the mechanism of the chromatographic retention allowed prediction of the RT 
of the known unknowns and helped in their identification in the sample extract although 
standards for these compounds were not available in house (Paper 6).  
The fact that the reversed phase mechanism of action is also involved in the retention was 
shown by the analysis of the amino acids (Paper 6). The aromatic amino acids, tyrosine (RT 
1.3 min) and phenylalanine (RT 2.2 min) were retained using ion-pair chromatography 
(Figure 12), although their overall charge was 0. 
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Figure 12. Chromatogram showing the reversed phase mechanism of retention during the IP-RP by retaining 
the tyrosine (RT 1.3 min) and phenylalanine (RT 2.2 min) which overall charge was 0. (Dead volume = 0.8 
min). Column used: Poroshell 120 Phenyl-Hexyl. Eluent A:10 mM TBA and 10 mM acetic acid, eluent B: 90 
% MeOH containing 10 mM TBA and 10 mM acetic acid. Gradient: 0-5 min 0 % B, 5-10 min 0-2 % B, 10-11 
min 2-9 % B, 11-16 min 9 % B, 16-24 min 9-50 % B, 24-28 min 50 % B, 28-28.5 min 100 % B, 28.5-30 min 
100 % B, 30-30.5 min 100-0 % B, 30.5-36 min 0 % B. 
This could be explained by the reversed phase interactions between the aromatic part of the 
amino acids and the phenyl hexyl groups from the stationary phase. Although the column was 
covered by the ion-pair reagent, the reverse phase mechanism of interaction was also 
responsible for the retention. Furthermore the tyrosine was eluting earlier due to the presence 
of the polar hydroxyl group.  
Summary of the tested conditions during the optimization of the ion-pair separation of the 
intracellular metabolites and the results obtained is given in Table 5. Furthermore, a list of 
standard metabolites for which detection was optimized is given in Supplementary material. 
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Table 5. Summary of the tested conditions and the results obtained from the optimization of the ion-pair 
chromatography. 
                  1NMPs - nucleotide monophosphates; NDPs – nucleotide diphosphates; NTPs – nucleotide triphosphates 
 
 
 
 
 
Tested conditions Result 
Type of ion pair reagent RT increases by an increase of the number and the length 
of the alkyl chains (TEA<DBA<TBA) 
 TEA - not enough RT to achieve good separation 
 DBA- lower intensity of the nucleotides when 
compared to TBA 
 TBA -  gives better separation of the isomers AMP and 
dGMP than DBA 
Increasing the concentration of TBA 
while keeping the pH constant 
 Early eluting compounds - RT decreases 
 Compounds eluting in the middle of the gradient - RT 
slightly affected 
 Late eluting compounds - RT increases  
Changing pH while keeping the 
concentration of TBA constant 
 pH 5.4: NMPs and NDPs higher intensity than NTPs
1
 
 pH 7.7: NMPs and NDPs lower intensity than  NTPs 
Column chemistry Affects peak shape and separation 
Organic solvent  Isopropanol - stronger elution power than MeOH 
 Better compromise between the retention and 
separation with MeOH than isopropanol 
Addition of TBA in the injection 
solvent 
In general increases the intensity of the analytes 
Isocratic run at the beginning of the 
run 
Necessary to separate the sugar phosphates 
Keeping 100 % of organic phase 
during the gradient 
Necessary for complete elution of the more retained 
compounds  
Column equilibration Overnight equilibration with the eluent containing the 
ion-pair reagent is necessary 
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2.1.2 Establishment of  quenching and extraction procedures 
This section outlines the work done during this Ph.D. study related to the testing of different 
sample preparation methods for yeast, bacteria, filamentous fungi and mammalian cells. ECR 
of 0.80-0.95 was taken as criteria for a successful quenching. The organisms for which 
several different quenching and extraction procedures were tested during this Ph.D. study as 
well as the aim of the studies are given in Table 6. 
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Table 6. Quenching and extraction procedures tested, the obtained energy charge ratio and the aim of the study of the different organisms during this Ph.D. 
1 The numbers in the brackets indicate standard deviation (SD) 
2 This extraction method was applied on yeast but not during the vanillin-β-glucoside project 
                                                          
a
 The Microbispora corallina project was called LAPTOP and was funded from the European Commission contract no. 245066 for FP7-KBBE-2009-3. 
Organism Aim of  the study Quenching Extraction ECR (SD)1 Metabolites 
measured 
Saccharomyces 
cerevisiae 
Is the difference in the 
production of vanillin-β-
glucoside between two 
yeast strains related to 
the differences in their 
intracellular metabolite 
pools? 
1. -40 °C MeOH/ H2O (60/40, v/v) 
 
1.1. Boiling EtOH/H2O (75/25, v/v) 
1.2.  MeOH/CH3Cl (2:1, v/v)
2 
 
1. 0.91 (0.01) 
1.2. 0.91 (0.006) 
 
ATP, ADP, AMP, 
redox cofactors, UDP, 
UDP-Glc and UTP 
Lactococcus lactis Dispersive solid phase 
extraction of nucleotides  
     10 M HCOOH  3x freeze/thaw  0.97(0.0001) Nucleotides  
Ruegeria mobilis Are shifts between 
motile and sessile life 
correlated to intracellular 
concentrations of c-
diGMP? 
1.  10 M HCOOH  
2.  cooling on ice 
1.  3x freeze/thaw 
2.  Boiling EtOH/H2O (75/25, v/v) 
- 
- 
c-diGMP 
Microbispora 
corallinaa 
Is the improved 
production of lantabiotic 
correlated to the changes 
in the energy 
metabolism?  
1.  10 M HCOOH  
2. -40 °C MeOH/glycerol (60/40, v/v) 
3. -40 °C MeOH/glycerol (40/60, v/v) 
4. Phosphate buffered saline (PBS) 
5. -40 °C MeOH/10 mM HEPES (60/40, v/v) 
6. -40 °C MeOH/ H2O (60/40, v/v) 
 
1.  3x freeze/thaw 
2.  Boiling EtOH/H2O (75/25,  v/v) 
3.  Boiling EtOH/H2O (75/25, v/v) 
4.  CH3COONH2 and bead beater 
5.  Boiling EtOH/H2O (75/25, v/v) 
6.1.  Boiling EtOH/H2O (75/25, v/v) 
6.2.  MeOH/CH3Cl (2:1, v/v) 
1. 0.80 (0.004); 0.28 (0.1) 
2. 0.06 (0.01) 
3. 0.06 (0.02) 
4. 0.16 (0.03) 
5. 0.62 (0.03) 
6.1. 0.58 (0.07) 
6.2. 0.87 (0.01) 
ATP, ADP, AMP, 
redox cofactors 
Streptomyces 
coelicolor 
The effects of altered 
redox and energy levels 
on the production of two 
antibiotics. 
1. 10 M HCOOH 
2. -40 °C MeOH/ H2O (60/40, v/v) 
 
1.  3x freeze/thaw 
2.1.  Boiling EtOH/H2O (75/25, v/v) 
2.2.  MeOH/CH3Cl (2:1, v/v) 
1. 0.54 (0.01) 
2.1. 0.52 (0.12) 
2.2. 0.89 (0.03) 
ATP, ADP, AMP, 
redox cofactors 
Chinese hamster 
ovary cells (CHO) 
Are the differences in 
erythropoietin 
productivity between 
two clones related to the 
difference in their central 
carbon metabolism? 
Ice cold 0.9 % (w/v) NaCl MeOH and ACN 0.92 (0.02) Glycolytic 
intermediates, ATP, 
ADP, AMP, redox 
cofactors 
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 Table 6. Continued 
 
Organism Aim of  the study Quenching Extraction ECR (SD) Metabolites 
measured 
Aspergilus nidulans Testing different 
quenching and extraction 
procedures (master thesis 
project) 
1. -40 °C MeOH/ H2O (40/60, v/v)  
2. 0°C 0.9% (w/v) NaCl  
 
1.1 Centrifugation; MeOH/H2O (40/60, v/v), 3x freeze/thaw 
1.2 Filtration,  MeOH/H2O (40/60, v/v), 3x freeze/thaw 
1.3 Centrifugation, MeOH/CH3Cl (2:1,v/v) 
1.4. Filtration,  MeOH/CH3Cl (2:1,v/v) 
 
2.1 Centrifugation; MeOH/H2O (40/60, v/v), 3x freeze/thaw 
2.2 Filtration,  MeOH/H2O (40/60, v/v), 3x freeze/thaw 
2.3 Centrifugation, MeOH/CH3Cl (2:1,v/v) 
2.4. Filtration,  MeOH/CH3Cl (2:1,v/v) 
 0.79 (0.01)  
0.24 
 0.80 (0.04)  
 0.85(0.02) 
  
 0.79 (0.08)  
 0.24 
 0.85 (0.02)  
 0.84 
ATP, ADP, AMP 
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Yeast. Establishment of quenching and extraction procedures for S. cerevisiae has been a part 
of the work during this thesis. S. cerevisiae is a widely studied organism [27,34-37,79-81]. 
One of the most commonly applied quenching method for this organism is -40 °C MeOH/ 
H2O (60/40, v/v). In order to check the leakage during the cold MeOH quenching, four 
different types of S. cerevisiae samples were quenched and extracted: whole broth, quenching 
supernatant, culture filtrate and the biomass. The results are shown in Figure 13.      
 
 
 
 
 
Figure 13. Concentrations of ATP measured in the culture filtrate, the whole broth, quenching supernatant and 
in the biomass of S. cerevisiae using -40 °C MeOH/ H2O (60/40, v/v) as a quenching combined with boiling 
EtOH/H2O (75/25, v/v) or MeOH/chloroform (2:1, v/v) as extraction. 
The low concentration measured in the quenching supernatant indicated that the leakage 
percentage was very low. This was confirmed with the similar concentrations measured 
intracellular and in the whole broth.  
This method was applied in two different studies (Paper 4 and 5) in combination with two 
different extraction methods: boiling ethanol and MeOH/chloroform. In both cases high ECR 
was obtained (in the range of 0.80-0.95). 
Bacteria. As previously mentioned in the introduction part, bacteria are more prone to 
leakage during the quenching when compared to for example yeast [82,91]. 
 
Thus approaches 
where the cells are not divided from the medium were tested firstly. Change of the pH by 
addition of 10 M formic acid followed by 3x freeze thaw was shown to work very well for 
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quenching of L. lactis (Paper 1), giving an ECR of 0.970±0.001. Since the cells were not 
separated from the growth media, purification of the samples using dispersive solid phase 
extraction (DSPE) with charcoal was performed. This was done in order to reduce the matrix 
effects from the growth media and to separate the nucleotides from the other non-aromatic 
intracellular compounds. The retention of the nucleotides on the charcoal was based on the 
interaction of the aromatic ring electrons from the purine or pyrimidine moiety of the 
nucleotides with the π electrons form the charcoal.  Jendresen et. al. [92] used high pH in 
combination with ethanol to elute the nucleotides from the charcoal. During this Ph.D. study 
other organic modifiers (MeOH, isopropanol and acetonitrile) as well as ion-pair reagent 
(DBA) were tested in order to investigate the possibilities of improvement of the recovery of 
the nucleotides. It was found that acetonitrile in combination with high pH gives the best 
elution of the nucleotides from the charcoal. The quenching using low pH proved to be 
efficient for quenching of L. lactis and was therefore tested for the other bacteria of interest 
during this Ph.D. study such as Ruegeria mobilis (R. mobilis), M. corallina and S. coelicolor.  
When the formic acid quenching method was applied on R. mobilis followed by 3x freeze-
thaw cycles and charcoal sample purification, no c-diGMP was detected in the extract. The 
reason for this was considered to be the low intracellular concentrations of c-diGMP that 
might be lost during the sample preparation. Furthermore, strong matrix suppression was 
observed even after the purification of the samples using DSPE with charcoal due to the 
complex media used for growth. This was assumed to be due to the unspecificity of the 
charcoal as a sorbent. Many of the media components were not removed after the purification 
and were concentrated with the evaporation. After the injection of the samples into the LC-
MS, deposition of the salts on the ion-source was observed that caused clogging of the ion 
source. Therefore an alternative sample preparation method was tested by cooling the cells on 
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ice followed by addition of boiling EtOH/H2O (75/25, v/v) which resulted in more clean 
samples and detection of the intracellular c-diGMP in R. mobilis (Paper 2). 
As previously mentioned, formic acid was also tested for quenching of the metabolic 
activities in M. corallina and S. coelicolor but without acceptable results. For M. corallina 
the main problem was the reproducibility of the acceptable values for the ECR (Table 6). 
Different values for the ECR were obtained on different days and were in the range between 
0.28-0.80 showing that the method was not reproducible. The reason for the non-reproducible 
results was speculated to be morphology related. M. corallina is filamentous bacteria that can 
exist in more dispersed or pelleted form depending on the nitrogen source used for growth. 
When sampling from the fermentors with pelleted growth (Figure 14), the cells settled on the 
bottom of the spin tube immediately after the sampling.  
 
 
 
 
 
Figure 14. Microscopic pictures of M. coralline pellets2 (magnified 60x). 
This together with the pelleting itself was speculated to result in non-reproducible dispersion 
of the formic acid around the cells thus non reproducible quenching (ECR between 0.28-
0.60). When existing in more dispersed phase better ECR was obtained but it was not 
reproducible (ECR in the range 0.64-0.80). It was speculated that this was due to grouping of 
the filaments. 
S. coelicolor is also a filamentous bacteria thus clump formation by the filaments was 
expected. Similar as for M. corallina the clump formation resulted in less effective quenching 
                                                          
2 Pictures taken from Subir Nandy, PostDoc at the section for Eukaryotic Biotechnology, Department of Systems Biology,   
Technical University of Denmark and collaborator in the Microbispora corallina project. 
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thus low ECR quenching with formic acid as a quenching solution. The low pH applied 
resulted in ECR of 0.54 which was not within the acceptance criteria (ECR of 0.80-0.95). 
Therefore other quenching and extraction methods were tested.  
As previously mentioned in the introduction part, glycerol combined with saline or MeOH 
has been shown to be a promising quenching mixture for microbial cells [84,85] and was 
therefore chosen for testing. However during this study, several problems were encountered 
with the glycerol based quenching solution: i) difficulties to determining leakage ii) longer 
time for separation of the cells from the supernatant by centrifugation; and iii) residues of the 
glycerol in the extract. The high amounts of glycerol present in the quenching supernatant 
could not be removed due to the high boiling point of glycerol. Therefore it was impossible to 
check the leakage during the quenching. Furthermore, the high viscosity of the saline/glycerol 
solution slowed down the decanting process and removal of the quenching supernatant from 
the cells. This was considered as a major drawback of this procedure due to the longer 
exposure of the cells to the quenching solution and therefore increasing the probability of 
leakage. Even exchanging the water with MeOH to decrease the viscosity and to allow 
operation at even lower temperatures did not improve the whole quenching process. 
Furthermore, the residues of the glycerol in the samples made them more viscose after the 
concentration causing problems in the analysis step (it was impossible to inject the samples 
into the LC-MS). Therefore the cells were washed twice with cold 0.9 % (w/v) NaCl in order 
to remove the glycerol residues. However, the ECR obtained was extremely low showing that 
the quenching was not successful. Due to the technical problems encountered, the 
MeOH/glycerol quenching was not further investigated as a quenching solution for S. 
coelicolor. 
Since one of the aims of the studies for M. corallina and S. coelicolor was also measurement 
of the redox pairs, quenching and extraction methods that will prevent the 
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oxidation/reduction of the redox compounds were necessary. Therefore a sample preparation 
procedure previously reported by Sporty et al. [88] for accurate measurement of NAD
+
 and 
NADH redox state was tested for M. corallina. Phosphate buffered saline was used for 
quenching the cells while the nitrogen saturated ammonium acetate used during the extraction 
was expected to prevent the oxidation of NADH to NAD
+
. However the concentrations of 
NAD
+
 and NADH obtained with this method were similar to the ones obtained with the other 
quenching methods. Furthermore, slightly higher concentration of NADP
+
 and quite low 
ECR values were obtained with this method when compared to the other quenching and 
extraction procedures tested for M. corallina.  
Kassama et al. [97] applied the commonly used quenching method for yeast (-40 °C 
MeOH/H2O (60/40, v/v)) to quench the metabolism of another species from the Streptomyces 
genus but the authors did not present data regarding the leakage. Due to the difficulties to 
find a method that will give an acceptable ECR value for M. corallina and S. coelicolor the 
yeast quenching method was further tested although leakage was expected to occur. This was 
done in order to inspect if the low ECR obtained using the previous quenching methods, were 
due to physiology reasons or due to the method used for quenching. When testing the cold  
-40 °C MeOH/H2O (60/40, v/v) quenching in combination with boiling EtOH as an 
extraction method ECR of 0.6 was obtained. This was unexpected result since it is well 
known that this type of quenching is able to stop the metabolic activities within a second and 
the problems are mainly related to the leakage. It was suspected that the high temperatures 
used during the extraction might cause conversion of ATP to ADP and AMP, leading to a 
low ECR. An additional attempt for improving the ECR value was done by changing the 
boiling EtOH extraction with MeOH/chloroform instead, which resulted in ECR values of 
around 0.87. In order to check the leakage the quenching supernatants were collected. Since 
the biomass pellet obtained after centrifugation was easily re-suspended in the quenching 
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solution, some of the biomass was lost during decanting. Thus there was a limited number of 
quenching supernatant samples that were free of the cells that could be used to check the 
leakage. However, the peak area of ATP, ADP and AMP detected in the supernatant was the 
same as in the biomass, indicating a severe leakage.  
Since sever leakage was observed for M. corallina an attempt was made to decrease the 
possible leakage that might occur in the case for S. coelicolor. As previously reported by 
Wellerdiek et al. [118] the metabolic reactions in quenched Corynebacterium glutamicum 
were stopped at -20 °C. Furthermore, Jonge et al. [95] showed that by increasing the 
temperature of the cold MeOH from -40 to -25 °C, successful quenching of Penicillium 
chrysogenum was achieved with decreased leakage. Therefore the MeOH/H2O (60/40, v/v) 
quenching method was tested using two temperatures: -40 and -25 °C both with boiling EtOH 
and MeOH/chloroform as an extraction methods. As for M. corallina, an acceptable ECR was 
observed only when MeOH/H2O (60/40, v/v) was combined with MeOH/chloroform. Similar 
concentrations were obtained for ATP, ADP, AMP and the redox compounds despite of the 
quenching temperature used for extraction. In all cases ECR of 0.80-0.95 was obtained. To 
investigate if any significant leakage occurs during the quenching, the adenylates ATP, ADP 
and AMP were measured in the quenching supernatant. Leakage was observed despite of the 
temperature tested and there was not difference in the leakage percentage between the two 
different temperatures. The highest leakage was observed for AMP (Figure 15). The 
differences in leakage between the compounds was explain by the fact that relatively smaller 
molecules permeate the cell membrane more easily than the larger polar molecules 
[28,81,82].  
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Figure 15. Concentrations of ATP, ADP and AMP measured intracellular and in the quenching supernatant 
from the WT strain of S. coelicolor at three time points during the exponential phase. The data presented are 
from the quenching at -40 °C.  The error bars indicate standard deviations from three technical replicates. 
The high concentration of AMP measured in WT time point (TP) 3 (Figure 15) was probably 
due to quenching problems. This was also reflected in the lower concentration of ATP 
measured in the same sample.  
Mammalian cells. The work related to the mammalian CHO cells was a part of a master 
project which main goal was to investigate if the additional metabolic burden induced by 
recombinant protein production affects the central carbon metabolism (Paper 3) (the analysis 
of the intracellular metabolites in this project was supervised by me). Dietmar et al. [24] 
showed that ice cold 0.9 % (w/v) NaCl did not to damage the membrane of the mammalian 
cells and was capable of arresting the cell metabolism. Therefore ice cold 0.9 % (w/v) NaCl 
as a quenching solution was combined with cold MeOH and ACN/H2O (50/50, v/v) as 
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extraction solvents which resulted in ECR values ranging from 0.8 to 0.9. No further 
optimization of the sample preparation was done due to the limited time that was available 
for this project.  
Filamentous fungi. Testing different quenching and extraction methods for filamentous 
fungi in this case, Aspergillus nidulans, was a part of a master project [119] in which I was 
involved as a supervisor. For this purpose, two types of quenching procedures: i) -40 °C 
MeOH/H2O and ii) 0 °C 0.9% (w/v) NaCl were combined with two extraction procedures i) 
MeOH combined with freeze thaw in liquid nitrogen and ii) MeOH/chloroform as given in 
Table 6. In addition both centrifugation and filtration were tested for separating the cells from 
the quenching solution. 
The reason for testing cold MeOH as a quenching method was due to the wide applicability 
of this method for quenching the metabolism of various microorganisms including 
Penicillium chrysogenum [95]. On the other hand, the isotonic water was considered to be a 
less aggressive quenching method consequently less leakage was expected during the 
quenching. Furthermore isotonic water has previously been shown to be a good quenching 
method for mammalian cells (Paper 3).  
In general, the problems that occurred were related to the technique itself and the leakage. 
The incomplete separation of the biomass from the quenching supernatant, when 
centrifugation was used, made the measurements of the leakage unreliable. Therefore all the 
methods that included centrifugation as separation were not taken into account for further 
optimization. From the methods that used filtration as a separation technique, the best energy 
charge ratio (~ 0.8) was observed with both the -40 °C MeOH/H2O (40/60, v/v) and isotonic 
water combined with MeOH/CH3Cl (2:1, v/v) as an extraction method. The -40 °C 
MeOH/H2O (40/60, v/v) was further investigated for leakage by comparing the amounts of 
the ATP, ADP and AMP detected in the quenching supernatant with those measured in the 
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biomass. Leakage was observed and was more pronounced for AMP and ADP than for ATP. 
The amounts of ADP and AMP found in the supernatant were around 30 % of the sum of the 
amounts detected in the supernatant and the biomass while for ATP it was 3 %. Furthermore, 
the concentrations of AMP and ADP in the supernatant were 10 times higher than those 
detected for ATP. This was considered to be due to the higher diffusion rate of smaller 
metabolites with lower net charge.  
This study showed that isotonic water can also be used for quenching of filamentous fungi. 
However, further investigations regarding the reproducibility of this method and the leakage 
percentage will be beneficial. 
The work covered in this section once more demonstrates the challenges related to the 
establishment of quenching and extraction methods, especially for bacteria and filamentous 
fungi. Furthermore, the transfer of sample preparation methods from the literature to the lab 
is not an easy task due to: i) the difference in the microorganism of interest, ii) sampling 
technique, iii) quenching equipment and iv) operator. Validation of the quenching method is 
necessary for the different organisms in order to obtain reliable data that represent the 
metabolic state of interest. When the cells are not separated from the quenching supernatant, 
special care needs to be taken due to the contaminants introduced to the sample, for example 
from the growth media. As shown for R. mobilis, the analysis might be significantly impaired 
by the sample preparation method, thus minimal growth media are preferred over complex 
media when the quenching and extraction is combined. Yeast has shown to be the easiest 
organism to work with however leakage during the quenching does occur as previously 
reported by other groups [81].   
2.1.3 Method validation and quantification 
In this section, the approaches for preparing the calibration curves and the quality control 
samples, used for quantification and validation are discussed. All the validation and 
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quantification experiments during this Ph.D. were based on i) the standard addition or ii) the 
external calibration approach (either matrix matched or calibrants prepared in the neat 
solution). In each of the approaches commercially available SIL-IS were used.   
Paper 1 discusses the challenges related to the quantitative measurement of the nucleotides 
in L. lactis. In this paper the validation and the quantitative measurements were performed 
using: i) the standard addition approach as suggested by Tsikas et al. [108]  and ii) the 
external calibration approach where the growth media was used as a matrix for spiking and 
preparing the calibration curves and the quality control samples. Furthermore SIL-IS were 
used in both approaches which showed to be very important for improvement of the linearity, 
accuracy/recovery and precision of the analytical method.  
The two major challenges when the standard addition approach was used were: i) the choice 
of the spiking concentrations and ii) the non-linearity of the calibration curves. Tsikas et al. 
[108] approach was used to determine the spiking concentration levels and the amounts added 
were approximately ranging from 50-250 % of the analyte concentration determined in the 
matrix, using an external calibration approach and corrected for the recovery.  
A narrow linear range, due to the detector saturation at the high concentration end of the 
calibration curve was especially prominent for the nucleotides that were present in a high 
concentration in the spiking matrix. The addition of SIL-IS improved the linearity (Figure 16) 
and resulted in calibration curves with correlation coefficients higher than 0.99, for most of 
the nucleotides. 
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Figure 16. Graph showing the comparison of the calibration curves for dATP obtained using the standard 
addition methods with and without addition of the SIL-IS [
15
N5]dATP. 
For the compounds such as ATP, GTP and UTP, that were present in high amounts in the 
matrix, it was noted that the intensity of their SIL-IS decreased by increasing the 
concentration of the coeluting non-labeled analyte. This was considered to be due to an ion-
suppression of the SIL-IS signal by the highly concentrated coeluting non-labeled analyte. 
Consequently non-linear calibration curve was obtained even when using the SIL-IS. The 
problem of suppression of the SIL-IS by the coeluting non-labeled analyte has previously 
been described by Sojo et al. [120] and was solved by addition of higher amounts of the SIL-
IS. However, for the compounds for which no SIL-IS was available, linearity improvement of 
the calibration curve was not possible. In the case of UDP-Glc the saturation of the detector 
due to the high amounts of this compound present in the spiking matrix resulted in accuracy 
and precision out of the acceptance criteria (acceptance criteria: accuracy within 80-120%; 
precision RSD ≤ 20 %). Appropriate dilutions of the spiking matrix could solve the problem 
with the non-linearity of UDP-Glc calibration curve. However this would require separate 
validation and quantification for this compound, which shows that the validation and 
quantification of the intracellular metabolites is less straightforward and might require 
additional steps for obtaining reliable results.  
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In the case of the external calibration approach (with the growth media as a spiking matrix), 
the major problem was considered to be related to the difference in the matrix effects 
between the matrix used to prepare the calibration standards and the matrix in which the 
compounds of interest needed to be quantified. In the standard addition approach the matrix 
effects were corrected. However, this was not the case for the external calibration approach, 
since the matrix used for preparation of the calibration standards was not the authentic one. 
Nevertheless, the addition of SIL-IS corrected for the possible differences in the matrix 
effects between the calibrants and the samples. Therefore for the compound for which SIL-IS 
was added, similar concentrations were obtained with the standard addition and the external 
calibration approach. However, this was not the case for the compounds for which no SIL-IS. 
was added. This was considered to be due to the difference in the matrix effects between the 
calibrants and the samples. In the case of UDP-Glc the validation failed when using the 
standard addition approach due to the high background amounts of this compound in the 
spiking matrix. This was not the case with the external calibration since UDP-Glc was not 
present in the spiking matrix. Good linearity was obtained in the concentration range between 
0.1-1.2 µg/ml.  
An example of an application where matrix matched calibration was used for quantification is 
given in Paper 2. Since more than one sample needed to be quantified, the standard addition 
approach was not taken into account in this study. A mutant that contained small amounts of 
c-diGMP was obtained and therefore the extract of this mutant was used as the spiking matrix 
for preparing the calibrants. The advantage of having such a matrix allowed preparation of 
matrix matched calibration curve (R
2 
of 0.99, Figure 8) without having saturation problems of 
the detector and linearity issues as in the case with UDP-Glc. Additionally, the results from 
the intraday precision experiments showed an RSD <15 % (n=3). SIL-IS for c-diGMP was 
not available. Therefore matrix matched calibrants that are processed through the sample 
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preparation were necessary in order to correct not only for the losses during the sample 
preparation procedure but also for the possible ion-suppression as a result of the matrix 
effects. Furthermore, the approach used for quantification is more straightforward when 
compared to the standard addition. The standard addition approach becomes more time 
consuming and requires more sample volume when multiple samples need to be quantified as 
in the case with Ruegeria mobilis. 
However, it is not always possible to create a mutant that contains low background amounts 
of the compound of interest. Alternative to this could be the use of a fully 
13
C labeled 
biomass to spike the standards for the calibration curve [61,80,113]. In that respect the 
standards will be prepared in the authentic matrix. However, in order to be able to use the 
commercially purchased 
13
C SIL-IS e.g. [
13
C10]ATP that were already available in-house, an 
alternative approach for creating an authentic matrix was investigated (Paper 5). The 
authentic matrix was prepared by growing S. cerevisiae in a medium that contained [
13
C6]-
glucose/non labeled glucose (50/50, w/w) which, as expected, resulted in pools of metabolites 
with labeling in different carbon positions. The advantage of this matrix was that the pools of 
the compounds with only 
12
C or 
13
C carbons were very low or even not measurable and 
showed minimal or no interference to the spiked amount of non-labeled standards and their 
SIL-IS (Figure 16).  
 
Figure 16. Measured (dashed line) and calculated (bars) isotopic patter of ATP extracted from S. cerevisiae 
cultivated in medium containing 50 % (w/w) [
13
C6]glucose/non-labelled glucose.  
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As a result of this, both the non-labeled and SIL-IS standards could be spiked in the matrix 
resulting in more straightforward validation and quantification. The highest interference from 
the matrix was to the MS signals of [
15
N5]ADP and [
15
N5]AMP while the lowest was to the 
coenzymes and the redox compounds (Figure 17).  
As expected, increase in the monoisotopic mass of 5 Da was observed for the 
15
N labeled 
ADP and AMP when compared to the non-labeled compound standards. This increase was 
also detected in the biological matrix obtained by growing S. cerevisiae in media containing 
[
13
C6]glucose/non-labeled glucose (50/50, w/w) (Figure 10). Therefore choosing 
13
C instead 
of 
15
N labeled ADP and AMP would have resulted in less interference. However, [
13
C10]ADP 
and [
13
C10]AMP were not commercially available when the study was conducted.  
The results from the validation showed good linearity over the inspected concentration range 
(R
2
>0.99) as well as acceptable accuracy and precision (RSD ≤20 % and accuracy within 80-
120 %) for all the compounds investigated. In the case of Ac-CoA, the difference in the 
monoisotopic mass between the non-labeled Ac-CoA and its SIL-IS was only 2 Da. This 
resulted in a cross signal contribution due to isotopic interference and increasing 
 
Figure 17. Superimposed chromatograms of [
15
N5]ADP, [
15
N5]AMP, ATP and Mal-CoA in the blank matrix 
(dashed line) and matrix spiked (solid line) with the corresponding standards with concentrations as given in the 
figure. 
0
100
50
Time (min)
11 11.5 12 12.5 13 13.5
C
o
u
n
ts
 (
%
)
A. [15N5]ADP
5 µg/ml spike
present in the 
matrix
present in the 
matrix
0
50
100
Time (min)
12.5 13 13.5 14 14.5 15
C
o
u
n
ts
 (
%
)
D. Mal-CoA 3 µg/ml spike
0
50
100
Time (min)
8 8.5 9 9.5 107.5
C
o
u
n
ts
 (
%
) 5 µg/ml spike
present in the 
matrix
B. [15N5]AMP
0
50
100
Time (min)
12 13 14 15
C
o
u
n
ts
 (
%
) 
7.5 µg/ml spike
present in the 
matrix
C. ATP
64 
 
concentration of the SIL-IS in the calibrants by increasing the concentration of the non-
labeled Ac-CoA (Figure 18A).  
 
 Figure 18. Response curves for A. Ac-CoA and 3 µg/ml [13C2] Ac-CoA and B. Ac-CoA and 10 µg/ml [
13
C2] 
Ac-CoA as a function of the Ac-CoA concentration.  
The cross signal contribution caused significant non-linearity at high concentration levels, 
when low amounts of SIL-IS were used (Figure 19). However, the linearity was improved by 
increasing the amount of SIL-IS added to the calibrants [121] (Figure 19).  
 
 
 
 
 
 
 
 
Figure 19. Calibration curves for Ac-CoA obtained using three different concentrations of the corresponding 
SIL-IS in this case [
13
C2]Ac-CoA.  
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Inspection of the matrix effects showed that the signal suppression at the beginning of the 
gradient (0-3 min) was related to the non-retained compounds that elute at the beginning of 
the analysis (Figure 20). 
 
Figure 20. Overlaid chromatograms of post column infusion of 10 µg/ml ATP into the MS after injecting eluent 
A or matrix blank with superimposed chromatograms of all the analyzed compounds. 
The suppression of the signal between 7 - 8 min. was due to the elution of PIPES, one of the 
buffering agents used during the extraction. Phosphate and EDTA affected the ion-signals of 
AMP and ADP, respectively. The phosphate was coming from the sample itself, while EDTA 
was used as a second buffering agent during the extraction. Furthermore, the validation 
showed that the SIL-IS successfully corrects for any matrix suppression and loss of analytes 
during the sample preparation, which indicates that a calibration curve could be prepared in 
the neat solution for the compounds for which SIL-IS is available.  
Due to the absence of a matrix free of the analyte, the quantitation of the analytes in Paper 3 
and Paper 4 was done using external calibration with standards prepared in the clean solvent. 
The main disadvantage of this approach is that the loss of the compounds during the sample 
preparation procedure and the matrix suppression will not be corrected unless a SIL-IS is 
added to both the samples and the calibration standards.  
0
25
50
Time (min)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
C
o
u
n
ts
 (
%
) 
Eluent A
Matrix blank
NAD+
AMP
NADH
ADP
NADP+
ATP
NADPH 
Ac-CoA
Mal-CoA
66 
 
As previously mentioned in the introduction part, the validation and quantification 
approaches for the intracellular metabolites are less straightforward. Finding an appropriate 
approach and matrix for preparation of the calibration curves was one of the biggest 
challenges during this Ph.D. thesis. Furthermore, the inspection of the recoveries and the 
matrix effects was shown to be a very important step during the validation of the method in 
order to get reliable data especially for the compounds for which SIL-IS were not available. 
The use of SIL-IS showed to be a very powerful approach for i) overcoming the issues with 
losses of metabolites during the sample preparation method, ii) preventing the over or 
underestimation of metabolite levels due to matrix effects and iii) improving the overall 
performance of the method. 
2.1.4 Summary of the findings using the targeted analysis with ion-pair LC-QqQ 
This section summarizes the results obtained from the application of the developed ion-pair 
LC-QqQ method.  
2.1.4.1 Measurement of the intracellular metabolites in S. cerevisiae   
The two most commonly used S. cerevisiae strains as cell factories are: CEN.PK and S288C 
[122]. When these two strains were engineered to produce vanillin-β-glucoside (VG), 
difference in the VG level produced was observed. In order to investigate the possible 
reasons for this, various ‘’omics’’ tools were applied, among which measurement of a range 
of intracellular metabolites such as ATP, ADP, AMP, NAD
+
, NADH, NADP
+
, NADPH, 
UDP, UDP-Glc and UTP (Figure 21).  
It should be noted that ATP, NADPH and UDP-Glc were directly involved in the production 
of VG. Three biological replicates for each strain were quenched and the intracellular 
metabolites were extracted with the most commonly used methods for quenching and 
extraction of yeast: -40°C MeOH/H2O (60/40, v/v) and boiling EtOH/H2O (75/25, v/v). The 
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high energy charge ratio of 0.91 obtained for all of the samples ensured good quenching of 
the metabolism and high quality metabolomics data.  
 
Figure 21. Diagram showing the measured intracellular concentrations of the metabolites extracted from CEN-
PK and S288C vanillin-β-glucoside producing strains during steady state growth. 
The concentrations of the intracellular metabolites between the VG producing CEN.PK (C-
VG) and S288C (S-VG) strains appeared to be very similar. A slight difference was observed 
only for ATP (Figure 21). Canelas et al.[123] reported concentrations for ATP in the 
CEN.PK and S288C yeast strains which were not genetically engineered to produce VG. The 
ATP concentration ratio between the C-VG and S-VG strains in our study was found to be 
very similar to the one reported by Canelas et al. [123]. Therefore it was assumed that the 
differences in the ATP concentrations between C-VG and S-VG strains is not related to the 
differences in the VG production.  
In the same study Canelas et al. [123] reported concentrations for ADP, AMP, UTP, UDP-
Glc, NAD
+
, NADP
+
, and NADPH as well. When looking at the absolute values, the 
intracellular concentrations of ATP and AMP measured in the C-VG and S-VG were slightly 
higher than the ones reported in the literature, while ADP was slightly lower. UTP 
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concentrations were found to be very similar to the literature [123], while 5 times lower 
concentrations of UDP-Glc were measured in our study.   
The slightly higher absolute values for ATP and AMP were speculated to be due to lab to lab 
differences. The slightly lower concentration of ADP measured in our study was speculated 
to be due to the absence of IS. Thus, the losses during the sample preparation, as well as the 
possible ionization suppression, were not corrected which might lead to underestimation of 
the concentration. The same was speculated for UDP-Glc. Therefore, inspection of the HR-
MS spectra of the samples was performed. This was done, in order to investigate if there is 
another compound that elutes at the same time as ADP and UDP-Glc which might cause 
suppression and therefore underestimation of the concentration. At an RT where ADP elutes 
no other major ions were detected except for m/z 426.0221 that corresponds to ADP. Thus, 
the slightly lower concentration measured in our study might be due to losses during the 
sample preparation. However, at the RT where UDP-Glc elutes, high intensity peak with m/z 
of 96.96 was observed which corresponds to phosphate, thus causing strong suppression of 
the UDP-Glc MS signal. Regarding the concentrations of the redox compounds, Canelas et 
al. [123] reported only relative amounts and there was no clear explanation how these 
amounts were calculated. Therefore it was not possible to compare the values obtained for the 
redox compound in our study to those in the literature.  
2.1.4.2 Measurement of nucleotides in L. lactis 
The applicability of the developed ion-pair LC-QqQ method was assessed by measurement of 
ribo- and deoxyribonucleotides in L. lactis. In the current study 15 nucleotides were 
quantified including ATP, ADP and AMP which allowed determination of the ECR as a 
measure for the quality of the metabolomics data. In general, the intracellular pools of the 
ribonucleotides were higher than the deoxyribonucleotides. The deoxyribonucleotides were   
either close to the limit of detection or non-detectable. However, the concentrations of all 
69 
 
measured nucleotides using the ion-pair LC-QqQ method were higher than the concentration 
obtained using the 
33
P labeling followed by thin layer chromatography (TLC) [92]  (Figure 
22).  
 
Figure 122. Comparison of the measured intracellular concentrations by ion-pair LCiMS/MS using two 
quantification approaches with the concentrations determined using 
33
P labeling followed by TLC (dCMP, 
CMP, TMP, and UMP were not measured by TLC) [92]. 
 
Furthermore, the ratio between cytidine 5'-triphosphate (CTP) and deoxycytidine 5'-
triphosphate (dCTP) has been found to be between 5 and 8 in the cells [124], however in this 
case slightly higher concentration of dCTP was measured giving a CTP/dCTP ratio close to 
1. Even by growing L. lactis in a media that contained cytidine that should boost the CTP 
pool, the same ratio was obtained. On the contrary, the CTP/dCTP ratio in S. cerevisiae and 
CHO cells was found to have the expected value (between 5 and 8). In addition, similar 
concentration for CTP and dCTP were obtained with the two different quantification 
approaches (standard addition and external calibration). Therefore, the difference in the 
CTP/dCTP ratio between the current study and the literature was assumed to be due to 
physiology difference and not a technical error related to the analytical method.  
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2.1.4.3 Measurement of c-diGMP in R. mobilis 
The main idea of this study (Paper 2) was to investigate whether the shift between motile and 
sessile life in the marine bacteria, R. mobilis F1926, is correlated to the intracellular 
concentration of c-diGMP. It has previously been shown that c-diGMP regulates the 
transition between planktonic and attached phenotype in other bacteria [125]. Therefore 
intracellular levels of c-diGMP were measured in: i) the wild type (WT) strain, ii) the pYedQ 
plasmid carrying mutant that contained a gene encoding c-diGMP synthesizing diguanylate 
cyclase, iii) the pYhjH plasmid carrying mutant that contained a gene encoding c-diGMP-
degrading phosphodiesterase and iv) vector control strains F1926 pRK404A and F1926 
pBBR1MCS3. It should be noted that for all of the strains, both shaken and static cultures 
were grown in order to mimic the motile and sessile lifestyle. In general for all the strains, the 
film forming static cultures contained higher amounts of c-diGMP than the shaken cultures, 
where no film was formed. Furthermore, the introduction of pYedQ plasmid into Ruegeria 
mobilis F1926 increased the levels of c-diGMP under both shaken and static conditions when 
compared to the other strains. In addition, more aggregates were formed in the pYedQ 
plasmid carrying mutants than in the WT in both shaken and stagnant cultures. The static 
cultures of pYhjH plasmid carrying mutant, showed decreased concentrations of c-diGMP 
when compared to the vector control strain. The addition of the pYhjH plasmid caused 
formation of more motile cells in the static cultures and prevented formation of aggregates in 
the static cultures. The data obtained showed that the developed IP-RP LC-QqQ method was 
capable of detecting the altered levels of c-diGMP in the mutants. Moreover, the data 
obtained, confirmed the hypothesis that c-diGMP is the key second messenger in the 
transition between motile and sessile life also in R. mobilis. 
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2.1.4.4 Measurement of the intracellular metabolites in CHO cells 
The aim of this study was to investigate the effect on the central metabolism of an additional 
metabolic burden induced by recombinant protein production. Therefore seven clones with 
different EPO productivities were quenched followed by extraction of their metabolites. 
Different intracellular metabolites from the central carbon metabolism ranging from sugar 
phosphates, redox compounds as well as nucleotides were measured using the developed ion-
pair LC-QqQ method. As described in Paper 3 no differences in the ECR were detected 
among the CHO cells, showing that the cells energy metabolism is keeping up with the 
energy demand.   
2.1.4.5 Measurement of intracellular metabolites in M. corallina 
It should be mentioned that this was an EU project in collaboration with an italian company 
and due to confidentiality issues and lack of information, the data will be discussed only from 
analytical point of view.  
The main idea of this project was to develop an economically viable production process for a 
lantibiotic which is produced by M. corallina. Two different strains were used: i) WT that 
was able to produce the lantibiotic and ii) a null strain that did not produce the lantibiotic. 
When growing on nitrate as a nitrogen source, the two strains showed difference in the 
production of the lantabiotic. In order to check if the differences in the lantibiotic production 
between the two strains results in any differences in the energy metabolism, IP-RP LC-QqQ 
was used to determine the intracellular pools of ATP, ADP, AMP and the redox pairs: 
NAD
+
/NADH and NADP
+
/NADPH. For this purpose both the WT and the null strain were 
grown in the same minimal medium with glucose as a carbon source in continuous 
cultivations and samples were taken from the chemostat when steady state was reached. The 
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samples were quenched using -40 °C MeOH/H2O (60/40, v/v) and extracted using 
MeOH/CH3Cl (2:1, v/v) 
The results from the measurements of the intracellular metabolites are given in Table 7. 
Table 7. Intracellular concentration of the measured metabolites in M. corallina expressed in 
nmol/mgDW.  
  1
The numbers in the brackets are the standard deviations
 
calculated from three technical replicates and two biological replicates. 
 
The main problems encountered during this study were both organism and sample 
preparation method related. The organism dependent problems were related to the slow 
growth of this organism. The generation of the biomass was a long process (doubling time ~ 
35 h), thus creating difficulties in the cases when some of the fermentations needed to be 
repeated. Consequently the frequency of sample generation was not as high as with the other 
organisms during this Ph.D. study, thus limiting the number of different sample preparation 
protocols that could be tested. The method dependent problems were related to the 
centrifugation as a technique for separation of the cells from the quenching supernatant. As 
explained in the sample preparation part, the pellet formed during the centrifugation was very 
easily re suspended in the quenching supernatant, thus resulting in losses of the biomass 
during the decanting.  This was considered to be the reason for the big standard deviations 
observed between the technical (n=3) and the biological (n=2) replicates (Table 7). Longer 
time than 5 min for centrifugation was not considered in order to avoid exposure of the cells 
to the quenching supernatant and loss of the metabolites due to leakage. Furthermore, 
 nmol/mgDW 
Strain  ATP ADP AMP NAD
+
 NADH NADP
+
 NADPH 
WT  2.9 (1.4)
1
 1.7 (0.8) 0.2 (0.1) 1.4 (0.7) ND 0.3 (0.1) 0.03 (0.009) 
Null strain 1.5 (0.8) 0.5 (0.3) 0.1 (0.03) 0.7 (0.6) 0.05 (0.04) 0.2 (0.03) 0.03 (0.01) 
73 
 
quantification of the NAD/NADH and NADP/NADPH pairs was considered to be very 
challenging. As previously explained in the development of IP-RP part, oxidation of NADH 
and NADPH into NAD+ and NADP+, respectively was happening in the injection vial. This 
resulted in very high NAD+/NADH and NADP+/NADPH ratios. As previously explained re-
dissolving the pure standards of NADH and NADPH in ammonium acetate pH 8, prevented 
the oxidation of these two compounds. Therefore re-dissolving the extracts into ammonium 
acetate pH 8 might solve the problem, however this needs to be further investigated.  
2.1.4.6 Measurement of intracellular metabolites in S. coelicolor 
The main idea behind the development of a method for quenching and extraction of 
intracellular metabolites from S. coelicolor was to investigate the effects of altered redox and 
energy levels in the metabolism on the production of the antibiotic actinorhodin (ACT). 
However, both the establishment of the sample preparation method (quenching and 
extraction) as well as the analysis of the redox compounds were challenging as explained 
previously. 
ACT synthesis is a high energy demanding process, where 6 molecules of NADPH, 16 
molecules of Ac-CoA and 16 molecules of ATP are utilized to produce one molecule of 
ACT. Consequently, it was expected that the production of ACT will be affected when the 
energy levels are perturbed. In this respect, two mutants were constructed by: i) 
overexpression of a nox gene that encodes an NADH oxidase that can oxidize NADH to 
NAD
+
 (oxp-nox) and ii) overexpression of a pos5 gene that encodes an NADH kinase that 
catalyzes the conversion of ATP and NADH into ADP and NADPH (oxp-pos5). The 
measurements of ACT in the two strains showed that the oxp-nox strain had an increased 
production of ACT while the oxp-pos5 showed decreased ACT production. Since the 
perturbations made were expected to also have an impact on the energy metabolism, the 
concentrations of ATP, ADP, AMP and the redox compounds were measured in the WT, the 
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oxp-nox and oxp-pos5 strains. The sampling was done at 6 different TP during batch 
fermentation: i) 3 TP during the exponential and ii) 3 TP during the antibiotic producing 
phase. It should be mentioned that the data regarding the redox compounds were not 
processed at the time when the thesis was written due to the lack of time. Therefore, only the 
concentrations of ATP, ADP and AMP are presented in this thesis.  
As explained previously in the part regarding the establishment of the quenching and 
extraction procedures, leakage was observed when S. coelicolor was quenched with the cold 
MeOH. Figure 23 shows the measured concentrations of the ATP, ADP and AMP in the 
biomass and the supernatant of the WT and the oxp-nox mutant. It should also be noted that 
due to lack of time the supernatants from the oxp-pos5 strain were not processed and 
therefore data on the leakage is presented only for the WT and the oxp-nox. Although leakage 
was observed, when looking at Figure 23, trend could be seen for the measured 
concentrations of ATP, ADP and AMP in the WT and the oxp-nox mutant.   
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Figure 23. Concentrations of ATP, ADP and AMP measured intracellular and in the quenching supernatant at 3 
TP in exponential phase from the WT and the oxp-nox strain of S. coelicolor.  The error bars indicate standard 
deviations from three technical replicates. 
Furthermore, the data from the measured concentrations of ATP, ADP and AMP in the 
biomass form the three strains (WT, oxp-nox, oxp-pos5) at 3 TP (TP1-3) during the 
exponential and 3 TP during the antibiotic production phase are given in Table 8.  
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Table 8. Concentrations of ATP, ADP and AMP in the WT, oxp-nox and the oxp-pos5, measured in the 
biomass samples at 3 different TP during the exponential phase and 3TP during the antibiotic production phase.  
Sampling 
phase 
Strain 
nmol/mgDW 
ECR
1
 
ATP ADP AMP 
Exponential 
phase 
WT TP1 3.82 (0.18)
2
 1.49 (0.18) 0.13 (0.08) 0.84 
WT TP2 4.86 (0.54) 1.65 (0.43) 0.35 (0.07) 0.83 
WT TP3 4.04 (0.69) 1.32 (0.08) 0.33 (0.15) 0.83 
oxp-nox TP1 0.59  (0.05) 0.24(0.02) 0.02 (0.003) 0.83 
oxp-nox TP2 0.74 (0.14) 0.28 (0.04) 0.06 (0.03) 0.82 
oxp-nox TP3 1.09 (0.30) 0.46 (0.07) 0.07 (0.005) 0.82 
oxp-pos5 TP1 2.04 (0.80) 0.83 (0.15) 0.68 (0.02) 0.69 
oxp-pos5TP2 1.17 (0.29) 0.49 (0.12) 0.41 (0.04) 0.69 
oxp-pos5 TP3 1.04 (0.33) 0.39 (0.16) 0.31 (0.05) 0.71 
Antibiotic 
production 
phase 
WT TP1 4.34(0.14) 0.37 (0.02) 0.38 (0.02) 0.89 
WT TP2 3.24 (0.08) 0.26 (0.02) 0.30 (0.01) 0.89 
WT TP3 1.83 (0.04) 0.19 (0.03) 0.23 (0.04) 0.85 
oxp-nox TP1 1.66 (0.16) 0.79 (0.09) 1.40 (0.08) 0.53 
oxp-nox TP2 1.89 (0.28) 1.22 (0.71) 1.82 (0.17) 0.51 
oxp-nox TP3 1.32 (0.34) 1.19 (0.36) 2.06 (0.63) 0.42 
oxp-pos5 TP1 1.88 1.09  0.92  0.62 
oxp-pos5 TP2 1.66  1.26  0.99  0.59 
oxp-pos5 TP3 2.08 (0.02) 1.20 (0.16) 1.21 (0.02) 0.60 
                                       1ECR- Energy charge ratio calculated as (ATP + 0.5ADP) (ATP + ADP + AMP)⁄  
                          2The numbers in the brackets are the standard deviations calculated from three technical replicates.  
                                       3No standard deviation given due to lack of replicates                       
In the exponential phase, the oxp-nox strain showed lower ATP concentrations when 
compared to the WT. This was due to an increased oxidation of NADH and consequently 
lower production of ATP during oxidative phosphorylation. In the antibiotic production phase 
there was an increase of the ATP concentration due to the decreased growth.  
In comparison to the oxp-nox mutant, increased concentration of ATP was detected in the 
oxp-pos5 mutant and was speculated to be due the higher NADPH production. In order to 
maintain the NADPH/NADP ratio, higher ATP is produced. However, we could not explain 
why the ATP concentration decreased during the antibiotic phase of the oxp-pos5 strain.   
Crucial part for this study will be the comparison of the data for NADH/NAD+ and 
NADPH/NADP+ pools between the mutant and the reference strains. As previously explained 
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in the thesis, problem with the oxidation of NADH and NADPH was observed. Since re-
dissolving the standards of these compounds into ammonium acetate pH 8 decreased the 
oxidation, re-dissolving the extract into the same solution might be taken into consideration 
in order to inspect if this will reduce the oxidation in the samples as well.  However, in order 
to get reliable data and confirm the assumptions presented here, quenching method that will 
result in less leakage needs to be established. 
2.2 Multitargeted approach using IP-RP LC-Q-TOF MS 
The main idea of the coupling the ion-pair method to the Q-TOF-MS instrument was to 
explore the applicability of the high resolution instrument for simultaneous identification of 
as many intracellular metabolites as possible (Paper 6). The feasibility of using the Q-TOF 
was evaluated with identification of compounds from three different organisms: S. cerevisiae, 
M. corallina and S. coelicolor.  
The multitargeted approach in this study included: i) aggressive dereplication of the full scan 
HR-MS data using search lists of known compounds and ii) MS/HRMS data searched in 
METLIN library. Both auto and all ions MS/MS approaches were investigated for obtaining 
fragmentation spectra. As previously explained in the introduction part, the auto MS/MS 
approach was based on the selection of a precursor ion by the quadrupole that is further on 
fragmented in the collision cell, while in the all ions MS/MS (MS
E
) approach all the ions 
generated are fragmented using low and high CE values. However, the all ions MS/MS 
approach was not suitable for the current study due to the similarities in the fragmentation 
patterns between the intracellular metabolites. For example all phosphorylated metabolites 
gave m/z 96.96 and m/z 78.959 and were primarily chosen by the software as qualifier ions. 
These two ions were considered to not be specific enough to confirm the identity of the 
compounds. Therefore, auto MS/MS approach was used for acquiring the MS/HRMS data.  
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The principle of the screening method was firstly to analyze the sample extract from the 
organism of interest using the ion-pair Q-TOF MS. Aggressive dereplication was done as 
described in Kildegaard et al. [126] by creating *.csv files that contained the empirical 
formula and the name of the compounds listed in an in-house database created in the ACD 
chemfolder format. This database was created by importing the online available metabolom 
databases of Escherichia coli (E. coli metabolome database, http://www.ecmdb.ca/) and yeast 
(Yeast Metabolome Database, http://www.ymdb.ca/) in the sdf format. Tentative 
identification was based on matching the accurate mass and isotopic pattern of the 
compounds in the search lists to that measured by the instrument. If a compound from the 
search lists was detected in the samples, the chromatographic peak that corresponds to that 
compound was colored. The aggressive dereplication was shown to be a fast approach for 
tentative identification of hundreds of compounds by using their accurate mass and isotopic 
pattern. The search lists could easily be changed and made more specific, which was an 
advantage when screening for only one group of compounds (e.g. nucleotides) was needed. 
Furthermore, the aggressive dereplication using search lists provided an ability to quickly get 
an overview of the possible isomers assigned to one peak.  
Although the data analysis approach described in this study yielded putative identifications 
for several hundreds of compounds in a very short time, one should also be aware of the 
pitfalls of this approach. Very often one peak was assigned to more than one compound and 
vice versa. If the adduct of one compound had the same mass as the molecular ion of another 
compound, the software was reporting two hits for the same peak. Therefore a manual 
inspection of the results was required which was considered as a bottleneck of the approach. 
Even though the approach was helpful in giving a quick overview of the structural isomers 
present in the sample, it was not able to distinguish between them unless an RT was 
available. Furthermore, an in-source fragmentation was also shown to lead to miss-
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identification. This was the case when an in-source fragment of one compound had the same 
elemental composition as the molecular ion of another compound, as shown for               
ADP-ribose 1″-2″cyclic phosphate and NADP+, where an in-source fragment of NADP+ 
had the same mass as ADP-ribose 1″-2″ cyclic phosphate. In this respect the RT would be 
beneficial for identification, however a standard of ADP-ribose 1″-2″ cyclic phosphate 
was not available in-house. 
To overcome the above mentioned issues HRMS/MS dereplication was performed. This 
dereplication procedure was based on usage of HRMS/MS library for screening of the data 
acquired in auto MS/MS mode. The library allows the user to compare both the accurate mass 
and fragmentation data acquired form the sample with those from the library. The spectral 
library was created by analyzing the standards available in-house at three different collision 
energies (10, 20 and 40 eV) due to the different energy needed to fragment the different 
compounds. It should be noted that the creation of the library itself is a labor intense work 
since all the standards need to be analyzed using the IP-RP LC-QTOF MS methods and their 
fragmentation patterns are manually added into the library. However due to the fact that only 
limited number of primary metabolite standards were available in-house, the online METLIN 
library was mainly used. The HRMS/MS dereplication approach improved the efficiency and 
the confidence of the identification results. However, in the case of structural isomers that 
generated similar fragmentation patterns, (e.g. sugar phosphates) RT was the key parameter 
to differentiate between them. The limiting factor of the HRMS/MS dereplication was the 
size of the library and therefore when an MS/MS spectrum for a certain compound was not 
available in METLIN, manual inspections of the fragmentations spectra was performed for 
losses of e.g. phosphate, carboxylic groups etc.  
Figure 24 shows the chromatograms of some of the identified intracellular metabolites in S. 
cerevisiae, M. corallina and S. coelicolor. 
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Figure 24. Extracted ion chromatograms of the most intense peaks identified in S. cerevisiae, M. corallina and 
S. coelicolor using the aggressive dereplication in combination with the MS/HRMS data searched in METLIN 
library.  
 
In general the coupling of the ion-pair chromatography with Q-TOF-MS was shown to 
provide an opportunity to detect and identify many compounds. Having the full scan HR-MS 
data is very beneficial since they allow retrospective data analysis and search for other 
interesting target compounds that have been measured but have not been of interest for the 
current study. Processing the data using statistical tools can help in finding metabolites which 
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concentrations have been changed due to genetic manipulations or stress conditions. 
Furthermore, having the HR-MS and MS/HRMS data identification of the compounds can 
often be achieved without the need of standard compounds. The full scan data can help to 
identify the causes for suppression/enhancement of the MS signal. This information may help 
in improvement of the sample preparation method.     
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3. Future perspectives 
Despite the great progress within the microbial metabolomics, further research, especially on 
the sample preparation techniques, is highly required. This will help in understanding which 
sample preparation methods should be used for which type of organisms and analysis. 
Furthermore, knowing the shortcomings of the methods applied will help in understanding 
the limitations of the data collected. To minimize the variability between the laboratories and 
analysts, more standardized methods are highly needed. 
In order to improve the quenching of the bacteria the alternatives could include: i) measuring 
the intracellular metabolites in the total broth using the cold methanol quenching or ii) fast 
filtration since it could also solve the problem with instability of the biomass pellet of M. 
corallina obtained after centrifugation which resulted in biomass losses during decanting. 
Furthermore, standardized sampling system is highly required for future analysis of 
intracellular metabolites. This will increase the sampling frequency and will decrease the 
variations in the sample volume taken.  
For improving the analysis, lowering the amount of buffers used during the sample 
preparation would be very beneficial, especially in the MeOH/chloroform extraction. In the 
case when organic acids need to be analyzed a selective removal of phosphate using anion 
exchange SPE and low pH could be considered as a solution [105].  
Ammonium acetate (pH 8) showed to reduce the oxidation of NADH to NAD
+
 and NADPH 
to NADP
+
. By processing the standards prepared in the ammonium acetate through the 
sample preparation, one can investigate if oxidation occurs during the sample handling. 
Furthermore, re-dissolving of the sample extracts into ammonium acetate (pH 8) instead of 
TBA might improve the analysis of these compounds. However, further investigation of the 
long term stability of these compounds in the ammonium acetate solution is highly required. 
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Moreover, standardized analytical method validation strategies and reference materials for 
intracellular metabolites are sorely missing. These strategies are highly needed in order to 
confirm the accuracy and validity of the quantitative data acquired. Therefore, a debate in 
order to define the conditions and the metabolites for which this material will be produced is 
necessary in future. In respect to the validation of the analytical methods, the approach 
reported by Mashego et al. [113] which is an alternative to the SIL-IS approach used during 
this thesis, could be taken into consideration for future studies. In this approach extracts form 
cells grown on 
13
C labeled glucose are used as SIL-IS. The advantage of the Mashego et al. 
[113] approach is that SIL-IS will be obtained for compound for which there are no 
commercially available SIL-IS, thus improving the reliability of the quantitative data for 
those compounds. 
Finally, as proposed by Nielsen and Oliver [127] and Griffin [128], building a database that 
will contain accurately measured metabolites under standardized conditions can serve as a 
good reference and a good assessment of the developed methods used for quantifying 
intracellular metabolites. 
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4. Conclusion  
An IP-RP LC-MS based method was established for targeted and multitargeted analysis of 
intracellular metabolites from various microorganisms. 
The optimization of the detection resulted in optimized MRM transitions for more than 50 
metabolites including nucleotides, coenzymes, sugar phosphates and organic acids. IP-PR 
chromatography showed to give a good compromise between the retention and the separation 
of the metabolites of interest. The IP-RP method allowed separation of compounds with the 
same elemental composition (e.g. sugar phosphates, AMP/dGMP, G3P/DHAP) which was an 
advantage due to their similar fragmentation pattern. 
Several different quenching and extraction methods were tested for yeast, bacteria, 
filamentous fungi and mammalian cells. High ECR values (0.80-0.95) were obtained for 
yeast when cold MeOH was combined with either boiling EtOH or MeOH/chloroform as 
extraction methods. Formic acid showed to be a good quenching method for L. lactis but not 
for the filamentous bacteria M. corallina and S. coelicolor. The reason for this was speculated 
to be morphology related. Several other quenching techniques were tested for the filamentous 
bacteria based on saline, glycerol or cold methanol. The main problems observed were either 
low ECR or leakage during the quenching. As in the case for the filamentous bacteria, 
leakage during the cold methanol quenching was also observed for filamentous fungi. Ice 
cold 0.9 % (w/v) NaCl combined with MeOH/ACN as an extraction was shown to be able to 
stop the mammalian cell metabolism (ECR of 0.92). In this study, metabolites from 
glycolysis, TCA and PPP pathway were analyzed.  
The sample preparation showed to be very important step not only for obtaining meaningful 
metabolomics data but also for the analysis step itself. The buffering agents (e.g. EDTA or 
PIPES) used in the sample preparation as well as the highly abundant compounds present in 
the cells, such as phosphate, were shown to cause suppression of the LC-MS signal.   
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The addition of SIL-IS after the quenching was shown to be very important for i) correction 
of metabolites losses during the sample preparation, ii) correction of suppression caused by 
coeluting compounds and iii) improvement of the linearity. It was shown that for good 
linearity the amount of the SIL-IS should be in sufficient amount, either close to the amount 
of non-labeled metabolite that need to be quantified or close to the middle concentration point 
on the calibration curve. The validation approaches used along this study shown acceptable 
accuracy/recovery (80-120 %) and precision (RSD ≤ 20 %) as well as good linearity 
confirming the reliability of the data obtained.  
An approach for creating a spiking matrix based on 
13
C labeling was established as well. This 
allowed preparation of the quality control samples in the matrix, by spiking both SIL-IS and 
non-labeled standards. One of the requirement here is that the 
13
C SIL-IS should be used 
instead of 
15
N labeled in order to minimize the matrix interferences.  
Finally, coupling of the IP-RP to a Q-TOF showed to be a powerful tool for identification of 
known unknowns without the need of a standard. The analysis resulted in identification of 60 
compounds from different microorganisms such as S. coelicolor, M. corallina and S. 
cerevisiae.  The identification was based on their HR-MS and MS/HRMS spectra.   
The data presented in this thesis, showed that the established analytical and sample 
preparation methods are a valuable addition to the ‘’omics tools’’ use to reveal key 
information regarding the biochemical processes within the cells. 
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a b s t r a c t
Analysis of intracellular metabolites in bacteria is of utmost importance for systems biology and at the
same time analytically challenging due to the large difference in concentrations, multiple negative
charges, and high polarity of these compounds. To challenge this, a method based on dispersive solid
phase extraction with charcoal and subsequent analysis with ion-pair liquid chromatography coupled
with electrospray ionization tandem mass spectrometry was established for quantiﬁcation of intracellu-
lar pools of the 28 most important nucleotides. The method can handle extracts where cells leak during
the quenching. Using a Phenyl-Hexyl column and tributylamine as volatile ion-pair reagent, sufﬁcient
retention and separation was achieved for mono-, di-, and triphosphorylated nucleotides. Stable isotope
labeled nucleotides were used as internal standards for some analytes. The method was validated by
determination of the recovery, matrix effects, accuracy, linearity, and limit of detection based on spiking
of medium blank as well as standard addition to quenched Lactococcus lactis samples. For standard addi-
tion experiments, the isotope-labeled standards needed to be added in similar or higher concentrations
as the analytes. L. lactis samples had an energy charge of 0.97 ± 0.001 which was consistent with litera-
ture, whereas some differences were observed compared with legacy data based on 33P labeling.
 2013 Elsevier Inc. All rights reserved.
The nucleotides are particularly important parts of the intracel-
lular metabolome not only because of their role as substrates in the
synthesis of RNA and DNA but also because they are involved in
virtually every metabolic pathway either directly as providers of
energy or as allosteric effectors. Cyclic nucleotides have been
shown to be a part of many signaling pathways, guanine nucleo-
tides are involved in protein synthesis, and adenosine 50-triphos-
phate serves as a primary energy supply for transport, cell
motion, and many biosynthetic processes [1–4]. Thus, knowing
the intracellular concentration of nucleotides is important for
understanding many biological processes within the cell.
For quantitative measurement of nucleotide pools, the sample
preparation is of utmost importance because instant quenching
of the cell metabolism is required due to the very fast turnover
rates of the nucleotide pools within the cell [5,6]. This step can eas-
ily be a source of errors due to the possible enzymatic change of
nucleotide pools as well as cell leakage in cases where the cells
are separated from the growth medium [7]. Thus, merging the
quenching and extraction steps is a solution for leaky cells, as
shown by Martinussen and coworkers [8], where formic acid was
added to Lactococcus lactis cells and subsequently three freeze–
thaw cycles were used to extract the intracellular metabolites [9].
Puriﬁcation of the extracted intracellular metabolites is a difﬁ-
cult task, considering both the wide range of concentrations and
the diverse physiochemical properties of the intracellular metabo-
lites. Solid phase extraction (SPE)1 is a widely used method for
either sample cleanup or trace enrichment in a variety of matrices,
from environmental to biological samples [10–12]. Anastassiades
and coworkers [13] proposed an SPE method for cleanup of food
and environmental samples called dispersive solid phase extraction
(DSPE). In DSPE, the sorbent material is added to the extract to sep-
arate the compounds of interest from the matrix components and
then is removed from the extract by centrifugation. One of the main
advantages of using DSPE is the small amounts of sorbent and sol-
vent that are required, reducing handling and costs [11]. In this re-
gard, charcoal has been proven to be a suitable sorbent that is able
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to retain nucleotides from biological extracts [9,14]. Nucleotide
adsorption on charcoal is based on interaction of the aromatic ring
electrons from the purine or pyrimidine moiety with the p electrons
from the charcoal.
Quantiﬁcation methods for nucleotides, given in the literature,
involve incorporation of radioactive phosphate followed by one-
or two-dimensional thin-layer chromatography (TLC) [9,15] as well
as less sensitive and selective ion-pair, ion-exchange, and ion chro-
matography with ﬂuorescence, ultraviolet, and conductivity detec-
tion [16–19]. In addition, the combination of liquid
chromatography (LC) and mass spectrometry (MS) has been shown
to be a powerful analytical technique for quantitative analysis of
nucleotides in Saccharomyces cerevisiae, Bacillus subtilis, Escherichia
coli, human plasma, and animal tissue [20–23]. In addition, LC–
MS/MS (tandem mass spectrometry) with porous graphitic carbon
as a stationary phase has been used for analysis of araCTP, CTP,
and dCTP [24]. LC–MS/MS fulﬁlls three important requirements
when dealingwith analysis of intracellularmetabolites: (i) sensitiv-
ity, (ii) wide linear range, and (iii) no need to form thermally stable
derivatives of the tri-, di-, ormonophosphorylatednucleotides as re-
quired for gas chromatographymass spectrometry [6,25]. Due to the
highpolarity andmultiple charges, nucleotides are notwell retained
under reversed phase conditions, and therefore methods such as
hydrophilic interaction chromatography (HILIC) and ion-exchange
chromatography are needed for their separation [26,27]. A subtype
of the latter is ion-pair chromatography that is made by dynamic
modiﬁcation of a reversed phase separation by coating the surface
with charged but still hydrophobic ion-pair reagent added to the
mobile phase [20,21,28,29]. Ion-pair chromatography is a promising
alternative especially when dealing with isomeric compounds that
any other chromatography technique fails to separate. Furthermore,
the hydrophobic parts of the nucleotides can also interact with the
hydrophobic parts of the reversed phase column, thereby giving
mixed-mode conditions. For compatibilitywith atmospheric ioniza-
tion techniques used for LC–MS, volatile ion-pairing reagents such
as tributyl-, dibutyl-, and triethylamine are required because the
ion source will clog within minutes of operation if a nonvolatile re-
agent such as tetrabutylamine is used [30].
When using LC–MS as a detection technique for analysis of
complex biological extracts, enhancement or suppression of the
ionization is often observed, resulting in different responses for
the compounds of interest than are seen from pure standard solu-
tions [31,32]. This occurs when target compounds coelute with
matrix interferences and, therefore, the modulation of the LC–MS
signal (i) affects reproducibility, (ii) leads to systematic errors,
and (iii) can obscure the detection of the target compound in ex-
treme cases.
To prevent the signal modulation especially observed in electro-
spray ionization (ESI), four alternatives exist: (i) development of
more selective chromatographic separation, (ii) better sample
puriﬁcation (e.g., by SPE), (iii) use of more sensitive MS instru-
ments that allow sample dilution, and (iv) use of stable isotope-la-
beled internal standards (ISs) that can compensate for matrix
effects [33]. Due to the similar physicochemical properties, the iso-
tope-labeled ISs also correct for losses and decomposition during
sample preparation.
In this study, we present an ion-pair LC isotope dilution MS/MS
method combined with charcoal sample puriﬁcations for analysis
of nucleotide pools. Tributylamine (TBA) was used as ion-pair re-
agent to modify the mobile phase and facilitate the retention of
the nucleotides. Subsequently the applicability of the method
was demonstrated by analysis of nucleotide pools in L. lactis. To
the best of the authors’ knowledge, there is no previous report
regarding the combination of DSPE puriﬁcation using charcoal
and ion-pair LC–MS/MS analysis for determination of nucleotide
pool sizes.
Materials and methods
Materials
Nucleotide standards were purchased from Sigma–Aldrich
(Steinheim, Germany). Uniformly isotope-labeled (13C and/or 15N)
nucleotides were used as ISs and were purchased from Silantes
(Munich, Germany) and Sigma–Aldrich. The chemical purity and
isotope enrichment of the isotope-labeled nucleotides were more
than 90 and 98%, respectively, except for [U-13C]ATP, [U-13C]GTP,
and [U-13C15N]CTP, which had a chemical purity of 95%. Amino
acids, vitamins, glucose, inorganic salts, active charcoal (C3345),
hydrochloric acid (HCl), TBA (puriss. plus grade), 0.5 M dibutyl-
amine acetate (DBAA) concentrate (LC–MS grade), ethanol, metha-
nol, acetonitrile, and acetic acid (LC–MS grade) were obtained from
Sigma–Aldrich. Water was puriﬁed using a Milli-Q system (Milli-
pore, Bedford, MA, USA).
Stock solutions
Stock solutions of the nucleotides with concentration of 1 mg/
ml were prepared in water and stored under –20 C until use. Ali-
quots of the stock solutions were used to prepare the daily working
solutions by further dilution in 10 mM TBA and 10 mM acetic acid
solution. Stock solutions (1 and/or 0.2 mg/ml) of labeled ISs were
prepared in water and kept under –20 C until use. The concentra-
tion of the labeled nucleotides used to prepare the IS mixture for
spiking the calibration standards and the extracts is given in
Table 1.
Cell growth and sampling
L. lactis wild-type strain was grown overnight at 30 C on agar
plates containing M17 broth medium obtained from Oxoid sup-
plied with 1% glucose (GM17) [34]. Ten single colonies were used
to inoculate synthetic amino acid (SA) medium [35] containing
0.5% glucose. The culture was subjected to 10-fold dilution series
(up to 10–7) and grown overnight at 30 C. Then 50 ml of culture
from the dilution where the cells were still in exponential growth
was transferred into 500 ml of preheated SA medium at 30 C. The
OD450 of the cultures was measured continuously, starting from
0.03 until 0.5, when 5 ml of culture was quenched with 1 ml of
10 M cold formic acid, followed by the addition of 65 ll of IS mix-
ture. After vigorous mixing, the cultures were stored at –80 C. For
extraction of the metabolites, the cultures were subjected to three
freeze–thaw cycles by placing the samples from a –80 C freezer to
an icewater bath, followed by mixing. Then the samples were cen-
trifuged at 4248g and the supernatant (6.0 ml) was transferred to a
chilled Falcon tube.
Charcoal sample cleanup
Activated charcoal (0.75 g) was suspended in 5 ml of 96% etha-
nol and 45 ml of water and was vortexed. The suspension was cen-
trifuged for 20 min at 4248g and 4 C, and the supernatant was
discarded. The pellet was then mixed with 1.5 ml of 1 M HCl and
centrifuged. After discarding the supernatant, the charcoal pellet
was washed with 10 ml of water three times and ﬁnally resus-
pended in 1 ml of water.
The quenched bacterial sample was transferred to a chilled tube
containing 0.6 ml of the activated charcoal suspension and was
vigorously mixed and kept on ice. The suspension was centrifuged
for 20 min at 4248g and 4 C. The supernatant was transferred to a
chilled Falcon tube and stored at –80 C. The charcoal pellet was
washed two times with ice-cold water and centrifuged for
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20 min at 4248g and 4 C. The nucleotides were eluted from the
charcoal with ice-cold solvent containing 2% NH3 and 50% acetoni-
trile in water. The samples were evaporated under nitrogen and ﬁ-
nally resuspended in 325 ll of 10 mM TBA and 10 mM acetic acid
solution.
UHPLC–MS/MS analysis
Analysis was performed on an Agilent 1290 binary ultra high-
performance liquid chromatography (UHPLC) system coupled with
an Agilent 6460 triple quadrupole system (Torrance, CA, USA)
equipped with an Agilent jet stream ESI source and was operated
in negative ion mode. Nitrogen was used as collision gas. The
source and fragmentation parameter were optimized for each of
the nucleotides using 10 lg/ml single standard dissolved in mobile
phase A (10 mM TBA containing 10 mM acetic acid), bypassing the
column. The most intense product ions were selected by increasing
the collision energy voltage in the product ion scan and monitoring
the intensity of their MS signal. The optimized ion-source-depen-
dent parameters were as follows: gas temperature, 300 C; sheath
gas temperature, 400 C; nebulizer gas ﬂow rate, 8 L/min; nebu-
lizer pressure, 50 psi; and capillary voltage, 4500 V. The entrance
potential (DEMV, electron multiplier voltage) was kept at 500 V
for all of the transitions. The mass spectrometer resolution was
set to ‘‘unit’’ in both Q1 (ﬁrst quadrupole) and Q3 (third quadru-
pole). Unless otherwise stated, separation was performed by using
an Agilent Poroshell 120 Phenyl-Hexyl column (2.7 lm,
100  2.1 mm, operated at 40 C). An Agilent 1290 Inﬁnity in-line
ﬁlter (0.3 lm) was used to protect the column. Mobile phase A
was 10 mM TBA and 10 mM acetic acid (pH 5.5), and mobile phase
B was 90% (v/v) methanol containing 10 mM TBA and 10 mM acetic
acid. The gradient used was as follows: 0 to 5 min of 0% B, 5 to
10 min of 0 to 2% B, 10 to 11 min of 2 to 9% B, 11 to 16 min of
9% B, 16 to 24 min of 9 to 50% B, 24 to 28.5 min of 100% B, 28.5
to 30 min of 100% B, 30 to 30.5 min of 100 to 0% B, and 30.5 to
36 min of 0% B. The injection volume was 10 ll. The LC–MS/MS
run was divided into three time segments. During the ﬁrst (0–
11 min) and third (32–36 min) time segments, the valve from the
mass spectrometer was diverted to waste in order to minimize
the contamination of the source. The intracellular concentrations
were determined assuming an intracellular volume of 1.67 ml for
1 g (dry weight) of cells [36].
UHPLC accurate mass veriﬁcation
To investigate sample purity and adduct pattern and to verify the
dCTP/CTP ratio, few representative extracts were analyzed by pass-
ing the efﬂuent coming from the Agilent 1290 binary UHPLC system
to an Agilent 6550 quadrupole time-of-ﬂight (QTOF) instrument
operated in ESI– in the 2-GHz extended dynamic mode at a resolu-
tion of 25,000 full width at half-maximum (FWHM). The QTOF
instrument was tuned for fragile molecules by lowering all of the
potentials in the ion path by 5 V relative to the autotune values.
Method validation and quantiﬁcation
For calculating the accuracy/recovery and precision, two ap-
proaches were used: (i) the standard addition approach for endog-
enous compounds proposed by Tsikas [37] and (ii) validation based
on spiking of the medium used for growing the cells. For the ﬁrst
Table 1
Precursor and product ions of the labeled and unlabeled standards used in the analysis.
Nucleotide RT(min) Precursor
ion (m/z)
Product
ion (m/z)
Collision
energy (V)
Fragmentor
voltage (V)
Cell acceleration
voltage (V)
Labeled
nucleotides
Precursor
ion (m/z)
Product
ion (m/z)
Concentration
(lg/ml)a
AMP 22.1 346 79 20 130 3 [U-15N]AMP 350.8 79 2.5
ATP 26 505.9 273 30 95 3 [U-13C]ATP 515.9 278 100
CMP 18.5 322 79 40 120 4 [U-13C15N]CMP 334 79 2.5
CTP 25.6 481.9 159 30 125 4 [U-13C15N]CTP 493.9 159 6
dATP 26.2 489.9 158.9 35 130 3 [U-15N]dATP 495 158.7 2
dCMP 19.8 306 79 40 130 4 [U-13C15N]dCMP 318 79 1.25
dCTP 25.6 465.9 158.9 25 120 3 [U-13C15N]dCTP 477.9 158.9 5
dGMP 21.8 346 79 30 90 4 [U-13C15N]dGMP 361.1 79 2
dGTP 25.8 505.9 257 35 115 3 [U-13C15N]dGTP 521.1 262 2.5
TMP 21.9 321 124.9 20 110 4 [U-13C15N]TMP 333 131.8 1.5
GMP 20.8 362 79 25 110 4 [U-13C15N]GMP 377.1 79 2.5
GTP 25.7 521.9 159 35 100 3 [U-13C]GTP 531.9 159 60
TTP 26 480.9 159 25 100 3 [U-13C15N]TTP 493 159 1.5
UMP 20 323 79 40 100 4 [U-13C15N]UMP 334 79 2.5
UTP 25.8 482.9 159 30 95 4 [U-15N]UTP 485.1 158.9 50
ADP 24.7 425.9 134 25 115 3 – – – –
cAMP 21.1 328.1 134 25 115 4 – – – –
c-diGMP 23.5 689 149.9 35 100 4 – – – –
CDP 24.4 401.9 79 40 90 4 – – – –
cGMP 19.3 344 150 25 115 3 – – – –
dUMP 21.1 307 195 15 110 4 – – – –
IMP 21 347 79 35 115 4 – – – –
OMP 24.4 367 79 25 95 3 – – – –
UDP-Glc 21.8 564.9 323 30 120 3 – – – –
UDP 24.4 402.9 79 40 115 3 – – – –
XMP 24.5 363 211.1 20 100 4 – – – –
ZMP 20.7 337 78.9 35 115 3 – – – –
GDP 24.3 442 159 30 120 3 – – – –
Note: Retention time (RT), optimized collision energy, fragmentor voltage, and cell acceleration voltage of the multiple reaction monitoring transitions are also given in the
table. c-di-GMP, cyclic diguanylate; UDP-Glc, uridine diphosphate glucose; GTP, guanosine-50-triphosphate; ATP, adenosine-50-triphosphate; dGTP, deoxyguanosine tri-
phosphate; dATP, deoxyadenosine triphosphate; UTP, uridine-50-triphosphate; CTP, cytidine-50-triphosphate; TTP, thymidine triphosphate; dCTP, deoxycytidine triphos-
phate; GDP, guanosine-50-diphosphate; ADP, adenosine-50-diphosphate; UDP, uridine-50-diphosphate; CDP, cytidine-50-diphosphate; OMP, orotidine-50-monophosphate;
XMP, xanthosine monophosphate; GMP, guanosine-50-monophosphate; IMP, inosine-50-monophosphate; AMP, adenosine-50-monophosphate; dGMP, deoxyguanosine
monophosphate; cGMP, guanosine cyclic-30 ,50-monophosphate; ZMP, 5-aminoimidazole-4-carboxamide ribotide; cAMP, adenosine cyclic-30 ,50-monophosphate; UMP, uri-
dine-50-monophosphate; CMP, cytidine-50-monophosphate; TMP, thymidine monophosphate; dUMP, deoxyuridine monophosphate; dCMP, deoxycytidine monophosphate.
The experimental details are given in Materials and Methods.
a Concentration of the labeled nucleotides in the IS mixture used to spike the calibration standards and the extracts for the quantiﬁcation experiments.
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Table 2
Accuracy and precision of the standard addition experiment including the determined intracellular nucleotide amounts in L. lactis.
Nucleotide R2 LOD
(lg)
Measureda
(lg)
Added amountb (lg) Day 1 Day 2 Day 3 nmol/mg
dry
weight
Intracellular
concentration
(lM) d
Accuracyc(%) Precisionc(RSD%) Accuracy
(%)
Precision
(RSD%)
Accuracy
(%)
Precision
(RSD%)
With IS AMP 0.992 0.004 0.07 0.05 0.11 0.16 0.22 0.27 87 17 95 9 87 2 0.4 0.2
ATP 0.995 0.004 4 1.66 3.33 4.99 6.66 8.32 88 17 88 15 87 15 16 10
CMP 0.995 0.03 0.01 0.08 0.16 0.24 0.32 0.40 94 7 84 19 94 6 0.1 0.1
CTP 0.985 0.001 0.3 0.11 0.21 0.32 0.43 0.53 88 16 85 17 82 19 1 0.6
dATP 0.987 0.001 0.1 0.02 0.05 0.07 0.09 0.12 95 6 95 1 94 10 0.4 0.2
dCMP 0.994 0.002 0.005 0.02 0.04 0.06 0.08 0.10 91 13 91 14 88 8 0.03 0.02
dCTP 0.993 0.003 0.3 0.17 0.33 0.50 0.67 0.83 93 9 90 11 93 10 1.4 0.9
dGMP 0.990 0.015 ND 0.17 0.33 0.50 0.67 0.84 94 4 93 12 94 7 ND ND
dGTP 0.95 0.008 0.01 0.10 0.20 0.29 0.39 0.49 92 5 89 17 86 23 0.04 0.03
dTMP 0.991 0.003 0.05 0.08 0.15 0.23 0.30 0.38 95 7 94 8 90 7 0.3 0.2
GMP 0.992 0.005 0.02 0.03 0.07 0.10 0.13 0.16 89 2 84 18 89 12 0.1 0.05
GTP 0.994 0.003 3 1.68 3.36 5.04 6.72 8.40 93 8 86 11 96 0.4 10 6
TTP 0.991 0.001 0.2 0.17 0.34 0.51 0.68 0.85 84 19 92 9 85 11 0.8 0.5
UMP 0.991 0.001 0.1 0.09 0.17 0.26 0.35 0.43 86 11 92 14 89 8 0.5 0.3
UTP 0.992 0.001 1 0.79 1.59 2.38 3.17 3.96 84 22 98 1 86 13 5 3
Without
IS
ADP 0.975 0.004 0.4 0.02 0.04 0.06 0.08 0.10 87 2 95 1 99 2 1.7 1
cAMP 0.987 0.001 ND 0.02 0.04 0.07 0.09 0.11 92 14 76 14 89 7 ND ND
cdiGMP 0.988 0.001 ND 0.05 0.10 0.15 0.19 0.24 87 6 91 14 91 11 ND ND
CDP 0.99 0.009 0.003 0.08 0.16 0.25 0.33 0.41 85 19 66 34 84 6 0.02 0.01
cGMP 0.986 0.001 ND 0.02 0.04 0.05 0.07 0.09 86 12 85 19 88 14 ND ND
dUMP 0.982 0.002 ND 0.08 0.17 0.25 0.33 0.41 84 4 84 4 96 8 ND ND
IMP 0.798 0.002 0.1 0.05 0.10 0.15 0.20 0.25 79 7 80 2 80 8 0.6 0.4
OMP 0.981 0.003 ND 0.06 0.12 0.17 0.23 0.29 85 9 84 15 91 8 ND ND
UDP-Glc Failed 0.00001 0.04 0.08 0.12 0.16 0.20 255 59 115 87 862 173 – –
UDP 0.987 0.004 0.04 0.07 0.14 0.22 0.29 0.36 89 11 95 1 83 21 0.2 0.1
XMP 0.984 0.002 0.1 0.16 0.32 0.49 0.65 0.81 89 3 86 20 86 16 0.5 0.3
ZMP 0.923 0.09 0.02 0.15 0.30 0.45 0.60 0.75 88 16 86 5 85 2 0.12 0.07
GDP 0.99 0.003 0.002 0.04 0.08 0.12 0.16 0.20 85 18 91 9 91 13 0.003 0.002
a Amount measured in the sample before spiking.
b Externally added amounts of a particular nucleotide.
c Accuracy and precision of the measurement of the underlined added amount of a particular nucleotide on 3 different days.
d Concentration determined assuming an intracellular volume of 1.67 ml for 1 g dry weight of cells [29]. ND not detected.
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approach, a mixture containing 28 target nucleotides at different
concentrations was prepared in levels of approximately 0, 40, 80,
120, 160, and 200% of the mass (Table 2) determined in L. lactis
samples via external calibration. For the compounds that were
not detected in the L. lactis samples, the concentration in the mix-
ture was approximately 50 times the limit of detection (LOD) in
spiked growth medium.
For the standard addition approach, a 500-ml batch of L. lactis
culture was quenched by transferring 20 ml of culture into 100-
ml Erlenmeyer ﬂasks containing cold 4 ml of 10 M formic acid, fol-
lowed by freezing at –80 C. After thawing, all cultures were pooled
together. The pooled culture was divided by pipetting 6 ml into 15-
ml Falcon tubes. These cultures were used in the spiking experi-
ments done on 3 different days by spiking 0, 30, 60, 90, 120, and
150 ll (each level in triplicates) of the concentrated nucleotide
mixture and 65 ll of IS mixture (Table 1), resulting in 54 validation
samples in total.
For the spiked growth medium validation approach, three
groups of samples were prepared: (i) in the neat solution (eluent
A), (ii) spiking the medium after charcoal puriﬁcation and (iii) spik-
ing the medium before charcoal puriﬁcation by adding 65 ll of IS
mixture and all target nucleotides to concentrations of 0, 0.1, 0.3,
0.6, 1.2, and 6 lg/ml. The samples were prepared in triplicates
and analyzed by UHPLC–MS/MS on 3 different days.
The calibration curves, for the nucleotides for which isotope-la-
beled analog was added, were constructed by plotting the peak
area ratios of the unlabeled nucleotide standard to the correspond-
ing labeled one versus the concentrations of the nucleotide stan-
dard added. For the nucleotides where no IS was added, the
calibration curves were constructed by plotting the peak area of
the nucleotide versus the concentration of the nucleotide standard
added. The quantiﬁcation was done in Excel. The LOD for the nucle-
otides was determined at a signal-to-noise (S/N) ratio of 5 from
samples spiked in the medium, followed by charcoal puriﬁcation.
Assessment of matrix effects from growth medium
The approach of Matuszewski and coworkers [32] was used for
determination of the matrix effects coming from the medium. Two
groups of samples were prepared: (i) in the neat solution (eluent A)
and (ii) in the medium after charcoal puriﬁcation (in triplicates) by
adding 65 ll of IS mixture and all target nucleotides to concentra-
tions of 0, 0.1, 0.3, 0.6, 1.2, and 6 lg/ml. The samples were analyzed
by UHPLC–MS/MS on 3 different days.
The matrix effects were determined by the ratio of the slope of
the calibration curve (1/x weighting) of standards in the neat solu-
tion and in the medium spiked after charcoal puriﬁcation.
Assessment of matrix effects of ATP by T-piece infusion test
To study the total ion suppression, a T-piece infusion test was
conducted [38] using 10 lg/ml ATP standard prepared in the mo-
bile phase. This was continuously infused in the eluent from the
UHPLC using a syringe pump at 5 ll/min. While monitoring the
signal from the infusion, three different samples were injected
and separated on the ﬁnal gradient method: (i) mobile phase, (ii)
medium used for growing the cells previously puriﬁed with char-
coal, and (iii) L. lactis extract puriﬁed with charcoal.
Results and discussion
Optimization of MS parameters
Due to the strongly ionizing TBA in the eluents, it was only pos-
sible to operate the mass spectrometer in negative mode, where all
target compounds generated [M–H]– as the most intense ion. The
nucleotides with similarities in their structure (e.g., those contain-
ing purine base or mono-, di-, or triphosphate groups) showed a
common fragmentation pattern. The fragments used for quantiﬁ-
cation as well as the optimized collision energy, fragmentor, and
cell accelerator voltage values for each fragment are given in
Table 1.
Optimization of ion-pair chromatography
To ﬁnd the separation conditions for the nucleotides, two vola-
tile ion-pair reagents were tested: 10 mM DBAA (pH 7.3) and
10 mM TBA containing 10 mM acetic acid (pH 5.5). Both ion-pair
reagents gave sufﬁcient retention for both deoxy- and ribonucleo-
tides that increased in the order of monophosphates < diphos-
phates < triphosphates, as reported previously by others [20]. The
number of phosphate groups, interacting with the ion-pair reagent,
determined the elution pattern. As expected, DBAA gave less reten-
tion of the nucleotides compared with TBA, which was explainable
by the one fewer alkyl chain. During method optimization, various
reversed columns were also tested: Phenomenex Luna C18(2)-HST
and Onyx Monilithic C18, Agilent Zorbax extended C18, and Poro-
shell 120 Phenyl-Hexyl. It was noted that the Onyx Monolithic col-
umn was signiﬁcantly less retentive than the other columns and
gave broader chromatographic peaks. In general, the Poroshell
120 Phenyl-Hexyl column gave better spreading and less tailing
of the chromatographic peaks (data not shown) and, thus, was se-
lected as our standard column.
For the separation, Buescher and coworkers’ chromatographic
gradient [39] was taken as a starting point, but because interfer-
ence was observed from A+1 isotopomer on compounds with a
1-Da higher mass (e.g., UMP and CMP with [M–H]– ions of 323
and 322, respectively), a better separation was needed and it was
necessary to use a less steep gradient between 16 and 24 min.
For total elution of the nucleotides, it was necessary to increase
phase B to 100%.
When conducting the experiments with TBA and dibutylamine,
it was noticed that the analysis in which TBA was used as ion-pair
reagent gave at least a 5-fold increase in intensity of all the nucle-
otides. To investigate the effect of the pH of the eluents, additional
experiments were performed at pHs 7.3 and 5.5 for both dibutyl-
amine and TBA. In these experiments, the concentration of the acid
was changed, whereas the concentration of ion-pair reagent was
kept constant. As expected by reducing the acetic acid concentra-
tion in both TBA and dibutylamine eluent, there was an increase
of nucleotide retention due to the reduced competitive effect of
the acetate [29]. When compared, the results obtained with dibu-
tylamine at two different pHs showed only minor differences in the
nucleotide signal intensities. The decrease in the acetic acid con-
centration (pH 7.3), when TBA was used as eluent, led to a decrease
of the MS signal for the monophosphates and diphosphates when
compared with the analysis obtained with pH 5.5 TBA, but better
peak shape and increased MS signal for the triphosphates were ob-
tained with pH 7.3 TBA. Due to a lack of reproducibility of the chro-
matography obtained using pH 7.3 TBA as eluent and the lower
signal intensity obtained with dibutylamine as ion-pair reagent,
pH 5.5 TBA was chosen as eluent for further experiments.
In addition, the effect of the solvent used to prepare the samples
on the UHPLC–MS/MS analysis was investigated. It was noted that
when standard solutions were prepared in mobile phase A, a 2-fold
increase of the signal intensity for the nucleotides was observed
compared with the standards prepared in water/methanol mix-
ture. This effect was more prominent when higher injection vol-
umes were used. Not only an increase of the intensity but also a
reduction of the peak tailing was observed when preparing the
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standard solutions in mobile phase A, which corresponded to basic
chromatographic rules for achieving better peak shape.
Due to their identical elemental composition, ATP and AMP
had the same precursor m/z as dGTP and dGMP, respectively.
AMP and dGMP were separated, which was not the case for
ATP and dGTP. MS separation was achieved for the latter two
by identifying fragments generated as a result of loss of adenine
and guanine units, respectively. Fig. 1 shows the chromatograms
of the nucleotides obtained by measurement of 1.2 lg/ml stan-
dard mixture.
Due to the one mass unit difference between UMP and CMP, it
was necessary to achieve baseline separation in order to eliminate
the contribution of the [M–H] – A+1 isotopic ion of CMP (m/z 322)
to the [M–H]– ion of UMP (m/z 323). The same was achieved for
dTMP (m/z 321), dUMP (m/z 307), and dCMP (m/z 306), IMP (m/z
347), AMP (m/z 346), and dGMP (m/z 346), and XMP (m/z 363)
and GMP (m/z 362). Sufﬁcient separation was obtained for CTP
(m/z 482) and dTTP (m/z 481) as well, but not for UTP (m/z 483)
and CTP (m/z 482). Therefore, inspection of the chromatograms
and manual correction of the software automatic integration of
the peaks needed to be done. The latter one was applicable for
UDP and CDP as well.
Fig. 2 shows the chromatograms of the unlabeled nucleotides
from L. lactis together with the added isotope-labeled analogs.
cdiGMP
UDP-Glucose
GTP
ATP
dGTP
dATP
UTP
CTP
TTP
dCTP
Time (min)
16 18 20 22 24 26
GDP
ADP
UDP
CDP
OMP
XMP
GMP
IMP
AMP
dGMP
Time (min)
16 18 20 22 24 26
cGMP
ZMP
cAMP
UMP
CMP
TMP
dUMP
dCMP
Fig. 1. Chromatograms of the nucleotides obtained from the analysis of 1.2 lg/ml standard mixture. The second time segment, when the nucleotides elute from the column,
is shown in the ﬁgure. The experimental conditions are given in Materials and Methods. For abbreviations, see note in Table 1.
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The retention times of the nucleotides detected in the extract were
consistent with those from the standard mixture.
Optimization of sample charcoal puriﬁcation
Jendresen and coworkers [9] used charcoal for sample puriﬁca-
tion in combination with TLC detection of radioactively 33P-labeled
nucleotides. On the basis of their ﬁndings, more detailed investiga-
tion was performed on each step of the charcoal cleanup proce-
dure. By analyzing the second step of elution, it was found that
only a small amount of the nucleotides remained bound to the
charcoal. For ATP, this amount was less than 10% when compared
with the whole amount eluted in the ﬁrst and second elutions
(data not shown). To avoid the possible elution of undesired impu-
rities in the second elution step, further experiments were per-
formed with only one elution step. Moreover, to determine the
amount of unbound nucleotides, the supernatant was subjected
to a second charcoal extraction step. The analysis showed that an
insigniﬁcant amount (e.g., for ATP, <2% of the total amount de-
tected) of the nucleotides remains in the supernatant unretained
by the charcoal (data not shown).
In addition, different organic modiﬁers such as ethanol, metha-
nol, isopropanol, and acetonitrile in combination with 2% ammonia
or 30 mM ion-pair reagent were tested as solvents for eluting the
nucleotides from the charcoal. Fig. 3 summarizes the results ob-
tained using different eluents for the elution of the nucleotides
from the charcoal. It is shown that in combination with 2% ammo-
nia, 50% (v/v) acetonitrile showed slightly better elution power
when compared with the other organic modiﬁers. For example,
15% more ATP was eluted from the charcoal by using 2% ammonia
and 50% acetonitrile compared with the ethanol/ammonia mixture.
On the other hand, the combination of organic modiﬁer and ion-
Time (min)
16 18 20 22 24 26
[U-13C]GTP
GTP
[U-13C]ATP
ATP
[U-13C15N]dGTP
dGTP
[U-15N]dATP
dATP
[U-15N]UTP
UTP
[U-13C15N]CTP
CTP
[U-13C15N]TTP
TTP
[U-13C15N]dCTP
dCTP
[U-13C15N]GMP
GMP
[U-15N]AMP
AMP
[U-13C15N]dGMP
dGMP is not detected
16 18 20 22 24 26
Time (min)
Time (min)
[U-13C15N]UMP
UMP
[U-13C15N]CMP
CMP
[U-13C15N]TMP
TMP
16 18 20 22 24 26
[U-13C15N]dCMP
dCMP
Fig. 2. Chromatograms of the unlabeled nucleotides from L. lactis together with the added isotope-labeled analogs.
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pair reagent was not sufﬁciently strong for elution of most of the
nucleotides from the charcoal in a quantitative manner, indicating
that the high pH was more important than the nature of the
organic modiﬁer. Fully 50% less ATP was eluted from the charcoal
by using an acetonitrile/DBAA mixture when compared with the
amount of ATP eluted when using the acetonitrile/ammonia
mixture.
Method validation and assessment of matrix effects
Due to the large difference in the intracellular concentration,
the validation was performed at different concentration levels to
assess the variation at relevant concentrations. Due to the lack of
commercially available isotope-labeled analogs for all of the nucle-
otides, only those available were used and, thus, the results are di-
vided into two groups: metabolites measured with IS and those
measured without IS. Table 2 summarizes the validation data from
the measurement of the lowest externally added amounts of a par-
ticular nucleotide that were measured with acceptable accuracy
and precision. The bolded values, in the columns with the added
amounts, represent the levels that fall into the accepted range of
±20% deviation, whereas the shown accuracy and precision data
are from the measurement of the underlined values.
As expected, better recovery/accuracy, precision, and R2 were
obtained for the compounds quantitated using stable isotope ana-
logs as ISs. It is important to mention that in order to obtain good
linearity and acceptable precision and accuracy for all of the levels
in the standard addition experiment, it was necessary to add IS at a
concentration equal to or higher then the concentration of the
compound detected in the sample. For example, ATP, UTP, and
GTP are compounds present in higher amounts in the cell, and
the externally added amounts of these compounds brought the
concentration into a range where the IS was not capable of correct-
ing for the variations unless it was present in a sufﬁcient amount.
When the amounts of the [13C]ATP, [15N]UTP, and [13C]GTP were
increased 10, 25, and 12 times, respectively, the linearity was im-
proved from 0.966 to 0.992 for ATP, from 0.973 to 0.992 for UTP,
and from 0.992 to 0.995 for GTP. This suggests that the IS should
be added in similar concentrations as the target compounds,
although this will be very costly (U.S. $250/sample). An alterna-
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Fig. 3. Relative abundances of the metabolites detected in the L. lactis extracts after charcoal puriﬁcation using different solvents for elution from the charcoal. Bar heights
show the averages and standard deviations of duplicate samples. The bars show the differences in metabolite levels related to the different eluents used for elution of the
metabolites from the charcoal relative to the amounts obtained when ethanol was used as organic modiﬁer (relative abundance of 1). Legend for bars in upper graph: black,
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tive could be to use intracellular metabolites extracted from cells
grown on 13C-labeled glucose, as published previously [20,33]. In
our setup with the DSPE, we believe that it will not be an option
in this analysis due to the additional impurities that will be intro-
duced into the samples and will further affect the measurement.
Only UDP–glucose had accuracy and precision outside the al-
lowed range of ±20% for all of the levels. The reason for the inaccu-
rate measurement of UDP–glucose was assumed to be the high
concentration of this compound present in the cell along with
the externally added amounts in the standard addition experiment,
which brought the concentration levels into the nonlinearity range.
The latter, combined with the absence of isotope-labeled IS for this
compound, resulted in the validation failing. To solve this problem,
one could dilute the samples, which would require the sample to
be analyzed twice due to the low concentration of some of the
nucleotides.
Second validation approach was preformed by spiking the
growth medium in concentrations ranging from 0 to 6 lg/ml be-
fore charcoal puriﬁcation (Table 3). For the compounds for which
IS was available, the measurements of the samples prepared by
spiking the medium before charcoal puriﬁcation showed linearity
across the entire range with acceptable accuracy (80–120%) and
precision (relative standard deviation [RSD] of ±20%). Due to the
lower concentration of the nucleotides in the spiking samples,
the IS was able to correct for both the matrix effects and the losses
during the sample preparation. Regarding the nucleotides for
which IS was not added, the linearity was in the range between
0.1 and 1.2 lg/ml in most of the cases. UDP–glucose also showed
acceptable accuracy and precision in the range between 0.1 and
1.2 lg/ml, which adds to the previous assumption that the valida-
tion with the standard addition experiment failed due to the con-
centrations exceeding the linearity range.
In addition, the matrix effects were evaluated from the neat
standards and the samples prepared by spiking the medium with
standards and IS after charcoal puriﬁcation. The reason for choos-
ing the medium is due to the sample preparation procedure, where
the cells are kept in the growth medium during the extraction and
some of the medium components can interfere with the targets of
interest.
The results are given in Table 4.
The classic T-piece infusion test [38] shown in Fig. 4 shows the
drops in the signal intensity of ATP (m/z 505.9 > 407.9) in the chro-
matograms, indicating the presence of interfering compounds
causing ion suppression. The strongest suppression was observed
at the beginning of the gradient, presumably caused by salts.
Although the nucleotides elute later in the method, they can still
be affected by some impurities present in the samples due to the
contamination of the ion source after several injections. In addi-
tion, Fig. 4 shows the effect on the signal intensity of ATP caused
by injection of L. lactis sample puriﬁed with charcoal. As expected,
more suppression is observed in this case, which can be assigned to
both the medium and all of the other extracted metabolites from
the cell during the sample preparation as well as self-suppression
coming from the coeluting nucleotides.
Comparison with legacy data
The measured intracellular concentrations are given in Table 2.
As mentioned in Materials and Methods, the intracellular concen-
trations were estimated assuming an intracellular volume of
1.67 ml for 1 g (dry weight) of cells [36]. Fig. 5 shows the compar-
ison of the determined intracellular concentration by the ion-pair
LC–MS/MS method with the data obtained using 33P labeling fol-
lowed by TLC.
Table 3
Repeatability and reproducibility of the measurements done by spiking the medium before charcoal puriﬁcation.
R2 Repeatability (%)a,b Reproducibility (%)
0.1 lg/ml 0.3 lg/ml 0.6 lg/ml 1.2 lg/ml 6 lg/ml 0.1 lg/ml 0.3 lg/ml 0.6 lg/ml 1.2 lg/ml 6 lg/ml
Compound Acc RSD Acc RSD Acc RSD Acc RSD Acc RSD Acc RSD Acc RSD Acc RSD Acc RSD Acc RSD
With IS AMP 0.995 97 7 98 4 94 4 104 6 100 13 99 8 98 2 93 6 105 9 100 10
ATP 0.994 105 7 94 12 99 5 102 8 101 11 105 10 99 13 99 5 103 9 102 11
CMP 0.994 104 11 89 7 93 9 106 8 100 7 105 10 88 7 95 10 107 7 100 6
CTP 0.996 100 11 90 8 87 11 89 4 103 15 99 10 91 8 83 10 90 3 100 12
dATP 0.994 99 13 91 14 85 7 95 5 102 10 102 13 90 13 83 8 95 5 101 9
dCMP 0.998 102 12 94 5 96 8 103 5 100 5 102 12 95 5 98 6 102 4 100 4
dCTP 0.995 98 11 92 15 97 10 100 8 102 4 102 15 89 14 96 12 99 8 102 4
dGMP 0.991 110 10 90 11 86 5 92 6 103 10 111 11 96 14 88 6 93 7 102 8
dGTP 0.996 110 10 90 11 86 5 92 6 103 10 111 11 96 14 88 6 93 7 102 8
dTMP 0.998 102 7 92 7 95 10 104 7 100 5 102 9 91 7 95 9 105 6 100 4
GMP 0.991 116 19 81 19 88 6 96 5 102 6 108 16 85 18 89 6 96 5 101 5
GTP 0.992 94 12 90 18 84 11 84 11 106 5 92 19 82 15 90 11 90 11 107 5
TTP 0.992 97 11 93 5 88 6 96 4 102 9 98 11 93 5 87 6 97 4 102 9
UMP 0.995 97 8 93 9 88 6 104 5 103 5 97 8 93 8 88 5 104 5 100 4
UTP 0.992 90 16 94 8 105 8 95 7 96 7 91 15 95 10 103 12 101 7 94 20
Without IS ADP 0.999 105 16 96 10 118 6 104 1 99 6 101 18 94 9 101 6 104 2 99 5
cAMP 0.990 97 5 105 6 93 20 108 2 – – 104 7 106 5 88 18 108 5 – –
cdiGMP 0.989 106 15 98 11 92 9 104 7 – – 104 13 96 12 93 8 103 5 – –
CDP 0.943 – – 95 15 106 7 98 7 – – – – 95 13 108 9 97 6 – –
cGMP 0.988 103 8 99 10 97 18 103 2 – – 102 8 99 9 91 18 103 2 – –
dUMP 0.990 108 12 96 5 98 8 114 5 – – 92 12 94 5 96 6 115 4 – –
IMP 0.989 92 14 103 17 112 18 – – – 94 17 88 16 102 17 – – – –
OMP 0.973 91 17 107 18 103 12 97 9 – – 96 20 103 17 101 11 98 8 – –
UDP-Glc 0.992 102 10 100 11 104 12 101 5 – – 101 9 99 9 98 10 100 4 – –
UDP 0.970 99 16 97 14 97 14 102 7 – – 100 18 96 14 97 12 102 7 – –
XMP 0.993 103 11 100 14 95 8 102 4 – – 102 9 99 11 95 7 102 3 – –
ZMP 0.997 – – 110 16 101 15 102 6 – – – – 109 15 95 14 102 8 – –
GDP 0.988 – – 95 8 99 9 105 5 – – – – 95 12 98 8 107 10 – –
a The intraday repeatability and interday reproducibility were determined by analyzing triplicates of ﬁve different concentration levels at 3 different days.
b The accuracy was determined as 100  [(added-measured)/measured  100].
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Two different quantiﬁcation approaches were used: (i) standard
addition and (ii) external calibration by using calibration standards
prepared by spiking the medium before charcoal puriﬁcation. For
the compounds for which IS was used, similar concentrations were
obtained independent of the quantiﬁcation approach. This once
more conﬁrms that the IS is capable of correcting the losses and
the matrix effects during the analysis if present in a sufﬁcient
amount, as mentioned before. Regarding the compounds for which
quantiﬁcation was done without the addition of IS, different con-
centrations were obtained depending on the quantiﬁcation ap-
proach used. The differences could be explained by the different
matrix effects between the samples and the standard in the exter-
nal calibration experiment and the absence of the IS in general.
However, as has been previously published by Liu and coworkers
[40], even the addition of isotope-labeled analog will not always
improve the accuracy.
For most of the nucleotides for which IS was added, no statisti-
cal difference (proved by two-tailed t test [data not shown]) was
observed for the amounts found in L. lactis with standard addition
versus quantiﬁcation based on spiking the medium (Fig. 5). How-
ever for compounds with no isotope-labeled standard, big differ-
ences were observed; thus, standard addition is essential for a
correct quantiﬁcation, whereas spiked medium will easily work
for mutant or growth condition comparisons for all compounds
quantiﬁed using isotope-labeled standards (at a similar analyte
concentration).
The energy charge deﬁned as (ATP + 0.5ADP)/(ATP + AD-
P + AMP) was determined from the quantiﬁed amounts of ATP,
ADP, and AMP and was 0.97 ± 0.001, as reported previously in
the literature [41].
The ratio between CTP and dCTP has been found to be between
5 and 10 [8], which is a general trait of many organisms, including
mammalian cells [15]. To investigate whether the low CTP pool
size was due to partial CTP starvation, L. lactis cultures were grown
in SA medium with the addition of 200 lg/ml cytidine. This addi-
tion should boost the CTP pool of CTP-starved cells because cyti-
dine is readily converted into CTP [15]. The results from the
latter measurement showed the same trend. In addition, the ex-
tracts from the cells grown in a medium with and without the
addition of cytidine were analyzed by the same UHPLC method
now coupled to a QTOF instrument (high-resolution MS) to inves-
tigate the possible presence of coeluting compounds that might
impair the analysis. The accurate mass UHPLC–MS measurement
veriﬁed the dCTP/CTP ratio and showed that it was the two major
ionizable compounds eluting at the speciﬁc time window, indicat-
ing no ion suppression. Finally, analysis of extracts from mamma-
Table 4
Matrix effects from the medium expressed as the ratio of the slope of the calibration
curve constructed from standards spiked in the charcoal-puriﬁed medium, before the
analysis, to the standards prepared in the neat solution multiplied by 100.
Nucleotide Slope from the linear regression analysis Matrix
effectsa
(%)
Neat
standards
Standards spiked in the puriﬁed
medium before injection into the LC–
MS
c-diGMP 12.8 8.0 63
UDP-Glc 109 80.9 74
GTP 53.8 37.9 71
ATP 49.7 37.0 74
dGTP 10.3 5.6 55
dATP 262 155 59
UTP 305 90.7 30
CTP 201 105 53
dTTP 338 133 39
dCTP 25.4 15.5 61
GDP 167 142 85
ADP 49.1 26.4 54
UDP 48.7 41.7 86
CDP 48.7 35.1 72
OMP 57.9 46.5 80
XMP 61.6 30.8 50
GMP 44.4 30.7 69
IMP 36.0 23.8 66
AMP 117 71.5 61
dGMP 57.4 22.5 39
cGMP 204 130 63
ZMP 15.4 7.9 51
cAMP 375 201 54
UMP 112 112 100
CMP 47.3 32.9 70
dTMP 103 51.7 50
dUMP 57.2 32.3 56
dCMP 63.6 57.5 90
Note: For abbreviations, see note in Table 1. The experimental details are given in
Materials and Methods.
a 100% corresponds to no matrix effect.
0
50
100
Time (min)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
0
5
10
15
Time (min)
2 4 6 8 10 12 14 16 18 20 22 24
Co
u
n
ts
 
(%
) Co
u
n
ts
 
(%
)
Fig. 4. Inspecting ion suppression by monitoring ATP signal from continuous infusion of ATP standard solution and injection of: i) mobile phase; ii) medium puriﬁed with
charcoal; iii) and puriﬁed L. lactis sample. Legend: red signal, injection of mobile phase; blue signal, injection of L. lactis extract; green signal, injection of medium used for
growing the cells puriﬁed with charcoal.
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lian cells (Chinese hamster ovary [CHO] cells, saline quenched
[42]) as well as S. cerevisiae (60% cold methanol, quenched) showed
the expected CTP/dCTP ratio (results not shown), suggesting that
the unexpected CTP/dCTP ratio is caused by cell physiology and
not a technical error. When compared with the amounts of the
nucleotides determined by TLC detection of radioactively 33P-la-
beled nucleotides by Jendresen and coworkers [9] (Fig. 5), higher
concentrations were measured with the LC–MS/MS method for
most of the compounds. Because both LC–MS/MS calibrationmeth-
ods gave the same results, this supports the results obtained here
and substantiates that the cells may have been in different physi-
ological states in the two experimental setups. We are currently
pursuing an explanation for these issues.
Conclusion
An analytical method for 28 nucleotides in L. lactis has been
established. The method can, via charcoal puriﬁcation, handle ex-
tracts where the fragile cells leaks during the quenching. In addi-
tion, separation of isobaric and most of the compounds that
differ in one mass unit (e.g., dTMP, dUMP, dCMP) was achieved
either by MS/MS (speciﬁc fragments) or chromatographically. The
combination of ion-pair LC–MS/MS together with charcoal sample
preparation proved to be suitable for simultaneous analysis of
mono-, di-, and triphosphorylated deoxy- and ribonucleotides
and partly sugar nucleotides. The method was successfully applied
for analysis of nucleotide pools in L. lactis but also showed that for
the standard addition experiment the isotope-labeled standards
needed to be added in similar or higher concentrations as the
analytes.
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Summary
In many species of the marine Roseobacter clade,
periods of attached life, in association with phyto-
plankton or particles, are interspersed with planktonic
phases. The purpose of this study was to determine
whether shifts between motile and sessile life in the
globally abundant Roseobacter clade species
Ruegeria mobilis are associated with intracellular con-
centrations of the signal compound cyclic dimeric
guanosinmonophosphate (c-di-GMP), which in bacte-
ria regulates transitions between motile and sessile
life stages. Genes for diguanylate cyclases and
phosphodiesterases, which are involved in c-di-GMP
signalling, were found in the genome of R. mobilis
strain F1926. Ion pair chromatography-tandem mass
spectrometry revealed 20-fold higher c-di-GMP con-
centrations per cell in biofilm-containing cultures than
in planktonic cells. An introduced diguanylate cyclase
gene increased c-di-GMP and enhanced biofilm
formation and production of the potent antibiotic
tropodithietic acid (TDA). An introduced phospho-
diesterase gene decreased c-di-GMP and reduced
biofilm formation and TDA production. tdaC, a key
gene for TDA biosynthesis, was expressed only in
attached or biofilm-forming cells, and expression was
induced immediately after initial attachment. In con-
clusion, c-di-GMP signalling controls biofilm forma-
tion and biofilm-associated traits in R. mobilis and, as
suggested by presence of GGDEF and EAL domain
protein genes, also in other Roseobacter clade
species.
Introduction
The Roseobacter clade (Alphaproteobacteria) accounts
for a significant part of the microbiota in the oceans,
especially in coastal zones and surface waters (Gonzalez
and Moran, 1997; Buchan et al., 2005; Brinkhoff et al.,
2008; Newton et al., 2010; Wietz et al., 2010).
Roseobacter clade species are metabolically and ecologi-
cally diverse, comprising aerobic anoxygenic phototrophs,
sulphur metabolizers, carbon monoxide oxidizers and
degraders of aromatic compounds (Shiba et al., 1979;
Sorokin and Lysenko, 1993; Moran and Hodson, 1994;
Buchan et al., 2001; Allgaier et al., 2003; Moran et al.,
2003; 2004). However, most species of the Roseobacter
clade are classified as ecological generalists (Moran et al.,
2004; Newton et al., 2010). Abundance and activity of
many Roseobacter clade members are correlated with
phytoplankton population densities, and one prominent
ability of many Roseobacter clade members is the conver-
sion of the phytoplankton osmolyte dimethylsulfonio-
propionate to the volatile dimethyl sulphide, which influ-
ences the local and global climate (Charlson et al., 1987;
Gonzalez and Moran, 1997; Gonzalez et al., 2000; Moran
et al., 2003; Geng and Belas, 2010b).
Belas and colleagues (2009) noticed that many
Roseobacter clade species have a ‘biphasic swim-or-stick
lifestyle’ that enables their symbiosis with phytoplankton,
and suggested that a central regulation mechanism
coordinated the shift between planktonic and attached
phenotype. Accumulating evidence indicates that bis-(3′-
5′)-cyclic dimeric guanosinmonophosphate (c-di-GMP)
functions as a nearly universal second messenger in bac-
teria, regulating transitions between planktonic and sed-
entary phases by controlling phenotypic features such as
flagellar motility and production of extracellular polymeric
substances (EPS) (Hengge, 2009; McDougald et al.,
2012). Above that, c-di-GMP regulates important func-
tions that are associated with either one of the lifestyles,
such as virulence or antibiotic production (Schmidt et al.,
2005; Cotter and Stibitz, 2007; Tamayo et al., 2007). The
intracellular pool of c-di-GMP is balanced by diguanylate
cyclases (GGDEF-domain proteins) that synthesize the
compound and by specific phosphodiesterases (EAL-
domain proteins) that degrade it (Ausmees et al., 2001;
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Ryjenkov et al., 2005; Gjermansen et al., 2006). The
activity of these antagonistic enzymes is controlled by
sensory domains or proteins that allow external or internal
stimuli to act on the intracellular pool of c-di-GMP and thus
influence the decision between sessile and motile life.
Here, we hypothesized that the transition between plank-
tonic and attached lifestyle in Roseobacter clade species
is induced by intracellular c-di-GMP levels. To test this, we
introduced the plasmids pYedQ and pYhjH that have been
used as tools to demonstrate that c-di-GMP signalling
regulated Pseudomonas putida biofilm formation and dis-
persal (Gjermansen et al., 2006). The plasmids contain
either one of the Escherichia coli genes yedQ and yhjH,
which encode a diuguanylate cyclase that synthesizes
c-di-GMP and a c-di-GMP-degrading phosphodiesterase
respectively. Intracellular levels of c-di-GMP in Ruegeria
mobilis F1926 wild-type and plasmid-carrying mutants
were assessed using ion pair liquid chromatography-
tandem mass spectrometry (Ion-Pair UHPLC-MS/MS).
The Roseobacter clade genera Ruegeria and
Phaeobacter have been of particular interest due to
their ability to form the potent antibacterial compound
tropodithietic acid (TDA). Phaeobacter strains have been
isolated from coastal zones, especially from biofilms in
fish and invertebrate larvae cultures, and have been
studied for their antibacterial activity and as probiotics for
marine aquaculture (Ruiz-Ponte et al., 1998; Brinkhoff
et al., 2004; Hjelm et al., 2004; Planas et al., 2006;
Porsby et al., 2008; D’Alvise et al., 2010). Ruegeria
(Silicibacter) sp. TM1040 is a symbiont of the dinoflagel-
late Pfisteria piscicida and was the first TDA-producing
bacterium in which parts of the TDA biosynthetic pathway
were elucidated (Alavi et al., 2001; Miller and Belas, 2006;
Bruhn et al., 2007; Moran et al., 2007; Yi et al., 2007;
Geng et al., 2008; Geng and Belas, 2010a). R. mobilis
(Ruegeria pelagia) has been isolated in surface ocean
waters in most climatic zones, except Arctic and Antarctic
waters, and it occurs in both coastal zones and open
oceans (Gram et al., 2010; Lai et al., 2010). Several
strains of R. mobilis, which all produce TDA, have been
isolated from microalgae cultures, highlighting their pref-
erence for phytoplankton (Porsby et al., 2008).
TDA production is influenced by culture conditions, and
Bruhn and colleagues (2005) found that TDA production
by Phaeobacter sp. 27-4 in Marine Broth (MB; Difco Labo-
ratories, Detroit, MI, USA) only occurred under static
growth conditions but not in shaken broth cultures. TDA
production coincided with formation of a thick layer of
biofilm at the air–liquid interface consisting of multicellular,
star-shaped aggregates. To our knowledge, Ruegeria
strains can only produce TDA in static liquid cultures,
where a biofilm at the air–liquid interface is formed,
whereas most Phaeobacter strains are able to produce
TDA in shaken liquid cultures as well. This makes
Phaeobacter sp. 27-4 an exemption among the TDA-
producing Phaeobacter strains (Porsby et al., 2008). A
later study, also using strain 27-4, demonstrated that
attachment to an inert surface was affected by culture
conditions as well (Bruhn et al., 2006). However, although
the tight association between biofilm formation and TDA
production strongly indicates that TDA is only produced by
attached or biofilm-forming cells, this was never verified.
In the present study, we demonstrate that c-di-GMP plays
a major role in the transition from motile to sessile state in
R. mobilis, and this led us to hypothesize that formation of
TDA, which is associated with biofilms, could be corre-
lated with c-di-GMP. Consequently, investigating whether
TDA production was affected by altered c-di-GMP levels
became a second aim of this study. Therefore, we meas-
ured the impact of changed c-di-GMP levels on antibac-
terial activity and TDA production and studied the
expression of the tdaC gene in attached and planktonic
cells.
Results
Bioinformatic analysis
The genome of R. mobilis F1926 was Illumina-sequenced
and assembled into 1065 contigs with a total length of
about 4.5 Mb. One hundred ten contigs were larger than
10 kb and contained together 2.5 Mb. For comparison,
the closest genome-sequenced relative (on 16S-rRNA-
gene-level) of strain F1926, Ruegeria sp. TM1040 (Sup-
porting Information Fig. S1), contains 4.2 Mb of genomic
DNA, a megaplasmid of 0.8 Mb and a large plasmid of
0.1 Mb (Moran et al., 2007). Nine genes encoding
diguanylate cyclases and c-di-GMP-specific phosphodie-
sterases were identified in R. mobilis F1926 based on
Prokaryotic Genomes Automatic Annotation Pipeline
(PGAAP) annotation, which was manually controlled by
Pfam classification (Table 1). Six of these encoded pro-
teins that contained both a GGDEF and an EAL domain.
This could indicate that these enzymes have alternating
c-di-GMP synthesizing or degrading activity; however,
there are examples of proteins that contain both GGDEF
and EAL domains, but act only as either diguanylate
cyclase or phosphodiesterase, or have no c-di-GMP con-
verting activity at all, but act as signalling proteins
(Christen et al., 2005; Matilla et al., 2011; Newell et al.,
2011).
c-di-GMP analysis by ion pair UHPLC-MS/MS
The plasmids pYedQ and pYhjH, as well as the respective
vector controls pRK404A and pBBR1MCS-3, were intro-
duced into R. mobilis F1926 with the aim of manipula-
ting intracellular c-di-GMP concentrations, which was
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subsequently verified by ion pair chromatography-MS/MS
in extracts of 24 h old shaken and static MB cultures. The
compound was detected in all extracts with the same
retention time as an authentic standard. A chromato-
graphic plot of a standard and a sample is given in the
Supporting Information Fig. S2. Concentrations in the
extracts ranged from 26 to 770 nM and were divided by
the optical density (OD600) of the original culture to obtain
a relative measure of c-di-GMP per cell (Fig. 1). Care was
taken to break up the biofilms of the static cultures before
sampling and OD measurement to allow comparison of
cell density to shaken cultures. Static cultures of the wild
type, where thick air liquid interface biofilms were
observed, contained 20 times more c-di-GMP per cell
than shaken cultures, where no biofilms were formed.
Plasmid pYedQ increased c-di-GMP per cell to the 30-fold
concentration of the vector control under shaken condi-
tions (P < 0.001) and to the threefold concentration in
static cultures (P < 0.001). In the static cultures of the
mutant carrying plasmid pYhjH, c-di-GMP concentration
per cell was reduced to about half of the respective vector
control; however, this was not significant (P > 0.05), and
under shaken conditions, no further reduction in c-di-GMP
was found. Regardless of the introduced plasmids, culti-
vation conditions influenced c-di-GMP levels. For all
strains, c-di-GMP concentrations per cell were higher in
static cultures than in shaken cultures (P < 0.001).
Phenotypic effects of altered c-di-GMP levels
Shaken cultures of R. mobilis F1926 wild type were domi-
nated by single cells, and about half of these were motile
(Fig. 2A). Introduction of pYedQ, which increased c-di-
GMP concentrations, caused disappearance of motile
cells and increased formation of multicellular aggregates
in shaken cultures (Fig. 2C). R. mobilis F1926 pYhjH,
which contained less c-di-GMP, grew almost exclusively
as single motile cells in shaken cultures (Fig. 2E). Static
cultures of the wild type were dominated by biofilms con-
sisting of multicellular, star-shaped aggregates (rosettes),
but also, motile single cells were present (Fig. 2B). In
static cultures of the pYedQ-carrying mutant, even thicker
rosette-containing biofilms were formed, and no motile
cells were observed (Fig. 2D). Introduction of pYhjH
increased the proportion of motile cells and prevented
formation of rosettes in static cultures (Fig. 2F). However,
no difference in motility on population level could be
detected in a motility-agar test (data not shown).
Table 1. GGDEF- and EAL-domain protein genes identified in Ruegeria mobilis F1926.
Locus tag Predicted gene product Pfam domain E-value (Pfam) Length [aa]
K529_01085 diguanylate cyclase GGDEF 4.1 × 10−29 313
K529_06935 diguanylate cyclase/phosphodiesterase GGDEF 2.5 × 10−35 684
EAL 5.4 × 10−66
K529_19462 diguanylate cyclase/phosphodiesterase GGDEF 1.7 × 10−45 700
EAL 1.7 × 10−59
K529_09228 diguanylate cyclase GGDEF 3.3 × 10−39 342
K529_12495 diguanylate cyclase domain-containing protein GGDEF 2.8 × 10−34 674
EAL 6.4 × 10−67
K529_13194 diguanylate cyclase/phosphodiesterase GGDEF 6.9 × 10−6 393
EAL 7.6 × 10−57
K529_15333 diguanylate cyclase/phosphodiesterase GGDEF 7.7 × 10−23 496
EAL 2.3 × 10−57
K529_15543 diguanylate cyclase/phosphodiesterase ammonium transporter GGDEF 5.7 × 10−35 904
EAL 4.4 × 10−59
Ammonium_transp 1.8 × 10−96
K529_20992 response regulator receiver modulated diguanylate cyclase GGDEF 8.0 × 10−46 467
Fig. 1. Cyclic di-GMP concentrations in extracts of 24 h old shaken
and static cultures of Ruegeria mobilis F1926 wild type, F1926
pYedQ, F1926 pYhjH and the respective vector control strains
F1926 pRK404A and F1926 pBBR1MCS3, divided by OD600 of
the cultures. Given values are averages of three independent
replicates.
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Biofilm formation and attachment were assessed in the
plasmid-carrying strains and wild type (Fig. 3). Biofilm for-
mation (Fig. 3A) was significantly increased in F1926
pYedQ (P < 0.001), whereas in F1926 pYhjH, it was
reduced as compared with the respective vector controls
and the wild type (P > 0.001). Attachment of planktonic
cells from shaken cultures was measured as stained
biomass of cells attaching to polystyrene pegs within
Fig. 2. Phase-contrast micrographs of shaken (A, C, E) and static (B, D, F) Marine Broth cultures of Ruegeria mobilis F1926 wild type (A, B),
F1926 pYedQ (C, D) and F1926 pYhjH (E, F). All scale bars indicate 10 μm. The vector control strains were similar to the wild type (not
shown).
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1 min (Fig. 3B). The wild type attached most efficiently,
whereas the attachment was reduced in both the pYhjH-
carrying strain and the strain carrying pYedQ, indicating
that both a decrease and an increase of intracellular c-di-
GMP levels interfere with attachment. Although attach-
ment was also reduced in the vector controls, which might
be an effect of the tetracycline in the medium, the reduc-
tion of attachment conferred by the introduced GGDEF-
and EAL-domain proteins was significant (P < 0.001).
The antibacterial effect of the plasmid-carrying mutants
and the wild type was compared in agar-diffusion-
inhibition assays, and TDA production was measured by
ultra-performance liquid chromatography high-resolution
mass spectrometry (UHPLC-TOFMS). In static cultures,
the pYedQ-carrying mutant caused inhibition zones of
equal or larger size than the wild type and vector controls,
whereas the mutant carrying pYhjH was less inhibitory
(Table 2). As opposed to the wild type, vector controls and
the pYhjH-carrying mutant, the pYedQ-carrying mutant
caused inhibition also in shaken cultures. As indicated by
the inhibition test, TDA production was influenced by intra-
cellular c-di-GMP concentrations (Fig. 4). Brown pigmen-
tation of the cultures, which is indicative of TDA production
(Bruhn et al., 2005), was correlated with inhibition and
TDA production (not shown).
Expression of tdaC on single-cell level
TDA production has been suggested to be regulated on
community level by auto-induction (Geng and Belas,
2010a) or by quorum sensing (QS) (Berger et al., 2011).
However, the observation that inhibitory activity was influ-
enced by intracellular c-di-GMP levels, which can be dif-
ferent between attached and planktonic cells of the same
community, suggested that TDA production could differ in
cells within the same culture. This prompted us to study
the expression of a key gene involved in TDA biosynthesis
(tdaC) on single-cell level by using a promoter-gfp fusion.
In shaken cultures, R. mobilis F1926 pPDA11 (PtdaC::
gfp) cells were predominantly planktonic (Fig. 5B), and
approximately half the cells were motile, as described
above for the wild type. tdaC was not expressed, as
indicated by lack of green fluorescence (Fig. 5A and B),
correlating with a lack of antibacterial activity and TDA
formation (Table 2, Fig 4). Yet a few small multicellular
aggregates in which tdaC was expressed were found
(Fig. 5A and B). In contrast, major proportions of the
cells from static cultures were situated in biofilms or
multicellular aggregates and expressed the tdaC gene
(Fig. 5C and D). However, a part of the single cells in the
samples from static cultures was not fluorescent, and a
fraction of these was motile. No expression of tdaC, as
indicated by green fluorescence, was observed in motile
cells. This indicated that tdaC, a gene encoding a central
enzyme in the TDA biosynthesis pathway, is expressed
differently in adjacent cells within the same cultures, and
Fig. 3. Biofilm formation (A) and attachment (B) of Ruegeria
mobilis F1926 wild type, F1926 pYedQ and F1926 pYhjH, and the
respective vector control strains F1926 pRK404A and F1926
pBBR1MCS3, measured in crystal violet assays. Cells from shaken
cultures were used in the attachment assay. Sterile medium (1.5
YTSS) was used as control. Given values are averages of two
independent replicates.
Table 2. Inhibition of V. anguillarum 90-11-287 by cell-free superna-
tants of R. mobilis F1926 wild type, F1926 pYedQ, F1926 pYhjH,
F1926 pRK404A and F1926 pBBR1MCS-3 cultures, grown in shaken
(200 r.p.m.) or static MB for 72 h at 25°C.
Strain
Inhibition zone diameter
without well diameter
[mm] ± standard deviation
Shaken cultures Static cultures
R. mobilis F1926 wild type 0 ± 0 13.5 ± 0.7
R. mobilis F1926 pYedQ 1.5 ± 0.7 15 ± 0
R. mobilis F1926 pYhjH 0 ± 0 8 ± 1.4
R. mobilis F1926 pRK404A 0 ± 0 12 ± 0
R. mobilis F1926 pBBR1MCS-3 0 ± 0 12 ± 1,4
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that its expression coincides with attachment and is
enhanced in biofilms or aggregates where high c-di-GMP
levels are found.
Induction of tdaC expression in response to attachment
When a sample of a shaken R. mobilis F1926 pPDA11
culture was prepared for microscopy, some of the non-
motile single cells attached immediately to the cover
glass. A time series of fluorescence and phase contrast
micrographs showing newly attached cells on the cover
glass was recorded (Fig. 6). Gfp expression was initiated
in the newly attached cells, and green fluorescence
could be observed already 10 min after preparation of the
microscope slide. Maximal fluorescence of the initially
attached cells was reached about 15–20 min after start of
the experiment. Considering the time needed for gfp gene
expression and maturation, this suggests that expression
was initiated immediately when the cells attached. This
instant initiation of tdaC expression may indicate a regu-
latory connection between TDA production and initial
attachment, which is likely accompanied by rising c-di-
GMP levels.
Discussion
Attachment to surfaces and biofilm formation are charac-
teristic features of many Roseobacter clade species, and
a more comprehensive understanding of the transition
between motile and sessile life stages in the Roseobacter
clade is needed to understand carbon and nutrient cycling
in the oceans (Slightom and Buchan, 2009). Also, produc-
tion of the antibacterial substance TDA in Phaeobacter
spp. has been associated with biofilms (Bruhn et al.,
2005), and since TDA is a key component for their
probiotic effect on fish larvae (D’Alvise et al., 2012),
understanding the transition between motile and
sessile stages may provide new perspectives on their
application.
Many bacteria have two distinct lifestyles, a sessile or
biofilm stage on a substrate or within a host, which is
mostly characterized by increased metabolic activity and
proliferation, and a mobile stage, where the cells are
metabolically less active, disperse into the wider environ-
ment and persist until a new substrate or host is found.
The transition between these two distinct states is in many
bacteria controlled by a pool of intracellular c-di-GMP that
exerts control on every level of regulation. C-di-GMP
binds to transcriptional regulators and also exerts control
at translational and allosteric levels, regulating a multitude
of phenotypic traits, e.g. motility, EPS production,
extracellular appendage formation, virulence or produc-
tion of secondary metabolites (Hengge, 2009; McDougald
et al., 2012). The results of our study suggest that c-di-
GMP signalling plays a similar role in R. mobilis. Intracel-
lular concentrations of c-di-GMP changed with cultivation
conditions that favoured or prevented biofilm formation.
Manipulation of c-di-GMP levels seemed to alter the pro-
portions of motile and sessile cells under different culture
conditions and affected expression of phenotypes that are
associated with either planktonic or attached lifestyle.
Increased levels of c-di-GMP promoted biofilm formation,
whereas a decrease in c-di-GMP concentrations pre-
vented formation of star-shaped aggregates and reduced
TDA production. The finding that an introduced GGDEF
domain protein increased biofilm formation and interfered
with motility is consistent with previous studies (Ausmees
et al., 2001; Simm et al., 2004; Gjermansen et al., 2006;
Wolfe and Visick, 2008; Hengge, 2009; McDougald et al.,
2012) and indicates a functional c-di-GMP signalling
system in R. mobilis. This is confirmed by presence of
genes encoding GGDEF and EAL domain proteins in the
genome of R. mobilis F1926. Presence of similar genes
annotated as diguanylyl cyclases and c-di-GMP-specific
phosphodiesterases in the closely related strains
Ruegeria sp. TM1040, Ruegeria sp. R11 and
Phaeobacter gallaeciensis DSM17395, as well as
in more remote Roseobacter clade species such as
Roseobacter litoralis Och149, Roseovarius sp. 217,
Octadecabacter arcticus 238 and Dinoroseobacter shibae
DFL12 (Supporting Information Table S1), suggests
that c-di-GMP signalling is a universal feature of the
Roseobacter clade. We conclude that in the Roseobacter
clade, in analogy with many other bacteria, intra and
Fig. 4. Concentrations of TDA in shaken and static cultures of
Ruegeria mobilis F1926 wild type, F1926 pYedQ, F1926 pYhjH and
the respective vector control strains F1926 pRK404A and F1926
pBBR1MCS3, grown in shaken or static MB for 72 h at 25°C.
Values are averages of two independent replicates.
6 P. W. D’Alvise et al.
© 2013 Society for Applied Microbiology and John Wiley & Sons Ltd, Environmental Microbiology
extracellular cues are integrated via a c-di-GMP second
messenger system and that expression of phenotypic
traits specific for either planktonic or attached life is regu-
lated in response to c-di-GMP concentrations. Belas and
colleagues (2009) have introduced the term ‘swim-or-stick
switch’ for the molecular mechanism that regulates tran-
sitions between motile and sessile stage in Roseobacter
clade species. We think that the intracellular concentra-
tion of c-di-GMP is the swim-or-stick switch.
Recently, Zan and colleagues (2012) revealed that in
Ruegeria sp. KLH11, a sponge symbiont, motility and
biofilm formation are controlled by N-acyl homoserine
lactone-based QS. Similarly, Sule and Belas (2012) found
that in Ruegeria sp. TM1040 motility and biofilm formation
are controlled by a QS-like system based on a diffusible
signal compound with a molecular mass of about 226 Da.
R. mobilis strain F1926 may utilize the same or a similar
QS system as Ruegeria sp. TM1040, and since in this
case QS and c-di-GMP signalling control the same phe-
notypes, the two regulation systems are likely connected
at some level. In a review of connections between QS
and c-di-GMP signalling, Srivastava and Waters (2012)
propose that QS signals are generally integrated into the
epistatic c-di-GMP signalling system, allowing information
about local cell density to be merged with other environ-
mental cues for making a decision between attached and
planktonic life. Thus, studying the connection between QS
and c-di-GMP signalling may provide further insight into
how motility and biofilm formation are controlled.
Most studies of c-di-GMP signalling have approached
the role of the compound using bioinformatic and tran-
scriptional tools or genetic manipulation. Few studies
actually measured concentrations of c-di-GMP to sub-
stantiate their findings (e.g., Weinhouse et al., 1997;
Waters et al., 2008; Merritt et al., 2010; Spangler et al.,
2010). However, due to the ionic nature of c-di-GMP, it
used to be difficult to obtain reproducible retention times,
as well as sharp symmetrical peaks using conventional
Fig. 5. Expression of tdaC in Ruegeria mobilis F1926 grown in shaken (A, B) and static (C, D) MB cultures, monitored using a plasmid-bound
reporter fusion of the tdaC-promoter with a promoterless gfp-gene (pPDA11). Fluorescence (A, C) and phase contrast (B, D) micrographs
were each recorded using the same settings.
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Fig. 6. Time series of tdaC expression in newly attached Ruegeria mobilis F1926 pPDA11. The images were recorded 1 min (A, B), 10 min
(B, C) and 20 min (E, F) after preparing the specimen. Fluorescence (A, C, E) and phase contrast (B, D, F) micrographs of the same area
were each recorded using the same settings. The focal plane was set right beneath the cover slip to record attached cells. White arrows
indicate the position of the same attached cell in all images. Right after preparing the specimen, the freshly attached cells were not fluorescent
(A), yet green fluorescence indicating expression of tdaC was observed in attaching cells after 10 min. All scale bars indicate 10 μm.
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reversed phase chromatography (Werner, 1991; Simm
et al., 2004). LC-MS/MS with tributylamine as ion pair
reagent was chosen due to its sensitivity and higher vola-
tility of the tributylamine (Magdenoska et al., 2013) when
compared with tetrabutylammonium (Witters et al., 1997)
which reduces background and ion-source pollution
(Holcapek et al., 2004).
A relative of the Roseobacter clade within the
α-Proteobacteria, Caulobacter crescentus, has a very
sophisticated variant of c-di-GMP-mediated ‘swim-and-
stick’ life (Viollier et al., 2002; Aldridge et al., 2003; Paul
et al., 2004; Huitema et al., 2006; Duerig et al., 2009; Abel
et al., 2011). The cell cycle comprises a stage of flagel-
lated swarmer cells, in which replication is inhibited via
low c-di-GMP levels, and a stage of sessile, stalked cells
that form new swarmer cells at their non-attached end. In
the stalked cells, c-di-GMP is unequally distributed as an
effect of antipodal location of GGDEF and EAL domain
proteins, restricting cell division to the non-attached pole.
In the present study, star-shaped rosettes were not
formed in a mutant with lowered c-di-GMP levels, indicat-
ing an involvement of the compound in producing
that phenotype. Rosette formation in Roseobacter clade
species could be the result of a process involving polar
differences in c-di-GMP contents, where cell division is
possibly restricted to one pole of the rosette-forming cell
and its daughter cells.
Bruhn and colleagues (2007) demonstrated that cells of
Phaeobacter sp. 27-4 from static cultures attached better
to a glass surface than cells from shaken cultures. The
same pattern was observed in this study. However, com-
paring attachment between shaken cultures of wild type
and mutants with altered c-di-GMP levels, we found that
initial attachment was compromised both by increased
and decreased c-di-GMP levels. Miller and Belas (2006)
demonstrated that in Ruegeria sp. TM1040, motility is
crucial for initiating the Ruegeria–dinoflagellate symbio-
sis. Consequently, the strain with increased c-di-GMP
levels may have a reduced capability of attaching to sub-
strates because motility was repressed. Interestingly,
attachment of the pYhjH-carrying strain with decreased
c-di-GMP and increased motility was reduced as well,
even if not to the same extent. This might be caused by a
reduced ability to turn off flagellar motility in response to
initial surface contact by c-di-GMP-mediated allosteric
inhibition of the flagellar motor as known from
C. crescentus (Christen et al., 2007).
Antibacterial activity, production of the brown pigment
and TDA production were reduced by decreased intracel-
lular c-di-GMP levels, suggesting that the association
between the biofilm phenotype and TDA production could
be c-di-GMP-mediated. This led us to study expression of
tdaC as indicator of TDA production on single-cell level,
and we found that tdaC is expressed differently within
different cells of the same cultures. This argues against a
regulation mechanism based exclusively on community
level. Two regulation mechanisms for TDA production
were identified on community level. QS was found to
activate production of TDA in P. gallaeciensis (Berger
et al., 2011), and also TDA itself was observed to act as
an autoinducer, causing increased expression of genes
necessary for its own production (Geng and Belas,
2010a). However, both mechanisms fail to explain how
tdaC can be expressed differently in adjacent cells. The
hypothesis that TDA production is regulated by c-di-GMP
provides an alternative explanation for how TDA produc-
tion can be different in cells within the same culture, and
for how it can, on single-cell level, be spontaneously
induced by attachment despite absence of TDA.
The tdaC gene is expressed only in biofilms or aggre-
gates, and its expression could be initiated in planktonic
cells by physical attachment to a surface. Thus, tdaC was
expressed where high or rising levels of c-di-GMP would
probably be found. Geng and Belas (2011) showed that
the TdaA protein, a LysR-type transcriptional regulator,
binds to the tdaC promoter and activates tdaC expres-
sion. The ligands of LysR-type transcriptional regulator
are small molecules (Schell, 1993), and it could be specu-
lated whether c-di-GMP is the ligand of TdaA, or whether
intermediate steps are involved.
In conclusion, our study adds organisms from the
Roseobacter clade to the list of bacteria that use c-di-
GMP as a key secondary messenger. Notably, c-di-GMP
may be the key molecule in the often described ‘stick-and-
swim’ lifestyle of several roseobacters.
Experimental procedures
Strains, plasmids and media
An overview of strains and plasmids is provided in Table 3.
R. mobilis F1926 was isolated from the central Indian Ocean
(coordinates −31.4061, 91.17758) during the Galathea III
expedition and was identified by its 16S rRNA gene sequence
(L. Gram, P. D’Alvise, C. Porsby, J. Melchiorsen, J. Heilmann,
M. Jensen, et al., unpublished data) using procedures
described in Gram and colleagues (2010). The strain was
revived from frozen stock cultures (−80°C) on half-strength
marine agar [1⁄2MA; 27.6 g Difco 212185 marine agar (Difco
Laboratories, Detroit, MI, USA), 15 g sea salts (Instant
Ocean, Vernon, Canada), 7.5 g agar, 1 l deionized water].
Plasmids pYedQ and pYhjH were obtained from Tim Tolker-
Nielsen (University of Copenhagen) and electroporated into
R. mobilis F1926, as described below. Half-strength yeast-
tryptone-sea-salts broth (1⁄2YTSS) [2 g yeast extract (Bacto
Laboratories, Sydney, Australia), 1.25 g tryptone (Bacto
Laboratories, Sydney, Australia), 20 g sea salts (Sigma-
Aldrich, St. Louis, MO, USA), 1l deionized water] and agar
(Gonzalez et al., 1996) containing 50 μg ml−1 of tetracycline
were used for selecting transconjugants after the electro-
porations and for routine culturing of the plasmid-carrying
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mutants. Cultures for microscopy and for chemical measure-
ments of c-di-GMP were grown in full strength MB that con-
tained 50 μg ml−1 of tetracycline for the plasmid-carrying
mutants. For inhibition testing and TDA analysis, all strains
were cultured in MB without addition for 3 days. A 1.5 YTSS
with and without tetracycline was used for biofilm and attach-
ment assays. All cultures were grown as 20 ml batches in
250 ml glass bottles at 25°C, except as noted otherwise, and
shaking velocity was 200 r.p.m.
Genome sequencing
Genomic DNA was obtained from strain F1926 by successive
phenol-chloroform purification steps (Sambrook and Russel,
2001). Mate pair library preparation and Illumina Hi Seq 2000
(Illumina, San Diego, CA, USA) sequencing were carried out
by the Bejing Genomic Institute (Shenzhen, China). Contigs
were assembled using CLC Genomic Workbench (CLC
Bio, Aarhus, Denmark). The genomic DNA sequence has
been submitted to the National Center for Biotechnology
Information (NCBI) database under accession number
AQCH00000000.1.
Detection of genes with GGDEF and EAL domains
The genome draft was annotated by NCBI using the PGAAP,
and genes encoding diguanylate cyclases and phosphodie-
sterases were identified (Table 1). The sequences of these
genes were used to search the Pfam database (Punta et al.,
2012), and the e-values of the Pfam-identification of the
GGDEF- and EAL-domain proteins are stated in Table 1.
Electroporations
The electroporation method was adapted from Miller and
Belas (2006). Recipient cells were grown in 50 ml 1⁄2YTSS
(R. mobilis) or LB medium (E. coli, 37°C) until OD600 was
about 0.5, chilled on ice for 30 min, harvested by centrifuga-
tion at 2380 × g, washed twice in 10 ml autoclaved, ice-cold
MilliQ-water (Merck Millipore, Billerica, MA, USA) and
resuspended in 0.5 ml ice-cold 10% glycerol. Aliquots of 70 μl
were stored at −80°C until use. Electrocompetent cells were
mixed with 180–230 ng plasmid DNA, incubated 30 min on
ice, transferred to a 0.2 cm electroporation cuvette (165–
2086 Biorad, Hercules, CA, USA) and electroporated at
2.5 kV cm−1, 200 Ω, 25 μF using a Biorad Gene Pulser
(Biorad). The cells were immediately transferred to liquid
growth medium without antibiotics, recovered for 2–4 h and
plated on selective agar.
c-di-GMP extraction
Shaken and static cultures of R. mobilis F1926 wild type
and the plasmid-carrying mutants were inoculated from
OD-adjusted overnight precultures and grown for 24 h in
triplicates. The cultures were cooled on ice, and static cul-
tures were shaken briefly to break up the biofilms. One mil-
lilitre was sampled and vortexed vigorously to further break
up aggregates before measuring OD600. Cultures were har-
vested (5000 × g), and the pellets were extracted with 10 ml
75% (v/v) boiling ethanol/water containing 10 μM HEPES
[4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid]. The
pellets were resuspended in 75% ethanol, and the suspen-
sions were left in an 80°C water bath for 5 min. Subsequently,
the suspensions were centrifuged (4250 × g), and the super-
natants were evaporated to dryness under nitrogen. The
samples were dissolved in 100 μl mobile phase A
and filtered through 0.2 μm PTFE (polytetrafluoroethylene)
hydrophilic filters before analysis.
Ion pair UHPLC-MS/MS analysis of c-di-GMP
The analysis was carried out on an Agilent 1290 (Agilent,
Torrance, CA, USA) binary UHPLC system coupled with a
6460 triple quadrupole mass spectrometer (Agilent). The MS
was operated in negative electrospray using the [M-H]- m/z
689.1 as parent ion, and m/z 149.9 and 537.9 as quantifier
and qualifier ions respectively. Separation of 10 μL samples
was performed by ion pair chromatography, as described
Table 3. Bacterial strains and plasmids used in the present study.
Strain or plasmid Genotype or relevant markers Source or reference
Strain
Ruegeria mobilis F1926 Wild type Gram et al. 2010; L. Gram, P. D’Alvise,
C. Porsby, J. Melchiorsen, J. Heilmann,
M. Jensen, et al., unpubl. data
E. coli TransforMax EC100D pir+ pir+ Epicentre
Plasmids
pRK415 Conjugative broad host range vector, TetR Keen et al. 1988
pPDA11 tdaCp::gfp ligated into pRK415, TetR This study; D’Alvise et al 2012
pYedQ E. coli gene yedQ (diguanylyl cyclase) ligated into
pRK404A, TetR
Ausmees et al. 2001; Gjermansen
et al. 2006
pYhjH E. coli gene yhjH (c-di-GMP-specific phosphodiesterase)
ligated into pBBR1MCS-3, TetR
Gjermansen et al. 2006
pRK404A Standard broad host range cloning vector, TetR, control for
pYedQ
Ditta et al. 1985
pBBR1MCS-3 Standard broad host range cloning vector, TetR, control for
pYhjH
Kovach et al. 1995
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in detail in (Magdenoska et al., 2013), using 10 mM tributyla-
mine as ion pair reagent. The gradient used was 0–12 min
0-50% B, 12–12.5 min 50-100% B, 12.5–13 min 100% B,
13–13.1 min 100–0% B, 13.1–18 min 0% B. Three hundred
and sixty milliliters of shaken cultures of the pYhjH-carrying
mutant were split into eighteen 50 ml falcon tube and used for
matrix-matched calibration. One mg/ml c-di-GMP in water
was used to prepare the spiking solutions. After centrifugation
and removal of the supernatants, 75% boling EtOH was
added to the tubes followed by spiking with, 100 µl of 0 ng/ml,
35 ng/ml, 100 ng/ml, 200 ng/ml, 600 ng/ml and 1000 ng/ml
c-di-GMP standard in triplicates. The spiked cultures were
extracted and prepared for analysis as described above. The
amount of c-di-GMP detected in the blank was subtracted
from the spiked calibrants, and the analysis was calibrated by
linear regression (r2 = 0.993). To obtain a relative estimate of
c-di-GMP concentrations per cellular biomass, c-di-GMP con-
centrations were divided by the measured OD600 of the
original cultures.
Biofilm and attachment assay
Biofilm formation in R. mobilis F1926 wild type, F1926 pYedQ
and F1926 pYhjH was measured by a crystal violet method
(O’Toole et al., 2000). Briefly, shaken precultures were diluted
with fresh medium to an OD600 of 0.1, pipetted into a 96-well
microtiter plate and incubated for 24 h. Culture liquid was
removed, and biofilms were washed and stained in 1% (w/v)
crystal violet solution. After washing, the crystal violet was
extracted from the stained biofilms with 96% ethanol and
quantified by measuring absorption at 590 nm.
Attachment to an inert surface was measured in a modified
crystal violet assay. Static cultures were grown in 96-well
plates as described above. Shaken cultures were grown in
glass bottles for 24 h; OD600 was adjusted to 1.0, and 200 μl
were pipetted into the wells of a micotiter plate. A lid with 96
polystyrene pegs (Innovotech, Edmonton, Canada) was
placed on the plate, and the cells were allowed to attach to
the pegs for 1 min. Adherent biofilms on the pegs were
washed twice by dipping into water, dried for 5 min and
stained in crystal violet solution. After triple washing in water,
the crystal violet was extracted from the stained biofilms on
the pegs in each 200 μl of ethanol, and absorption was meas-
ured at 590 nm. Both assays were conducted in duplicates
and reproduced independently.
Measurement of antibacterial activity
Inhibition of Vibrio anguillarum 90-11-287 in a standard well-
diffusion assay was measured as an approximation to
TDA production as adapted from (Hjelm et al., 2004).
V. anguillarum 90-11-287 was grown in MB for 1 day at 25°C
with aeration at 200 r.p.m. A 50 μl of the V. anguillarum
preculture was added to 50 ml molten Instant Ocean agar
[1.5 g of Instant Ocean sea salts, 0.1 g of casamino acids
(Bacto Laboratories, Sydney, Australia), 0.2 g glucose, 0.5 of
g agar] at 41.5°C and poured into a 14 cm Petri dish. Wells of
6 mm diameter were punched into the solidified agar and
filled with 50 μl of R. mobilis F1926 culture supernatant. The
assay was incubated for 1 day at 25°C, and diameters of
inhibition zones were measured. The results are based on
two independent replicates.
TDA extraction and analysis
A 1 ml of each MB culture was mixed with 3 ml ethyl acetate
containing 1% formic acid and extracted for 30 min on a
shaking table at room temperature. A 2.5 ml of the organic
phase was evaporated to dryness under nitrogen flow at
35°C and redissolved in 100 μl 85% acetonitrile/15% MilliQ
water. Blank medium samples spiked with 0.13–100 μM pure
TDA (BioViotica, Dransfeld, Germany) served as standard.
UHPLC-TOFMS analysis was conducted on an Agilent 1290
UHPLC coupled to an Agilent 6550 qTOF (Agilent) equipped
with a dual electrospray source. Separation was performed at
40°C on a 2.1 mm ID, 50 mm, 1.8 μm of Eclipse Plus C18
(Agilent) column using a water-acetonitrile gradient solvent
system, with both water and acetonitrile containing 20 mM of
formic acid. Using a flow of 0.8 ml/min, the gradient was
started at 15% acetonitrile and increased to 60% acetonitrile
within 1.8 min, then to 100% in 0.2 min, keeping this for
0.8 min, returning to 15% acetonitrile in 0.2 min and equili-
brating for the next sample in 1.5 min (total runtime is
4.5 min). TDA was determined in ESI+ mode and quantified
from its [M + H]+ ion 212.9674 ± 0.005 with the same reten-
tions as the authentic standard (0.97 min). Quantification was
done using 1/x weighted linear regression based on the peak
area in the MASSHUNTER QUANT 5.0 software (Agilent). Dupli-
cate cultures were used for TDA analysis, and the experiment
was reproduced independently.
Statistics
Cellular c-di-GMP concentrations and TDA concentrations
were compared by t-tests. Differences in average crystal
violet absorption values in the biofilm and attachment assays
were examined by one-way ANOVA with Tukey’s multiple
comparison test using the software PRISM version 4.03
(GraphPad Software, La Jolla, CA, USA). All average values
and standard deviations are based on biological replicates.
Construction of a tdaCp::gfp reporter fusion
A transcriptional fusion between the promoter of tdaC and a
promoterless gfp gene was constructed similarly to pHG1011
(Geng and Belas, 2010a). The promoter sequence of the
tdaC gene was amplified using the primers ptdacF (5′-
GTCCCAGAGACCAACGCAATGAGTAAAGGAGAAGAA-3′)
and ptdacR (5′-TTCTTCTCCTTTACTCATTGCGTTGGTCTC
TGGGAC-3′). The gfp open reading frame in pAKN137
(Lambertsen et al., 2004) was amplified using the primers
gfpF (5′-GTCCCAGAGACCAACGCAATGAGTAAAGGAGAA
GAA-3′) and gfpR (5′-TGATAAGCTTTTATTTGTATAGTTCAT
CCATGCCATGT-3′). Primer ptdacF created a PstI-restriction
site, and gfpR created a HindIII-site. Primer ptdacR and gfpF
created identical 36-bp-sequences in the adjacent ends of
the two amplicons, each containing the end of the promoter
and the start of the gfp open reading frame. This allowed
seamless cloning of promoter and gfp gene by overlap-
extension polymerase chain reaction. The product was
cloned into the broad-host range vector pRK415 (Keen et al.,
1988) after both had been digested with PstI and HindIII (New
England Biolabs, Ipswich, MA, USA) to yield plasmid
pPDA11.
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Microscopy
Shaken and static cultures of R. mobilis F1926 wild type and
the mutants carrying pYedQ and pYhjH were grown in dupli-
cates for 24 h and were compared by phase contrast micros-
copy. Before specimen preparation, static cultures were
agitated briefly to break the biofilms into smaller pieces for
sampling. Images that were representative of the specimen
were recorded. Screening the whole specimen, rosette for-
mation, and the proportion of single cells and cells in biofilms
were registered. The proportion of motile cells was estimated
visually. Absence of motile cells or rosettes was stated if no
motile cell or rosette was observed in either of the duplicate
samples.
Gfp-fluorescence of R. mobilis F1926 pPDA11 was
detected by microscopy using a long-pass fluorescence cube
(Olympus, Tokyo, Japan; WIB ex. 460–490, em. > 515).
Shaken and static cultures were grown for 3 days. Again,
static cultures were briefly shaken before specimen prepara-
tion. Representative fluorescence micrographs were
recorded with 1.5 s exposure, and a phase contrast image of
the same area was recorded right thereafter. To record a time
series showing the onset of gfp expression in response to
attachment, a 3 day old shaken culture was diluted 1:2 with
fresh medium and grown for 4 h at the same conditions. A
specimen was prepared, and a time series of fluorescence
micrographs was recorded as described above. For better
display, contrast of the phase, contrast pictures and bright-
ness of the fluorescence micrographs were enhanced using
Photoshop (Adobe, San Jose, CA, USA). The same adjust-
ments were made on all images of the same type.
Motility agar
Motility agar was prepared based on half-strength and 1/10-
strength YTSS (0.4 g Bacto Yeast extract, 0.25 g Bacto
Tryptone, 20 g Sigma sea salts, 1l deionized water) with
different agar percentages (0.5, 0.45, 0.4, 0.35, 0.3 and
0.2%) and 5 ml/l 1% tetrazolium red solution, and Stab agar
tubes and Petri dishes were prepared. The Petri dishes were
inoculated with 5 μl of OD-adjusted (OD600 = 0.5) 1.5 YTSS
precultures, and the stab agar cultures were inoculated with
a needle dipped into the same OD-adjusted precultures. The
diameters of growth were compared after 1, 2 and 5 days.
Acknowledgements
We thank Tim Tolker-Nielsen (University of Copenhagen) for
providing plasmids pYedQ and pYhjH, as well as the vector
controls, and we thank Jens Bo Andersen (University of
Copenhagen) for technical advice with the construction of
plasmid pPDA11. We are grateful to Agilent technologies for
the Thought Leader Donation of the UHPLC-qTOF system.
This work was funded by the Danish Research Council for
Technology and Production Sciences (project 09-066524).
References
Abel, S., Chien, P., Wassmann, P., Schirmer, T., Kaever, V.,
Laub, M.T., et al. (2011) Regulatory cohesion of cell cycle
and cell differentiation through inter linked phosphorylation
and second messenger networks. Mol Cell 43: 550–560.
Alavi, M., Miller, T., Erlandson, K., Schneider, R., and Belas,
R. (2001) Bacterial community associated with Pfiesteria-
like dinoflagellate cultures. Env Microbiol 3: 380–396.
Aldridge, P., Paul, R., Goymer, P., Rainey, P., and Jenal, U.
(2003) Role of the GGDEF regulator PleD in polar devel-
opment of Caulobacter crescentus. Mol Microbiol 47:
1695–1708.
Allgaier, M., Uphoff, H., Felske, A., and Wagner-Dobler, I.
(2003) Aerobic anoxygenic photosynthesis in Roseobacter
clade bacteria from diverse marine habitats. Appl Environ
Microbiol 69: 5051–5059.
Ausmees, N., Mayer, R., Weinhouse, H., Volman, G.,
Amikam, D., Benziman, M., and Lindberg, M. (2001)
Genetic data indicate that proteins containing the GGDEF
domain possess diguanylate cyclase activity. FEMS
Microbiol Let 204: 163–167.
Belas, R., Horikawa, E., Aizawa, S.I., and Suvanasuthi, R.
(2009) Genetic determinants of Silicibacter sp. TM1040
motility. J Bacteriol 191: 4502–4512.
Berger, M., Neumann, A., Schulz, S., Simon, M., and
Brinkhoff, T. (2011) Tropodithietic acid production in
Phaeobacter gallaeciensis is regulated by N-acyl
homoserine lactone-mediated quorum sensing. J Bacteriol
193: 6576–6585.
Brinkhoff, T., Bach, G., Heidorn, T., Liang, L.F., Schlingloff, A.,
and Simon, M. (2004) Antibiotic production by a
Roseobacter clade-affiliated species from the German
Wadden Sea and its antagonistic effects on indigenous
isolates. Appl Environ Microbiol 70: 2560–2565.
Brinkhoff, T., Giebel, H.A., and Simon, M. (2008) Diversity,
ecology, and genomics of the Roseobacter clade: a short
overview. Arch Microbiol 189: 531–539.
Bruhn, J.B., Nielsen, K.F., Hjelm, M., Hansen, M., Bresciani,
J., Schulz, S., and Gram, L. (2005) Ecology, inhibitory
activity, and morphogenesis of a marine antagonistic bac-
terium belonging to the Roseobacter clade. Appl Environ
Microbiol 71: 7263–7270.
Bruhn, J.B., Haagensen, J.A.J., Bagge-Ravn, D., and Gram,
L. (2006) Culture conditions of Roseobacter strain 27-4
affect its attachment and biofilm formation as quantified by
real-time PCR. Appl Environ Microbiol 72: 3011–3015.
Bruhn, J.B., Gram, L., and Belas, R. (2007) Production
of antibacterial compounds and biofilm formation by
Roseobacter species are influenced by culture conditions.
Appl Environ Microbiol 73: 442–450.
Buchan, A., Neidle, E.L., and Moran, M.A. (2001) Diversity of
the ring-cleaving dioxygenase gene pcaH in a salt marsh
bacterial community. Appl Environ Microbiol 67: 5801–
5809.
Buchan, A., Gonzalez, J.M., and Moran, M.A. (2005) Over-
view of the marine Roseobacter lineage. Appl Environ
Microbiol 71: 5665–5677.
Charlson, R.J., Lovelock, J.E., Andreae, M.O., and Warren,
S.G. (1987) Oceanic phytoplankton, atmospheric sulfur,
cloud albedo and climate. Nature 326: 655–661.
Christen, M., Christen, B., Folcher, M., Schauerte, A., and
Jenal, U. (2005) Identification and characterization of a
cyclic di-GMP-specific phosphodiesterase and its allosteric
control by GTP. J Biol Chem 280: 30829–30837.
12 P. W. D’Alvise et al.
© 2013 Society for Applied Microbiology and John Wiley & Sons Ltd, Environmental Microbiology
Christen, M., Christen, B., Allan, M.G., Folcher, M., Jeno, P.,
Grzesiek, S., and Jenal, U. (2007) DgrA is a member of a
new family of cyclic diguanosine monophosphate receptors
and controls flagellar motor function in Caulobacter
crescentus. Proc Natl Acad Sci USA 104: 4112–4117.
Cotter, P.A., and Stibitz, S. (2007) c-di-GMP-mediated
regulation of virulence and biofilm formation. Curr Opin
Microbiol 10: 17–23.
D’Alvise, P.W., Melchiorsen, J., Porsby, C.H., Nielsen, K.F.,
and Gram, L. (2010) Inactivation of Vibrio anguillarum by
attached and planktonic Roseobacter cells. Appl Environ
Microbiol 76: 2366–2370.
D’Alvise, P.W., Lillebo, S., Prol-Garcia, M.J., Wergeland, H.I.,
Nielsen, K.F., Bergh, O., and Gram, L. (2012) Phaeobacter
gallaeciensis reduces Vibrio anguillarum in cultures of
microalgae and rotifers, and prevents vibriosis in cod
larvae. PLoS ONE 7: e43996.
Ditta, G., Schmidhauser, T., Yakobson, E., Lu, P., Liang,
X.W., Finlay, D.R., et al. (1985) Plasmids related to the
broad host range vector pRK290, useful for gene cloning
and for monitoring gene expression. Plasmid 13: 149–153.
Duerig, A., Abel, S., Folcher, M., Nicollier, M., Schwede, T.,
Amiot, N., et al. (2009) Second messenger-mediated
spatiotemporal control of protein degradation regulates
bacterial cell cycle progression. Genes Dev 23: 93–104.
Geng, H.F., and Belas, R. (2010a) Expression of
tropodithietic acid biosynthesis is controlled by a novel
autoinducer. J Bacteriol 192: 4377–4387.
Geng, H.F., and Belas, R. (2010b) Molecular mechanisms
underlying roseobacter-phytoplankton symbioses. Curr
Opin Biotech 21: 332–338.
Geng, H.F., and Belas, R. (2011) TdaA regulates
tropodithietic acid synthesis by binding to the tdaC pro-
moter region. J Bacteriol 193: 4002–4005.
Geng, H.F., Bruhn, J.B., Nielsen, K.F., Gram, L., and Belas,
R. (2008) Genetic dissection of tropodithietic acid
biosynthesis by marine roseobacters. Appl Environ
Microbiol 74: 1535–1545.
Gjermansen, M., Ragas, P., and Tolker-Nielsen, T. (2006)
Proteins with GGDEF and EAL domains regulate
Pseudomonas putida biofilm formation and dispersal.
FEMS Microbiol Lett 265: 215–224.
Gonzalez, J.M., and Moran, M.A. (1997) Numerical domi-
nance of a group of marine bacteria in the alpha-subclass
of the class Proteobacteria in coastal seawater. Appl
Environ Microbiol 63: 4237–4242.
Gonzalez, J.M., Whitman, W.B., Hodson, R.E., and Moran,
M.A. (1996) Identifying numerically abundant culturable
bacteria from complex communities: an example from a
lignin enrichment culture. Appl Environ Microbiol 62: 4433–
4440.
Gonzalez, J.M., Simo, R., Massana, R., Covert, J.S.,
Casamayor, E.O., Pedros-Alio, C., and Moran, M.A. (2000)
Bacterial community structure associated with a
dimethylsulfoniopropionate-producing North Atlantic algal
bloom. Appl Environ Microbiol 66: 4237–4246.
Gram, L., Melchiorsen, J., and Bruhn, J.B. (2010) Antibacte-
rial activity of marine culturable bacteria collected from a
global sampling of ocean surface waters and surface
swabs of marine organisms. Mar Biotechnol 12: 439–
451.
Hengge, R. (2009) Principles of c-di-GMP signalling in bac-
teria. Nat Rev Microbiol 7: 263–273.
Hjelm, M., Bergh, O., Riaza, A., Nielsen, J., Melchiorsen, J.,
Jensen, S., et al. (2004) Selection and identification of
autochthonous potential probiotic bacteria from turbot
larvae (Scophthalmus maximus) rearing units. Syst Appl
Microbiol 27: 360–371.
Holcapek, M., Volna, K., Jandera, P., Kolarova, L., Lemr, K.,
Exner, M., and Cirkva, A. (2004) Effects of ion-pairing
reagents on the electrospray signal suppression of
sulphonated dyes and intermediates. J Mass Spectrom 39:
43–50.
Huitema, E., Pritchard, S., Matteson, D., Radhakrishnan,
S.K., and Viollier, P.H. (2006) Bacterial birth scar proteins
mark future flagellum assembly site. Cell 124: 1025–1037.
Keen, N.T., Tamaki, S., Kobayashi, D., and Trollinger, D.
(1988) Improved broad-host-range plasmids for DNA
cloning in Gram-negative bacteria. Gene 70: 191–197.
Kovach, M.E., Elzer, P.H., Hill, D.S., Robertson, G.T., Farris,
M.A., Roop, R.M., and Peterson, K.M. (1995) 4 new deriva-
tives of the broad-host-range cloning vector pBBR1MCS,
carrying different antibiotic-resistance casettes. Gene 166:
175–176.
Lai, Q.L., Yuan, J., Li, F.Y., Zheng, T.L., and Shao, Z.Z. (2010)
Ruegeria pelagia is a later heterotypic synonym of
Ruegeria mobilis. Int J Syst Evol Microbiol 60: 1918–1920.
Lambertsen, L., Sternberg, C., and Molin, S. (2004) Mini-Tn7
transposons for site-specific tagging of bacteria with fluo-
rescent proteins. Environ Microbiol 6: 726–732.
McDougald, D., Rice, S.A., Barraud, N., Steinberg, P.D., and
Kjelleberg, S. (2012) Should we stay or should we go:
mechanisms and ecological consequences for biofilm dis-
persal. Nat Rev Microbiol 10: 39–50.
Magdenoska, O., Martinussen, J., Thykaer, J., and Nielsen,
K.F. (2013) Dispersive solid phase extraction combined
with ion-pair ultra high-performance liquid chromatography
tandem mass spectrometry for quantification of nucleotides
in Lactococcus lactis. Anal Biochem 440: 166–177.
Matilla, M.A., Travieso, M.L., Ramos, J.L., and Ramos-
Gonzalez, M.I. (2011) Cyclic diguanylate turnover medi-
ated by the sole GGDEF/EAL response regulator in
Pseudomonas putida: its role in the rhizosphere and an
analysis of its target processes. Env Microbiol 13: 1745–
1766.
Merritt, J.H., Ha, D.G., Cowles, K.N., Lu, W.Y., Morales, D.K.,
Rabinowitz, J., et al. (2010) Specific control of
Pseudomonas aeruginosa surface-associated behaviors
by two c-di-GMP diguanylate cyclases. mBio 1: 00183–10.
Miller, T.R., and Belas, R. (2006) Motility is involved in
Silicibacter sp. TM1040 interaction with dinoflagellates.
Environ Microbiol 8: 1648–1659.
Moran, M.A., and Hodson, R.E. (1994) Dissolved humic sub-
stances of vascular-plant origin in a coastal marine envi-
ronment. Limnol Oceanogr 39: 762–771.
Moran, M.A., Gonzalez, J.M., and Kiene, R.P. (2003) Linking
a bacterial taxon to sulfur cycling in the sea: studies of the
marine Roseobacter group. Geomicrobiol J 20: 375–388.
Moran, M.A., Buchan, A., Gonzalez, J.M., Heidelberg, J.F.,
Whitman, W.B., Kiene, R.P., et al. (2004) Genome
sequence of Silicibacter pomeroyi reveals adaptations to
the marine environment. Nature 432: 910–913.
c-di-GMP signalling in Ruegeria mobilis 13
© 2013 Society for Applied Microbiology and John Wiley & Sons Ltd, Environmental Microbiology
Moran, M.A., Belas, R., Schell, M.A., Gonzalez, J.M., Sun, F.,
Sun, S., et al. (2007) Ecological genomics of marine
roseobacters. Appl Environ Microbiol 73: 4559–4569.
Newell, P.D., Yoshioka, S., Hvorecny, K.L., Monds, R.D., and
O’Toole, G.A. (2011) Systematic analysis of diguanylate
cyclases that promote biofilm formation by Pseudomonas
fluorescens Pf0-1. J Bacteriol 193: 4685–4698.
Newton, R.J., Griffin, L.E., Bowles, K.M., Meile, C., Gifford,
S., Givens, C.E., et al. (2010) Genome characteristics of a
generalist marine bacterial lineage. ISME J 4: 784–798.
O’Toole, G., Kaplan, H.B., and Kolter, R. (2000) Biofilm for-
mation as microbial development. Ann Rev Microbiol 54:
49–79.
Paul, R., Weiser, S., Amiot, N.C., Chan, C., Schirmer, T.,
Giese, B., and Jenal, U. (2004) Cell cycle-dependent
dynamic localization of a bacterial response regulator with
a novel di-guanylate cyclase output domain. Genes Dev
18: 715–727.
Planas, M., Perez-Lorenzo, M., Hjelm, M., Gram, L., Fiksdal,
I.U., Bergh, O., and Pintado, J. (2006) Probiotic effect in
vivo of Roseobacter strain 27-4 against Vibrio (Listonella)
anguillarum infections in turbot (Scophthalmus maximus
L.) larvae. Aquacult 255: 323–333.
Porsby, C.H., Nielsen, K.F., and Gram, L. (2008)
Phaeobacter and Ruegeria species of the Roseobacter
clade colonize separate niches in a Danish turbot
(Scophthalmus maximus)-rearing farm and antagonize
Vibrio anguillarum under different growth conditions. Appl
Environ Microbiol 74: 7356–7364.
Punta, M., Coggill, P.C., Eberhardt, R.Y., Mistry, J., Tate, J.,
Boursnell, C., et al. (2012) The Pfam protein families data-
base. Nucleic Acids Res 40: D290–D301.
Ruiz-Ponte, C., Cilia, V., Lambert, C., and Nicolas, J.L.
(1998) Roseobacter gallaeciensis sp. nov., a new marine
bacterium isolated from rearings and collectors of the
scallop Pecten maximus. Int J System Bacteriol 48: 537–
542.
Ryjenkov, D.A., Tarutina, M., Moskvin, O.V., and Gomelsky,
M. (2005) Cyclic diguanylate is a ubiquitous signaling mol-
ecule in bacteria: insights into biochemistry of the GGDEF
protein domain. J Bacteriol 187: 1792–1798.
Sambrook, J., and Russel, D. (2001) Molecular Cloning – A
Laboratory Manual. 3rd edn. Cold Spring Harbor, NY, USA:
Cold Spring Harbor Laboratory Press.
Schell, M.A. (1993) Molecular biology of the LysR family
of transcriptional regulators. Ann Rev Microbiol 47: 597–
626.
Schmidt, A.J., Ryjenkov, D.A., and Gomelsky, M. (2005) The
ubiquitous protein domain EAL is a cyclic diguanylate-
specific phosphodiesterase: enzymatically active and inac-
tive EAL domains. J Bacteriol 187: 4774–4781.
Shiba, T., Simidu, U., and Taga, N. (1979) Another aerobic
bacterium which contains bacteriochlorophyll-A. B Jpn Soc
Sci Fish 45: 801.
Simm, R., Morr, M., Kader, A., Nimtz, M., and Romling, U.
(2004) GGDEF and EAL domains inversely regulate cyclic
di-GMP levels and transition from sessility to motility. Mol
Microbiol 53: 1123–1134.
Slightom, R.N., and Buchan, A. (2009) Surface colonization
by marine Roseobacters: integrating genotype and pheno-
type. Appl Environ Microbiol 75: 6027–6037.
Sorokin, D.Y., and Lysenko, A.M. (1993) Heterotrophic bac-
teria from the Black Sea oxidizing reduced sulfur com-
pounds to sulfate. Microbiology 62: 594–602.
Spangler, C., Bohm, A., Jenal, U., Seifert, R., and Kaever, V.
(2010) A liquid chromatography-coupled tandem mass
spectrometry method for quantitation of cyclic di-guanosine
monophosphate. J Microbiol Methods 81: 226–231.
Srivastava, D., and Waters, C.M. (2012) A tangled web: regu-
latory connections between quorum sensing and cyclic
Di-GMP. J Bacteriol 194: 4485–4493.
Sule, P., and Belas, R. (2012) A novel inducer of Roseobacter
motility is also a disruptor of algal symbiosis. J Bacteriol
195: 637–646.
Tamayo, R., Pratt, J.T., and Camilli, A. (2007) Roles of cyclic
diguanylate in the regulation of bacterial pathogenesis.
Ann Rev Microbiol 61: 131–148.
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M.,
and Kumar, S. (2011) MEGA5: molecular evolutionary
genetics analysis using maximum likelihood, evolutionary
distance, and maximum parsimony methods. Mol Biol Evol
28: 2731–2739.
Thompson, J.D., Higgins, D.G., and Gibson, T.J. (1994)
Clustal-W – improving the sensitivity of progressive multi-
ple sequence alignment through sequence weighting,
position-specific gap penalties and weight matrix choice.
Nucleic Acids Res 22: 4673–4680.
Viollier, P.H., Sternheim, N., and Shapiro, L. (2002) Identifi-
cation of a localization factor for the polar positioning of
bacterial structural and regulatory proteins. Proc Natl Acad
Sci USA 99: 13831–13836.
Waters, C.A., Lu, W.Y., Rabinowitz, J.D., and Bassler, B.L.
(2008) Quorum sensing controls biofilm formation in
Vibrio cholerae through modulation of cyclic Di-GMP
levels and repression of vpsT. J Bacteriol 190: 2527–
2536.
Weinhouse, H., Sapir, S., Amikam, D., Shilo, Y., Volman, G.,
Ohana, P., and Benziman, M. (1997) c-di-GMP-binding
protein, a new factor regulating cellulose synthesis in
Acetobacter xylinum. FEBS Lett 416: 207–211.
Werner, A. (1991) Analysis of nucleotides, nucleosides,
nucleobases in cells by ion-pair reversed-phase Hplc.
Chromatographia 31: 401–410.
Wietz, M., Gram, L., Jorgensen, B., and Schramm, A. (2010)
Latitudinal patterns in the abundance of major marine
bacterioplankton groups. Aquat Microb Ecol 61: 179–
189.
Witters, E., VanDongen, W., Esmans, E.L., and
VanOnckelen, H.A. (1997) Ion-pair liquid chromatography
electrospray mass spectrometry for the analysis of cyclic
nucleotides. J Chromatogr B 694: 55–63.
Wolfe, A.J., and Visick, K.L. (2008) Get the message out:
cyclic-Di-GMP regulates multiple levels of flagellum-based
motility. J Bacteriol 190: 463–475.
Yi, H., Lim, Y.W., and Chun, J. (2007) Taxonomic evaluation
of the genera Ruegeria and Silicibacter: a proposal
to transfer the genus Silicibacter Petursdottir and
Kristjansson 1999 to the genus Ruegeria Uchino et al.
1999. Int J Syst Evol Microbiol 57: 815–819.
Zan, J.D., Cicirelli, E.M., Mohamed, N.M., Sibhatu, H., Kroll,
S., Choi, O., et al. (2012) A complex LuxR-LuxI type
quorum sensing network in a roseobacterial marine
14 P. W. D’Alvise et al.
© 2013 Society for Applied Microbiology and John Wiley & Sons Ltd, Environmental Microbiology
sponge symbiont activates flagellar motility and inhibits
biofilm formation. Mol Microbiol 85: 916–933.
Supporting information
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Fig. S1. Phylogenetic tree of Ruegeria mobilis constructed
from 16S rRNA gene sequences. R. mobilis F1926 is
compared with the R. mobilis type strain NBRC 101030
(accession number NR_041454), other R. mobilis isolates
(accession numbers HQ338144.1, HQ338146.1,
HQ338142.1, HQ338140.1, HQ338148.1, HQ338141.1,
HQ338145.1, HQ338143.1) and other species from the
Ruegeria/Phaeobacter subcluster (Newton et al., 2010) of
the Roseobacter clade (accession numbers NR_074151.1,
NR_042675.1, NR_043449.1, GU176618.1, HQ_908721.1,
NR_029273.1, NR_027609.1, NR_042761.1, AJ536669.1,
NR_074150.1, FJ872535.1). Rhodobacter capsulatus
ATCC11166 and Rhodobacter sphaeroides ATTC BAA-808
(accession numbers DQ342320.1 and NR_074174.1) served
as outgroup. The 16S sequences were aligned using
ClustalW (Thompson et al., 1994), and the neighbour-joining
tree was constructed using MEGA version 5 (Tamura et al.,
2011). Numbers at the nodes are bootstrap values from 500
replications.
Fig. S2. Cyclic di-GMP detection in extracts of Ruegeria
mobilis F1926. Example chromatograms of F1926 pYhjH
shaken culture spiked with c-di-GMP (top) and F1926 wild
type static culture (bottom). The MRM transition monitored is
m/z 689.1→149.9. The counts on the y-axis are relative to the
highest peak in the respective sample; thus, the figure does
not allow for quantitative comparison.
Table S1. Guanylate cyclase and phosphodiesterase genes
in TDA-producing and non-TDA-producing Roseobacter
clade species.
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ABSTRACT 1 
Chinese hamster ovary (CHO) cells are the preferred production host for many therapeutic 2 
proteins. The production of heterologous proteins in CHO cells imposes a burden on the host 3 
cell metabolism and impact cellular physiology on a global scale. In this work, a multi-omics 4 
approach was applied to study the production of erythropoietin (EPO) in a panel of CHO-K1 5 
cells under growth-limited and unlimited conditions in batch and chemostat cultures. 6 
Physiological characterization of the EPO-producing cells included global transcriptome 7 
analysis, targeted metabolome analysis, including intracellular pools of glycolytic 8 
intermediates, NAD(P)H/NAD(P)
+
, adenine nucleotide phosphates (ANP) and extracellular 9 
concentrations of sugars, organic acids and amino acids. Potential impact of EPO expression 10 
on the protein secretory pathway was assessed at multiple stages using quantitative PCR 11 
(qPCR), reverse transcription PCR (qRT-PCR), western blots (WB) and global gene 12 
expression analysis to assess EPO gene copy numbers, EPO gene expression, intracellular 13 
EPO retention and differentially expressed genes functionally related to secretory protein 14 
processing, respectively.  15 
We found no evidence supporting the existence of production bottlenecks in energy 16 
metabolism (i.e. glycolytic metabolites, NAD(P)H/NAD(P)
+ and ANP’s) in batch culture or  17 
in the secretory protein production pathway (i.e. gene dosage, transcription and post-18 
translational processing of EPO) in chemostat culture at specific productivities up to 5 19 
pg/cell/day. We have shown, that the metabolic response to EPO production includes a 20 
redistribution of carbon uptake in batch culture with increased glucose demand, possibly 21 
reflecting increased energy requirements from protein production. Furthermore, time-course 22 
analysis of high- and low producing clones in chemostat culture revealed rapid adaptation of 23 
transcription levels of amino acid catabolic genes in favor of EPO production within 9 24 
 3 
generations. Interestingly, the adaptation was followed by an increase in specific EPO 1 
productivity. 2 
Keywords: Chinese hamster ovary, erythropoietin, chemostat, metabolomics, transcriptomics, 3 
metabolic adaptation. 4 
 5 
Introduction 6 
Most biopharmaceutical products like monoclonal antibodies, hormones and blood-related 7 
proteins are produced in Chinese hamster ovary (CHO) cells (Walsh 2014). Studies of CHO 8 
cells have yielded a basic understanding of mammalian cell biology and driven the 9 
development of mammalian cell factories for production of structurally advanced 10 
pharmaceutical glycoproteins (Jayapal & Wlaschin 2007). For example, numerous studies 11 
have focused on resolving bottlenecks in the protein production and secretory pathway (i.e. 12 
transcription, translation, protein translocation, -folding, -modification and -secretion), which 13 
limit the cell-specific protein productivity (Kim et al. 2012). Often the production bottleneck 14 
is reported to be independent of the heterologous target protein, indicating a general 15 
limitation of the secretory protein processing capacity (Jossé et al. 2012), while in some cases 16 
the bottleneck is linked to the synthesis of a specific post-translational protein modification 17 
(Pybus et al. 2013).  18 
In brief, protein production bottlenecks in CHO cells have been reported at the level 19 
of transgene expression (Mason et al. 2012; Jiang et al. 2006; C. J. Lee et al. 2009) and 20 
stability of mRNA transcripts (Hung et al. 2010). Numerous studies report a non-linear 21 
correlation between mRNA copy numbers and specific protein secretion, indicating 22 
limitations of either mRNA translation or post-translational processes (Chusainow et al. 23 
2009; Mead et al. 2009; O’Callaghan et al. 2010; Reisinger et al. 2008; Lattenmayer et al. 24 
2007; Lattenmayer & Loeschel 2007). One study suggests that the translocation of mRNA to 25 
 4 
the endoplasmatic reticulum (ER) is limiting protein production in CHO cells (Kang et al. 1 
2014). Other studies have reported bottlenecks in protein folding capacity for specific 2 
proteins (Y. Y. Lee et al. 2009; Borth et al. 2005; Hwang et al. 2003; Chung et al. 2004; 3 
Mohan & Lee 2010). Furthermore, some studies have found bottlenecks within vesicular 4 
transport of proteins from ER to the Golgi apparatus and within exocytotic transport from the 5 
trans-Golgi cisternae to the plasma membrane (Peng & Fussenegger 2009; Peng et al. 2011). 6 
Finally, for specific glycoproteins, evidence suggest bottlenecks in the processing of N-linked 7 
glycan structures (Bolt et al. 2008). In general, all major steps (i.e. transcription, translation, 8 
protein translocation, protein folding, protein glycosylation and inter-organelle protein 9 
transport) have been argued to be a bottleneck. In many cases, it is possible that the 10 
cultivation method is confounding the, as one could expect that different cultivation modes 11 
(batch, fed-batch, continuous, various forms of nutrient starvation) will have varying 12 
requirements for native protein production, and thus influence the metabolic load on the cell. 13 
Cultivation of recombinant cells is performed in different ways, depending on the 14 
goal of the experiment. In batch cultivation, all nutrients are supplied initially in excess, -15 
allowing growth at maximum specific rate with maximum specific nutrient uptake and 16 
maximum production of native proteins. In an industrial context, the batch process is of 17 
limited use for protein production, since growth and productivity rapidly becomes limited by 18 
nutrient availability and by-product inhibition. As an alternative process, where growth, by-19 
product accumulation and nutrient consumption can be controlled, continuous cultures are 20 
operated with a constant in-flow of fresh medium, while spent medium, biomass and product 21 
is removed at an equal rate. A popular continuous cultivation format for physiological 22 
characterization of cells is the chemostat (Bull 2010), which is operated at a constant dilution 23 
rate (i.e. rate of medium flow per culture volume), thus ensuring a constant physiochemical 24 
environment in the bioreactor. This feature enables the study of effects of single parameters 25 
 5 
on the cell physiology. Moreover, the restricted in-flow of fresh medium allows tight control 1 
of the growth rate of cultivated cells as availability of nutrients becomes limiting in the 2 
culture. The operation at a fixed dilution rate thus enables the normalization of growth rates 3 
between parallel cultures, which has been shown to be a prerequisite for global 4 
transcriptional profiling as the expression level of many genes is affected by the specific 5 
growth rate (Regenberg et al. 2006). Chemostat cultures have been used extensively as a 6 
powerful tool for the study of e.g. metabolism, protein production, genetic stability and long-7 
term metabolic adaptation of microorganisms (comprehensively reviewed by Bull, 2010). 8 
However, so far only a few studies have described the physiological characterization of CHO 9 
cells in chemostat culture (Lee et al. 1998; Nyberg et al. 1999; Hayter et al. 1993; Hayter et 10 
al. 1992). 11 
The ‘omics technologies (e.g. genomics, transcriptomics, proteomics, metabolomics, 12 
glycomics and fluxomics) provide systems-level data on the intracellular state of a biological 13 
system crucial to elucidate the molecular basis of CHO cell physiology (reviewed by 14 
Kildegaard et al. 2013). Comparative analysis of ‘omics data gathered under specific 15 
physiological conditions has revealed differentially regulated molecular mechanisms 16 
responsible for desirable phenotypes in isogenic clone populations and guided the design of 17 
improved cell factories (Yee et al. 2009; Smales et al. 2004; Chong et al. 2010; Sengupta et 18 
al. 2011).  19 
The metabolic burden imposed by heterologous protein production in mammalian 20 
cells is still not well characterized and thus may offer opportunities for further improvement 21 
of protein productivity. A recent study by Niklas et al. 2013 comparing human cells 22 
expressing α1-antitrypsin found increased anabolic demand for RNA and lipids in protein 23 
producers and argued that such a phenotype could be caused by increased transcriptional load 24 
 6 
and expanded ER associated with secretory protein production. By simulating the theoretical 1 
metabolite demand using a network model, they linked the metabolic changes in protein 2 
producing cells to increased C1-unit, nucleotide and lipid metabolism, which led to specific 3 
adaptations in the amino acid metabolism and increased secretion of glycine and glutamate. 4 
The authors concluded that C1 and lipid metabolism seem important targets for improvement 5 
of protein production in mammalian cells.  6 
The glycoprotein hormone erythropoietin (EPO) is a commonly used model protein in 7 
development of CHO-based bioprocesses (Yoon et al. 2005; Surabattula et al. 2011; Choi et 8 
al. 2007; Sung et al. 2004) and metabolic engineering of CHO cells for improved protein 9 
production (Kim et al. 2011; Kim et al. 2004). The typical EPO expression levels from clones 10 
with no gene amplification are reported in the range of 1-10 pg/cell/day (Zhou et al. 2010; 11 
Kim & Lee 2009; Yoon et al. 2003), which is substantially lower than e.g. antibody 12 
production processes.  13 
 The aim of the current study was to discover bottlenecks in EPO production in CHO 14 
cells and characterize the burden of heterologous protein production under growth dependent 15 
and independent conditions. For this, a panel of stably EPO expressing CHO-K1 clones 16 
spanning a 25-fold productivity range was established and characterized in batch and 17 
chemostat cultures. We employed a multi-omic physiological characterization including 18 
NMR-based metabolic footprinting (exo-metabolome) of sugars, organic acids and amino 19 
acids, LC-MS based metabolite fingerprinting (endo-metabolome) of glycolytic 20 
intermediates, NAD(P)H/NAD(P)
+
 and ANP’s. Quantitative PCR (qPCR), quantitative 21 
reverse transcription PCR (qRT-PCR), western blots (WB) and Affymetrix CHO microarrays 22 
were used to assess EPO gene copy numbers, EPO gene expression, intracellular protein 23 
 7 
levels and genome-wide gene expression analysis of differentially expressed genes 1 
functionally related to secretory protein processing, respectively. 2 
Materials and methods 3 
Cell lines and media 4 
The EPO-expressing cell lines were developed from the ATCC (Manassas, Virginia) CHO-5 
K1 line cat no. CCL-61. Prior to cell line development the parental cell line was adapted for 6 
suspension and serum-free culture in a complex animal-component free Novo Nordisk 7 
proprietary medium supplemented with 4 mM L-glutamine (Thermo Scientific, Waltham, 8 
MA). During development of EPO-expressing cell lines the media were supplemented with 9 
2.5 mL anti clumping agent (Gibco) per 1 L medium and Penicillin-Streptomycin mix 10 
(Gibco) in concentrations of 100 unit/mL of penicillin and 100 μg/mL streptomycin. 600 11 
µg/mL Geneticin / G418 (Gibco) was applied as selection pressure one day after transfection 12 
and throughout the cell line generation process. 13 
 14 
Primers 15 
Primers for Uracil-specific excision reagent (USER) cloning procedure (Table I) were 16 
designed according to the USER cloning design scheme in (Lund et al., 2014) and purchased 17 
from Integrated DNA Technologies (Leuven, Belgium). Primers for specific amplification of 18 
target sequences in hEPO, β-actin (Actb) and glyceraldehyde-3-phosphate dehydrogenase 19 
(Gapdh) (Table I) were designed using the online quantitative PCR primer design tool from 20 
Roche, which is based on the Primer3 software (Untergasser et al. 2012) and gene sequences 21 
were retrieved from www.chogenome.org (Hammond et al. 2012). 22 
 23 
Chemicals for analysis of intercellular metabolites 24 
 8 
Isotope-labeled standards were purchased from Silantes Gmbh (München, Germany). All 1 
other standards of metabolites were obtained from Sigma-Aldrich (St. Louis, MO), except for 2 
acetyl coenzyme A that was produced by Santa Cruz Biotechnology (Dallas, TX). High 3 
purity solvents and reagents were used in order to reduce the background noise from 4 
impurities as much as possible. The solvents acetonitrile and methanol used for extraction 5 
were HPLC grade from Sigma-Aldrich while the methanol used for chromatography was LC-6 
MS grade from Fluka. All water was milli-Q purified. The ion pair reagent tributylamine 7 
(TBA) (HPCL grade) was from Sigma-Aldrich, while the acetic acid (LC-MS grade) was 8 
from Fluka. 9 
 10 
Plasmid construction 11 
A vector plasmid pEPO-NEOR was assembled using the uracil-specific excision reagent 12 
(USER) based FAST-mediated vector assembly procedure as previously described (Lund et 13 
al. 2014). Neomycin resistance was included in the construct as selection marker. The human 14 
erythropoietin (EPO) gene (Powell & Berkner 1986) in the plasmid construct was codon-15 
optimized for CHO and synthesized from Geneart (Regensburg, Germany). The mammalian 16 
expression vector pU0002 (Hansen et al. 2011) harboring an E. coli origin of replication 17 
element and an ampicillin resistance gene was used as plasmid backbone. The EPO gene was 18 
under control of the human cytomegalovirus (CMV) promoter and flanked by the bovine 19 
growth hormone polyadenylation signal (BGHpA), while the NEO
R
 gene was regulated by 20 
the simian vacuolating virus 40 (SV40) promoter and polyadenylation signal (SV40pA). 21 
USER elements harboring promoter regions, polyadenylation signals, the NEO
R
 gene, and 22 
the protein backbone were produced exploiting PCR primers and protocols from (Lund et al. 23 
2014). Analogously, a USER element with EPO was prepared using the uracil-containing 24 
primers found in table I. The NEO
R
 gene was assembled with its promoter and 25 
 9 
polyadenylation signal in one USER cloning event exploiting the USER enzyme mix (New 1 
England Biolabs, Ipswich, MA) and the competent E. coli DH5α strain (Invitrogen, Carlsbad, 2 
CA) as described in details in (Lund et al. 2014). Subsequently, the formed selection marker 3 
element was amplified by PCR and used in a second USER cloning procedure for generation 4 
of the vector plasmid pEPO-NEOR. Plasmid sequence was verified by sequencing (Star SEQ, 5 
Mainz, Germany). 6 
 7 
Generation of EPO-expressing cell lines 8 
Transfection of the parental CHO-K1 cell line with the plasmid vector pEPO-NEO
R
 was 9 
performed by electroporation in a BioRad GenePulser Xcell set to deliver a single pulse of 10 
900 µF at 300 V and infinity resistance in a 4 mm cuvette. As positive control a subset of 11 
cells were transfected with a mammalian expression vector with the gene for enhanced green 12 
fluorescent protein (eGFP) and neomycin resistance. The control transfection was used to 13 
estimate transfection efficiency, follow cell death, clone expansion, and transgene expression. 14 
Prior to each transfection 40 µg of plasmid DNA was added directly to the cuvette containing 15 
10
7
 cells in growth medium. Twenty-four hours after transfection G418 selection pressure 16 
was added and the transfected cells were split into two. Single clones were isolated from one 17 
half of the transfected cells in a limiting dilution experiment with twenty 96-well plates 18 
containing either 500 or 1000 transfected cells/well. During two weeks of cultivation one 96-19 
well plate was exposed to microscope inspection daily to observe initial cell death and stable 20 
clones expanding. From the untouched 96-well plates circular monoclonal cultures were 21 
screened for EPO production using a dot blot procedure followed by WB and enzyme-linked 22 
immunosorbent assay (ELISA) (see below) and expanded further.  23 
The second half of the transfected cells were maintained as a polyclonal shake flask 24 
culture for three weeks. For the first two weeks the culture volume was gradually decreased 25 
 10 
in each passage to maintain a viable cell density of 0.3 10
6
 cells/ml. Single clones were 1 
isolated from the polyclonal culture by limiting dilution into 384-well plates and robot-2 
assisted single clone selection in a Cello system (TAP Biosystems, Royston, UK). The cells 3 
were cultivated and photos were taken for 13 days with medium change every 6 days. Single 4 
clone cultures were screening for EPO production and scaled up to 30 ml shake flask 5 
cultures. 6 
 7 
Screening cell lines for EPO production 8 
Isolated monoclonal cell lines were screened for EPO production using WB and selected 9 
clonal cultures were up-scaled and evaluated further using the Quantikine IVD ELISA kit 10 
(R&D systems, Minneapolis, MN) following the manufacturer’s protocol.  11 
The Invitrogen NuPAGE system was used for WB. Samples of culture supernatant were 12 
drawn and centrifuged at 15000 x g for 1 min and treated following the NuPage guidelines 13 
for preparation of reduced samples and peptide N-glycosidase treated samples using PNGases 14 
F (New England Biolabs). Samples were run at 12% NuPAGE Novex bis-tris mini gels with 15 
MOPS running buffer in an Xcell SureLock mini cell at 200 V (constant) for 45 min with 16 
MagicMark™ XP Western protein standard (Invitrogen) and Full-range rainbow molecular 17 
weight marker (GE Healthcare). Gel separated proteins were transferred by an Invitrogen 18 
iBlot device to a nitrocellulose membrane with 0.45 µm pore size (Invitrogen). 2.0 % TBS-T, 19 
was used as blocking buffer and for washing steps 0.5 % TBS-T was employed. The 20 
membrane was incubated with 1 µg/ml polyclonal rabbit anti-EPO antibody (AbCam, 21 
Cambridge, United Kingdom) in 10 ml 0.5 % TBS-T at room temperature with gentle 22 
shaking at 45 rpm for 45 min. Following three washing steps with 0.5 % TBS-T the 23 
membrane was incubated with 0.2 µg/ml IRDye 680 goat anti-rabbit (Li-Cor Biosciences) 24 
fluorescent labeled secondary antibody in 0.5 % TBS-T for 45 min with shaking at 45 rpm. 25 

 11 
The membrane was analyzed in a Li-Cor Odyssey infrared imaging system. Supernatant from 1 
eGFP clones served as negative control.  2 
 3 
Cell culture 4 
Cell culture was performed in vented Erlenmeyer shake flasks (Corning, NY) in a shaking 5 
incubator operated at 36.5°C, 5 % CO2 and 140 rpm. Cells were cultured in repeated batch 6 
cultivation during the development of EPO-expressing cell lines. The cells were passaged 7 
twice a week and the viable cell density was adjusted to 0.3 x 10
6
 cells/mL. 8 
Pre-cultures were initiated from frozen cells and cultivated as above, but without 9 
selection pressure. The pre-cultures were passaged every other day to ensure growth at 10 
maximum specific growth rate. 11 
 12 
Bioreactor cultivation and analysis 13 
Parental and recombinant CHO-K1 cells were cultivated in 1.5 L bioreactors (Eppendorf 14 
DASGIP multi-fermentor system, Jülich, Germany) with a working volume of 1 L. 15 
Temperature was maintained at 36.5°C with an agitation rate of 200 rpm using two three-way 16 
segmented impellers. Dissolved oxygen was maintained at 50 % of air saturation using air, 17 
O2 and CO2 operated at a constant flow rate of 0.6 L/h. Culture pH was maintained at 7.15 18 
with a deadband of 0.25 using intermittent CO2 addition to the gas mix and 2M sodium 19 
carbonate. Culture pH and pO2 was measured on-line and calibrated to an offline reference 20 
RAPIDpoint 500 blood gas analyzer (Siemens Healthcare Diagnostics, Erlangen, Germany) 21 
subsequent to inoculation. Cell number, viability, cell size and aggregation was measured 22 
using a CedeX HiRes (Roche, Basel, Switzerland), extracellular concentrations of glucose, 23 
lactate, glutamine, glutamate and ammonium was measured with a Bioprofile 100
PLUS
 (Nova 24 
 12 
Medical, Waltham, MA). Supernatant samples for extracellular EPO quantitation were stored 1 
at -80°C until HPLC analysis. 2 
 Batch cultures were seeded with 0.3 x 10
6
 cells/mL and samples were drawn on a 3 
daily basis and analyzed for cell density, viability, cell size and aggregation rate. Extracted 4 
culture supernatants were analyzed for glucose, lactate, glutamine, glutamate, ammonium, 5 
EPO, pH, pO2 and pCO2. Genomic DNA was extracted after 48 hours and analyzed for EPO 6 
gene copy numbers by quantitative PCR. The culture was terminated after 160 hours. 7 
 Chemostat cultures were seeded with 0.3 x 10
6
 cells/mL and chemostat cultivation 8 
mode was initiated 72 hours subsequent to inoculation with a constant dilution rate of 0.3 9 
volumes per day. The cultures were sampled daily and analyzed for cell density, viability, 10 
cell size and aggregation rate. The supernatant was analyzed for glucose, lactate, glutamine, 11 
glutamate, ammonium, EPO, pH, pO2 and pCO2. Samples for metabolic footprinting were 12 
analyzed for amino acids, sugars and organic acids by quantitative NMR analysis 13 
(Spinnovation Biologics, Nijmegen, Netherlands). Genomic DNA and RNA was extracted 14 
and analyzed for EPO gene copy number and EPO gene expression level by qPCR and qRT-15 
PCR, respectively. Selected cultures were subjected to microarray based gene expression 16 
analysis. 17 
 18 
HPLC quantitation of erythropoietin 19 
EPO from thawed supernatant samples was quantified by RP-HPLC on an Agilent 1200 20 
using an XBridge C8 4.6 x 150 mm (3.5 µm) column (Waters), operated at 42°C and a flow 21 
rate of 1 mL/min. Buffer A was composed of 0.1 % TFA in milliQ water and buffer B was 22 
composed of 0.07 % TFA in acetonitrile. The elution gradient consisted of 30-70 % buffer B 23 
over 16 min. Protein detection was performed by UV light absorption at 214 nm and EPO 24 
 13 
concentration was determined using human erythropoietin (Cell Signaling, Danvers, MA) as 1 
standard. 2 
 3 
Preparation of DNA, RNA and cDNA  4 
Genomic DNA (gDNA) was isolated from pellets of 3 x 10
6
 CHO cells using a DNAeasy 5 
blood and tissue genomic DNA purification kit (Qiagen, Hilden, Germany) following the 6 
manufacturers instructions. DNA concentration and purity was determined using a Nanodrop 7 
8000 (Thermo Scientific, Wilmington, DE, USA). Samples with A260/280 ratios ≥ 2 were 8 
considered to be of sufficient purity.  9 
For total RNA isolation, 3 mL culture sample was extracted and centrifuged at 900 x 10 
g for 5 min. The supernatant was discarded and the cell pellet was homogenized in 2 mL 11 
Trizol reagent  (Invitrogen) and stored at -80°C. Total RNA was extracted using an RNA plus 12 
mini kit (Qiagen) according to the manufacturer’s instructions including column-based 13 
digestion of DNA. Total RNA quantity was determined spectrophotometrically using a 14 
Nanodrop 8000 (Thermo Scientific, Wilmington, DE) and RNA sample integrity was 15 
determined using an Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA) ensuring RIN 16 
values above 9.0. 17 
cDNA was generated from total RNA using a High Capacity cDNA Reverse 18 
Transcription kit (Applied Biosystems, Foster city, CA) according to the manufacturers 19 
instructions.  20 
 21 
Determination of relative hEPO gene copy numbers and mRNA levels 22 
Relative EPO transgene copy numbers and mRNA levels were determined using real-time 23 
quantitative PCR on gDNA and mRNA, respectively. Primer pairs were tested for specificity 24 
and amplification efficiency. Primer dimerization and specificity was investigated using 25 
 14 
melting curve analysis, which revealed a single thermal transition confirming that the primers 1 
were specific for the target genes and indicating absence of primer dimerization. Standard 2 
curves were generated from serial dilutions of pooled gDNA in triplicates and amplification 3 
efficiencies close to 100 % were achieved for all primer pairs. Primers targeting the 4 
commonly used reference genes Gapdh and Actb were screened for amplification efficiency 5 
and Gapdh was selected as reference gene as the primers produced amplification efficiencies 6 
closer to 100 %.  Quantitative PCR was performed using a QuantiFast SYBR Green PCR Kit 7 
(Qiagen) containing the fluorescent dye SYBR green I and ROX as fluorescent reporter. 8 
Quantification of relative EPO gene dosage and expression level was carried out in 384 well 9 
plates in a 7900HT FAST Real-Time PCR System (Applied Biosystems) with a reaction 10 
volume of 10 µL. All PCR reactions were run in triplicates. The assay was executed with the 11 
following thermal profile: 10 min heat activation of the polymerase at 95°C followed by 40 12 
amplification cycles consisting of DNA dissociation at 95°C for 5 s and primer annealing at 13 
60°C for 20 s. The dissociation stage consisted of a linear temperature ramp from 60°C to 14 
95°C over the course of 10 min. The CT values were computed using the AutoCT algorithm 15 
found in the software package SDS 2.4 (Applied Biosystems). For calculation of gene copy 16 
numbers cells were assumed to be diploid.  17 
 18 
Transcriptomics sample preparation and data analysis 19 
Chemostat cultivations of three clones (clone 1, clone 4 and clone 7) were carried out in two 20 
parallel cultures (biological replicates) and samples for RNA isolation were taken during the 21 
steady state phase of each culture, as determined by constant concentrations of medium 22 
components (amino acids and sugars). RNA samples were isolated from the culture as 23 
described above. RNA sample integrity was determined using Agilent 2100 Bioanalyzer and 24 
RNA 6000 Nano LabChip kit (Agilent, Santa Clara, CA), ensuring RIN values above 9.0, and 25 
 15 
total RNA quantity was determined with a NanoDrop 3300 UV–Vis spectrophotometer 1 
(Thermo Scientific, Rockford, IL). Using the GeneChip Hybridization, Wash and Stain Kit, 2 
the probe preparation and hybridization to Affymetrix CHO Gene 2.0 ST Arrays were 3 
performed according to manufacturer’s instructions (Affymetrix GeneChip Expression 4 
Analysis). Washing and Staining of arrays were performed using the GeneChip Fluidics 5 
Station 450 and scanning with the Affymetrix GeneArray 3000 7G Scanner (Affymetrix, 6 
Santa Clara, CA). The Affymetrix GeneChip Command Console Software (AGCC) was used 7 
to generate CEL files of the scanned arrays. 8 
 Differential gene expression analysis was performed using the Transcriptome 9 
Analysis Console (TAC) 2.0 (Affymetrix) software package using One-Way ANOVA, p-10 
values were corrected for multiple comparisons by Benjamini & Hochberg False Discovery 11 
Rate (FDR). Transcripts with a FDR p-value <0.05 were considered statistically significant. 12 
 13 
Western blot analysis of intracellular EPO retention 14 
Intracellular EPO retention was examined using SDS-PAGE in conjunction with WB 15 
analysis. Intracellular proteins were extracted from pellets of 5 x 10
6
 cells in mid-exponential 16 
phase using 1 mL Mammalian Protein Extraction Reagent with complete
TM
 protease inhibitor 17 
cocktail added (Thermo Scientific). The mixture was left to react for 10 minutes with gentle 18 
shaking and cell debris were removed by centrifugation at 14000 x g for 15 minutes. For 19 
electrophoresis, 28 µL total protein sample was denatured with 4µL NuPage Sample 20 
Reducing Agent (Invitrogen) and 8 µL NuPage LDS Sample Buffer (Invitrogen) at 80°C for 21 
5 minutes and size fractionated on a 12 % NuPAGE Novex Bis-Tris mini gel with MOPS 22 
running buffer. Gel separated proteins were transferred to a 0.45 µm pore size nitrocellulose 23 
membrane using an iBlot (Invitrogen), mouse anti-EPO (RnD Systems, Minneapolis, MN) 24 
was used as primary antibody and a fluorescent labeled donkey anti-mouse antibody (Licor) 25 
 16 
was used as secondary antibody. The fluorescence was quantified using an Odyssey CLx 1 
(Licor) with human erythropoietin (Cell Signaling) as positive control.  2 
 3 
Quenching and extraction of intracellular metabolites 4 
For analysis of intracellular metabolite pools, 10
7
 cells were extracted from mid-exponential 5 
batch cultures and immediately quenched with four sample volumes 0°C 0.9 % w/v NaCl on 6 
ice (inspired by Dietmair et al. 2010). The cooled cell suspension was immediately spun 7 
down at 1000 x g for 1 min at 0°C and the supernatant discarded. 1mL of -79°C methanol 8 
was added to the cell pellet followed by addition of an internal standard mixture containing 9 
10 µg/mL of [U-
13
C] ATP and [U-
13
N] AMP and flash freezing in liquid nitrogen (inspired 10 
by Sellick et al. 2010). Samples were stored at -80°C before thawing on ice and two 11 
successive extractions were performed with 1 mL 50 % v/v acetonitrile in water (inspired by 12 
Dietmair et al. 2010). The extraction procedure included addition of solvent solution, 13 
resuspension of cell pellet by vortexing, incubation on ice for 10 min and separation of cell 14 
debris and liquid phase by centrifugation at 4200 x g for 5 min. The pooled extraction 15 
supernatants were filtered through a 0.45 µm teflon syringe filter Ø17 mm (National 16 
Scientific, Rockwood, TN). 8 mL acetonitrile was added to the filtrate to facilitate water 17 
evaporation before drying under nitrogen atmosphere at room temperature. The extracted 18 
metabolites were dissolved in 150 µL milliQ water containing 10 mM tributylamine and 10 19 
mM acetic acid resulting in a final concentration of 1 µg/mL of each of the internal isotope-20 
labeled standards. Prior to the analysis the samples were filtrated using a 0.45 µm teflon 21 
syringe filter Ø17 mm (National Scientific).  22 
 23 
Ion-pair liquid chromatography tandem mass spectrometry 24 
All LC-MS/MS experiments were performed on an Agilent 1290 Infinity LC coupled with an 25 
 17 
Agilent 6460 triple quadrupole MS analyser equipped with electrospray ionization source. 1 
The MS was operated in negative multiple reaction monitoring (MRM) mode.  2 
10 μg/mL single standard solutions in 10 mM TBA and 10 mM acetic acid were used 3 
to optimize the compound specific MS and ion source parameters. The two most intense 4 
MRM transitions for each metabolite were determined in a direct infusion experiment using a 5 
KDS100 infusion pump with a flow rate of 9,8 μL/min. Then, for each chosen MRM 6 
transition the collision energy (CE), fragmentor and cell accelerator voltages (CAV) were 7 
optimized by injecting 1 μl of 10 μg/mL single standard solutions. When investigating the 8 
optimal compound specific parameters for the MS/MS analysis, the following range of 9 
voltages were tested: fragmentor voltage 90-130 V in steps of 10 V, CE 5-35 V in steps of 5 10 
V and CAV 3 and 4 V. The MRM’s used for the analysis are given in supplementary 11 
materials. The best compound specific parameters were those giving the most intense LC-MS 12 
peak. The ion source dependent parameters were as follows: gas temperature 300°C; sheath 13 
gas temperature 400°C; nebulizer gas flow rate 8 L/min; nebulizer pressure 50 psi; and 14 
capillary voltage 4500 V. Nitrogen was used as collision gas. The entrance potential (ΔEMV) 15 
and dwell time were kept at 500 and 30 ms respectively for all transitions.  16 
The chromatographic separation was obtained on a Luna 2.5µ C18(2)-HST (100 x 2.0 17 
mm) HPLC column (Phenomenex, Aschaffenburg, Germany) operated at 40°C. Eluent A was 18 
water containing 10 mM tributylamine and 10mM acetic acid and eluent B was 90% (v/v) 19 
methanol containing 10 mM tributylamine and 10mM acetic acid. The gradient was stepwise 20 
0-5 min, 0% B; 5-10 min, 0-2 % B; 10-11 min, 2-9 % B; 11-16 min, 9% B; 16-24 min, 9-21 
50% B; 24-28 min, 50% B; 28-28.5 min, 50-100% B; 28.5-30 min, 100% B; 30-30.5, 100-22 
0% B; 30.5-36 min, 0%. The final 5.5 min were used for equilibration of the column prior to 23 
the next run. The flow rate was 0.3 mL/min and the sample injection volume was set to 5 μL.  24 
 18 
1 mg/mL single standard stock solutions in water were used to prepare 10 µg/mL 1 
mixture of the compounds of interest in eluent A. The latter mixture was used to prepare the 2 
calibration solutions with concentrations ranging from 0.05 to 10 µg/mL. Standard curves 3 
used for the quantification were constructed by plotting the peak area of the compounds 4 
against the concentration. For the compounds for which internal standards were available the 5 
calibration curves were constructed by plotting the ratio of the peak area of labeled and 6 
unlabeled compounds against their concentrations. A chromatogram of detected compounds 7 
in mammalian cell extracts is supplied in supplementary materials.  8 
 9 
Metabolic network reconstruction 10 
A draft network reconstruction of the glycolytic and amino acid catabolic pathways in CHO 11 
cells was generated using the mouse metabolic pathways as template. Biochemical pathway 12 
data from mouse metabolism was retrieved from the Kyoto Encyclopedia of Genes and 13 
Genomes database (Kanehisa & Goto 2000; Kanehisa et al. 2014) and homologous gene 14 
sequences in the CHO genome were identified using the Chinese hamster genome database 15 
www.CHOgenome.org (Hammond et al. 2012). The draft network reconstruction was further 16 
refined by careful curation of gene-protein-reaction relationships using manual genome 17 
annotation and literature evidence. The finalized reconstruction featured 319 proteins 18 
catalyzing 183 reactions with 188 metabolites (metabolic map is supplied in supplementary 19 
materials).  20 
 21 
Statistical analysis 22 
The statistical test for determination of physiological differences between clone populations 23 
was performed using Student’s t-test with a significance level of α = 0.05. 24 
 19 
 1 
 2 
 3 
 4 
 5 
Results 6 
Cell line generation and clone selection 7 
Seven single cell clones were selected based on proliferation rate and EPO expression to 8 
establish a panel of stable clones with specific EPO productivities (qEPO) ranging from less 9 
than 0.2 to 5 pg/cell/day (determined in exponential growth phase), thus covering a 25-fold 10 
range of productivity (Figure 1). All EPO producing clones and a non-transfected parental 11 
clone were adapted to the growth medium (Q-CM105) to exclude the influence of ongoing 12 
medium adaptation on physiological characterization. During the adaptation phase, clones 13 
were monitored for specific growth rate, specific glucose and glutamine uptake rates, specific 14 
lactate and ammonium secretion rates and specific EPO production rate. After 20 days in 100 15 
mL repeated batch culture, all measured parameters had stabilized (i.e. remained within 7 %). 16 
Thus, the clones were considered fully adapted to the growth medium and a master cell bank 17 
was established.  18 
 19 
EPO production has no effect growth, nutrient uptake or by-product secretion 20 
Clones C1-7 and the parental clone were physiologically characterized in duplicate batch 21 
cultivations in bioreactors under nutrient excess conditions, to ensure maximum specific 22 
growth rate (supplementary materials). To assess the physiological impact of EPO 23 
production, the control was compared to the EPO producing clones (data displayed in table 24 
II). No significant difference was found in growth characteristics (i.e. specific growth rate 25 
and biomass yield), excluding major physiological stress from EPO production. An analysis 26 
 20 
of correlation (supplementary materials) between the cell phenotypic variation displayed in 1 
Table II and qEPO was performed to identify patterns in clone physiology that might explain 2 
the difference in qEPO. The analysis identified no correlations in the dataset (Table II), 3 
suggesting that an in-depth physiological analysis was required to discover phenotypic 4 
markers for high qEPO. 5 
 6 
Comparison across EPO producing clones reveals no detrimental effect on glucose 7 
metabolism 8 
In order to assess possible metabolic impact of differential EPO expression on energy 9 
metabolism, we performed a quantitative characterization of intracellular metabolites related 10 
to glucose energy and redox metabolism (i.e. specific glycolytic intermediates, NAD(P)H-11 
/NAD(P)
+
 and ANP’s). For this, triplicate batch cultures of all EPO producing clones were 12 
sampled in parallel, during mid-exponential growth phase and metabolite profiles were 13 
generated using an extraction technique that does not differentiate between cellular 14 
compartments, thus picturing the average concentration of intracellular metabolites. The 15 
differences in concentrations of adenosine phosphates and nicotinamide adenine 16 
dinucleotides did not exhibit a marked correlation to qEPO (linear regression analysis, R
2
 < 17 
0.36) (Figure 2 A+C). The adenylate energy charge (AEC) ratio represents the amount of 18 
metabolically available energy stored in the adenine nucleotide pool (Atkinson 1968). The 19 
catabolic- and anabolic reduction charges represent the redox state of the cell (Andersen & 20 
von Meyenburg 1977). The observed distributions (Figure 2 B, D, E) indicate that EPO 21 
production is not limited by insufficient energy availability from adenosine phosphates or 22 
nicotinamide adenine nucleotides (linear regression analysis, R
2
 < 0.36). 23 
Furthermore, intracellular concentrations of several carbon metabolites from 24 
glycolysis and acetyl coenzyme A were determined and compared between clones (Figure 3). 25 
 21 
As observed for adenosine phosphates and nicotinamide adenine nucleotides, the differential 1 
qEPO was not reflected in metabolite concentrations indicating that EPO production is not 2 
limited by glucose metabolism (linear regression analysis, R
2
 < 0.33).  3 
 4 
Chemostat cultivation of three EPO producing clones show temporal correlations in 5 
gene expression and EPO titer 6 
To identify the bottleneck in the protein production pathway, three clones (C1, C4 and C7) 7 
were selected for an in-depth physiological characterization under growth-limited conditions 8 
in duplicate chemostat cultivations. The cultures were continued for 31 days with a fixed 9 
specific growth rate of 0.3 day
-1
 corresponding to 15 generations at 30 % of maximum 10 
growth rate. The chemostat cultivation mode was selected to normalize for growth-related 11 
effects on protein productivity across the three clones, thus unveiling physiological variation 12 
in protein production efficiency regardless of maximum growth capacity. The assumption 13 
here was that normalization of the specific growth rate lead to normalization of metabolic 14 
fluxes and therefore picture the intrinsic metabolic efficiency of protein production between 15 
the clones. Samples were taken daily from each chemostat culture and the secreted protein 16 
levels, EPO gene copy numbers, mRNA levels (Figure 4) and amount of intracellular 17 
accumulated EPO were determined (supplementary materials). The viable cell density 18 
(Figure 4 A), stabilized at approximately 5 million cells per mL after 10 days. Analysis of 19 
spent growth medium suggested that the cultures reached steady-state at day 12, as 20 
concentrations of medium components (amino acids and sugars) and metabolic by-products 21 
(lactate and ammonium) were constant in all cultures from this time-point (supplementary 22 
materials). The dynamics of EPO titers pictures three distinct phases (Figure 4 B). In phase I 23 
(day 1-10) the EPO titers decrease as the cells adjust to the imposed growth limitation and the 24 
steady state. During phase II (day 10-20) the cells reach steady-state and protein titers are 25 
 22 
relatively stable in all cultures. In phase III (day 20-31) the EPO titers increase corresponding 1 
to an increase of qEPO by 56 %, 74 % and 83 % for clone 1, clone 4 and clone 7, respectively 2 
in phase III relative to phase II (Figure 4, E+F bars). The EPO gene copy numbers were 3 
determined by qPCR using relative quantitation with Gapdh as reference gene. The dynamics 4 
of EPO gene copy numbers feature a steady increase over the course of the cultivation 5 
(Figure 4 C). Starting with 1.5 relative EPO gene copies, the determined gene copy numbers 6 
slowly increase towards 2 EPO gene copies, suggesting a culture-average absolute EPO gene 7 
copy number of 3 at the beginning of the cultivation and 4 in the end. The dynamics of EPO 8 
gene expression pictured a decrease around day 12 consistent in all cultures (Figure 4 D). The 9 
basis of the sudden decrease is unknown, but the timing correlates with depletion of lactate in 10 
the growth medium. From day 20, the EPO gene expression increased in all clones 11 
throughout the cultivation, correlating well with the increased EPO titers in phase III. 12 
 13 
Post-transcriptional protein processing efficiency of EPO in the protein secretory 14 
pathway correlates with specific EPO productivity across clones 15 
For determination of differences in EPO transcription efficiency across clones, we compared 16 
the ratios of culture-average EPO gene expression per EPO gene, i.e. the ratio of EPO mRNA 17 
to EPO gene (Figure 4 E). It was noticed that the transcriptional efficiency of clone 4 and 18 
clone 7 was identical throughout the experiment and that the transcriptional efficiency of 19 
clone 1 was consistently 20 % lower than the other clones. To determine differences in post-20 
transcriptional processing of EPO across the clones, we compared the culture-average ratios 21 
of EPO titer and EPO gene expression, i.e. EPO titer per EPO mRNA, thus reflecting the 22 
efficiency of protein translation and secretory protein processing (protein folding, -maturation 23 
and -secretion) across clones (Figure 4 F). It was noticed that the post-transcriptional 24 
 23 
efficiency was significantly higher in clone 7 relative to clone 4 and clone 1 and 1 
corresponded well to the observed difference in qEPO. Therefore, we investigated whether 2 
different amounts of EPO were retained intracellular in the clones. For this, total cellular 3 
protein extracts were separated using SDS-PAGE and analyzed for EPO contents using WB 4 
(supplementary materials). The differences in intracellular EPO levels corresponded to the 5 
observed extracellular EPO titers (Figure 4 B) indicating that EPO is not retained intracellular 6 
in any clones.   7 
 8 
Global gene expression analysis indicate adaptation of gene expression levels of amino 9 
acid catabolic genes to preserve most abundant amino acids in EPO 10 
To identify differentially expressed genes functionally related to secretory protein processing 11 
across the EPO producers we performed a global gene expression analysis comparing the 12 
highest and lowest EPO producers (clone 7 and clone 1, respectively) during the steady-state 13 
phase of chemostat culture in phase II (triplicate samples were generated from day 12, 15 and 14 
18). The differential gene expression analysis identified no enrichment in the gene expression 15 
landscape of genes related to protein translocation, protein folding, protein glycosylation or 16 
vesicular transport (supplementary materials), indicating that neither of these processes was 17 
limiting the protein productivity. Next, we investigated whether the protein production 18 
bottleneck was reflected in differential expression of metabolic genes. For this analysis, we 19 
generated a network reconstruction of the glycolytic pathway and the amino acid catabolic 20 
pathways, as these are the most active catabolic pathways and thus most likely to limit energy 21 
metabolism (the reconstructed metabolic network is displayed in supplementary materials). 22 
The network reconstruction served as a framework for meaningful interpretation of the 23 
differential gene expression data on a pathway level. The results indicated a general up-24 
 24 
regulation of glycolytic genes in clone 7, suggesting a possible increased energy demand in 1 
this clone. Interestingly, when inspecting the differential gene expression levels of amino 2 
acid catabolic genes, we discovered a tendency towards preservation of the most abundant 3 
amino acids in EPO in the high producer relative to the low producer (i.e. decreased 4 
transcription level of genes responsible for degradation of the amino acids most frequently 5 
found in EPO) (Figure 5). Specifically, 12 of the 13 most abundant and non-secreted amino 6 
acids in EPO had reduced expression of catabolic reactions in the high producer relative to 7 
the low producer (Figure 5B). Thus, the result indicated possible regulatory adaptation of 8 
gene expression towards decreased amino acid catabolism specific for the most abundant 9 
amino acids in EPO, in the high producer relative to the low producer. It was noticed that the 10 
observation was followed by an increase of qEPO by 56 % and 83 % in the clone 1 and clone 11 
7, respectively (phase III, Figure 4 B).  12 
 13 
Discussion 14 
Comparison across EPO producing clones revealed no apparent bottlenecks in the 15 
protein expression and secretory pathway or energy metabolism 16 
The secretory production of proteins in CHO cells can be characterized as a cascade of 17 
protein modification and quality control steps catalyzing the post-translational processing of a 18 
nascent polypeptide into a functionally mature protein (Hussain et al. 2014). The 19 
overproduction of a heterologous protein increases the trafficking through the secretory 20 
pathway to the limit of the protein processing capacity leading to productivity bottlenecks. To 21 
increase the knowledge of the bottleneck associated with secretory production of EPO in 22 
CHO cells, we established a panel of CHO-K1 clones spanning a 25-fold range of specific 23 
EPO productivity and assessed the phenotypical differences at multiple stages within the 24 
protein expression and secretion pathway. 25 
 25 
The comparison of transcriptional efficiency (Figure 4, E) showed a lower 1 
transcription rate per EPO gene in clone 1 compared to clone 4 and clone 7 throughout the 2 
experiment, indicating that the EPO gene was inserted in a locus with less transcriptional 3 
activity in clone 1. While clone 4 and clone 7 showed identical transcriptional efficiencies, 4 
the comparison of post-transcriptional efficiency (Figure 4, F) revealed that clone 1 and clone 5 
4 were severely limited in EPO secretion per EPO transcript compared to clone 7  (23 % and 6 
50 % of C7 at day 15, respectively). It was observed that the difference in post-transcriptional 7 
efficiency corresponded to the difference in qEPO indicating that the expression bottleneck 8 
was enrooted downstream of transcription (i.e. translation, translocation, protein folding, -9 
glycosylation and -transport). The differential EPO expression was not reflected in 10 
intracellular protein concentration as determined by Western blot, as this correlated well with 11 
the difference in extracellular protein concentration, indicating that post-translational 12 
processing of EPO in the secretory pathway is not a bottleneck. This indication was 13 
underlined by the fact that the global gene expressing analysis of clone 1 and clone 7 found 14 
no significant (p-values > 0.05) difference in expression level of single genes or expression 15 
enrichment within a group of genes functionally related to secretory protein production (i.e. 16 
genes involved in translocation, protein folding, -glycosylation and -transport). 17 
The determination of gene- and transcript levels during prolonged chemostat 18 
cultivation led to some noteworthy observations. The slightly increasing trend of EPO gene 19 
copy numbers was surprising. However, the effect may be explained by presence of a sub-20 
population of cells with different copy numbers of hEPO or Gapdh, as previously 21 
demonstrated by Beckmann et al. 2012. Similarly, the sudden decrease of EPO transcripts 22 
around day 12 (Figure 4, D) was surprising. The basis of the decrease was unknown, but the 23 
timing in all 5 cultures correlated well with the depletion of lactate in the growth medium and 24 
may be associated with a metabolic shift.  25 
 26 
It was investigated whether the differential EPO expression across the clones was 1 
caused by a bottleneck in carbon and/or energy metabolism. For this, intracellular metabolites 2 
were sampled in mid-exponential growth phase as this was assumed to picture the maximum 3 
metabolic capability of each clone. Comparison of intracellular concentrations of adenosine 4 
phosphates and nicotinamide adenine dinucleotides across clones showed no correlation to 5 
qEPO (Figure 2). This observation indicated that the energy metabolism was keeping up with 6 
the increased energy requirement in the EPO producing clones, which is in agreement with 7 
similar studies of other mammalian cell types (Khoo et al. 2007; Niklas et al. 2013). 8 
Furthermore, the lack of correlation between concentrations of glycolytic intermediates and 9 
qEPO (Figure 3) indicated that glucose metabolism was not limiting for EPO productivity in 10 
batch culture. However, in the chemostat culture, we observed a change in the expression 11 
landscape of metabolic genes between the two EPO producing clones. The genes in the 12 
glycolytic pathway were generally up-regulated in the high producing clone, possibly 13 
reflecting an increased energy demand corresponding to the increased EPO productivity of 14 
this clone. That is, the normalization of growth rates in chemostat culture normalized the 15 
metabolic energy consumption from growth, thus allowing the quantification of energy 16 
requirement from heterologous protein production. Increased glycolytic flux in response to 17 
protein production during glucose-limited growth-restricted culture has been demonstrated in 18 
the eukaryotic production host P. pastoris (Heyland et al. 2010). 19 
 20 
Heterologous protein production causes metabolic changes in favor of the produced 21 
protein 22 
Heterologous protein production imposes a metabolic burden on the host cell metabolism, 23 
which causes redistribution of metabolic precursor fluxes to meet the increased anabolic 24 
demand for e.g. nucleotides for synthesis of RNA and activated sugar precursors associated 25 
 27 
with secretory protein production (Niklas et al. 2013). The same study demonstrated that 1 
anabolic demand for nucleotide biosynthesis results in extracellular secretion of glycine and 2 
glutamate. Interestingly, we found that during steady state in chemostat culture, extracellular 3 
concentrations of glycine and glutamate were 1.8-fold and 2-fold higher in C7 relative to C1, 4 
respectively. This indicated that the secretion rates of glycine and glutamate increased with 5 
qEPO, suggesting that the findings of Niklas et al. (2013) in human cells expressing α1-6 
antitrypsin are also valid for CHO cells expressing EPO. 7 
The use of a nutrient-limited cultivation format restricts the possibility to increase 8 
nutrient uptake and inflict regulatory changes on cell metabolism, which may lead to flux-9 
redistribution in favor of the heterologous protein. To further increase the knowledge on the 10 
adaptability of CHO cell metabolism, we performed a comparative transcriptome analysis of 11 
two clones with 25-fold differential EPO productivity in glucose-limited chemostat 12 
cultivations at D = 0.3 day
-1
. Interestingly, we observed a change in the gene expression 13 
landscape of catabolic genes between the clones. The genes in the glycolytic pathway 14 
generally showed higher expression levels in the high producing clone, possibly reflecting an 15 
increased energy demand corresponding to the increased EPO productivity of this clone. 16 
Furthermore, the comparison of gene expression levels in the amino acid catabolism revealed 17 
a regulatory change around the amino acids, which are most abundant in EPO and not 18 
secreted from the cell. That is, the gene expression levels of enzymes producing these amino 19 
acids were generally up-regulated and expression levels of enzymes consuming the same 20 
amino acids were generally down-regulated in the high producer relative to the low producer 21 
(Figure 5). This observation indicated a comparatively larger degree of metabolic adaptation 22 
to EPO production in the high producer, which may explain the larger increase of qEPO in the 23 
high producer in phase III of chemostat culture (83 % vs. 56 % in high- and low producers, 24 
respectively). Based on these data, we speculate that the amino acid metabolism in CHO cells 25 
 28 
may undergo adaptation in favor of the produced heterologous protein during long-term 1 
cultivation. The adaptation of gene expression levels in amino acid metabolism in favor of 2 
heterologous protein production during prolonged chemostat cultivation has been reported 3 
before in the eukaryotic protein production host S. cerevisiae (Kazemi Seresht et al. 2013).  4 
In conclusion, we provide evidence that EPO production up to 5 pg/cell/day is not 5 
limited by metabolism (i.e. glycolysis and associated energy metabolites) or bottlenecks in 6 
gene dosage, transcription and post-translational processing of EPO. Furthermore, we showed 7 
that glutamate and glycine secretion is increased in the high producing EPO clone, relative to 8 
the low producing clone, echoing the findings of Niklas et al. (2013) thus indicating possible 9 
anabolic demand for nucleotides and lipids, which could be candidate targets for medium 10 
supplementation to improve protein productivity. 11 
Finally, we demonstrate that heterologous protein production can inflict metabolic 12 
changes in favor of the produced protein during prolonged chemostat cultivation. The 13 
observed adaptations of glycolysis and amino acid metabolism were followed by increased 14 
protein productivity in phase III (83 % vs. 56 % in high- and low producers, respectively), 15 
suggesting that metabolic engineering of amino acid metabolism to reduce catabolism of 16 
amino acids present in the target protein could improve specific protein productivity in 17 
continuous culture. It was not possible to verify the reduced amino acid catabolism at the 18 
metabolite level using metabolic foot printing, thus future work should include quantification 19 
of intracellular levels of amino acid catabolic proteins or metabolic flux analysis to verify the 20 
suggested link between amino acid catabolism and heterologous protein production in 21 
chemostat culture.  22 
 23 
 24 
 25 
 29 
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TABLES 1 
Table I. List of primers and corresponding sequences used for quantitation of gene copy 2 
numbers and gene expression levels.  3 
Primer name Target 
gene 
Purpose Primer sequence 5’-3’ 
EPO-Fwd hEPO Copy number determination AGAGGCCGAGAACATCACCA 
EPO-Rev hEPO Copy number determination CCCACTTCCATCCGCTTA 
GAPDH-Fwd Gapdh Copy number determination AGCTTGTCATCAACGGGAAG 
GAPDH-Rev Gapdh Copy number determination ATCACCCCATTTGATGTT 
ActB-Fwd Actb Copy number determination CCAGCACCATGAAGATCAAG 
ActB-Rev Actb Copy number determination TGCTTGCTGATCCACATCTC 
EPO (CHO 
optimized)-Fwd 
hEPO Plasmid construction AGTGCGAUATGGGCGTGCACGAG
TGTC 
EPO (CHO 
optimized)-Rev 
hEPO Plasmid construction AGACTGTGUTAATCTATCGCCGGT
CCGGC 
 4 
  5 
Table II. Raw data obtained in duplicate batch cultivations of EPO producing clones (C1-C7) 6 
and the parental clone (Control) in bioreactors. Abbreviations: µmax = maximum specific 7 
growth rate, IVCD = Integral of viable cell density (biomass yield), qGlc = maximum specific 8 
glucose uptake rate, qLac = maximum specific lactate secretion rate, qGLN = maximum 9 
specific glutamine uptake rate, qGLU = maximum specific glutamate secretion rate, qNH4 = 10 
maximum specific ammonium secretion rate, YLac/Glc = yield of lactate on glucose, YNH4/GLN 11 
= yield of ammonium on glutamine, qEPO = specific EPO productivity, Glc/GLN 12 
consumption = uptake ratio of glucose per glutamine. 13 
Clo
ne 
µmax 
[day-1] 
IVCD 
[106 
cells*h/mL] 
qGlc 
[pmol/cel
l/day] 
qLac 
[pmol/cel
l/day] 
qGln 
[pmol/cel
l/day] 
qGlu 
[pmol/cel
l/day] 
qNH4 
[pmol/cel
l/day] 
YLac/Glc 
[mol/mol] 
YNH4/Gl
n 
[mol/mol] 
qEPO 
[pg/cell/da
y] 
C1 0.97 / 1.00 712 / 639 5.88 / 4.52 7.08 / 6.91 1.10 / 1.07 0.20 / 0.17 0.94 / 0.73 1.20 / 1.53 0.86 / 0.69 0.18 / 0.17 
C2 0.91 / 1.05 627 / 587 6.73/ 5.28 7.14 / 7.59 0.96 / 1.05 0.16 / 0.16 0.80 / 0.64 1.06 / 1.44 0.84 / 0.61 0.36 / 0.21 
C3 0.70 / 0.81 446 / 456 5.78 / 5.57 7.88 / 9.20 0.92 / 0.97 0.21 / 0.30 1.01 / 0.90 1.36 / 1.65 1.09 / 0.92 0.60 / 0.36 
 36 
C4 0.86 / 0.97 544 / 532 4.58 / 4.69 6.88 / 7.17 1.00 / 1.06 0.23 / 0.18 0.88 / 0.78 1.50 / 1.53 0.88 / 0.73 0.76 / 0.54 
C5 0.80 / 0.81 308 / 254 6.56 / 7.30 10.7/ 10.9 1.63 / 1.50 0.33 / 0.28 1.50 / 1.16 1.63 / 1.50 0.92 / 0.77 2.64 / 1.06 
C6 0.89 / 1.00 585 / 579 5.86 / 5.18 5.96 / 7.42 1.05 / 1.00 0.20 / 0.21 0.87 / 0.72 1.02 / 1.43 0.82 / 0.71 3.05 / 3.39 
C7 0.89 / 0.97 584 / 500 4.62 / 6.07 7.74 / 8.80 1.17 / 1.22 0.29 / 0.24 0.87 / 0.88 1.68 / 1.45 0.83 / 0.72 4.66 / 5.42 
Co
ntr
ol 
0.92 / 0.98 528 / 557 4.67 / 4.94 7.01 / 7.72 1.18 / 1.15 0.26 / 0.17 0.92 / 0.75 1.50 / 1.56 0.78 / 0.65 - 
 
 1 
Clone Glc/Gln Consumption 
[mol/mol] 
Cell size 
[µm] 
Aggregation rate 
[%] 
     
C1 5.36/ 4.26 13.41 / 13.30 29.52 / 15.85       
C2 7.05 / 5.03 13.38 / 13.41 18.83 / 12.12       
C3 6.27 / 5.73  13.05 / 12.90 25.85 / 11.97       
C4 4.58 / 4.40  13.40 / 13.06 23.70 / 13.38       
C5 4.02 / 4.87  16.25 / 16.01 35.04 / 32.18       
C6 5.56 / 5.13  13.51 / 13.37 19.27 / 12.86       
C7 3.95 / 4.96  13.94 / 13.69 20.03 / 8.61       
Control 3.95 / 4.30  13.92 / 13.37 22.64 / 11.81       
 2 
LIST OF FIGURES + LEGENDS 3 
Figure 1. Specific EPO productivity. The error bars indicate standard deviation of two 4 
biological replicates. 5 
Figure 2. Overview of intracellular energy and redox-related metabolites in EPO 6 
clones. A. Intracellular concentration of adenosine phosphates. B. Adenylate energy 7 
charge. C. Intracellular concentration of phosphorylated and non-phosphorylated 8 
nicotinamide adenine dinucleotides. D. Catabolic reduction charge. E. Anabolic 9 
reduction charge. Error bars indicate standard deviation of three biological replicates. 10 
Figure 3. Schematic representation of glycolysis and associated levels of 11 
intracellular metabolites. Quantified metabolites are indicated with black font on the 12 
pathway map (left). The concentrations of 3-phosphoglycerate and 2-phosphoglycerate 13 
 37 
were pooled, as they could not be separated in the method. Error bars indicate standard 1 
deviation of three biological replicates. 2 
Figure 4. Culture dynamics of clone 1, clone 4 and clone 7 during 31 days of 3 
continuous culture in chemostat. A Viable cell densities. B Extracellular EPO titres. C 4 
Determined EPO gene copy numbers. D Determined EPO gene expression. E Ratio of 5 
determined EPO mRNA transcript per EPO gene (curves) and averaged specific EPO 6 
productivity for phase I, phase II and phase III (bars). F Ratio of secreted EPO per mRNA 7 
transcript (curves) and averaged specific EPO productivity for phase I, phase II and 8 
phase III (bars). Error bars indicate standard deviation of two biological replicates. 9 
Figure 5. Differential gene expression analysis of amino acid catabolic genes in 10 
the high and low producer. A. Gene expression landscape of genes catalyzing the 11 
degradation or synthesis of amino acids. Circles indicate genes next to the reaction the 12 
encoded enzyme catalyzes. Gene expression values are shown as log fold-change 13 
indicating up- or down regulated genes in clone 7 relative to clone 1. Amino acids are 14 
colored blue, redox active metabolites are colored red and metabolites from the central 15 
metabolism are colored yellow. Reactions that do not produce or consume amino acids 16 
have been left out for simplicity. Dashed lines indicate multiple catalytic reactions.                         17 
B. Frequency distribution of amino acids in human EPO without signal peptide. Black 18 
bars correspond to amino acids, which are preserved in clone 7 relative to clone 1. Grey 19 
bars indicate amino acids, which are not preserved. Red bars indicate amino acids that 20 
are secreted from the cells and therefore not considered in the analysis.  21 
 22 
 23 
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 1 
Abstract  2 
The yeast Saccharomyces cerevisiae is a widely used eukaryotic model organism and a key cell 3 
factory for production of biofuels and wide range of chemicals. From the broad palette of available 4 
yeast strains, the most popular are those derived from laboratory strain S288c and the industrially 5 
relevant CEN.PK strain series. Importantly, in recent years these two strains have been subjected to 6 
comparative “-omics” analyses pointing out significant genotypic and phenotypic differences. It is 7 
therefore possible that the two strains differ significantly with respect to their potential as cell 8 
factories for production of specific compounds. To examine this possibility, we have reconstructed a 9 
de novo vanillin-β-glucoside pathway in an identical manner in S288c and CEN.PK strains. 10 
Characterization of the two resulting strains in two standard conditions revealed that the S288c 11 
background strain produced up to 10-fold higher amounts of vanillin-β-glucoside compared to 12 
CEN.PK. This study demonstrates that yeast strain background may play a major role in the outcome 13 
of newly developed cell factories for production of a given product. 14 
 15 
 16 
Keywords: Yeast; Cell factory; Strain choice; Heterologous production; Vanillin-glucoside; Shikimate 17 
pathway. 18 
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1 Introduction 1 
The recent achievements in the field of systems biology and metabolic engineering combined with a 2 
wide array of molecular biology tools has established the yeast Saccharomyces cerevisiae  as a key 3 
cell factory for heterologous production of scientifically and industrially relevant products. The latter 4 
comprise a large variety of products ranging from low-value bulk chemicals and biofuels (e.g., 5 
ethanol) to food additives (e.g., flavors and colorants) and high value pharmaceuticals (e.g., 6 
recombinant proteins) [1], [2]. Today, a range of different S. cerevisiae strain backgrounds are 7 
available for the yeast community of which BY (S288c), W303 and CEN.PK are the most frequently 8 
used [3]. The variety of strains has been developed by different laboratories to suit a range of 9 
diverse research goals within different disciplines such as genetics, physiology and biochemistry. For 10 
example, CEN.PK strain [4], is a popular platform for physiological as well as metabolic engineering 11 
studies  whereas S288c, the first eukaryote to be sequenced [5], was mainly used for genetic studies, 12 
but has in recent years been increasingly used as an alternative platform for metabolic engineering 13 
experiments [1], [2]. Specifically, recent surveys show that over the past ten years the two strains 14 
were used in more than 50% of the analyses with CEN.PK series being the most popular (approx. 15 
37% - CEN.PK vs. 24% - S288c and its derivatives) [1], [2]. The importance of the two strains as cell 16 
factories is further substantiated by an extensive multi-laboratory efforts which were made for 17 
systematic comparisons of S288c and CEN.PK [6]–[8]. Genetic differences of these strains were 18 
revealed first by microarray studies [9] and more recently genotype to phenotype relation was 19 
investigated after whole-genome sequencing of the CEN.PK113-7D strain [10], [11]. For example, the 20 
sequencing comparison studies revealed that 83 genes were absent in CEN.PK relative to S288C [11] 21 
and that more than 22,000 single nucleotide polymorphisms (SNPs) exist between the two strains. 22 
13,000 of the SNPs are distributed in 1,843 open reading frames (ORFs) and the activity of a large 23 
number of proteins may therefore differ in the two strains; especially since 35 % of these SNPs result 24 
in amino-acid residue substitutions. The remaining 9,000 SNPs, which are mainly distributed in the 25 
intergenic regions, may potentially impact gene expression and thereby protein levels in the two 26 
strains. The fact that the highest enrichment of SNPs was detected in genes involved in carboxylic 27 
acid, organic acid, and carbohydrate metabolism, as well as, in nitrogen, amino acid, lipid and 28 
aromatic compound metabolism suggests that the basic metabolism in the two strain background 29 
may be quite different [10]. Importantly, based on the combined “-omics” analyses, several 30 
phenotypic differences between the two strains were assigned to these mutations, e.g., differences 31 
in galactose uptake and ergosterol biosynthesis, etc. in two strains [10]. 32 
The fact that the two main S. cerevisiae backgrounds for construction of cell factories are 33 
genetically/phenotypically quite different raises the possibility that heterologous production of a 34 
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given compound in CEN.PK and in S288c may result in significantly different yields. To examine this 1 
possibility, we therefore constructed comparable cell factories for vanillin-β-glucoside (VG) 2 
production in S288c and CEN.PK backgrounds. Importantly, all five relevant genes for VG production 3 
in S. cerevisiae, (see Figure 1 and Hansen et al.[12]) were integrated at phenotypically neutral and 4 
well defined locations in the yeast chromosome using a recently published integration platform [13]. 5 
Moreover, in order for the engineered strains to be directly comparable, auxotrophies were 6 
eliminated by a sexual backcross to the corresponding wild-type strains. Remarkably, the 7 
physiological characterizations of both VG cell factories in two different cultivation modes revealed 8 
major differences in the VG production. Next, we examined the comprehensive “-omics” datasets for 9 
S288c and CEN.PK strains [7] to look for plausible reasons for the different VG production profiles in 10 
the two genetic backgrounds. Together our analyses serve as a step towards a scenario where the 11 
optimal genetic background for cell factory construction can be successfully selected based on a 12 
systems biology model for yeast cell factories. 13 
2 Materials and Methods 14 
2.1 DNA cloning procedures 15 
The DNA fragments used for vector construction were amplified by PCR with PfuX7 polymerase 16 
developed by Nørholm et al. [14] using the primers listed in the Table 2. Molecular coning was done 17 
by uracil-speciﬁc excision reagent (USER™) as previously described in [15], [16].Final constructs were 18 
validated by sequencing (StarSEQ® GmbH, Germany). The genes constituting the de novo VG 19 
pathway (1-3DSD, 2- ACAR, 3-EntD, 4-HsOMT, and 5-UGT) and a set of bidirectional promoter 20 
(pPGK1/pTEF1) were amplified by PCR from the appropriate vector templates (see Table 1). The 21 
pathway genes and promoters were assembled into vectors designed to integrate on chromosome 22 
XII [13]. A total of three plasmids were produced: pXII1-23 (pPGK1::ACAR; pTEF1::EntD), pXII2-54 23 
(pPGK1::UGT; pTEF1::HsOMT) and pXII5-01 (pTEF1::3DSD), see Figure S1. For a full list of plasmids 24 
used or constructed in this work see Table 1. 25 
2.2 Strain construction 26 
The genotype and source of the strains used in this study is given in the Table 3. Two different 27 
background strains CEN.PK113-11C and X2180-1A (isogenic to S288c  [17]) were used as hosts for 28 
reconstruction of the de novo vanillin-β-glucoside (VG) pathway. All yeast constructs were generated 29 
by high efficiency transformation method (lithium acetate/polyethylene glycol/single carrier DNA) 30 
previously described by Gietz et al. [18]. 31 
To construct two yeast strains containing the VG pathway, vectors pXII1-23, pXII2-54 and pXII5-01 32 
harboring the following genes (ACAR and EntD), (UGT and HsOMT) and (3DSD), respectively, were 33 
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digested with NotI restriction enzyme (Fermentas-Thermo Fisher Scientific) and gel-purified using 1 
illustra GFX PCR DNA and Gel Band Purification Kit (GE Lifesciences). The individual gene targeting 2 
substrates were transformed iteratively into both yeast strain backgrounds in three consecutive 3 
transformations. To prevent undesired production of toxic intermediates especially protocatechuic 4 
aldehyde (PAL), the 3DSD gene was cloned at the latest step. After each round of transformation the 5 
URA3 marker was eliminated by direct repeat recombination and counter-selection on 5-FOA [19] 6 
allowing the URA3 marker to be recycled. 7 
Complete gene deletions of BGL1 and ADH6 were achieved using method described by Güldener et 8 
al [20]. PCR fragment carrying loxP-KanMX-loxP flanked by 40 nt long segment homologous to 9 
sequences of Up- and Down-stream of the appropriate open reading frame (ORF) to be deleted were 10 
amplified form plasmid pUG6. The KanMX marker was excised by expressing Cre recombinase from 11 
the vector pSH47 [20]. All gene targeting events were validated by diagnostic PCR using specially 12 
designed primer pairs (see Table 2). 13 
To eliminate any auxotrophies, two engineered strains S-VG-aux and C-VG-aux were sexually crossed 14 
to S288c and CEN.PK110-16D, respectively. This resulted in two final prototrophic vanillin-β-15 
glucoside producing yeast strains S-VG (S288c based) and C-VG (CEN.PK based). Genetic cross and 16 
selection procedures were performed as described in [21]. Schematic flowchart representing the 17 
strain construction is depicted in Figure S2. 18 
2.3 Media  19 
For cloning purposes lysogeny broth (LB) [22] supplemented with 100 mg/L of ampicillin (Sigma-20 
Aldrich) was used for growing of Escherichia coli DH5α. 21 
All media used for genetic manipulations of yeast were prepared as previously described by 22 
Sherman et al. [23], with minor modifications of synthetic medium where leucine concentration was 23 
doubled to 60mg/L. All yeast transformants with gene integrations were selected on synthetic 24 
complete media missing uracil (SC-ura). For subsequent round of transformations URA3 marker was 25 
recycled through direct repeat recombination and selected on synthetic complete media containing 26 
30 mg/L uracil and 740mg/L 5-fluoroorotic acid (5-FOA) (Sigma-Aldrich).  27 
Yeast transformants with necessary gene deletions were selected on Yeast Extract Peptone Dextrose 28 
(YPD) plates supplemented with 200 mg/L of G418 (Sigma-Aldrich) [20]. The medium composition is 29 
as follows: 10 g/L of yeast extract, 20 g/L of peptone and 20 g/L of glucose and 20 g/L of agar. 30 
A defined minimal medium previously described by Verduyn [24] with glucose as a carbon source 31 
was used for S. cerevisiae cultivations in batch and chemostat cultures. For batch cultivations the 32 
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medium was supplemented with 30 g/L  of glucose [7], whereas for feed media for continuous 1 
cultivations contained 7.5 g/L of glucose. The medium was composed of: 7.5 g/L (NH4)2SO4, 3 g/L 2 
KH2PO4, 0.75 g/L Mg2SO4, 1.5 mL/L trace metal solution, 1.5 mL/L vitamins solution, 0.05 mL/L 3 
antifoam 204 (Sigma-Aldrich). Trace metal solution contains 3 g/L FeSO4∙7H2O, 4.5 g/L ZnSO4∙7H2O, 4 
4.5 g/L CaCl2∙6H2O, 0.84 g/L MnCl2∙2H2O, 0.3 g/L CoCl2∙6H2O, 0.3 g/L CuSO4∙5H2O, 0.4 g/L 5 
NaMoO4∙2H2O, 1 g/L H3BO3, 0.1 g/L KI and 15 g/L Na2EDTA∙2H2O. Vitamins solution includes 50 mg/L 6 
d-biotin, 200 mg/L para-amino benzoic acid, 1.0 g/L nicotinic acid, 1.0 g/L Ca-pantothenate, 1.0 g/L 7 
pyridoxine HCL, 1.0 g/L thiamine HCl and 25 mg/L minositol. Glucose was autoclaved separately and 8 
vitamins solutions were sterile filtered (pore size 0.2 μm Ministart®-Plus, Sartorius AG, Germany) 9 
and added after autoclavation. 10 
2.4 Batch and chemostat cultivations 11 
For each biological replica separate colonies of engineered yeast strains from YPD plate were 12 
inoculated to the 0.5 L shake flasks with 50 mL of the previously described minimal medium (pH 6.5). 13 
Pre-cultures were incubated in an orbital shaker set to 150 rpm at 30°C until mid-exponential phase 14 
OD600 ≈ 5 and directly used for inoculation. In this experiment, batch cultivations were performed in 15 
duplicates and continuous cultures – in triplicates. 16 
Batch cultivations were performed under aerobic conditions in 1L fermenters equipped with 17 
continuous data acquisition (Sartorius, B. Braun Biotech International, GmbH, Melsungen, Germany) 18 
with a working volume of 1L. Fermenters were inoculated with initial O.D.600 =0.05. To ensure 19 
aeration a stirrer speed was set to 600 rpm and airflow rate to 1.0 v.v.m. (60 L/h). The temperature 20 
was maintained at 30°C during the cultivation and pH=5.0 level was controlled by automatic addition 21 
of 2M NaOH or 2M H2SO4. The batch cultures were sampled in regular intervals through both 22 
glucose and ethanol growth phases. Glucose-limited chemostat cultures were grown in the same 23 
conditions as previously described for batch cultivations. Chemostats were initiated as batch 24 
cultivations with starting glucose concentration of 15 g/L and OD600 =0.05 and switched to 25 
continuous mode in early exponential phase. Minimal medium was fed at a constant dilution rate of 26 
0.1 h–1 [7].The working volume of 1 L was kept constant by a level based outlet. Samples were taken 27 
after at least five residence times (50 hours) of constant biomass and carbon dioxide concentration 28 
readings. 29 
In both cultivation experiments exhaust gas composition was constantly monitored by off gas 30 
analyzer (1311 Fast response triple gas, Innova) combined with Mass Spectrometer (Prima Pro 31 
Process MS, Thermo Fisher Scientific, Winsford UK). No elevated ethanol concentration in the 32 
exhaust (less than 1.5% of Ethanol evaporation) was detected. 33 
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The biomass concentration was monitored by measuring both optical density at 600nm wavelength 1 
(OD600) and cell dry weight (DW) in the cultivation broth. OD600 was estimated using a UV mini 1240 2 
spectrophotometer (Shimadzu, Kyoto, Japan), biomass samples were diluted with distilled water to 3 
achieve OD600 reading within 0.1 to 0.4 range. DW measurements were performed using 4 
polyethersulfone (PES) filters with a pore size of 0.45 μm Montamil® (Membrane Solutions, LLC). The 5 
filters were pre-dried in a microwave oven at 150 W and weighed. A known volume of cultivation 6 
broth (5 mL) was filtered and then washed with approx. 15 mL of distilled water. Finally, the filters 7 
with biomass were dried in the microwave oven at 150 W and cell DW was determined [25].  8 
2.5 Extracellular metabolite measurements 9 
Extracellular metabolites were determined by high performance liquid chromatography (HPLC) 10 
analysis. Two distinct HPLC methods were applied for analysis of different groups of extracellular 11 
metabolites. 12 
The submerged cultivation samples for yeast primary metabolites were centrifuged at 12000xg for 2 13 
min, supernatant was transferred to a new tube and stored at -20 oC until further analysis. Glucose, 14 
ethanol, glycerol, pyruvate, succinate and acetate were determined by high performance liquid 15 
chromatography (HPLC) analysis using an Aminex HPX-87H ion-exclusion column (Bio-Rad 16 
Laboratories, Hercules, CA). The column temperature was kept at 60 oC and the elution was 17 
performed using 5 mM H2SO4 with constant flow rate of 0.6 mL min
-1. Metabolite detection was 18 
performed by a RI-101differential refractometer detector (Shodex) and an UVD340U absorbance 19 
detector (Dionex) set at 210 nm.  20 
Samples for quantification of vanillin-β-glucoside and its pathway metabolites were prepared as 21 
follows: 1mL of cultivation broth and 1mL of 96% EtOH was carefully mixed by vortex and 22 
centrifuged at 12000xg for 2 min, supernatant was transferred to a new tube and stored at -20oC 23 
until further analysis. Extracellular vanillin-β-glucoside (VG), vanillin (VAN), protocatechuic acid 24 
(PAC), protocatechuic aldehyde (PAL) and vanillic acid (VAC) were quantified using Agilent 1100 25 
series equipment with a Synergi Polar-RP 150*2 mm 4u column (Phenomenex). A gradient of 26 
acetonitrile (ACN) with 1% tetra-fluoroacetic acid (TFA) and water with 1% TFA at a constant flow 27 
rate of 0.5 mL/min was used as mobile phase. The elution profile was as follows: 5% ACN — 1 min, 28 
5% ACN to 30% ACN — 8 min, 30% ACN to 100% ACN — 1 min, 100% ACN — 1 minute, 100% ACN to 29 
5% ACN — 3 min. The column was kept at 40 oC and metabolite detection was performed using a UV 30 
diode-array detector set to 230 and 280 nm. 31 
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2.6 Intracellular metabolite measurements 1 
Samples for intracellular co-factor metabolites were taken during steady state conditions at the end 2 
of continuous cultivation. The samples were quenched and extracted as previously described by 3 
Villas-Boas et al. [26]; 5 mL of culture broth was sprayed into pre-cooled (-40°C) falcon tube 4 
containing 20 mL of 60% methanol, spun down for 2 min at 5000xg in precooled centrifuge (-10°C) 5 
and extracted using boiling ethanol method [26]  followed by evaporation under nitrogen. The 6 
samples were re-dissolved in 300 µL eluent A (10 mM tributylamine and 10 mM acetic acid). The 7 
analysis was carried out on an Agilent 1290 binary UHPLC system coupled with an Agilent 6460 triple 8 
quadrupole mass spectrometer (Torrance, CA, USA). The MS was operated in negative ion and 9 
multiple reactions monitoring mode. Separation of 0.5 µL samples was performed by ion-pair 10 
chromatography, as described in details in Magdenoska et al.  [27] using 10 mM tributylamine as ion 11 
pair reagent. The gradient used was: 0-12 min 0-50% B, 12-12.5 min 50-100% B, 12.5-14 min 100% B, 12 
14-14.5 min 100-0% B, 14.5-19.5 min 0% B. External standard calibration method was used for 13 
quantification. The calibration curves were constructed by preparing calibration solutions ranging 14 
from 1 to 100 µg/mL for ATP and 0.3 to 25 µg/mL for NADPH and UDP-glucose. Both the quenched 15 
extracts and the calibration solutions were spiked with 60 µL mixture containing 150 µg/mL [U-13C] 16 
ATP. The quantification was carried out using Mass Hunter Quantitative analysis software (version 17 
B.06.00). 18 
3 Results 19 
3.1 De novo pathway reconstruction in CEN.PK and S288c backgrounds 20 
To compare CEN.PK and S288c for their ability to produce VG in a fair manner, it was necessary to 21 
insert all genes identically in both strain backgrounds. In the original VG producing strain, the 22 
individual genes of the pathway were inserted by repeated integrations into the TPI1 promoter 23 
region in an S288c based strain [12]. Consequently, the gene order is ill-defined and not easy to 24 
reconstruct in CEN.PK. We therefore introduced the VG pathway in the two strain backgrounds, 25 
S288c (isogenic isolate X2180-1A [17]) and CEN.PK113-11C [4] in a defined manner. Specifically, the 26 
five genes used by Hansen et al [12] for VG production were integrated into three sites located on 27 
chromosome XII (see Figure 2), which are part of a defined gene expression platform we have 28 
previously established [13]. Importantly, prior to integration, we compared the up- and downstream 29 
sequences at these integration sites in CEN.PK and S288c and found that they differ by only a single 30 
SNP, a C in CEN.PK and G in S288c, which is present in the upstream targeting sequence of the XII-5 31 
site. The five genes are therefore inserted into a genetic context, which is essentially identical. 32 
Additionally, two genes ADH6 and EXG1 were deleted in both strains to minimize unwanted side 33 
reactions with VG pathway metabolites. Finally, for both genetic backgrounds, auxotrophic markers 34 
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were eliminated by sexual back crossing to wild-type variants of the two strain backgrounds to 1 
produce two prototrophic VG producing strains, C-VG (CEN.PK based) and S-VG (S288c based), which 2 
we used for further analysis.  3 
3.2 Physiological characterization of vanillin-β-glucoside producing strains 4 
during batch and continuous fermentations 5 
Before evaluating the VG production ability of the two strain backgrounds, we first assessed whether 6 
VG production affected the overall physiology of the C-VG and S-VG strains. Hence, they were grown 7 
in batch and as continuous cultures in well-controlled bioreactors under standard laboratory 8 
cultivation conditions [7]. Like for wild-type strains, the overall growth profiles exhibited by the S-VG 9 
and C-VG strains in batch reactors were composed by two growth phases. One initial growth phase 10 
where all glucose was fermented (GF – phase); followed, after the diauxic shift, by a second growth 11 
phase where all accumulated ethanol was respiro-fermented (ER – phase), see Figure 3. We note 12 
that the specific biomass yield on glucose (Table 4) appeared higher (14%) in C-VG as compared to S-13 
VG, but in our experiment this difference was not significant (p > 0.33). A similar difference has 14 
previously been observed for the parental S288c and CEN.PK strains grown at the same conditions 15 
[3], [7]. It has previously been shown that CEN.PK grows faster than S288c at these conditions, μmax ≈ 16 
0.4 h-1 vs. μmax ≈ 0.3 h
-1, respectively [7], [10].  In contrast, C-VG and S-VG grew slower than the 17 
corresponding wild-type strains and both strains displayed identical growth rates on glucose (μmax ≈ 18 
0.2 h-1). Further analysis of the cultivation broth obtained at different time points during growth, 19 
showed that the production profiles of five primary metabolites (ethanol, pyruvate, succinate, 20 
glycerol, and acetate) in the central carbon metabolism of S-VG and C-VG were similar to what has 21 
previously been observed with the corresponding wild-type strains (Figure S3). Among the remaining 22 
parameters —rGlc, rEth, and rGly, only the latter varied between the two strains as it was approx. three-23 
fold higher in the S-VG (p < 0.002). Finally, we also note that S-VG displayed a growth deficiency 24 
during the ER phase which was nearly twice as long with S-VG (23 h) than with C-VG (12 h) partly due 25 
to a much longer delay from the diauxic shift to exponential growth is resumed. This deficiency has 26 
also been previously reported for wild-type S288c [10]. 27 
In chemostats, steady-state conditions with constant production of biomass as well as stable 28 
readings of carbon dioxide and oxygen by the off-gas analyzer where obtained for both strain 29 
backgrounds. For the C-VG strain this was achieved in less than 5 residence times (50 hours) after 30 
feeding was initiated, whereas for the S-VG strain it took more than 8 residence times (80 hours), 31 
see Figure S4. Importantly, at a dilution rate of 0.1 h-1, both strains propagated exclusively by 32 
glucose respiratory metabolism [28] as no production of ethanol, glycerol and organic acids was 33 
observed (see Table 4). The C-VG strain produced significantly more (seven percent, p < 0.01) 34 
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biomass as compared to S-VG, on the contrary, the specific glucose uptake rate was approx. seven % 1 
higher (p < 0.01) in S-VG strain.  2 
3.3 High VG yields with S288c are generated during its prolonged ethanol 3 
respiratory growth phase 4 
VG production in the S-VG and C-VG strains was initially compared at 45 h after both cultures have 5 
reached stationary phase. In the original VG producing strain constructed by Hansen et al [12], 6 
various levels of intermediates were observed due to an unbalanced heterologous VG pathway [12], 7 
[29]. In agreement with this, analyses of the extracellular metabolite levels in the cultivation broth 8 
showed that PAC, PAL, VAC, and VAN accumulated in both S-VG and C-VG in batch cultivation. The 9 
yields of each of the intermediates were similar in the two strains (Figure 4) with PAC being by far 10 
the most prominent metabolite. In fact, PAC accounted for ~70- and 75% of the carbon ending up as 11 
intermediates in C-VG and S-VG strains, respectively. However, when the two strains were analyzed 12 
for VG production, we surprisingly observed that twice as much VG was produced with the S-VG 13 
strain than with the C-VG strain (p < 0.05). This finding prompted us to determine and compare the 14 
production of VG and its intermediates of the two strains during the different growth phases 15 
throughout the entire batch cultivation (Figure 5A-B). The VG yields were almost identical with the 16 
two strains during the GF phase (Figure 5C). The total carbon ending up in VG pathway metabolites 17 
(TCV) is 14% lower in C-VG as compared to S-VG. This effect is mainly due to less accumulated PAC in 18 
C-VG (37% less in C-VG, p < 0.05). In contrast, with S-VG, a two-fold higher (p < 0.05) VG yield was 19 
generated during the ER phase than with C-VG despite that the amounts of intermediates 20 
accumulating at the end of the phase were similar in both strains (see Figure 5C). As a result, TCV 21 
was 45% higher with S-VG as compared to C-VG. Yields and productivities on glucose during 22 
exponential growth and during steady state condition are represented in the Table S1). 23 
To further understand why VG yields were higher with S-VG than with C-VG, we determined whether 24 
production of VG and VG-intermediates was proportional to biomass during all time-points. Based 25 
on this analysis, we observed for both strains that the efficiencies of TCV, VAC and VG production 26 
were higher in the ER phase as compared to the GF phase. In contrast, for both strains PAC was 27 
produced with equal efficiency in the two phases Figure 6. After the diauxic shift, C-VG quickly 28 
entered a new state where these metabolites were produced in amounts proportional to biomass. 29 
With S-VG such states are also achieved for TCV, PAC and VAC although, for TCV and VAC, more time 30 
was required for these states to be reached in this strain as compared to C-VG. In contrast, with S-31 
VG a state where VG was produced proportionally to biomass was never achieved as the VG 32 
production efficiency increased during the entire phase, see Figure 6D.  33 
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3.4 Steady-state VG production at glucose limitation is higher in S288c than in 1 
CEN.PK  2 
Next, we investigate VG production in continuous cultures where we could obtain strictly glucose 3 
respiratory conditions for both strains, see above. Dramatically, this analysis revealed that the 4 
amounts of TCV and VG were significantly increased to levels four- and ten-fold higher with S-VG 5 
than with the C-VG strain (p < 8.8E-9, p < 1.1E-10, respectively), see Figure 7. When the levels of 6 
intermediates were inspected, we observed that with S-VG, the majority (68%) of the TCV ended up 7 
in VG, whereas the rest of the carbon ended up in PAC (18%) and in VAC (13 %). In contrast, VG 8 
constituted only 20 % of the TCV in the C-VG strain. The remaining carbon was mainly ending up in 9 
VAC (approx. 70 %) and only little (less than 5 %) in PAC. 10 
Four co-factors, ATP, NADPH, SAM and UDP-Glc, are used for formation of VG. In the paper by 11 
Canelas et al. ([7]) where “-omics” data for the two background strains were compared, the levels of 12 
three of these cofactors (ATP, NADPH and UDP-Glc) were measured. We were able to quantify ATP 13 
and therefore determined the concentrations of this metabolite in C-VG and S-VG to investigate 14 
whether ATP levels were altered due to the presence of the VG pathway. Analysis of samples 15 
obtained at steady state showed that concentrations of ATP were 10.6 µmol/g DW and 8.5 µmol/g 16 
DW for C-VG and S-VG, respectively. These numbers are somewhat higher than the corresponding 17 
numbers reported by Canelas et al. and this may be due to lab to lab differences. Importantly, the 18 
relative ATP levels of the two strains (C-VG to S-VG) is 1.2 in our experiment as well as in theirs [7]. 19 
This indicates that the presence of the VG pathway does not change ATP levels in the two strains 20 
despite that 10-fold more VG is formed in S-VG as compared in to C-VG. Due to the absence of 21 
internal standards for NADPH and UDP-Glc, we were not able to compare our data with those in the 22 
literature. However, UDP-Glc levels were 0.5 µmol/g DW for both strains. These results were also 23 
confirmed by a high resolution mass spectrometer, where similar chemical profiles were obtained 24 
for both strains. The NADPH levels measured in C-VG and S-VG in our study were close to the limit of 25 
detection preventing a comparison between the two strains. 26 
 27 
4 Discussion 28 
The importance of Saccharomyces cerevisiae in the development of novel cell factories is 29 
demonstrated by the large number of industrially relevant substances that can now be produced in 30 
this organism [1], [2], [31]. Several laboratory yeast strains have been used for this purpose with 31 
S288c and CEN.PK being the most popular [2], [7]. However, despite that the two strains are 32 
genetically and physiologically very different [3], [7], [10], [11]; these differences are rarely used to 33 
 12 
 
determine, which strain background should be chosen as a cell factory for de novo production of a 1 
given compound. In this study, we therefore investigated whether choice of yeast strain background 2 
for production of vanillin-β-glucoside (VG) is an issue that can be advantageously considered. Our 3 
finding that heterologous production of VG was dramatically more efficient in an S288c based strain 4 
compared to CEN.PK in both batch and continuous cultivations demonstrates that this is indeed the 5 
case.  6 
Our physiological characterizations of the C-VG and S-VG strains show that the S-VG strain produces 7 
significantly more VG in both batch and continuous cultivations. One explanation could be a higher 8 
flux of carbon into the VG pathway in the S-VG strain. In agreement with this, both the first 9 
intermediate in the VG pathway (PAC) and TCV accumulate to significant higher levels with S-VG as 10 
compared to with C-VG during both continuous and batch cultivations, see Figure 4 and Figure 7. For 11 
batch cultivation, we note this is true at all time points examined, see Figure 6.  12 
Carbon for VG production is recruited from the shikimate pathway, which is a part of the aromatic 13 
amino acid biosynthesis and, which is well characterized in yeast [32], [33]. The pathway is tightly 14 
regulated via two 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP) synthase isoenzymes Aro3 15 
and Aro4, which are feedback inhibited by phenylalanine and tyrosine, respectively (Figure 1). In this 16 
context, we note that in the case of CEN.PK derived strains, the flux through the shikimate pathway 17 
is increased more than four-fold if feedback inhibition is eliminated [34]; and that this feature has 18 
been successfully exploited in a metabolic strategy to increase the yield of CEN.PK strains producing 19 
the plant flavonoid naringenin, which is derived from phenylalanine and tyrosine [35]. Interestingly, 20 
two of the genes in the shikimate pathway, ARO1 and ARO3, contain ten SNPs that result in amino 21 
acid substitutions. Moreover, a large number of SNPs are distributed in the up- and downstream 22 
regions of the genes in the shikimate pathways. It is therefore likely that the level and/or activities of 23 
enzymes of the shikimate pathway are different in the two strain backgrounds.  In agreement with 24 
this, the available “-omics” datasets presented by Canelas [7] show that the intracellular 25 
concentration of shikimic acid (the direct metabolite of 3-DHS) is significantly higher in S288c than in 26 
CEN.PK strains at similar conditions in batch and continuous cultivations. Moreover, they also 27 
reported that under batch conditions CEN.PK strains are able to maintain higher intracellular amino-28 
acid pools, which was suggested, and later shown, to be a result of increased protein turnover rate 29 
[36]. 30 
In VG producing strains, we therefore speculate that higher concentrations of intracellular aromatic 31 
amino acids in C-VG might inhibit Aro3 and Aro4 leading to a decreased flux towards 3-DHS and 32 
consequently to a lower capacity for VG production. When the genomes of S288c and CEN.PK SNPs 33 
 13 
 
were compared, several SNPs exist in genes encoding for enzymes involved in the amino acid and 1 
aromatic compound metabolism. For example, we have compared ORFs sequences of several ARO 2 
genes in the strains, see Table 5. Importantly, the gene of the pentafunctional enzyme Aro1 (which is 3 
directly involved in synthesis of 3-DHS) contains 15 SNPs, of which, seven results in non-synonymous 4 
amino acid substitutions. Moreover, the gene of the regulatory protein Aro3 was found to contain 5 
23 SNPs, where three caused amino acid substitutions. It is therefore possible that the flux through 6 
the shikimate pathway could be different in the two strain backgrounds.  7 
 8 
Other features in the two strain backgrounds could influence VG production. For example, in the 9 
case of batch cultivation, the higher VG yields in S-VG strains are mainly created after the diauxic 10 
shift. This suggests that the S-VG strain has increased activity of the aromatic biosynthetic pathway 11 
only at respiratory metabolism, which is consistent with the even higher activity in the glucose 12 
limited chemostat cultures. This could be due to a limitation in the supply of erythrose-4-phosphate, 13 
a precursor for aromatic amino acid biosynthesis and an intermediate of the pentose-phosphate (PP) 14 
pathway. In this context, we note that at fermentative conditions the flux through the PP pathway is 15 
much lower than at respiratory conditions [37]. 16 
One feature that could influence the final VG yield is availability of co-factors that are required to 17 
convert PAC to VG. To this end we note that ATP and UDP-glucose levels seem to be unaffected by 18 
the VG pathway in the two strain backgrounds. Moreover, we have previously introduced mutations 19 
designed to increase the NADPH/NADP level in the original VG producing strain (S288c background) 20 
and this resulted in higher VG levels showing that cofactor availability appears limiting. However, we 21 
note that in this study, the organization of the inserted VG pathway genes, including gene copy 22 
numbers, in the producer strain is not known [29]. We did not measure  SAM - levels in C-VG and S-23 
VG and this co-factor may vary between the two strains. Similarly, the activity of the PPTase, EntD, 24 
which activates ACAR by covalently attaching phosphopantheine to the apoenzyme is unknown and 25 
may differ in the two strain backgrounds. Considering the more than 13,000 SNPs between CEN.PK 26 
and S288c, one may also expect that differences in the global metabolism may influence VG 27 
production. For example, 20 genes in the mitogen-activated protein kinase (MAPK) signaling 28 
pathway contain SNPs resulting in amino acid residue substitutions. Among those, one is in Cyr1, 29 
which changes the activity through the pathway controlled by the global regulator protein kinase A, 30 
PKA [11], [38], [39]. The ability of the two strains to adapt to toxic intermediates, especially PAL and 31 
VAN [12], may also vary and influence yields. Even if they do not, accumulation of these 32 
intermediates vary slightly in the two strain back grounds and may therefore differentially influence 33 
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VG yields. To this end, we note that the growth rates for C-VG and S-VG are reduced as compared to 1 
the corresponding strains that do not contain the VG pathway. 2 
Since, the VG yield for S-VG is approximately 20-fold below the maximum theoretical yield; the 3 
effects described above are unlikely due to carbon being channeled into the VG pathway at the 4 
expense of other destinations and functions. An interesting question that still remains to be 5 
answered is therefore how the two strain backgrounds develop as VG producers as yields are 6 
improved by e.g. metabolic engineering. Similarly, it would be interesting to address whether some 7 
of the obvious genetic differences pointed out above can be transferred from S-VG to C-VG to 8 
improve the VG yields in the latter.  9 
In conclusion, we have shown that heterologous production of VG differs dramatically in two 10 
different strain backgrounds. Moreover, our analyses taking advantage of the “-omics” data 11 
presented in the literature suggest that it may be possible to predict, which of the two strain 12 
backgrounds that would be the better producer. As additional data constantly accumulate we expect 13 
that such qualified guesses can be made in an increasingly safe manner, but with the present 14 
insights, we recommend to test more than one genetic background during construction of a novel 15 
cell factory. 16 
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Table 1. List of the plasmids used and constructed in this study. 1 
Name Genetic element Reference 
pXII1-23 pPGK1::ACAR, pTEF1::EntD  This study 
pXII2-54 pPGK1::UGT, pTEF1::HsOMT This study 
pXII5-01 pTEF1::3DSD This study 
pXII1 ― Mikkelsen et al. [13] 
pXII2 ― Mikkelsen et al. [13] 
pXII5 ― Mikkelsen et al. [13] 
pSP-G2 pPGK1;pTEF1 Partow et al. [40] 
pJH500 3DSD Hansen et al. [12] 
pJH674 ACAR Hansen et al. [12] 
pJH589 EntD Hansen et al. [12] 
pJH543 HsOMT Hansen et al. [12] 
pJH665 UGT Hansen et al. [12] 
pUG6 KanMX Güldener et al [20] 
pSH47 Cre recombinase Güldener et al [20] 
 2 
  3 
 21 
 
Table 2. List of the primers used in this study. All sequences are presented in 5’ to 3’ direction, 1 
standard capital letter are gene specific sequences, bold letters represent USER specific tails, regular 2 
underline letters represent targeting sequences for appropriate gene deletions. Italic letters 3 
represent translational enhancer sequence [41], [42]. 4 
Name Sequence 
Primers for cloning purposes 
PGK_R- ACCCGTTGAUGCCGCTTGTTTTATATTTGTTG 
TEF_F+ CGTGCGAUGCCGCACACACCATAGCTTC 
TEF_R+ ACGTATCGCUGTGAGTCGTATTACGGATCCTTG 
DSD_F+ AGCGATACGUAAAAATGCCTTCCAAACTCGCC 
DSD_R+ CACGCGAUTTACAAAGCCGCTGACAGC 
ACAR_F- ATCAACGGGUAAAAATGGCTGTTGATTCACCAGATG 
ACAR_R- CGTGCGAUCTTATAACAATTGTAACAATTCCAAATC 
hOMT_F+ AGCGATACGUAAAAATGGGTGACACTAAGGAGCAA 
hOMT_R+ CACGCGAUCTTATGGACCAGCTTCAGAACC 
PPT1_F+ AGCGATACGUAAAAATGGTCGATATGAAAACTACGC 
PPT1_R+ CACGCGAUTTAATCGTGTTGGCACAGC 
UGT1_F- ATCAACGGGUAAAAATGCATATCACAAAACCACACG 
UGT1_R- CGTGCGAUACTAGGCACCACGTGACAAGTC 
Deletion primers 
BGL1_del_F ATTTTTTGTTTACTTTCTTTTTCTAGTTAATTACCAACTAAACTTCGTACGCTGCAGG
TC 
BGL1_del_R CATTAGAAAATTCAGCTAAAATGAGCGGACTGAGGGCGACTAGTGGATCTGATAT
CACCTA 
ADH6_del_F GAGGAAGAAATTCAACACAACAACAAGAAAAGCCAAAATCCTTCGTACGCTGCAG
GTC 
ADH6_del_R GTTAAAAAGAAAGGAGCTACATTTATCAAGAGCTTGACAACTAGTGGATCTGATA
TCACCTA 
Verification primers 
XII-1-up-out-sq  CTGGCAAGAGAACCACCAAT 
XII-2-up-out-sq  CGAAGAAGGCCTGCAATTC 
XII-5-up-out-sq  CCACCGAAGTTGATTTGCTT 
C1_TADH1_F CTTGAGTAACTCTTTCCTGTAGGTC 
BGL1_VF TCATCCTCCCTGTGTTTACA 
BGL1_VR AGTTGAAACAGAGGATAAGGTG 
ADH6_VF GTTTTGCTTTTTTCTCTGGG 
ADH6_VR GGAGTATCAACCACTAAAGCG 
Primers for sequencing 
S1_TEF_F CGGTCTTCAATTTCTCAAGTTTC 
S1_PGK_F CAAGGGGGTGGTTTAGTTTAGT 
S1_ACAR_F CATTGTTCGTTCCAGACACTGAC 
S2_ACAR_F GAAATTGTCTCAAGGTGAGTTCG 
S3_ACAR_F TTTGGGTAGATTCTTGTGTTTGG 
YF19 AAAAAATAAATAGGGACCTAGACTTCA 
YF21 GACCTACAGGAAAGAGTTACTCAAGAAT 
 5 
  6 
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Table 3. List of the yeast strains used in this study. 1 
Name Genotype Reference 
X2180-1A (ura3) MATa SUC2 mal mel gal2 CUP1 ura3-52 Public domain [17] 
S288c MATα SUC2 gal2 mal mel flo1 flo8-1 hap1 ho bio1 bio6 ATCC 204508 
CEN.PK113-11C MATa MAL2-8C SUC2 ura3-52 his3Δ Peter Kötter1 
CEN.PK110-16D MATα MAL2-8C SUC2 trp1-289 Peter Kötter1 
C-VG-aux MATa MAL2-8C SUC2 ura3-52 his3Δ XII2(pTEF1-HsOMT, pPGK1-
UGT) XII1(pTEF1-PPT, pPGK1-ACAR) XII5(pTEF1-3DSD) Δbgl1::loxP 
Δadh6::KanMX 
This study 
S-VG-aux MATa SUC2 gal2 mal mel ura3-52 XII2(pTEF1-HsOMT, pPGK1-UGT) 
XII1(pTEF1-PPT, pPGK1-ACAR) XII5(pTEF1-3DSD) Δbgl1::loxP 
Δadh6::KanMX 
This study 
C-VG MATα MAL2-8C SUC2 XII2(pTEF1-HsOMT, pPGK1-UGT) XII1(pTEF1-
PPT, pPGK1-ACAR) XII5(pTEF1-3DSD) Δbgl1::loxP Δadh6::KanMX 
This study 
S-VG MATα SUC2 gal2 mal mel XII2(pTEF1-HsOMT, pPGK1-UGT) 
XII1(pTEF1-PPT, pPGK1-ACAR) XII5(pTEF1-3DSD) Δbgl1::loxP 
Δadh6::KanMX 
This study 
 2 
  3 
                                                          
1
 Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany. 
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Table 4. Physiologic parameters of the two engineered strains. Ysx – biomass yield on glucose, r – 1 
specific metabolite production or consumption rates (C-mmol/g(DW)∙h); Glc –glucose, Eth – ethanol 2 
and Gly – glycerol. NA – not applicable and ND – not detected. The yield coefficient Ysx for biomass is 3 
calculated based on a molecular weight for biomass of 26.4 g/C-mol [43]. Errors represent standard 4 
deviation, 2≤n≤3. 5 
 6 
Cultivation mode Batch Chemostat 
Strain S-VG C-VG S-VG C-VG 
Glucose μ, h-1 0.209 ± 0.002 0.199 ± 0.002 (0.1)* (0.1)* 
Ethanol μ, h-1 0.05 ± 0.01 0.08 ± 0.01 NA NA 
Ysx (C-mol/C-mol) 0.133 ± 0.014 0.151 ± 0.001 0.56 ± 0.02 0.60 ± 0.02 
-rGlc 60.7 ± 8.0 49.9 ± 0.60 6.81 ± 0.29 6.37 ± 0.20 
rEth 25.9 ± 3.1 20.9 ± 3.00 ND ND 
rGly 4.05 ± 0.05 1.40 ± 0.13 ND ND 
* - the dilution rate used in this study. 
 7 
  8 
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Table 5. Point mutations of ARO genes found in CEN.PK113-7D compared to S228c. Mutations 1 
represented by one letter code for amino acid and number denoting the position in the protein. 2 
Genes 
SNPs 
Amino acid substitution 
Total Non-synonymous 
ARO1 15 7 
T225I, P337S, S517P, N844T,  
M1141K, V1386I, G1576A 
ARO3 23 3 K141R, E214D, S349T 
ARO4 — — — 
ARO7 — — — 
 3 
  4 
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Figure 1. De novo vanillin-β-glucoside pathway in S. cerevisiae assembled by Hansen and co-workers 1 
[12]. Colored boxes represent metabolites of the pathway: PAC – protocatechuic acid, PAL – 2 
protocatechuic aldehyde, VAC – vanillic acid, VAN – vanillin, VG – vanillin-glucoside. Black thick 3 
arrows show enzymatic reactions by heterologous enzymes: 3DSD – 3-dehydroshikimate 4 
dehydratase (Podospora pauciseta), ACAR – aromatic carboxylic acid reductase (Neurospora sp.), 5 
EntD – phosphopantetheine transferase (Escherichia coli), HsOMT – O-methyltransferase (Homo 6 
sapiens) and UGT – UDP-glycosyltransferase (Arabidopsis thaliana). Grey arrows and boxes (left side 7 
of the picture) represent simplified shikimate biosynthetic pathway and native parts of yeast 8 
metabolism: PPP – pentose phosphate pathway, DAHP – 3-deoxy-D-arabinoheptulosonate 7-9 
phosphate, 3-DHS – 3-dehydroshikimic acid, Trp – tryptophan, Phe – phenylalanine, Tyr – tyrosine. 10 
Key enzymes of the shikimate pathway: ARO3 and ARO4 – DAHP synthase isoenzymes and ARO1 – 11 
pentafunctional enzyme catalyzing DAHP conversion to chorismate. 12 
Figure 2. Schematic representation of VG pathway reconstruction in two different S. cerevisiae 13 
background strains. T1, T2 – terminators of ADH1 and CYC1, respectively; P1, P2 – promoters of 14 
PGK1 and TEF1, respectively. Red arrows represent essential genetic elements of S. cerevisiae and 15 
numbered yellow boxes are integration sites characterized by Mikkelsen et al [13]. 16 
Figure 3. Growth profiles of the two strains in the batch cultures: a) S-VG and b) C-VG. Grey areas 17 
represent ethanol respiration (ER) phase; GF – glucose fermentation. qCO2 – carbon dioxide 18 
production rate, qO2 – oxygen consumption rate; Glc – glucose, Eth – ethanol and DW – cell dry 19 
weight. Error bars represent standard deviation, n=2. 20 
Figure 4. Final yields (45 hours after inoculation) of VG, its intermediates, and TCV produced by S-VG 21 
(blue) and C-VG (yellow) during batch cultivation. Error bars represent standard deviation, n=2. 22 
Figure 5. Metabolic profiles of VG and its intermediates in batch cultivation in a) S-VG and b) C-VG 23 
strains. c) Accumulation of VG pathway metabolites during the glucose fermentation (GF) and 24 
ethanol respiration (ER) growth phases. 25 
Figure 6 Distribution of VG pathway metabolite per biomass throughout entire batch cultivation: a) 26 
TCV, b) PAC, c) VAC, d) VG. Blue circles data for S-VG, yellow circles – C-VG. Grey areas represent 27 
ethanol respiration phase (narrow in C-VG and wide in S-VG). Error bars represent standard 28 
deviation, n≥2. The amounts of PAL and VAN constituted less than 7% percent of TCV at all time 29 
points and were not depicted. 30 
 26 
 
Figure 7. Yields of VG, its intermediates, and TCV produced by S-VG (blue) and C-VG (yellow)during 1 
continuous cultivation; a) Average of last three samples with more than one retention time in 2 
between. Error bars represent standard deviation, n=3. 3 
  4 
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Supplementary Information 1 
 2 
Table S1. Yields (YS Met in mg/g(Glc)) and production rates of VG and its intermediates (rMet in C-3 
mmol/g(DW)∙h). Errors represented as a standard deviation, 2≤n≤3. 4 
 Batch A Chemostat 
Strain S-VG C-VG S-VG C-VG 
YS PAC 19.0 ± 1.8 15.2 ± 0.2 3.57 ± 0.62 0.26 ± 0.04 
YS PAL 1.9 ± 0.2 2.0 ± 0.2 ND 
 
0.09 ± 0.01 
YS VAC 1.5 ± 0.2 4.3 ± 1.5 2.56 ± 0.66 3.65 ± 0.10 
YS VAN 0.1 ± 0.1 0.2 ± 0.1 0.18 ± 0.14 ND  
YS VG 5.4 ± 0.8 7.4 ± 0.3 13.7 ± 1.4 1.06 ± 0.18 
rPAC 1.59 ± 0.35 1.03 ± 0.03 0.64 ± 0.11 0.044 ± 0.008 
rPAL 0.18 ± 0.04 0.15 ± 0.01 ND 
 
0.016 ± 0.002 
rVAC 0.13 ± 0.03 0.31 ± 0.10 0.46 ± 0.12 0.62 ± 0.03 
rVAN 0.01 ± 0.01 0.01 ± 0.01 0.17 ± 0.12 ND 
rVG 0.45 ± 0.12 0.50 ± 0.02 2.47 ± 0.25 0.18 ± 0.03 
Note: A – for the batch experiments calculations were made only for exponential 
growth phase on glucose. 
 5 
  6 
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 1 
Figure S1. Schematic representation of cloning procedure for transferring vanillin-β-glucoside pathway 2 
genes. Targeting vectors pXII1, pXII2 and pXII5 are linearized with AsiSI and Nb.BsmI enzymes. Yellow 3 
boxes UP and DW are targeting sequences homologous to chromosomal integration sites. T1 and T2 are 4 
terminator sequences Tadh1 and Tcyc1, respectively. Black arrow is counter-selectable auxotrophic 5 
marker URA3.   White, grey and black boxes represent USER cloning compatible tails.  6 
  7 
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 1 
Figure S2 Flowchart representing reconstruction of Vanillin-β-glucoside producing strains. De novo 2 
biosynthetic pathway was reconstructed in two strains by sequential transformation with appropriate 3 
DNA fragments depicted in the center of the figure. Native genes were deleted with loxP-KanMX-loxP 4 
cassette. Prototrophy was restored by genetic cross. 5 
 6 
 7 
Figure S3 Primary metabolite profiles in strains S-VG (a) and C-VG (b) during batch cultivation. (Error 8 
bars represent standard deviation, n=2). 9 
 10 
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 1 
Figure S4 Time profiles of online fermentation data of two strains A) S-VG and B) C-VG in chemostat 2 
cultivation mode. Orange line – volumetric rates of CO2 production; red line – volumetric rates of 3 
oxygen consumption. Grey vertical lines represent the sampling points and the start of the chemostat 4 
phase. One residence time is equal to 10 hours. 5 
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Abstract 22 
For quantification of intracellular metabolites, LC-MS/MS is currently the method of choice, 23 
especially when combined with stable isotopically labeled internal standards (SIL-IS). However due 24 
to the presence of the intracellular metabolites in the biological matrix a standard addition based 25 
analytical validation is needed. Here we present an alternative solution for minimizing the signal 26 
interference from the biological matrix on both the analytes and their SIL-IS’s and for compounds 27 
with more than 12 C atoms the interference is totally eliminated. This was done by using a matrix 28 
obtained from a cultivation of Saccharomyces cerevisiae in [
13
C6]glucose/non-labeled glucose (50/50, 29 
w/w) growth medium. The areas of both 
12
C6 and 
13
C6 fractions of ATP in the matrix were measured 30 
to be 2 % of the sum of the areas of all ATP isotopes detected in the matrix. The produced biological 31 
matrix allowed spiking of both the non-labeled and the SIL-IS and thus more straightforward method 32 
validation. The intra and inter day accuracy and precision were ≥80% and ≤20%, respectively. The 33 
methodology was used for quantification of nucleotides, coenzymes and redox compounds from 34 
Saccharomyces cerevisiae. The determined energy charge ratio was 0.9 while the Mal-CoA/Ac-CoA 35 
ratio was 0.04.  36 
 37 
Keywords: intracellular metabolites; ion-pair UHPLC-MS/MS; blank matrix; 
13
C labeling; validation; 38 
stable isotopically labeled internal standards (SIL-IS). 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
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Introduction 50 
The intracellular metabolome does not only supply the cell with energy but also provides building 51 
blocks, and is involved in the cell signaling pathways [1-3]. Determining the intracellular metabolite 52 
pool sizes thus helps in defining the metabolic state of the cell and in identifying the bottlenecks in 53 
precursor supply as possible targets for metabolic engineering.  However, most of intracellular 54 
metabolites are ionic and highly polar providing a formidable analytical task seen from a separation 55 
perspective. Even more importantly, the enzyme activities need to be quenched instantaneously to 56 
provide the true metabolic image of the cell which is often done by changes in temperature or pH    57 
[4-7]. Furthermore, the extraction methods are often not selective and result in a very complex 58 
biological extracts that contain large amounts of different interfering compounds and salts that can 59 
impair the analysis of the metabolites of interest. Therefore both sensitive and very selective 60 
analytical methods are required with liquid chromatography tandem mass spectrometry (LC-MS/MS) 61 
or capillary electrophoresis MS/MS (CE-MS/MS) as the most commonly applied techniques [8-9]. 62 
For the ionic and polar intracellular compounds, electrospray (ESI) ionization is needed which 63 
unfortunately suffers significantly from suppression and/or enhancement of the signal [10-11]. 64 
Although the exact reasons for the signal modulation are still debated, several theories exists such as: 65 
i) formation of more [M+Na]
+
,  [M+H+Y]
+
 and [M+X]
+
 rather than [M+H]
+
 (where Y is a neutral and 66 
X a charged compound) in positive mode,  while in negative mode [M+Na-2H]
-
, [M+X]
-
 and [M+Y-67 
H]
-
 rather than [M-H]
-
 could be formed [12], ii) increased surface tension of the droplets during 68 
evaporation in the ESI [13] and iii) limited amount of charges available in the ESI droplets [14]. 69 
Altogether these factors result in very different signals for the same analyte concentration in different 70 
biological matrices as well as from a clean solution, leading to over- or underestimation of the 71 
concentration of analytes and thus incorrect interpretation of the metabolomics data. The use of a 72 
stable isotopically labeled internal standard (SIL-IS) is the optimal solution to the problem with the 73 
LC-MS signal modulation as a result of the matrix interferences as they both can compensate for 74 
losses during sample preparation and elutes at the same time as the analyte, thus suffering the same 75 
spray modulation [5, 15].  76 
 4 
 
Despite of the approach chosen, the quantification of the metabolite of interest requires that the 77 
response of the calibrants correspond to the response of the metabolite of interest in the true analyte-78 
free matrix. However, it is often difficult if not impossible to find a matrix free of the analyte, thus 79 
complicating the quantification [16,17]. Furthermore, the analytical validation is becoming 80 
increasingly important, but the absence of guidelines for validation of analytical methods for 81 
intracellular metabolites together with the absence of a certified analyte-free matrix makes the 82 
validation less straightforward [16,17]. This article describes a method for quantification of 83 
intracellular metabolites in Saccharomyces cerevisiae (S. cerevisiae) based on SIL-IS UHPLC-84 
MS/MS. The method has been validated using a novel approach for producing [
13
C6] labeled/non 85 
labeled (50/50, w/w) biological matrix, where the interference is minimized with respect to both the 86 
signal from the unlabeled naturally occurring analytes spiked in and to the SIL-IS. The described 87 
approach eliminates the need for double labeled (e.g. 
13
C and 
15
N) SIL-IS’s that are very costly and 88 
often unavailable. 89 
 90 
 91 
 92 
 93 
 94 
 95 
 96 
 97 
 98 
 99 
 100 
 101 
 102 
 103 
 104 
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Methods and material 105 
Chemicals 106 
The chemicals for Yeast extract-Peptone-Dextrose (YPD) and minimal medium were obtained from 107 
Merck Millipore (Darmstadt, Germany) or Sigma-Aldrich Co. (St. Louis, MO/USA). Standards of 108 
ATP, ADP, AMP, NAD
+
, NADH, NADPH, NADP
+
, acetyl coenzyme A (Ac-CoA) and malonyl 109 
coenzyme (Mal-CoA), [
13
C10]ATP and [
15
N5]ADP were purchased from Sigma–Aldrich (Steinheim, 110 
Germany) while [
15
N5]AMP was from Silantes (Munich, Germany). [
13
C6]glucose [
13
C3]Mal-CoA, 111 
and [
13
C2]Ac-CoA were from Euriso-top (Gif sur Yvette Cedex, Paris, France). Tributylamine (TBA) 112 
(puriss plus grade), methanol, CH3Cl, 1,4-Piperazinediethanesulfonic acid (PIPES), EDTA and acetic 113 
acid (LC–MS grade) were obtained from Sigma–Aldrich. Glucose test strips were purchased from 114 
Machery-Nagel, Düren, Germany. Water was purified using a Milli-Q system (Millipore, Bedford, 115 
MA, USA).  116 
 117 
Stock solutions 118 
Stock solutions of the unlabeled compounds with concentration of 1 mg/ml were prepared in H2O and 119 
stored under –80 °C until use. Aliquots of the stock solutions were used to prepare the daily working 120 
sub stock solutions used in the quantification and the validation by further dilution in 10 mM TBA 121 
and 10 mM acetic acid solution. Two sub stock solutions were used: one containing 325 µg/ml ATP, 122 
130 µg/ml of ADP, AMP, NADH and NADPH and the other one containing 130 µg/ml of Ac-CoA 123 
and Mal-CoA and 91 µg/ml of NAD
+
 and NADP
+
 (keeping the redox pairs separated for assessment 124 
of the degree of oxidation/reduction during the sample preparation). 125 
Stock solutions (1 and/or 0.2 mg/ml) of SIL-IS were prepared in H2O and kept under –80 °C until use. 126 
Aliquots of these stock solutions were used to prepare a mixture containing 5 µg/ml of [
13
C10]ATP, 127 
[
15
N5]ADP, [
15
N5]AMP and 10 µg/ml of both [
13
C3]Mal-CoA and [
13
C2]Ac-CoA. A volume of 40 µl 128 
from this mixture, was used to spike both the standards and the samples.  129 
 130 
 131 
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Preparation of 
13
C labeled Saccharomyces cerevisiae extracts 132 
Saccharomyces cerevisiae CEN.PK113-7D (MATα, MAL2-8c SUC2) was maintained on YPD 133 
medium. Shake flask cultivations were carried out in defined medium [18] with 20 g.L-1 D-glucose 134 
(non-labeled for pre-cultures while for isotope enrichment experiments [
13
C6]glucose/non-labeled 135 
glucose (50/50, w/w)). The inoculum for the isotope enrichment experiment was prepared by sub-136 
culturing a single colony from a plate in a shake flask with 100 ml of sterile minimal medium for 14-137 
16 h at 30 °C at 150 rpm. From this exponentially growing pre-culture, cells were harvested and used 138 
to inoculate shake flasks containing 100 ml of sterile isotopically enriched medium to a final optical 139 
density (OD) of 0.001. The entire culture (OD ~4) was harvested after approx. 22 h, while it was still 140 
exponentially growing determined by the presence of glucose measured by glucose test strips.  141 
At OD ~4, 5 ml of the S. cerevisiae culture was quenched in 20 ml of MeOH/H2O (60/40, v/v) 142 
precooled to -40 °C in an ethanol/dry ice bath followed by centrifugation at -10 °C for 3 min at 5000 x 143 
g. After decanting, the pellets were re-dissolved in ice-cold buffer (pH 7.2) containing 3 mM PIPES 144 
and 3 mM EDTA. Two milliliter of the re-dissolved pellet was extracted by adding 7.5 ml of 145 
MeOH:CH3Cl (1:2) mixture. The reason for adding the buffer before the MeOH:CH3Cl was to avoid 146 
the formation of the pellets and ability to split the labeled matrix in equal portions further used in the 147 
validation and the quantification. The samples were shaken in a 4 °C room for 60 min followed by 148 
centrifugation for 3 min at 4 °C and 5000 x g in order to separate the organic and the H2O phase. The 149 
upper H2O phase, 3.7 ml was transferred to another 15 ml falcon tube. To the rest of the 150 
MeOH:CH3Cl biomass mixture, 2 ml of the PIPES EDTA buffer pH 7.2 and 2 ml MeOH was added 151 
followed by mixing. The samples were once more centrifuged using the above conditions followed by 152 
collecting 4 ml of the upper phase that was combined with the 3.7 ml taken from the first 153 
centrifugation. After evaporation using lyophilisation, the samples were re-dissolved in 200 µl of 154 
eluent A and filtered through a hydrophilic PTFE filter (Advantec, Tokyo, Japan, diameter 13 mm; 155 
pore size 0.2 µm). 156 
 157 
 158 
 159 
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Preparation of unlabeled Saccharomyces cerevisiae extracts  160 
Chemostat cultivations were carried out in Sartorious and 1 l bioreactors (Satorious, Stedim Biotech, 161 
Goettingen, Germany) with a working volume of 0.6 l, equipped with baffles and 2 Rushton six-blade 162 
disc turbines. Culture conditions were pH 5, stir rate 800 rpm and air flow 1 volume of air per volume 163 
of liquid per minute (vvm).  The pH electrode (Mettler Toledo, OH/USA) was calibrated according to 164 
manufacturer’s standard procedures.  The bioreactor was sparged with sterile atmospheric air and off-165 
gas concentrations of oxygen and carbon dioxide were measured with a Prima Pro Process Mass 166 
Spectrometer (Thermo-Fischer Scientific, Waltham, MA/USA), calibrated monthly with gas mixtures 167 
containing 5 % (v/v) CO2, 0.04 % (v/v) ethanol and methanol, 1 % (v/v) argon, 5 % (v/v) and 15 % 168 
(v/v) oxygen all with nitrogen as carrier gas (Linde Gas, AGA, Enköping, Sweden). Temperature was 169 
maintained at 30 °C throughout the cultivation and pH controlled by automatic addition of 2 N NaOH 170 
and H2SO4. 171 
Continuous cultivations were initiated and cultivated as batch until late exponential phase where 172 
supply of the feed medium was initiated (D = 0.1 h
-1
). The feed medium was identical to the batch 173 
medium with the exception of the glucose concentration, which was 10 g/l glucose. Feed supply was 174 
controlled by a gravimetrically controlled peristaltic pump and reactor volume was kept constant 175 
applying a level probe ensuring continuous removal of excess volume. Automatic addition of feed 176 
was initiated at late exponential growth at a rate of 60 ml per hour ensuring a dilution rate                  177 
D = 0.1 h
-1
. The culture was left for at least 5 residence times before samples were taken ensuring 178 
steady state conditions. 179 
The quenching and the extraction were done as previously explained for the labeled biomass. The 180 
only difference was that during the extraction first 7.5 ml of MeOH:CH3Cl (1:2) were added to the 181 
biomass followed by the addition of 2 ml of the PIPES EDTA buffer. 182 
 183 
Ion-pair UHPLC 184 
All experiments were carried out using Agilent 1290 binary UHPLC system. The chromatographic 185 
conditions have previously been described in Magdenoska et al. [5]. In brief ion pair chromatography 186 
was used for separation using TBA as ion pair reagent. The gradient used was: 19.5 min. (0-12 min. 187 
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from 0 to 50 % B, 12-12.5 min. from 50 to 100 % B, 12.5 -14 min. 100 % B, 14-14.5 min. from 100 188 
to 0 % B, 14.5-19.5 0 % B). The injection volume used was 3 µl. 189 
 190 
Full scan and MS/MS measurements 191 
Agilent 6460 triple quadrupole system (Torrance, CA, USA) equipped with an Agilent Jet Stream ESI 192 
source was used for the validation and quantification. The optimized ion source MS parameters used 193 
in this study has previously been described in Magdenoska et al. [5]. The MS was operated in 194 
negative ion mode with nitrogen as a collision gas. For full scan experiments the MS was operated in 195 
MS2 Scan mode and spectra were acquired in the range between m/z 50 and 1000. Multiple reactions 196 
monitoring (MRM) was used for the validation and quantification experiments. Both a quantifier and 197 
a qualifier ion were monitored for each metabolite. To verify the metabolite presence in the samples, a 198 
qualifier/quantifier ion ratio within ± 20% was required (Table 1).  199 
For the high resolution MS measurements, the ion-pair effluent from the Agilent 1290 binary UHPLC 200 
system was passed through an Agilent 6550 quadrupole time-of-flight (QTOF) instrument operated in 201 
negative and the 2-GHz extended dynamic mode at a resolution of 25,000 full width at half-maximum 202 
(FWHM).  203 
 204 
Linearity, quantification and limit of detection (LOD)  205 
To check the linearity, 2 ml of the previously prepared isotope enriched biomass, re-dissolved in the 206 
PIPES/EDTA buffer, was pipetted into 20 50 ml spin tubes, followed by addition of 7.5 ml 207 
MeOH:CH3Cl (1:2, v/v) extraction mixture. Fourteen of these tubes were spiked with 40 µl of IS mix 208 
and different volumes of the previously prepared stock solution in order to get concentration levels 209 
ranging from 2.5 to 250 µg/ml for ATP, 1 to 100 µg/ml for AMP, ADP, NADPH, NADH, NAD
+
, Ac-210 
CoA and Mal-CoA and 0.7 to 70 µg/ml for NADP
+
, NAD
+
. The remaining six tubes were kept as 211 
matrix blanks. Three of the matrix blanks were spiked with 40 µl of IS mixture and the other three 212 
were spiked only with H2O to simulate the spiking of the standards. The samples were processed 213 
through the extraction procedure described above.  214 
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For ATP, ADP, AMP, Ac-CoA and Mal-CoA for which SIL–IS was available, the calibration curves 215 
were prepared by plotting the ratio between the peak areas of the non-labeled standard and SIL-IS 216 
versus the concentration of the particular compound. For the redox compounds for which SIL-IS was 217 
not available the calibration curves were prepared by plotting the peak area of the standard versus the 218 
concentration. Six matrix blanks were analyzed during the quantification and the average peak areas 219 
of each metabolite in the matrix blanks was subtracted from the peak area of that metabolite found in 220 
the spiked samples to correct for naturally-occurring amount of the particular metabolite [8]. 221 
Weighted linear regression (weighted to 1/x) was used to establish the linearity for each of the 222 
compounds. The generated calibration curves were also used for quantification of the non-labeled 223 
biomass. The calculations were done in Excel.  224 
The limit of detection was estimated to be the lowest concentration at which the signal was at least 5-225 
fold of the corresponding background.  226 
  227 
Matrix effects 228 
To determine the matrix effect over the gradient a T-piece infusion test was conducted. While 229 
infusing 10 µg/ml ATP into the MS at a constant flow using a syringe pump, two samples were 230 
injected: i) eluent A and ii) blank matrix processed through the sample preparation procedure. 231 
Quantitative determination of the matrix effects was done using the Matuszewski et al. approach. Two 232 
ml of the previously prepared biomass was pipetted into 14 50 mL spin tubes, followed by addition of 233 
7.5 ml of MeOH:CH3Cl (1:2, v/v). To each of the tubes, 200 µl of H2O was added in order to simulate 234 
the spiking of the standards. The samples were processed through the extraction. After the 235 
evaporation by lyophilisation, the pellet was re-dissolved in the 40 µl of IS and a volume of the 236 
previously prepared stock solutions in order to get the above given concentration ranges for the 237 
different compounds followed by filtration.  238 
 239 
Overall process recovery  240 
The process recovery was inspected at three different concentration levels in duplicates for all the 241 
metabolites by using the method described in Canelas et.al. [19]. 2 ml of the matrix was pipetted in 18 242 
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50 ml spin tubes resulting in 2 replicates per level. Half of them were spiked before the extraction 243 
with 40 µl of IS mix and a volume of the stock solution containing all the metabolites so that the final 244 
concentration after evaporation and re-dissolving is 2.5, 7.5 and 175 µg/ml for ATP, 3, 10 and 70 245 
µg/ml for ADP, AMP, NADP
+
, NADPH, Mal-CoA and Ac-CoA and 2.1, 7 and 49 µg/ml for NAD
+ 246 
and NADP
+
. The other half was spiked only with the standard mix. All the spiked samples were 247 
processed through the extraction procedure. After the extraction and the evaporation the samples that 248 
contained IS were re-dissolved in 200 µl of eluent. The rest of the samples were re-dissolved in 40 µl 249 
of IS and a volume of NAD
+
 and NADP
+
 or NADH and NADPH solution, so that the final 250 
concentrations for a particular metabolite after refilling to 200 µl with eluent A corresponds to the 251 
ones given above. The difference between the samples spiked before and after extraction with IS and 252 
NAD
+
/NADP
+
 or NADPH/NADH will give information on the losses during the extraction procedure.   253 
 254 
Accuracy/recovery and precision  255 
The intra and inter day variability of the method were inspected by using the same concentration 256 
levels as for the overall process recovery in triplicates on three different days. 2 ml of the previously 257 
prepared biomass was pipetted into 18 50 ml spin tubes, followed by addition of 7.5 ml of 258 
MeOH:CH3Cl (1:2, v/v) extraction mixture. The tubes were spiked with 40 µl of IS mix and different 259 
volumes of the previously prepared stock solution in order to get concentration levels corresponding 260 
to those for the inspection of the process recovery. The samples were extracted using the extraction 261 
procedure described above. 262 
 263 
Results and discussion 264 
Instrumental method 265 
Ion-pair UHPLC was coupled to MS/MS instrument for the analysis of ATP, ADP and AMP as well 266 
as NAD
+
, NADP
+
, NADH, NADPH, Ac-CoA and Mal-CoA. The precursor and product ions, as well 267 
as RT used in the MS/MS method are given in Table 1.  268 
[Table 1] 269 
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Using a 19.5 min, gradient successful baseline separation of all metabolites was obtained, except for 270 
the NADPH and the coenzymes which were coeluting. However, due to the difference in their 271 
precursor ions, separation via MS was possible, except for Ac-CoA and its SIL-IS. The reason for this 272 
was the 2 Da difference in their masses, which resulted in signal contribution from the [A+2] 273 
isotopomer from the non-labeled Ac-CoA to the SIL-IS. As previously also reported by Tan et al. [20] 274 
the cross signal contribution resulting from isotopic interference was not expected to cause any 275 
systematic errors since the same internal standard was used to prepare the calibration curves, the 276 
validation samples and the real samples. The % bias (data not shown) of the validation samples 277 
prepared using 10 µg/ml SIL-IS of the Ac-CoA was within the acceptance criteria of ±20%.  Figure 1 278 
shows the chromatograms of the labeled and non-labeled compounds. 279 
[Figure 1] 280 
 281 
Matrix used for validation and quantification 282 
The main purpose of this study was to explore alternative ways of producing a biological matrix with 283 
negligible influence to the MS/MS signals of the metabolites of interest and their SIL-IS, while still 284 
containing all the endogenous compounds and enzymes. For this purpose S. cerevisiae was cultivated 285 
in medium containing [
13
C6]glucose/non-labeled glucose (50/50, w/w). This ratio of labeled and non-286 
labeled glucose for cultivating the cells resulted as expected in pools of metabolites with labeling in 287 
different carbon positions. Figure 2 shows an isotopic pattern of ATP measured in the extract from the 288 
S. cerevisiae cultivated using this glucose mixture. It should be noted that unless otherwise stated, 289 
further on in the text the term ‘’blank matrix’’ refers to the extract obtained from the S. cerevisiae 290 
cultivated on this mixture. 291 
[Figure 2] 292 
From the measured and calculated isotopic pattern of ATP shown in Figure 2, it can be seen that the 293 
intensity of the peaks that correspond to m/z 505.9 ATP and m/z 515.9 [
13
C10]ATP, detected in the 294 
matrix, were very low (approximately 10 % of the highest isotope detected). The area of the 295 
[
12
C6]ATP and [
13
C6]ATP detected in the blank matrix were 13 % and 10 % relative to the area of the 296 
most abundant isotope detected (abundance of 100%), respectively. Consequently, there was a small 297 
A 
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interference of the naturally occurring ATP and [
13
C10]ATP
 
in matrix to the spiked amount of ATP 298 
and [
13
C10]ATP, respectively. The highest interference from the matrix was to the MS signals of 299 
[
15
N5]ADP and [
15
N5]AMP while the lowest was to the coenzymes and the redox compounds.  For 300 
comparison Figure 3 shows the normalized chromatographic peaks of [
15
N5]ADP, [
15
N5]AMP, ATP 301 
and Mal-CoA in the blank and spiked matrix, respectively, both processed as specified in the sample 302 
preparation. 303 
[Figure 3]  304 
As expected, increase in the molecular mass of only 5 Da was observed for the 
15
N labeled ADP and 305 
AMP. This increase was also detected in the biological matrix obtained by growing S. cerevisiae in 306 
media containing  [
13
C6]glucose/non-labeled glucose (50/50, w/w) (Figure 3), thus choosing 
13
C 307 
instead of 
15
N  labeled ADP and AMP in this context would have resulted in less interference. 308 
However, [
13
C10]ADP and [
13
C10]AMP were commercially not available when the study was 309 
conducted. Furthermore, due to the inconsistency in the labeling (all 
13
C, 
15
N or 
13
C
15
N) of the 310 
commercially available SIL-IS for the different compounds, it is difficult to produce a labeled matrix 311 
that will exhibit no interference to the SIL-IS signal. The amount in percentage of the non-labeled 312 
compounds that were replaced by their 
13
C fractions detected in the matrix is given in Table 2. 313 
[Table 2] 314 
The amount of some of the non-labeled metabolites present in the blank matrix was calculated to be 315 
approximately 50 times lower when compared to the amount expected to be measured if S. cerevisiae 316 
was grown on non-labeled glucose. Finally, the fewer the number of the carbons in the molecule, the 317 
higher the interference. Theoretically, the 
12
C fraction of a compound that has 15 carbons will have 30 318 
x lower abundance than the 
12
C fraction of a compound with 10 carbons. This shows the suitability of 319 
the presented approach for generating blank matrices with low background amounts of the compounds 320 
of interest. 321 
 322 
Validation 323 
The validation of the methods was done by determining: i) linearity; ii) the overall process recovery; 324 
iii) matrix effects; iv) intra day and inter day accuracy/recovery and precision.  325 
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Linearity. The linearity of the method was inspected by injecting 3 µl of samples prepared by spiking 326 
the matrix with standards, with concentrations over three orders of magnitudes, and subsequently 327 
processed through the sample preparation as explained in the Methods and material part. Different 328 
span of working concentrations were chosen due to the different amounts of the various compounds 329 
present in the cell. In general, all investigated metabolites showed good linearity over the inspected 330 
concentration range with correlations coefficients (R
2) of ≥0.990 (Table 3).  331 
[Table 3] 332 
Due to the cross signal contribution for Ac-CoA, resulting from isotopic interference, several 333 
concentrations (1, 3, 5 and 10 µg/ml) of internal standard were tested, with 10 µg/ml giving the best 334 
linearity (R
2 
of 0.998). The need for higher SIL-IS concentration for improved linearity when faced 335 
with cross signal contribution from isotopic interference has previously been reported by Tan et al. 336 
[20]. 337 
Overall process recovery. For ATP, ADP, AMP, Mal-CoA and Ac-CoA, for which SIL-IS were 338 
available, the overall process recovery was determined according to Canelas et al. [19] at three 339 
different concentrations. Two types of samples were prepared for each of these compounds in 340 
duplicates. All samples were spiked with standard mixture before the extraction, whereas only half of 341 
them were spiked with SIL-IS mixture before the extraction and the other half before the analysis. The 342 
recovery was calculated using the following formula [1]: 343 
 𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦 𝑤ℎ𝑒𝑛 𝑆𝐼𝐿 − 𝐼𝑆 𝑤𝑎𝑠 𝑎𝑣𝑎𝑙𝑖𝑎𝑏𝑙𝑒 =
𝑐𝑖(𝐵𝐴)
𝑐𝑖(𝐵𝐸)
 344 
where ci (BA) is the determined concentration of the analyte i in the sample prepared by spiking the 345 
blank matrix with the standard analyte i with certain concentration, processing the sample through the 346 
extraction and spiking it with the corresponding SIL-IS before the analysis, while ci (BE) is the 347 
determined concentration of the analysis i in the sample prepared by spiking the blank matrix with the 348 
standard analyte i and the corresponding SIL-IS and processing it through the extraction procedure. 349 
For the compounds, for which no internal standard was available, the recovery was determined by 350 
spiking half of the samples with non-labeled standards before the extraction and the other half before 351 
the analysis. The recovery was determined using the following formula [2]  352 
[1]
: 
[2] 
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𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦 𝑤ℎ𝑒𝑛 𝑆𝐼𝐿 − 𝐼𝑆 𝑖𝑠 𝒏𝒐𝒕 𝑎𝑣𝑎𝑙𝑖𝑎𝑏𝑙𝑒 =
𝑐𝑖(𝐵𝐸)
𝑐𝑖(𝐵𝐴)
  353 
The overall process recovery of all of the metabolites investigated during this study is shown in 354 
Figure 4, where the process recovery is plotted against the compounds investigated.  355 
[Figure 4] 356 
As shown in Figure 4, the adenosine mono-, di- and tri-phosphates, the coenzymes and the oxidized 357 
forms of the redox pairs showed a recovery of 0.7-0.8, indicating that high percentage of the 358 
metabolites investigated, has been recovered during the sample preparation procedure. Slightly lower 359 
recovery of 0.6 was obtained for the NADH.  360 
Matrix effects. The presence of ion suppression or enhancement was evaluated both qualitatively and 361 
quantitatively by using two approaches: i) the T-piece infusion test [21] and ii) the approach by 362 
Matuzewski et al. [10, 15], respectively. In order to evaluate the level of suppression or enhancement 363 
of the MS signal over the LC gradient, the T-piece infusion test was performed. While having a 364 
constant infusion of 10 µg/ml ATP into the MS, two samples were injected: matrix that has been 365 
processed through the extraction procedure and eluent A. Since ATP is constantly infused into the MS 366 
with a stable ion response over time, any compound that elutes from the column and goes into the MS 367 
will cause suppression or enhancement of the signal from the infused ATP. Figure 5 shows the 368 
chromatograms of post column infusion of 10 µg/ml ATP into the MS after injecting eluent A or 369 
matrix blank superimposed with the chromatograms of the compounds of interest to show their 370 
retention times. 371 
[Figure 5] 372 
In general the highest suppression was observed at the beginning and in the middle of the gradient. 373 
The suppression at the beginning was a result of not well retained compounds that elute in the time 374 
segment at or near the void volume of the column. The observed suppression in the middle of the 375 
gradient was due to the matrix compounds that have been retained on column and elute later in the 376 
analysis. The drop of the signal in the region between 7 and 8 min. and between 11 and 12 min. was 377 
due to the elution of the two buffering reagents used for the sample preparation procedure: PIPES and 378 
EDTA, respectively. PIPES formed dimer, trimer, tetramer and pentamer that were clearly seen in the 379 
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full MS scan with a mass difference between the aggregates of m/z 302.0. In the region where AMP 380 
eluted high intensity peak that had an m/z 96.9 and corresponds to a phosphate was detected, causing 381 
drop of the signal intensity as well. The strongest ion enhancement was mostly present at the end of 382 
the gradient in the region where none of the metabolites of interest eluted. Since the degree of 383 
suppression or enhancement is compound and concentration dependent, Matuzewski et al. [10] 384 
approach was adopted to investigate how does the matrix affect the compounds LC-MS signals at 385 
both high and low concentrations. The calculations from the quantitative evaluation of the matrix 386 
effects have been summarized in Table 4. 387 
[Table 4] 388 
All compounds exhibited suppression of the signal (36-91 %) and lower values for the slope of the 389 
matrix matched calibration curves when compared to the slope of the calibration curves obtained from 390 
pure standards. The strongest suppression was observed for AMP (91 %) and ADP (89 %), due to the 391 
elution of phosphate and EDTA, respectively. 392 
For inspecting whether the matrix effects and the losses during the sample preparation were corrected 393 
by using the internal standard, two calibration curves prepared over three days were compared: i) in 394 
the neat solution, ii) and the standard curves obtained by spiking the matrix before the extraction. For 395 
the compounds for which SIL-IS was available, the linear regression equations of the calibration 396 
curves obtained using the standards in the neat solution and the ones in the pure standards were 397 
comparable (data not shown). This indicates that the calibration curves prepared in the neat solution 398 
may also be used for quantification with this type of matrix. However, we suggest using the matrix 399 
spiked and processed standard curves, since SIL-IS is not always available, and thus reducing the 400 
number of samples per run.  401 
Accuracy/recovery and precision. The intra day precision and accuracy/recovery were determined by 402 
using matrix spiked QC samples prepared in triplicates at three different concentration levels 403 
processed in accordance with the sample preparation procedure. The inter day precision and 404 
accuracy/recovery were evaluated over three different days. The precision was given as the relative 405 
standard deviation of the determined concentrations, while the accuracy was calculated by dividing 406 
the mean measured concentration by the nominal concentration times 100 [22]. The results from the 407 
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validation (Table 3) showed acceptable precision and accuracy based on the commonly accepted 408 
criteria for a quantitative method (RSD less than 20 % and accuracy within 80-120 %).   409 
 410 
Evaluation of oxidation of NADH and NADPH to NAD
+
 and NADP
+
 respectively  411 
NADH and NADPH can be oxidized to NAD
+
 and NADP
+
, respectively, during the sample 412 
preparation. Therefore obtaining a snapshot of the levels of the NAD
+
/NADH and NADP
+
/NADPH 413 
can be very challenging. However during this study even oxidation of the NADPH and NADH 414 
standards prior to the sample preparation was encountered. Due to the fact that the oxidized and 415 
reduced forms of the redox pairs in the spiked samples were kept separated during the sample 416 
preparation, it was possible to check the degree of oxidation of NADH to NAD
+
 and NADPH to 417 
NADP
+
. The data in Table 5 show how much oxidized species (NAD
+
, NADP
+
) are formed by 418 
oxidation of NADH and NADPH. The results given in Table 5 are from triplicates, analyzed on three 419 
different days.
          420 
[Table 5]
                                             
 421 
Namely, a peak of NAD
+
 was detected in the NADH single standard solution freshly prepared in 422 
either H2O or eluent A. Interestingly enough, in the chromatogram of the single NADH standard, two 423 
peaks were detected that had the same mass as NAD
+
, where one of them had the same retention time 424 
as the NAD
+
 standard and the other one was eluting approximately 0.3 min. earlier. By inspecting the 425 
fragmentation pattern of these two peaks by interfacing the ion pair LC to a quadrupole time of flight 426 
MS (data not shown), it was found that these two peaks have identical fragments, but the ratios 427 
between the fragments were different. This leaded to a conclusion that the two peaks might 428 
correspond to α and β isomers of NAD+. In the case of NADPH, only one peak for NADP+ was 429 
observed. As previously reported in the literature [23] ammonium acetate pH 8 has been shown to 430 
improve the stability of NADPH and reduce the oxidation. In order to investigate this, the standards of 431 
NADH and NADPH were prepared in 5 mM ammonium acetate pH 8, which indeed reduced the 432 
oxidation of these two compounds. However the addition of TBA in the injection vial was proven to 433 
increase the sensitivity of the nucleotides [5]. Therefore 50 μg/ml solutions of NADPH and NADP 434 
were prepared by diluting the ammonium acetate stock solutions (pH 8) of these two compounds into 435 
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eluent A which contained TBA. It was noted that the addition of TBA did increase the sensitivity 436 
especially for NADPH. However further investigations are necessary in order to check the long term 437 
stability of the samples prepared in the ammonium acetate as well as the dilutions of these stocks into 438 
TBA. Further optimizations of the sample preparation procedure might be necessary as well in order 439 
to prevent the oxidation of NADPH and NADH, since it has been shown that the incubation time 440 
during CH3Cl extraction can also have an effect on the extent of oxidation [23]. 441 
 442 
Application of the method  443 
The validated quantitative method was used to determine the intracellular amounts of adenosine 444 
mono-, di- and tri-phosphate, the coenzymes and the redox pairs in S. cerevisiae. The quantitative data 445 
are given in Table 6 in nmol/mg dry weight. From the measured concentrations of ATP, ADP and 446 
AMP the energy charge ratio was determined to be 0.9, indicating a successful quenching and 447 
therefore high quality metabolomics data.      448 
[Table 6] 449 
The ratio between Mal-CoA and Ac-CoA was found to be 0.04. Similar concentration of Ac-CoA 450 
have also been measured before [24], however according to the authors knowledge values for the 451 
Mal-CoA/Ac-CoA ratio in S. cerevisiae have not been previously reported.   452 
The determined NAD
+
/NADH and NADP
+
/NADPH ratios were higher than some of the ones reported 453 
in the literature [25-30]. The reason for the high ratios was probably the oxidation of NADH and 454 
NADPH, consequently an increased concentration of NAD
+
 and NADH [30]. However Hou et al. [30] 455 
reported data for the NAD
+
/NADH and NADP
+
/NADPH ratios that are close to the ones measured in 456 
the present study. It should be noted that the same quenching and extraction procedure were used in 457 
the present and the study reported by Hou et al. [31]. Nevertheless, modification of the quenching and 458 
extraction procedures might help in prevention of the oxidation of the reduced species. Re-dissolving 459 
the samples in ammonium acetate pH 8 instead of eluent A might also be taken into account for 460 
improvement of the accuracy of the method.  In addition, SIL-IS of the redox compounds, which were 461 
not available during this study, will be beneficial for further investigation of the oxidation.  462 
 463 
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 464 
 465 
 466 
 467 
Conclusion 468 
An analytical method for quantitative measurement of intracellular metabolites in S. cerevisiae has 469 
been established. Using a novel approach, by cultivating S. cerevisiae on a media containing 470 
[
13
C6]glucose/non-labeled glucose (50/50, w/w), the interference from the naturally occurring 471 
intracellular metabolites in the spiking matrix were removed or reduced to a minimum. The reported 472 
approach allowed use of both non-labeled standards and their corresponding SIL-IS, therefore 473 
simplifying the method validation and quantification. The results show that the method was suitable 474 
for quantifying nucleotides, coenzymes and redox compounds in S. cerevisiae. Furthermore, the 475 
method can be applied to any analytical samples that exhibit high background amounts of the analytes 476 
of interest and when blank matrix free of the analyte is not available.  477 
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 599 
 600 
Tables 601 
Table 1. Optimized precursor ions, quantifier and qualifier product ions, collision energy, fragmentor 602 
and cell accelerator voltage used in the MRM measurements. 603 
 604 
 605 
 606 
 607 
 608 
 609 
 610 
 611 
Compound 
RT  
(min) 
Precursor ion 
(m/z) 
  
Quantifier Qualifier 
(m/z) 
Qualifier/Quantifier 
ion ratio 
(m/z) 
CE 
(V) 
Frag 
(V) 
CAV 
(V) 
ATP 13.4 505.9 273.0 30  95  3 407.9 19.2 
ADP 12.0 425.9 134 25 115 3 158.9 83.3 
AMP 9.1 346 79 20 130 3 211.1 4.7 
Ac-CoA 13.6 808 407.9 40 135 3 460.9 68.7 
Mal-CoA 13.6 852 807.9 25 135 4 407.9 49.1 
NAD+ 5.4 662 540 15 120 4 407.9 5.6 
NADH 10.6 664 397 30 110 4 346 62.7 
NADP+ 12.5 742 620 15 110 3 408 23 
NADPH 13.5 744 408 35 100 4 397 53 
[13C10]ATP 13.4 515.9 278 30 125 3 417.9 19.4 
[15N5]ADP 12.0 431 139.3 20 120 2 158.9 88.6 
[15N5]AMP 13.6 350.8 79 35 90 3 211.1 4.7 
[13C2]Ac-CoA 13.6 810 407.9 40 135 3 462.8 44 
[13C3]Mal  CoA 13.6 855 810.2 30 130 4 463 15.5 
 24 
 
 612 
 613 
Table 2. The amount in percentage of the replaced non-labeled compounds and their SIL-IS in the 614 
blank matrix with their 
13
C
 
 and/or 
12
C fractions expressed by the ratio between the area of the non-615 
labeled metabolite or SIL-IS and the sum of the areas of all isotopes of the particular compound 616 
detected in the blank matrix multiplied by 100.    617 
 618 
Compound Replaced amount in % 
ATP 98 
[13C10]ATP 98 
ADP 98 
[15N5]ADP 86 
AMP 98 
[15N5]AMP 87 
Ac-CoA 100 
[13C2]Ac-CoA 100 
Mal-CoA 100 
[13C3]Mal-CoA 100 
NAD+ 99 
NADH 100 
NADP+ 100 
NADPH 100 
  619 
 620 
 621 
 622 
 623 
 624 
 625 
 626 
 627 
 25 
 
 628 
 629 
Table 3. Linearity, correlation coefficient (R
2
), intra day (n=3) and inter day (n=9) precision, 630 
accuracy/recovery and LOD of the method for the measured compounds. 631 
 632 
 633 
 634 
 635 
 636 
 637 
 638 
 639 
 640 
 641 
Compound 
Linearity 
range (µg/ml) 
R2 
Levels 
(µg/ml) 
Intra day Inter day 
LOD (ng) Precision 
(RSD in %) 
Accuracy 
(%) 
Precision 
(RSD in %) 
Accuracy 
(%) 
ATP 2.5-250 0.994 
175 11 96 7 99 
1.2 25 6 87 5 90 
7.5 3 98 6 105 
ADP 1-100 0.997 
70 10 97 6 100 
0.5 10 1 100 8 93 
3 3 100 12 100 
AMP 1-100 0.997 
70 8 110 10 106 
0.3 10 10 101 13 99 
3 12 107 14 94 
Mal-CoA 1-100 0.999 
70 5 95 8 102 
0.0004 10 6 87 11 97 
3 3 96 5 101 
Ac-CoA 1-100 0.998 
70 3 95 4 97 
0.002 10 6 93 10 103 
3 6 91 12 92 
NADH 1-100 0.993 
70 6 99 10 97 
0.001 10 6 96 18 98 
3 18 97 19 83 
NADPH 1-100 0.99 
70 3 94 4 97 
0.0005 10 4 117 11 119 
3 18 95 22 87 
NADP+ 0.7-70 0.992 
49 13 97 7 98 
0.0001 7 9 111 14 113 
2.1 1 83 8 95 
NAD+ 0.7-70 0.989 
49 10 98 6 99 
0.0004 7 4 99 11 97 
2.1 1 83 13 96 
 26 
 
 642 
 643 
Table 4. Matrix effects evaluated using the Matuzewski et al. [10] approach. 644 
 645 
 646 
 647 
 648 
 649 
 650 
 651 
 652 
 653 
 654 
aMatrix effects are expressed as the ratio of the slopes of the calibration curves (1/x weighting) constructed from standards spiked before the 655 
analysis in matrix processed through the sample procedure to the standards prepared in the neat solution multiplied by 100. 100% indicates 656 
no matrix effects. 657 
 658 
 659 
 660 
 661 
 662 
 663 
 664 
 665 
 666 
 667 
 668 
 669 
Compound 
Slope of the linear regression 
Matrix effects 
(%)a Standards in neat solution 
Standards spiked in the matrix 
before the analysis 
ATP 141932 90326 64 
ADP 175368 18573 11 
AMP 197760 17878 9 
Mal-CoA 125069 65668 53 
Ac-CoA 100890 46985 47 
NAD+ 413125 191866 46 
NADH 103824 50004 48 
NADP+ 905022 317781 35 
NADPH 66962 25448 38 
 27 
 
 670 
 671 
Table 5. Amount of oxidized species detected in the samples spiked with NADPH and NADH at 672 
three different concentrations and processed through the sample preparation procedure.   673 
 674 
 675 
 676 
 677 
 678 
 679 
                                  aSD – standard deviation; number of replicates per day: 3; number of days: 3 680 
 681 
 682 
 683 
 684 
 685 
 686 
 687 
 688 
 689 
 690 
 691 
 692 
 693 
 694 
 695 
 696 
 697 
 698 
 699 
 700 
 701 
 702 
 703 
Compound 
Spiked amount 
nmol/mgDW 
Oxidized species  
nmol/mgDW (SD)a 
NADH 0.12 0.1 (0.04) 
 
0.40 0.3 (0.06) 
 
2.81 2.3 (0.15) 
NADPH 0.11 0.03 (0.002) 
 
0.36 0.1 (0.016) 
 
2.51 0.9 (0.155) 
 28 
 
 704 
Table 6. Intracellular concentrations of the compounds of interest in S. cerevisiae expressed as 705 
nmol/mg dry weight measured using the developed ion-pair UHPLC-MS/MS method. 706 
 707 
 708 
 709 
 710 
 711 
 712 
 713 
 714 
                      715 
                                                         a (SD) standard deviation, n=3 716 
 717 
 718 
 719 
 720 
 721 
 722 
 723 
 724 
 725 
 726 
 727 
 728 
 729 
 730 
 731 
Compound nmol/mg dry weight (SD) 
AMP 0.32 (0.03) 
ADP 0.91 (0.07) 
ATP 9.13 (0.6) 
Mal-CoA 0.03 (0.002) 
Ac-CoA 0.78 (0.05) 
NAD+ 6.24 (0.002) 
NADH 0.12 (0.02) 
NADP+ 0.71 (0.06) 
NADPH 0.07 (0.01) 
 29 
 
 732 
Figure legends 733 
Figure 1. Chromatograms of the labelled and non-labelled compounds spiked in the matrix before the 734 
extraction.  735 
 736 
Figure 2. Measured (dashed line) and calculated (bars) isotopic patter of ATP extracted from S. 737 
cerevisiae cultivated in medium containing 50 % (w/w) [
13
C6]glucose/non-labelled glucose.  738 
 739 
Figure 3. Superimposed chromatograms of [
15
N5]ADP, [
15
N5]AMP, ATP and Mal-CoA  in the blank 740 
matrix (dashed line) and matrix spiked (solid line) with the corresponding standards with 741 
concentrations as given in the figure. 742 
 743 
Figure 4. Overall process recovery of the analyzed compounds. Data shown are average of duplicate 744 
samples with their standard deviations.  745 
 746 
Figure 5. Overlaid chromatograms of post column infusion of 10 µg/ml ATP into the MS after 747 
injecting eluent A or matrix blank with superimposed chromatograms of all the analyzed compounds. 748 
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Abstracts 13 
Analysis of intracellular metabolites in microorganisms is important for understanding the regulation 14 
of the metabolic processes within the cells. Targeted LC-MS/MS are the methods of choice for 15 
analysis of these metabolites. These methods measure only targeted metabolites, thereby failing to 16 
detect major interference such as contaminants that has been introduced during the sample preparation 17 
or are coming from the sample itself. Here we investigate the use of QTOF accurate mass screening 18 
combined with auto MS/MS for measurement of intracellular metabolites extracted from 19 
Streptomyces coelicolor, Microbispora corallina and Saccharomyces cerevisiae. The analysis 20 
resulted in identification of 60 metabolites of which 40 were available as reference standards while 21 
the other 20 were tentatively identified based on retention time comparison to reference standards, 22 
MS/MS fragmentation, and accurate mass. Compared to the QqQ instrument sensitivity and 23 
specificity was improved for some compounds where specific low abundance daughter ions were 24 
needed by the QqQ instrument. The QTOF full scan data identified several major sources of ion-25 
suppressing contaminants, and also showed that the targeted QqQ detection did not overlook any 26 
major peaks.   27 
 28 
Introduction 29 
Intracellular metabolome consists of a highly complex and dynamic suite of molecules that 30 
interconnect and act as central players in many biochemical pathways within the cell [1,2]. 31 
The abundance of these metabolites can vary within the cell since their levels can change 32 
within seconds as a response to the changes in the environment [3-8]. Therefore the sample 33 
preparation for these metabolites consists of a quenching that will stop the metabolic 34 
activities followed by extraction [10-13]. The chemical properties of the metabolites in the 35 
extracts are widely diverse, however majority of them have masses below 1000 Da and are 36 
charged in aqueous solution [14]. A combination of different analytical platforms such as 37 
liquid chromatography–mass spectrometry (LC–MS), gas chromatography–mass 38 
spectrometry (GC–MS), or nuclear magnetic resonance spectrometry (NMR) are required for 39 
analysis of the whole suite of metabolites [13].  An alternative to this will be an analytical 40 
technique that will offer a broad coverage of metabolites involved in different pathways thus 41 
assisting in better understanding of the biochemical processes.  42 
LC-MS is a widely applied technique for analysis of intracellular metabolites. In combination 43 
with an effective sample preparation, LC-MS provides a high specificity, sensitivity as well 44 
as wide dynamic range and can be utilized for analysis of polar to semi-nonpolar compounds. 45 
Triple quadrupole instruments are traditionally applied for analysis of intracellular 46 
metabolites. Although they offer high sensitivity and wide dynamic range [15], the number of 47 
metabolites that can be analyzed in a single run is limited, although increasing dramatically 48 
with developments in electronics lowering the time used per MRM [15]. None the less with 49 
high resolution instruments such as quadrupole time-of-flight (Q-TOF) and Orbi-trap, data 50 
can be collected across a wide mass range without decrease in sensitivity and due to its high 51 
resolving power, it can distinguish between contaminants and signals of interest [15]. 52 
Therefore LC-HRMS is an effective technique for analysis of multiple compounds in 53 
complex biological matrices. Beside HRMS data, Q-TOF and Orbi-trap instruments offer two 54 
types of MS/MS acquisition, data depended and data independent. The advantage of the data 55 
dependent acquisition is that HRMS and MS/HRMS data are acquired in a single run without 56 
the need for precursor ion specification. However, not all ions will be fragmented, even using 57 
exclusion lists and time. The data independent acquisition (also called MS
E
)  is an alternative 58 
where all the ions generated will be fragmented using alternating low and high collision 59 
energies. Together with the accurate mass measurements this aid to the identification of 60 
unknown compounds.   61 
The data acquired by high resolution instruments are more complex and their analysis can 62 
become quite laborious. Hundreds to thousands of peaks can be detected in a single run that 63 
might correspond to compounds of interest, contaminators, artefacts etc. Therefore, tools that 64 
can help in fast characterization and assignment of the chromatographic peaks have been in 65 
focus from the instrument manufactures. Several manufactures now handle targeted search 66 
lists on 1000-3000 compounds, where  they for each compound search for one four 67 
characteristic ions (including fragments) and their accurate masses, chromatographic 68 
behavior, isotopic patterns. For the TOF instruments the software can also compensate for 69 
possible oversaturated scans in the peak apex where their mass accuracy is compromised 70 
[17]. Our group has for secondary metabolites refined the concept by building and improving 71 
the compound databases, organized in chemical database format as ACD for possible 72 
substructure searching and selection. These databases can then easily be converted to the MS 73 
vendor search formats.  74 
The auto MS/MS data acquisition provides and extra dimension for fast and very accurate 75 
identification. With the standardized fragmentation energies used for acquiring the data, 76 
database can be used across research fields. 77 
In this study a targeted ion-pair UHPLC-QqQ method is compared to a full scan accurate 78 
mass (QTOF). The methodology was used in combination with different quenching methods 79 
to evaluate not only how many compounds that were miss by the QqQ instruments but also to 80 
identify major interfering matrix components. By using the full scan and auto-MS/MS 81 
compounds not available as reference standards could be tentatively identified based on 82 
retention time, accurate masse, isotopic pattern and especially MS fragmentation.  83 
Materials and methods 84 
Chemicals  85 
The standards were purchased from either Sigma Aldrich (Steinheim, Germany) or Santa 86 
Cruz biotechnology. [
13
C10]ATP and [
15
N5]ADP were purchased from Sigma–Aldrich 87 
(Steinheim, Germany) while [
15
N5]AMP was from Silantes (Munich, Germany). [
13
C3]Mal-88 
CoA and [
13
C2]Ac-CoA were from Euriso-top (Gif-sur-Yvette Cedex, Paris, France). 89 
Tributylamine (TBA) (puriss plus grade), methanol (LC-MS and HPLC grade), CH3Cl, 1,4-90 
Piperazinediethanesulfonic acid (PIPES), EDTA and acetic acid (LC–MS grade) were 91 
obtained from Sigma–Aldrich. A Milli-Q system (Millipore, Bedford, MA, USA) was used 92 
for water purification. 93 
Cell growth and sample preparation 94 
Saccharomyces cerevisiae. Biomass was obtained from glucose chemostat cultures of S. 95 
cerevisiae (CEN.PK113-11C strain, dilution rate of 0.1 h
-1
, biomass dry weight of 4.07g/l). 96 
Details of the cultivation have been previously described in Tomas et al. 2015. Samples were 97 
taken during steady state conditions in the end of continuous cultivation and were quenched 98 
and extracted as previously described by Villas-Boas et al. In brief, 5 mL of culture broth was 99 
sprayed into pre-cooled (-40°C) falcon tube containing 20 mL of 60% methanol, spun down 100 
for 2 min at 5000xg in precooled centrifuge (-10°C) and extracted using boiling ethanol 101 
method [26] followed by evaporation under nitrogen. The samples were redissolved in 300 ul 102 
eluent A (10mM tributylamine and 10 mM acetic acid).  103 
Microbisporra corralina samples was obtained from glucose chemostat cultures with dilution 104 
rate of 0.01 h
-1
, nitrate as nitrogen source, pH 7.3, temperature 30 °C, biomass dry weight of 105 
7.07 g/l, 2.5 ml of culture was taken from the fermentor and released into 10 ml of 60% (v/v) 106 
methanol/water solution, precooled to -40 °C in an ethanol/dry ice bath. The mixture of 107 
culture and quenching solution was immediately removed from the bath and centrifuged for 3 108 
min at 4248 x g and 4 °C. After decanting, methanol/ CH3Cl (1:2, v/v) mixture precooled in 109 
the ethanol/dry ice bath was added to the cell pellet followed by vortexing, followed by 110 
adding 2 ml of ice-cold buffer (PIPES, 3 mM; EDTA, 3 mM; pH 7.2). The spin tubes with 111 
the mixture were placed on a platform shaker for 60 min at 4 °C and 160 rpm, followed by 112 
centrifugation for 3 min at 4248 x g and 4 °C. The upper aqueous phase (3.7 ml) was 113 
collected and transferred to another tube. Two milliliters of methanol and 2 ml of ice cold 114 
buffer was added to the CH3Cl phase followed by vortexing and centrifugation for 3 min at 115 
4248g and 4 °C. The upper aqueous phase was collected (4 ml) and pooled with the previous 116 
extract. The extract was lyophilized and redissolved in 200 ul of eluent A (10mM 117 
tributylamine and 10 mM acetic acid). 118 
Streptomyces coelicolor samples were obtained from a batch cultivation using a minimal 119 
medium as described in Borodina et al. (2008). The extraction and quenching procedure are 120 
the same as for Microbisporra corralina. The only difference is that here 5 ml of culture was 121 
taken from the fermentor and quenched with 20 ml -40 °C 60% (v/v) methanol/water 122 
solution.  123 
 124 
Ion pair chromatography 125 
LC separation was performed on an Agilent 1290 UHPLC system (Agilent Technologies, 126 
Torrance, CA, USA)  a previously described in Magdenoska et al. with 10 mM TBA as ion 127 
pair reagent.  Eluent A: 10 mM TBA and 10 mM acetic acid, while eluent B was 90% MeOH 128 
(v/v) containing 10 mM TBA and 10 mM acetic acid. 129 
Two different gradients were used: 19.5 min (0-12 min from 0 to 50 %B, 12-12.5 min from 130 
50 to 100% B, 12.5 -14 min 100% B, 14-14.5 min from 100 to 0% B, 14.5-19.5 0% B)  and 131 
36 min (0-5 min 0% B, 5-10 min from 0 to 2% B, 10-11 min from 2 to 9% B, 11-16 min 9% 132 
B,  16-24 min from 9 to 50% B, 24-28.5 min 100% B, 28.5-30 min 100% B, 30-30.5 min 133 
from 100 to 0% B, and 30.5 to 36 min 0% B). The injection volume was 0.5 µl unless 134 
otherwise stated. 135 
Q-TOF LC/MS 136 
Agilent 6550 iFunnel QTOF LC/MS system equipped with a Dual Agilent Jet Stream ESI 137 
source was operated in negative ion mode and 2-GHz extended dynamic range at a resolution 138 
of 25,000 full width at half-maximum (FWHM). The QTOF instrument was tuned for fragile 139 
molecules by decreasing the potentials in the ion path by 5 V relative to the auto-tune values. 140 
The ion source parameters were as follows: gas temperature, 290 °C; gas flow 14 l/min; 141 
sheath gas temperature, 400 °C; sheath gas flow 11 l/min; nebulizer pressure, 45 psi; 142 
capillary voltage 3000 V; nozzle voltage 2000 V. Mass to charge ratio range of 50-1700 was 143 
used for acquiring both MS and MS/MS spectra with a scan rate of 3 spectra/sec. Auto 144 
MS/MS spectra were acquired using three distinct collision energies: 10, 20 and 40 eV. 145 
MS/MS spectra were acquired using an intensity cut-off of 10 000 counts, ion-exclusion time 146 
was 0.15 min. Exclusion list was created with the lock masses and the most abundant 147 
background ions, thereby increasing the fraction of metabolites that were fragmented. For the 148 
compound for which fragmentation pattern was not acquired by the auto MS/MS, targeted 149 
MS/MS was conducted. Mass calibration was conducted by continuous pumping of a 150 
reference mass solution using isocratic pump at a flow of 1000 µl/min and a splitter (1:100) 151 
[15]. The reference mass solution contained 800 ml MeOH, 199 ml water, 1 ml of 1.1 mg/ml 152 
hexakis(2,2,3,3-tetrafluoropropoxy)phosphazine (Apollo Scientific Ltd., Cheshire, UK), and 153 
200 µl of 10% TFA (v/v). The reference masses used for mass calibration were m/z 154 
1033.9881 [M+TFA-H]
-
 and m/z 112.9855 [TFA-H]
-
. 155 
 156 
Data mining of QTOF data for known unknowns 157 
For identification of known unknowns (known metabolites not available as reference 158 
standards), negative ion ESI accurate mass data were obtained from the extracts using MS 159 
and auto MS/MS acquisition. Aggressive dereplication was done as described in Kildegaard 160 
et al. 2014 by creating *.csv files that contained the empirical formula and the name of the 161 
compounds listed in an in-house database created in the ACD chemfolder format (ref). This 162 
database was created by importing the online available metabolom databases of Escherichia 163 
coli (E. coli metabolome database, http://www.ecmdb.ca/) and yeast (Yeast Metabolome 164 
Database, http://www.ymdb.ca/) in the sdf format and adding all in-house available reference 165 
standards [Klitgaard et al. 2014]. The identification of the known unknowns was done using 166 
the find by formula feature of the Mass Hunter Qualitative analysis software (version 167 
B.06.00) using a mass tolerance of ± 10 ppm. The adducts ([M-H]- and [M+CH3COO]
-
) and 168 
dimers ([2M-H]
-
) were included in the search and all ions were treated as being singly 169 
charged. A minimum score of 70 was used to ensure that only compounds with fitting isotope 170 
patterns were marked.  171 
In addition, method, containing all identified compounds, was created in Mass Hunter 172 
Quantitative analysis software that facilitated the screening of different matrices for specific 173 
compounds as previously explained in Nielsen et al.2015. The MS/HRMS spectra acquired 174 
were compared against the online available METLIN database. For compounds for which no 175 
fragmentation pattern was available in the METLIN database manual inspection of the 176 
spectra was done for loss of a phosphate, fragmentation of a C-O, C-N bonds.  177 
 178 
Results and discussion 179 
Chromatography 180 
Prolongation of the gradient from 19 to 36 min was necessary for separating a number of 181 
compounds with the same elemental composition, especially the sugar phosphates (e.g. G6P, 182 
F6P, F1P, G1P). As their MS/MS spectra displayed the same ions albeit in slightly different 183 
abundances, their chromatographic separation was vital for quantification. In the case of the 184 
NTPs (e.g. ATP and dGTP have same composition, Table 1, specific fragments that 185 
correspond to the aromatic part of the molecule aided the identification when Auto-MS/MS 186 
was triggered. 187 
When installing a new column in the UHPLC, overnight equilibration with the ion-pair eluent 188 
was necessary in order to obtain reproducible retention times, narrow peaks and stable run to 189 
run RT, showing a slow equilibration of the reagent to the silica backbone of the column. 190 
Variation (30-60 sec) of retention times were mainly observed for the mono-phosphorylated 191 
compounds eluting in the middle of the gradient, and was correlated to replacement of the 192 
eluents. When the same eluent was used within a sequence no changes in the RT was 193 
observed. The late eluting compounds were not affected with the change of the eluent batch. 194 
The separation of some isomers was strongly affected by the column performance, e.g. could 195 
AMP and dGMP be baseline separated on a new column, but after 100-500 biological 196 
samples these two compounds co-eluted and had 30 % broader peaks and more pronounced 197 
tailing. Presumable due to fouling by polar compounds as high temperature and isopropanol 198 
wash could not reconstitute the column. The separation of the sugar phosphates and the AMP 199 
and dGMP isomers was shown to be a good indicator for column replacement. 200 
Sample preparation can also affected the LC peak shape of the compounds and is illustrated 201 
by the analysis of M. corallina extracts prepared using two different sample preparation 202 
methods (Figure 1).   203 
 204 
 205 
 206 
 207 
 208 
 209 
 210 
Figure 1. Effect of the sample preparation on the peak shape of glucose 6-phosphate extracted from M. 211 
corralina. The upper chromatogram is obtained from a sample quenched with formic acid and extracted by 3x 212 
freeze/thaw. The lower chromatogram is obtained from a sample quenched with 60% MeOH -40°C and 213 
extracted with MeOH/chloroform (2:1, v/v), showing the same RT as a pure reference standard. 214 
 215 
It can be clearly seen that the peak shape of G6P (formic acid quenching) is altered as a result 216 
of the matrix compounds impairing the chromatography. This effect is more pronounced at 217 
the beginning of the gradient as also know from reversed chromatography where injection of 218 
sample in stronger solvent than the start gradient shows the same effects.  219 
When a mixture of all the proteinogenic amino acids was analyzed, as expected the basic 220 
amino acids, lysine and arginine, were not retained at all (ion exclusion) and were eluted in 221 
the void volume of the column. The acidic amino acids were more retained and had an RT of 222 
2.8 min for glutamic acid (~0.8 min) and 2.9 for aspartic acid showing some ion exchange 223 
characteristics. The aromatic amino acids, tyrosine (RT 1.3 min) and phenylalanine (RT 2.2 224 
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min) were also retained although their overall charge was zero (Figure 2). This could be 225 
explained by the reversed phase interactions between the aromatic part of the amino acids and 226 
the phenyl hexyl groups from the stationary phase. This shows that a combination of an-ion-227 
pairing and reverse phase interactions are responsible for the retention of the compounds 228 
during IP-RP. Furthermore the tyrosine was eluting earlier due to the presence of the polar 229 
hydroxyl group.  230 
 231 
 232 
 233 
 234 
 235 
 236 
 237 
Figure 2. Chromatogram of tyrosine (RT 1.3min) and phenylalanine (RT 2.2 min) obtained 238 
by analyzing a standard mixture of amino acids using ion-pair LC-Q-TOFMS. Column used: 239 
Poroshell 120 Phenyl-Hexyl. Eluent A:10 mM TBA and 10mM acetic acid, eluent B: 90% 240 
MeOH containing 10 mM TBA and 10mM acetic acid. Gradient: 0-5min 0% B, 5-10 min 0-241 
2% B, 10-11 min 2-9% B, 11-16 min 9% B, 16-24min 9-50% B, 24-28min 50%B, 28-242 
28.5min 100%B, 28.5-30min 100%B, 30-30.5 100-0 %B, 30.5-36min 0%B. 243 
 244 
3.2 QTOF-MS performance 245 
Data on how the MS signal is affected by the injection solvent in which the standard solutions 246 
are prepared, were obtained by analyzing 0.5 μl of 50 µg/ml NADH, NADPH, 3-247 
phosphoglycerate and succinic acid prepared in water or eluent A (Figure 3).  248 
0
100
Time (min)
1 2 3 4 5 6 7 8 9 10 11
50
C
o
u
n
ts
 (
%
) 
A B
36
A. Tyrosine (RT 1.3 min) B. Phenylalanine (2.2 min)
NH2
OH
OHO
NH2
OHO
 249 
 250 
 251 
 252 
 253 
 254 
 255 
Figure 3. Effect of the injection solvent on the LC-MS signal intensity of succinic acid, 3PG, 256 
NADH and NADPH. 257 
As shown in Figure 3, the LC-MS peak area of succinic acid, 3PG and NADPH was 258 
increased by addition of TBA in the injection vial, but this was not the case for NADH. In 259 
addition, slight change in the retention time was observed for 3PG when TBA was added.  260 
 261 
3.3 Analysis of reference standard compounds 262 
In order to inspect the predominant molecular ions, the adduct and dimer formations as well 263 
as the ion-source fragmentation, different classes of compounds ranging from sugar 264 
phosphates, nucleotides, coenzymes, carboxylic acids, amino acids and sugar phosphates 265 
were analyzed (Table 1).  266 
For all the compounds, the analysis showed formation of [M-H]
-
 and [2M-H]
-
 ions, with [M-267 
H]
-
 as the predominant ion (Table 1). Acetate adducts were observed only for some of the 268 
coenzymes and the amino acids. Due to their very low intensity (below 5000 counts) they 269 
were not taken into consideration.  270 
When using the find by formula algorithm for teh long lists of tentative compounds, double 271 
peak was assigned to erythrose 4-phosphate (E4P) with one apex at a RT of 7.3 min. and the 272 
other one at 8.4 min. The predominant ion of the first peak (RT 7.3 min.) was m/z 259.0224 273 
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which corresponded to the acetate adduct of E4P, while the second most intense ion was m/z 274 
199.0013 that corresponded to [M-H]
- 
of E4P. The peak with an RT of 8.4 min showed the 275 
opposite. However, extracting the EIC’s of m/z 259.0224 and m/z 199.0013 both with mass 276 
tolerance of ±10 ppm resulted in two distinct peaks, which showed that the m/z 259.0224 277 
detected at RT of 8.4 min. was due to the tailing of the first peak (RT of 7.3). Since all the 278 
other sugar phosphates showed [M-H]
-
 as the predominant ion and no acetate adducts, the 279 
peak with a RT of 8.4 was considered to be corresponding to E4P while the peak with lower 280 
RT to be as a result of a contamination probably with sugar phosphates that have m/z 281 
259.0224 as previously reported by Luo et al. The MS/MS fragmentation pattern of the ions 282 
with m/z 259.0224 (RT of 7.3 min) and m/z 199.0013 (RT of 8.4 min.) were identical to the 283 
fragmentation patterns of the hexose phosphates and E4P in the METLIN database, 284 
respectively. Furthermore, when compared to the other sugar phosphates, the intensity of the 285 
[M-H]
-  
of E4P was lower, probably due to the more pronounced ion source fragmentation 286 
that was observed in the full scan spectra.   287 
In general loss of one phosphate group was observed for the phosphorylated compounds, loss 288 
of one or two CO2 group for carboxylated compounds, while the amino acids showed loss of 289 
CO2 or NH3 (Table 1). The most pronounced ion-source fragmentation was observed for cis-290 
aconitic acid where the area of the [M-H]
- 
was around 50% of the area of both of the 291 
fragments. For all the other compounds the ion-source fragments were lower than the 292 
molecular ion. This could be avoided by changing the settings in the ion source, however it 293 
would result in decreased sensitivity for other compounds. 294 
cGMP was formed by in-source fragmentation of c-diGMP. On the other hand the dimer of 295 
cGMP had the same mass of c-diGMP (m/z 689.0876). When a mix of cGMP and c-diGMP 296 
was analyzed, the EIC of m/z 689.0876 showed two chromatographic peaks one at a RT of 297 
cGMP and the other one at an RT of c-diGMP. It should be noted that conversion of c-298 
diGMP into cGMP did not occur in the vial which was confirmed by analyzing single pure 299 
standards of cGMP and cdiGMP that showed only one chromatographic peak for both cGMP 300 
(RT 20 min.) and cdiGMP (RT 23.9 min.). 301 
Table 1. Molecular ions, adducts and dimers formation and ion source fragmentation of the 302 
in-house available standards of primary metabolites.  303 
Compound RT [M-H]
-
 [2M-H]
-
 Ion source fragmentation 
Lys 0.6  +  -  - 
Arg 0.6  +  - Loss of CN2H2  
His 0.7  +  - Loss of NH3 or -CO2 
Ser 0.8  +  -  - 
Cys 0.8  +  -  - 
Thr 0.8  +  - Loss of C2H4O 
Pro 0.9  +  -  - 
Val 0.9  +  -  - 
Met 1.1  +  -  - 
Tyr 1.3  +  -  - 
Phe 2.3  +  - Loss of NH3  
Glu 2.9  +  - Loss of H2O or -CO2  
Asp 3.0  +  - Loss of -CO2  
E4P 8.4  +  +   - 
G6P 7.1  +  +  [H2PO4]
-
, [PO3]
-
 
G3P 7.7  +  +   - 
F6P 7.6  +  +  [H2PO4]
-
, [PO3]
-
 
M6P 7.9  +  +  [H2PO4]
-
, [PO3]
-
 
Gal6P 8.4  +  + [H2PO4]
-
, [PO3]
-
 
G1P 8.8  +  +  [H2PO4]
-
, [PO3]
-
 
X5P 9.8  +  +  [H2PO4]
-
, [PO3]
-
 
Ru5P 10.3  +  +  [H2PO4]
-
, [PO3]
-
 
CMP 11.9   +  +   - 
F1P 11.5  +  +  [H2PO4]
-
, [PO3]
-
 
dCMP 13.4   +  +  - 
DHAP 12.9  +  + [H2PO4]
-
, [PO3]
-
 
UMP 14.2   +  +  - 
NAD 14.3  +  +  - 
GMP 16.5   +  +   - 
IMP 16.8   +  +  - 
dUMP 17.0   +  +  - 
dGMP 19.2   +  +  - 
dTMP 19.4  +  +   - 
AMP 19.8   +  +   - 
cGMP 20.0   +  +  c-diGMP 
Succinate 20.3  +  - Loss of H2O and -CO2 
cAMP 21.5  +  +  - 
UDP-Glucose 22.3   +  +   - 
3PG 22.8  +  +  - 
2PG 22.8  +  +  - 
6PG 22.8  +  +   - 
XMP 22.9  +  +  - 
Fumarate 22.9  +  - Loss of -CO2 
α-KG 22.4  +  - Loss of -CO2  
NADH 23.1  +  + NAD 
UDP 23.4   +  +  UMP 
GDP 23.4   +  -  GMP 
PEP 23.6  +   +  PO3
-
 
c-diGMP 23.9  +  + cGMP 
cis-Aconitic acid 23.9  +  - Loss of -CO2 
ADP 23.9   +  +  - 
NADP 23.9  +  +  - 
Citric acid 24.0  +  -  - 
GTP 25.7  +  +  GDP 
dCTP 25.7  +  +   - 
UTP 25.8  +  +  UDP 
dGTP 25.9  +  +  - 
ATP 26.1  +  +  ADP 
dTTP 26.2  +  +   - 
dATP 26.5  +  +  - 
NADPH 26.8  +  + NADP 
FAD 27.1  +  +  - 
Acetyl-CoA 29.5  +  +  - 
Propionyl-CoA 29.5  +  -  - 
Malonyl-CoA 29.5  +  -  - 
Methylmalonyl-CoA 29.5  +  -  - 
 304 
 305 
3.3 Finding the ion-suppressing peaks  306 
 307 
3.4 Auto MS/MS 308 
Collision energies of 10 and 20 eV were enough to fragment most of the molecules while CE 309 
of 40 eV was in general necessary to fragment larger stable molecules such as FAD or 310 
NADPH.  311 
 312 
3.5 Aggressive dereplication combined with MS/HRMS library search 313 
Using the search lists, more than 300 peaks were assigned to different compounds and by 314 
using the Mass Hunter Quantitative software, very fast inspection of the chromatograms was 315 
possible in order to eliminate compounds that were assigned to peaks that were practically 316 
noise or blanks. 317 
The criteria used to confirm the tentative identification of the known unknown included: i) 318 
adduct formation, ii) RT and iii) MS/MS fragmentation pattern.  319 
 As described in the previous section, [M-H]
-
 was detected as the predominant ion for the 320 
different classes of compound. Therefore when an acetate adduct was detected in the extracts 321 
as the predominant ion those results were taken with precaution. In general it was observed 322 
that the m/z of an acetate adduct of one compound was the same with the m/z of the [M-H]
-
 323 
of another compound, thereby resulting in false identification.  324 
Based on the structural formula of the compound suggested as a possible match, a prediction 325 
of the retention time was possible. Due to the usage of an ion-pair chromatography with 326 
tributylamine as ion pair reagent an RT increase was expected when the overall negative 327 
charge of the molecules increased by increasing the number of present COO
-
 or PO4
-
 groups 328 
and decreasing of the number of groups e.g. NH2 that can be positively charged under the pH 329 
used during the analysis.  330 
The MS/MS fragmentation patterns were used to confirm the putative identities that were 331 
assigned by the software to a particular chromatographic peak.  The combination of RT and 332 
MS/HRMS spectra increased the confidence of the identification and was taken as the 333 
limiting factor for accepting the putative identities that were suggested by the software.  334 
The search list combined with the Find by Formula Feature provided a quick overview of the 335 
possible isomers that might be responsible for a certain chromatographic peak. This was 336 
especially useful when chromatographic separation of the isomers was not possible. 337 
ATP/dGTP, UDP-Glc/UDP-Gal are some of the many examples of isomers present in the cell 338 
extracts. 339 
 340 
3.6 Identification of known unknowns  341 
The untargeted approach using the aggressive dereplication combined with the METLIN 342 
library for searching MS/HRMS data was used to identify as many intracellular metabolites 343 
(known unknowns) as possible in three different matrices:  S. cerevisiae, M. corralina and S. 344 
coelicolor. Figure 1 shows the highlighted peaks of the identified compounds from the three 345 
different extracts.  346 
Figure 4. Base peak chromatograms Saccharomyces cerevisiae, Microbisporra corralina and 347 
Streptomyces coelicolor extracts in negative ESI mode. Peaks of the compounds identified 348 
using MS/HRMS are highlighted 349 
Compounds, ranging from amino acids, sugar phosphates, nucleotides and organic acids were 350 
identified using the aggressive dereplication approach (Table 2).  351 
TABLE 2 [In progress] 352 
Although the data analysis approach described in this study yielded putative identifications 353 
for several hundreds of compounds for a very short time, one should also be aware of the 354 
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pitfalls of this approach. One example of misidentification due to an in-source fragmentation 355 
using this approach was the detection of the sugar nucleotide ADP-ribose 1″-2″ cyclic 356 
phosphate. The aggressive dereplication approach led to tentative identification of ADP-357 
ribose 1″-2″ cyclic phosphate (m/z 620.0202) at a RT of 23.15 min. This was a compound for 358 
which a standard in-house was not available. Furthermore by using the aggressive 359 
dereplication approach NADP (m/z 742.0680) was also identified and had the same RT as 360 
ADP-ribose 1″-2″ cyclic phosphate. From previous measurements it was found that an in-361 
source fragmentation of NADP gives a fragment ion with m/z 620.0202 [C15H21N5O16P3-H]
-
 362 
which has the same m/z ratio as ADP-ribose 1″-2″ cyclic phosphate. This indicated a possible 363 
misidentification of ADP-ribose 1″-2″ cyclic phosphate due to the in-source formation of the 364 
fragment from NADP with the same m/z ratio as ADP-ribose 1″-2″ cyclic phosphate that 365 
further on gives positive match. When inspecting the fragmentation pattern of ADP-ribose 366 
1″-2″ cyclic phosphate a fragment [C10H15N5O13P3]
-
 (m/z 505.9836;  9 ppm) was detected 367 
that corresponds to a fragment that is specific for NADP, leading to the conclusion that ADP-368 
ribose 1″-2″ cyclic phosphate was misidentified.  369 
 370 
 371 
 372 
  Figure 5. A. Full scan showing the [M-H]
-
 of NADP (m/z 742.0680) and a fragment from 373 
ions source fragmentation of NADP (m/z 620.0202); B. MS/HRMS of m/z 620.0202 showing 374 
a fragment with an m/z 505.9873. 375 
The predominant ion detected by the aggressive dereplication can also be an indicator 376 
whether the identification result should be taken with a precaution. By using the aggressive 377 
dereplication a peak with an RT of 11.2 min had two IDs, UMP and D-4-hydroxy-2-378 
oxoglutarate. The predominant ion for UMP was [M-H]
- 
while for D-4-hydroxy-2-379 
oxoglutarate was [2M-H]
-
, both with m/z of 323.0286. The acetate adduct and the [M-H]
- 
of 380 
D-4-hydroxy-2-oxoglutarate were also detected and had 5 times lower intensity when 381 
compared to the [2M-H]
- 
ion of the same compound. As described before the predominant 382 
ions for the standards analyzed were the [M-H]
- 
ions. Furthermore, when compared to other 383 
carboxylic acids such as fumaric and succinic acid, the RT of 11.2 min was too low for an 384 
organic acid with two COOH groups. Furthermore, the measured MS/MS spectra of m/z 385 
323.0286 was identical to the MS/MS of UMP and did not contain any of the usual fragments 386 
for carboxylated compound such as loss of CO2 groups. Therefore it was concluded that the 387 
peak detected at a RT of 11.2 min. corresponded to UMP. Furthermore the ions that 388 
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corresponded to [M+CH3COO]
-
 and [M-H]
- 
 of d-4-Hydroxy-2-oxoglutarate, were found to 389 
be a background ions that were present over the whole chromatogram.  390 
When using the aggressive dereplication approach very often more than one peak is assigned 391 
to one compound. In this case, the RT criteria together with the MS/HRMS data can help 392 
solving this problem. An example for this is the identification of glutathione which was only 393 
detected in S. cerevisiae extract. Two chromatographic peaks were assigned to glutathione 394 
when using the aggressive dereplication approach. An acetate adduct of the glutathione m/z 395 
366.0972 (accuracy of 1.3 ppm) was detected at RT of 3.06 min while [M-H]
-
 m/z 306.0760 396 
(accuracy 1.6 ppm) was detected at 10.08 min. An MS/HRMS data was acquired from both 397 
the acetate adduct [M+CH3COO]
-
 and the [M-H]
-
. MS/HRMS data in the library were only 398 
available for glutathione but not for his acetate adduct. When the extracted MS/HRMS 399 
spectra of the [M+CH3COO]
-
  were compared with the glutathione fragmentation pattern in 400 
the METLIN library, no similarity was found. This leaded to the conclusion that the peak at a 401 
RT of 3.06 min is not glutathione. Furthermore the extracted MS/HRMS spectra of the [M-402 
H]
- 
at a RT of 10.08 min. were compared to the glutathione fragmentation spectra in the 403 
METLIN library which resulted in a positive match. In addition oxidized (RT 21.7 min) and 404 
dicarboxyethyl glutathione (RT 23.9 min) were also detected.  405 
…more cases of positive or misidentification 406 
 407 
 Conclusion 408 
Besides the tested on 60 reference standards further 20 compounds could be tentatively identified 409 
based on retention time comparison to reference standards, MS/MS fragmentation, and accurate mass. 410 
For method development the QTOF was superior for evaluating the reasons for ion-suppression and 411 
differences in sample preparation. 412 
 Compared to the QqQ instrument sensitivity and specificity was improved for some compounds (e.g. 413 
ATP, AMP) where specific low abundance daughter ions were needed by the QqQ instrument. The 414 
QTOF data allowed to verify that the compounds detected were not fragments from ion source 415 
fragmentation of co-eluting compounds. Most importantly the full scan QTOF data allows 416 
retrospective data analysis for both new compounds as well as decomposition products. 417 
 418 
 419 
 420 
 421 
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Supplementary material 
Table S1. Optimized precursor and product ion, fragmentor voltage, collision energy and cell 
accelerator voltage for the intracellular metabolites of interest during this Ph.D. study  
Compound Precursor Ion Product Ion 
Fragmentor 
Voltage  
Collision 
energy  
Cell Accelerator 
Voltage  
2PG 185 97 90 20 3 
HMG-CoA 910.1 425.9 135 45 4 
HMG-CoA 910.1 407.9 135 50 4 
3PG 185 97 90 15 3 
6PG 274.9 96.9 100 10 4 
Ac-CoA 808.1 426 100 30 4 
Ac-CoA 808.2 408 100 40 4 
ADP 425.9 158.9 120 25 3 
ADP 425.9 134 115 25 3 
AMP 346 211.1 100 15 3 
AMP 346 79 90 30 3 
ATP 505.9 407.9 100 20 3 
ATP 505.9 273 95 30 3 
cAMP 328.1 134 115 25 3 
cAMP 328.1 78.9 120 35 3 
c-diGMP 689 537.9 110 30 4 
c-diGMP 689 149.9 100 35 4 
CDP 401.9 158.9 130 25 3 
CDP 401.9 79 90 40 3 
cGMP 344 150 115 25 3 
cGMP 344 132.9 135 35 3 
Cis-aconitic acid 173 85 60 10 3 
Citric acid 191 111 95 10 4 
Citric acid 191 43 90 30 3 
CMP 322 97 90 20 3 
CMP 322 79 120 40 3 
CTP 481.9 384 110 20 4 
CTP 481.9 159 125 30 4 
dATP 489.9 391.9 115 25 4 
dATP 489.9 158.9 130 35 3 
dCMP 306 195 130 15 3 
dCMP 306 79 130 40 3 
dCTP 465.9 367.9 100 20 4 
dCTP 465.9 158.9 120 25 3 
dGMP 346 195.1 100 20 3 
dGMP 346 79 130 20 3 
98 
 
Table S1. Continued. 
Compound Precursor Ion Product Ion 
Fragmentor 
Voltage  
Collision 
energy  
Cell Accelerator 
Voltage  
dGTP 505.9 257 115 35 3 
dGTP 505.9 158.9 90 30 3 
DHAP 169 78.7 70 35 3 
DHAP 169 96.9 60 10 3 
dTMP 321 194.9 125 15 3 
dTMP 321 124.9 110 20 3 
dTTP 480.9 383 90 20 4 
dTTP 480.9 159 100 25 3 
dUMP 307 195 110 15 3 
dUMP 307 111 100 20 4 
E4P 199 79 100 30 3 
E4P 199 97 100 10 3 
F1P 259 198.9 110 10 3 
F1P 259 138.9 100 10 3 
F1P 259 97 90 10 3 
F1P 259 79 85 40 3 
F6P 259 96.9 90 20 3 
F6P 259 79 100 30 3 
F6P 259 198.9 110 10 3 
F6P 259 138.7 90 5 3 
FAD 784.1 437 135 25 3 
FAD 784.1 346.1 135 35 4 
FBP 339 241 100 10 4 
FBP 339 97 100 20 4 
Fumaric acid 115 70.8 80 5 1 
G1P 259 198.9 110 10 3 
G1P 259 138.9 100 10 3 
G1P 259 79 110 25 3 
G1P 259 97 115 10 3 
G3P 169 97 130 5 3 
G3P 169 79 130 30 3 
G6P 259 96.9 100 10 3 
G6P 259 79 100 30 3 
G6P 259 198.9 110 10 3 
G6P 259 138.7 90 5 3 
Gal1P 259 198.9 110 10 3 
Gal1P 259 138.7 90 5 3 
Gal1P 259 97 100 30 3 
Gal1P 259 79 100 30 3 
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Table S1. Continued. 
Compound Precursor Ion Product Ion 
Fragmentor 
Voltage  
Collision 
energy  
Cell Accelerator 
Voltage  
GDP 442 344.1 110 15 3 
GDP 442 159 120 30 3 
GMP 362 211 100 15 4 
GMP 362 79 110 25 3 
GTP 521.9 423.9 130 20 3 
GTP 521.9 159 100 35 3 
IMP 347 135 95 30 3 
IMP 347 79 115 35 3 
Malonyl CoA 852 807.9 135 25 4 
Malonyl CoA 852 407.9 130 45 4 
Man6P 259 198.9 110 10 3 
Man6P 259 138.7 95 5 3 
Man6P 259 96.8 90 15 3 
Methylmalonyl CoA 866 822 135 25 3 
Methylmalonyl CoA 866 407.9 115 40 3 
NAD
+
 662 540 120 15 4 
NAD
+
 662 407.9 120 35 4 
NADH 664 397 110 30 4 
NADH 664 346 110 35 4 
NADP
+
 742 620 110 15 3 
NADP
+
 742 408 110 35 3 
NADPH 744 408 100 35 4 
NADPH 744 397 100 35 4 
OMP 367 97 100 25 3 
OMP 367 79 95 25 3 
Oxaloacetic acid 131 86.6 110 5 4 
Oxaloacetic acid 131 43 110 5 4 
PEP 167 97 70 20 3 
PEP 167 79 70 10 3 
PEP 167 97 70 20 3 
PEP 167 79 70 10 3 
ppGpp 601.9 503.9 130 24 1 
ppGpp 601.9 423.9 130 24 3 
Propionyl CoA 822 425.9 125 35 4 
Propionyl CoA 822 407.9 120 40 4 
Pyruvate 87 44 70 10 3 
Pyruvate 87 43 70 5 3 
Ribu5P 229 79 70 30 3 
Ribu5P 229 97 60 15 3 
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Table S1. Continued. 
Compound Precursor Ion Product Ion 
Fragmentor 
Voltage  
Collision 
energy  
Cell Accelerator 
Voltage  
Succinic acid 117 72.9 80 10 3 
UDP 402.9 111 115 20 4 
UDP 402.9 79 115 40 3 
UDP-Glc  564.9 385 125 30 4 
UDP-Glc 564.9 323 120 30 3 
UMP 323 97 90 20 3 
UMP 323 79 100 40 3 
UTP 482.9 384.9 100 20 4 
UTP 482.9 159 95 30 3 
XMP 363 211.1 100 20 4 
XMP 363 151.2 125 30 4 
Xylu5P 229 79 30 3 3 
Xylu5P 229 97 5 3 3 
Xylu5P 229 138.8 5 3 3 
ZMP 337 125 130 25 4 
ZMP 337 97 125 15 4 
ZMP 337 78.9 115 35 4 
α-KG 145.1 57.3 80 10 5 
α-KG 145.1 101.2 80 5 1 
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Table S2. Optimized precursor and product ion, fragmentor voltage, collision energy and cell 
accelerator voltage for the SIL-IS used during this Ph.D. study  
SIL-IS Precursor Ion Product Ion 
Fragmentor 
Voltage  
Collision 
energy  
Cell Accelerator 
Voltage  
[
13
C]GTP 531.9 433.9 115 20 3 
[
13
C]GTP 531.9 159 135 35 3 
[
13
C]ATP 515.9 417.9 125 20 3 
[
13
C]ATP 515.9 278 125 30 3 
[
13
C
15
N]dGTP 521.1 262 100 35 3 
[
13
C
15
N]dGTP 521.1 159.1 110 35 3 
[
15
N]dATP 495 396.7 115 20 4 
[
15
N]dATP 495 158.7 115 30 3 
[
15
N]UTP 485.1 387 90 20 3 
[
15
N]UTP 485.1 158.9 100 30 4 
[
13
C
15
N]CTP 493.9 396 115 30 3 
[
13
C
15
N]CTP 493.9 159 115 30 3 
[
13
C
15
N]TTP  493 395 120 25 4 
[
13
C
15
N]TTP  493 159 120 30 3 
[
13
C
15
N]dCTP 477.9 379.9 125 20 4 
[
13
C
15
N]dCTP 477.9 158.9 125 25 3 
[
13
C
15
N]GMP 377.1 215.7 115 20 4 
[
13
C
15
N]GMP 377.1 79.1 115 25 4 
[
15
N]AMP 350.8 211.1 100 15 4 
[
15
N]AMP 350.8 79 90 35 3 
[
13
C
15
N]dGMP 361.1 200 100 20 4 
[
13
C
15
N]dGMP 361.1 79 115 20 3 
[
13
C
15
N]UMP 334.1 97 120 25 3 
[
13
C
15
N]UMP 334.1 79 120 35 3 
[
13
C
15
N]CMP 334 97 90 25 3 
[
13
C
15
N]CMP 334 78.9 90 35 3 
[
13
C
15
N]TMP  333 200 90 15 3 
[
13
C
15
N]TMP  333 131.8 90 25 3 
[
13
C
15
N]dCMP 318 200 90 15 4 
[
13
C
15
N]dCMP 318 78.8 115 30 4 
[
13
C2]Ac-CoA 810 462.8 135 35 3 
[13C2]Ac-CoA 810 407.9 130 45 4 
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Table S2. Continued 
[
13
C3]Mal  CoA 855 810.2 110 30 4 
[
13
C3]Mal  CoA 855 463 110 25 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
